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ABSTRACT 
 
Potential beneficial and/or adverse modulatory effects of polyphenol-enriched extracts of 
rooibos (Aspalathus linearis) and honeybush (Cyclopia spp.) on the antioxidant homeostasis in 
the liver were investigated. Phase II metabolism of aspalathin and mangiferin, the major 
polyphenols of rooibos and honeybush respectively, was assessed for potential glucuronidation 
and sulphation.  Glucuronidation resulted in a loss of antioxidant activity for aspalathin and 
mangiferin in post-column HPLC-DAD-DPPH• and HPLC-DAD-ABTS•+ assays and also a 
decreased activity of iron chelating properties of mangiferin in the FRAP assay.  Two 
independent studies for 28 and 90 days with polyphenol-enriched extracts (PEEs) of 
unfermented rooibos [Aspalathus linearis (PER)] and honeybush [Cyclopia. subternata 
(PECsub) and C. genistoides (PECgen)] in male Fischer rats were conducted to assess 
possible beneficial and/or adverse biological effects.  PECgen was only included in the 28 day 
study.  PEEs were characterised by in vitro antioxidant assays and HPLC analysis.  The 
importance of detailed chemical characterization of rooibos and honeybush when investigating 
biological effects in vivo is clear as distinctive biological effects and major differences in 
compositions were evident.  Biological parameters included were serum chemical parameters, 
activities of selected antioxidant enzymes, levels of glutathione and the modulation of 
expression of oxidative stress and antioxidant defense related genes in the liver.  Sub-chronic 
(90 days) exposure of rats to PER and PECsub both adversely affected iron absorption 
significantly (P<0.05) and significantly (P<0.05) and markedly lowered levels of reduced 
glutathione (GSH) in the liver.  The high levels of polyphenol intake were implicated and 
interaction with glutathione was postulated to occur via catechol o-quinone conjugations with 
GSH.  This was also implicated in the significantly (P<0.05) increased activity of glutathione 
reductase (GR) following 28 days.  These findings suggest that PEEs from rooibos and 
honeybush have the potential to alter the glutathione homeostasis, which could contribute to 
oxidative status in the liver.  PECsub resulted in alterations in the liver biliary system which was 
manifested as significantly (P<0.05) increased serum total bilirubin (Tbili) and alkaline 
phosphatase (ALP), depending on the age of the rats, level of total polyphenols and duration of 
exposure.  The expression of a number of oxidative stress and antioxidant defense related 
genes were differentially altered by the PEEs of rooibos and honeybush in rat liver and further 
indicated potential oxidative stress.  Modulatory effects of PEEs on expression of 84 of these 
genes in rat liver were assessed with a quantitative real-time reverse transcription polymerase 
chain reaction (RT-PCR) array and provided additional insights into the possible adverse and 
protective effects of rooibos and honeybush.  Further investigation on total polyphenol dose 
levels and time of exposure in the application of PEEs of rooibos and honeybush as dietary 
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supplements and functional foods is recommended and will also be of value in anticipated 
regulatory requirements for future substantiation of safety and efficacy.    
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UITTREKSEL 
 
Die moontlike voordelige en/of nadelige modulerende effekte van polifenol-verrykde ekstrakte 
van rooibos (Aspalathus linearis) en heuningbos (Cyclopia spp.) op die antioksidant 
homeostasis in die lewer is ondersoek.  Die fase II metaboliete van aspalatien en mangiferin, 
die hoof verbindings in rooibos en heuningbos onderskeidelik, is ondersoek t.o.v. 
glukuronidering en sulfonering.  Glukuronidasie het gelei tot n verlies in antioksidant aktiwiteit 
van aspalatien en mangiferin soos bepaal in post-kolom HPLC-DAD-DPPH• en HPLC-DAD-
ABTS•+ toetse, asook verminderde interaksie met yster van mangiferin in die FRAP toets.  Twee 
onafhanklike studies van 28 en 90 dae is onderneem met polifenol-verrykde ekstrakte (PVEs) 
van ongefermenteerde rooibos [Aspalathus linearis (PVR)] en heuningbos [Cyclopia. subternata 
(PVCsub) and C. genistoides (PVCgen)] in manlike Fisher rotte om die moontlike voordelige 
en/of nadelige biologiese effekte te ondersoek.  PECgen was slegs in die 28 dae studie 
ingesluit.  PVEs is gekarrakteriseer deur in vitro antioksidant en HPLC analises.  Die belang van 
chemiese karaktirisering van rooibos en heuningbos tydens ondersoeke na biologiese aktiwiteit 
is duidelik aangesien verskeie en variërende biologiese aktiwiteite en verskille in die komposisie 
in die huidige studie gesien is.  Die biologiese parameters wat ondersoek is om die effek van die 
PVEs te bepaal het serum kliniese parameters, aktiwiteit van geselekteerde ensieme, glutatioon 
en evaluering van die ekspressie van oksidatiewe en antioksidant verwante gene in die lewer, 
ingesluit.  Sub-kroniese (90 dae) blootstelling van rotte aan PVR en PVCgen het yster absorpsie 
negatief beïnvloed.  Die beduidende (P<0.05) verlaagde vlak van gereduseerde glutatioon in die 
lewer was toegeskryf aan die hoë vlakke van polifenole ingeneem tydens die studie en word 
moontlik veroorsaak deur n spesifieke katekol o-konjugasie van GSH.  Hierdie interaksie was 
ook moontlik die oorsaak van n beduidende (P<0.05) toename in die aktiwiteit van glutatioon 
reduktase.  Dié bevindinge het moontlike implikasies t.o.v die glutatioon homeostase en is n 
moontlike indikase dat PVEs van rooibos kan bydra tot oksidatiewe stres.  PVCsub het 
veranderinge in die lewer gal-sisteem tot gevolg gehad aangesien daar n beduidende (P<0.05) 
verhoging in die serum totale bilirubin en alkalien fosfaat was.  Hierdie veranderinge is 
beïnvloed deur die ouderdom, vlakke van die totale polifenole en die periode van blootstelling.  
Die uitdrukking van oksidatiewe en antioksidant verwante gene is op verskillende maniere 
beïnvloed deur die PVEs van rooibos en heuningbos in rot lewer and dien as n verdere 
indikasie van onderliggende oksidatiewe stres.  Die modulerende effekte van PVEs op 
geenuitdrukking het gelei tot additionele insig aangaande die moontlike skadelike of 
beskermende eienskappe van PVEs vir gebruik as kruie produkte of dieet aanvullings.  Die 
indikasies van moontlike oksidatiewe stres was duidelik van biologiese parameters en 
modulering van geenuitdrukking in die lewer, en vereis verdere ondersoek na die polifenool 
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dosis en periode van toediening voordat PVEs van rooibos en heuningbos as funksionele 
voedsel produkte gebruik word.  Hierdie ondersoek sowel as toekomstige ondersoeke in hierdie 
verband sal van waarde wees vir regulatoriese vereistes omtrent die veiligheid en effektiwiteit 
van rooibos en heuningbos kruie produkte.  
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8=luteolin, 9=unknown hydroxycinnamic acid derivative, 10=scolymoside.    
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Figure 8.3 Typical HPLC chromatogram of the unfermented polyphenol-enriched C. 
genistoides (PECgen) extract used in the 28 day feeding studies with rats.  
Polyphenolic compounds quantified and indicated on the chromatograms were:  
1=iriflophenone-3-C-glucoside, 2=unknown eriodictyol-glucoside, 3=phloretin-3',5'-
di-C-glucoside, 4=hesperidin, 5=naringenin, 6=mangiferin, 7=isomangife, 
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223 
 
ADDENDUM E 
   
Figure 9.1 RNA integrity numbers (RINs) of RNA extracted from rat liver tissue as assessed 
with an Agilent 2100 Bioanalyzer.   Sample 1 – 3 (Control), Sample  
4 – 6, (PER), Sample 7 – 9 (PECgen) and Sample 10 – 12 (PECsub).   
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Figure 9.2 Quality parameters for isolated RNA as determined with a Bioanalyser RNA 
nanolabchip. Sample 1–3 (CTRL), Sample 4–6, (PER), Sample 7–9 (PECgen) and 
Sample 10–12 (PECsub).   
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 1  
GENERAL INTRODUCTION 
 
Herbal treatments have never been trendier and the use of complementary and alternative 
medicines (CAM) is typical in the United Kingdom, European Union (EU), United States of 
America (USA) and Australia (Raynor et al., 2011).  In the EU tightened regulations (European 
Commission, 2004) for some herbal products came into effect in April 2011 and include 
requirements to provide safety information.  However, herbal products not classified as medicinal 
will escape these regulations.  In South Africa CAMs are not incorporated into the Medicines Act 
(Act No. 59 of 2002) or regulated under the current labeling regulations (R.146/2010) in the 
Foodstuffs, Cosmetics and Disinfectants Act (Act No. 54 of 1972), resulting in no requirements 
with regards to proving the quality, safety or therapeutic efficacy of these products.  The 
Department of Health in South Africa has stated that the numerous unregistered products in this 
category currently pose a serious public health risk.  In the ongoing debate and controversies in 
the classification, control and regulation of herbal products, the objective of global regulations is, 
however, clear and aims to protect the consumers from adverse health effects and being 
mislead.  Studies on the efficacy and safety are therefore central to future research strategies 
regarding the use of herbal products, specifically herbal products aimed at being used in 
functional foods, nutraceuticals or other therapeutic applications.    
The beneficial health effects associated with consumption of herbal products are generally 
attributed to the phytochemicals, polyphenols (Liu et al., 2008) that have been referred to as 
“magic bullets” (Duthie et al., 2003).  Consequently, research on the health properties of 
polyphenols has increased tremendously with an explosion of studies aiming to confirm their 
health benefits (Boudet, 2007).  The unique South African herbal teas, rooibos (Aspalathus 
linearis) and honeybush (Cyclopia spp.), are implicated as dietary sources of polyphenol 
antioxidants (Joubert et al., 2009; Joubert & De Beer, 2011; Joubert et al., 2011).  Research 
investigating the health properties of these herbal teas have mostly focused on rooibos (Joubert 
et al., 2008), with major recent advances including clinical studies on the bioavailability of the 
major polyphenols (Courts & Williamson, 2009; Stalmach et al., 2009; Villaño et al., 2010; Breiter 
et al., 2011) and the protective effects against cardiovascular disease (CVD) (Marnewick et al., 
2011).  Health properties of rooibos researched in animal models, comprise the protective effects 
on testicular tissue of oxidative stress induced rats (Awoniyi et al., 2011), anti-hyperlipidaemic 
activity in hyperlipidamic male LDLr-/- mice (Beltrán-Debón et al., 2011), hypoglycaemic activity 
in animals (Joubert et al., 2010) and anticancer properties utilising different cancer models in rats 
and mice (Marnewick et al., 2005; Marnewick et al., 2009; Sissing et al., 2011).  Recent studies 
regarding the health properties of honeybush (Cyclopia spp.) include investigations on 
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antidiabetic properties (Muller et al., 2011), potential as a phytoestrogen for the nutraceutical 
market (Mfenyana et al., 2008), antioxidant and anticancer activities (van der Merwe et al., 2006; 
Joubert et al., 2008) and bioavailability studies in pigs (Bock et al., 2008; Bock et al., 2010).  In 
vitro and in vivo studies on the health promoting properties of rooibos and honeybush (Cyclopia 
spp.) have been extensively reviewed recently (Joubert et al., 2008; Joubert et al., 2009; Joubert 
et al., 2011).  Patent protection with regards to the anti-diabetic potential has been obtained for 
extracts produced from rooibos (Mose Larsen et al., 2008a) and the patent for honeybush is in 
the application stage (Cyclopia spp.) (Mose Larsen et al., 2008b).     
Aspalathin and nothofagin, two C-linked dihydrochalcone glucosides, are the major 
flavonoid constituents of unfermented rooibos (Koeppen & Roux, 1966; Joubert & Schulz, 2006) 
and aspalathin is one of  the main components of fermented rooibos tea (Rabe et al., 1994; 
Joubert, 1996).  Other major phenolic compounds in rooibos include flavones, isoorientin, 
orientin and flavonols, quercetin-glucosides (Koeppen et al., 1962, Marais et al., 1996; Rabe et 
al., 1994; Shimamura et al., 2006; Joubert & De Beer, 2012).  As aspalathin is novel to rooibos 
it has been utilised as a potential quality control marker of rooibos herbal products (Joubert et 
al., 2008, Joubert & De Beer, 2012).  Detailed studies with regards to the biological properties, 
including in vitro antioxidant (Joubert et al., 2008; Snijman, 2009) and antimutagenic activity 
(van der Merwe et al., 2006) of this compound have been conducted.  The xanthone mangiferin 
is the major antioxidant of Cyclopia species (De Beer & Joubert, 2010) and has been implicated 
in the chemopreventive properties of Cyclopia intermedia (Marnewick et al., 2005; Marnewick et 
al., 2009; Sissing et al., 2011).  Another xanthone, isomangiferin, and the flavanone hesperidin 
are other major phenolic compounds present in Cyclopia spp. (De Beer & Joubert, 2010).         
 Key determinants of the potential health effects of polyphenols relate to their metabolism 
and bioavailibity resulting in the formation of conjugated metabolites aimed at facilitating their 
excretion. Knowledge regarding the circulating conjugated metabolites has been obtained from 
bioavailability studies with phenolic compounds (Manach et al., 2005; Williamson & Manach, 
2005; Crozier et al., 2009; Crozier et al., 2010).  However, limited investigations have been 
conducted on their antioxidant and other biologically relevant properties (Manach et al., 1998; 
Harada et al., 1999; Lu et al., 2003; Villaño et al., 2010; Lotito et al., 2011).  Glucuronides of (+)-
catechin and (-)-epicatechin displayed similar activity in scavenging superoxide generated by 
xanthine oxidase (Harada et al., 1999) and also retained some anti-inflammatory activity 
following biotransformation of quercetin and epigallocatechin gallate (Lotito et al., 2011).   
Safety concerns about herbal foodstuffs in conjunction with reports on pro-oxidant activity of 
popular products such as green tea (unfermented Camellia sinensis) (Lambert et al., 2010) and 
green tea derived products (Isbrucker et al., 2006) have led to scientific assessment of the 
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safety of some traditional herbal products.  At high dose levels polyphenols have the potential to 
act as mutagens, pro-oxidants that generate free radicals, and may also alter the activity of key 
metabolizing enzymes.  Excessive exposure to polyphenols may overwhelm the antioxidant 
defense mechanisms in the cell, resulting in the over-production of reactive oxygen 
intermediates (Skibola & Smith, 2000).  Therefore, the beneficial antioxidant properties can be 
outweighed by adverse effects, which is a concern with regards to the unregulated use of 
commercially available polyphenol-enriched foods or supplements/nutraceuticals.  Due to the 
potential use of rooibos and honeybush as value-added products, food supplements and/or 
pharmaceutical/nutraceutical products, it is essential to assess possible adverse biological 
effects. 
Metabolism, bioavailability and current challenges in research on health properties of 
polyphenols is critically reviewed in Chapter 2 and were considered in the study design and 
experimental approach in the present dissertation.   The effect of biotransformation, specifically 
glucuronidation on antioxidant activity of aspalathin, the major monomeric phenolic compound 
present in rooibos (Chapter 3, van der Merwe et al., 2010) and mangiferin, the major monomeric 
phenolic compound present in honeybush (Chapter 4, van der Merwe et al., 2012) were 
assessed and evaluated.  These studies were aimed at gaining knowledge on the main 
metabolic pathways involved and the effect thereof on the antioxidant activity of the major 
phenolic compounds to elucidate their potential role in altering cellular oxidative status in vivo.    
Short-term and sub-chronic feeding studies were conducted in male Fisher rats (Chapter 5) 
and serves as a first step toward safety evaluation of value added products of rooibos and 
honeybush.  In addition, the study intended to establish whether the well-characterized 
polyphenol-enriched rooibos and honeybush extracts adversely affect the liver of rats as a 
function of the polyphenol dose and the duration of exposure.  Quantitative real-time reverse 
transcriptase polymerase chain reaction (RT-qPCR) technology was applied to assess effects of 
the administrated dose on oxidative stress and antioxidant defense related gene expression in 
rat liver after consumption of polyphenol-enriched rooibos and honeybush for a short term 
period of 28 days (Chapter 6).  This information on the modulation of gene expression was used 
to provide new insights into the observations with conventional biomarkers, i.e. serum 
parameters, antioxidant enzymes and glutathione in rat liver.   
The key findings of the present study were placed in context (Chapter 7) by comparing the 
dose and human equivalent dose (HED) in the current study with doses, HEDs and biological 
effects of previous studies with rooibos and honeybush.  Associations and contradictions 
apparent from comparison of the oxidative stress parameters and the gene expression were 
discussed.  Implication of the modulatory effects of PEEs from rooibos and honeybush on gene 
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expression was postulated for disease conditions including cancer, cardiovascular disease and 
cancer.   
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INTRODUCTION 
 
There has been a significant increase in the use of botanical supplements (Dietz & Bolton, 
2011) and despite advances in conventional medicine, interest in phytomedicine and herbal 
remedies for professionals and the lay public is soaring (Stickel & Schuppan, 2007).  The 
majority of commercially available herbal supplements are not being rigorously tested for safety 
and efficacy, yet the perception that “natural” products equal “safe” products is increasing their 
market share (Molinari et al., 2006).  Herbal medicines can be defined as a category of products 
derived from plants and plant material and used for therapeutic purposes (Calapai, 2008).  
Beneficial effects of herbal medicine are generally contributed to the phenolic compounds 
contained in these preparations and their associated antioxidant activity (Liu et al., 2008).  
However, research suggests that bioactivities of these compounds are also manifested through 
modulation of several cellular signaling pathways involved in cell apoptosis, proliferation, 
survival and inflammatory responses (Zhang et al., 2007).  A number of human intervention 
studies indicated that polyphenols are at least partly absorbed with resultant biological effects 
(Kroon et al., 2004; Manach et al., 2005; Williamson & Manach, 2005).  Recent reports on 
metabolites resulting from polyphenol ingestion recommend that emphasis should shift towards 
research on the activity of these metabolites for better predicting the outcome of dietary 
polyphenol consumption in health (Walle, 2004; Spencer et al., 2004; Crozier et al., 2009; Rio et 
al., 2010; Kay, 2010).   
This review provides a brief summary of the mechanisms involved in metabolism and 
bioavailability of dietary polyphenols.  This is followed by a discussion on some of the current 
challenges in investigating the health and adverse effects of these compounds, including 
assessing bioavailability, different biomarkers used to study biological effects, experimental 
concentrations applied, dose translation and the effect of metabolism on the biological activity. 
The potential adverse effects of dietary polyphenols are discussed in terms of pro-oxidant 
activity, mutagenicity/carcinogenicity and the modulating effect of polyphenols on enzymes 
leading to potential herb-drug interactions. Global trends in polyphenol marketing and relevant 
regulations are highlighted and this forms the basis for a discussion on the background, current 
marketing trends, chemical composition, bioavailability and the safety and potential adverse 
effects of the South African herbal teas, rooibos and honeybush.   
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DIETARY POLYPHENOLS: METABOLISM, BIOAVAILABILITY AND CURRENT 
CHALLENGES IN ASSESSING HEALTH AND POTENTIAL ADVERSE EFFECTS 
 
Phytochemicals are secondary metabolites in plants (Duthie et al., 2003) and are viewed as 
essential for health and well-being in adulthood and in the elderly population (Holst & 
Williamson, 2008). However, it is generally regarded as non-essential dietary components for 
short-term well-being in the human body (Crozier et al., 2009).  The cell treats these compounds 
as non-nutrient xenobiotics and consequently their metabolism is aimed at efficient elimination 
(Holst & Williamson, 2008).  Phytochemicals, which include flavonoids, phenolic and 
polyphenolic compounds are currently a major focus of functional food development.    
Polyphenols are the most abundant antioxidants in the diet with their total dietary intake 
estimated as high as 1 g per day, being much higher than for other classes of phytochemicals 
and known dietary antioxidants (Scalbert et al., 2005a).  Major dietary sources of polyphenols 
include fruits, vegetables and plant-derived beverages such as fruit juices, tea, coffee and red 
wine (Manach et al., 2004; Scalbert et al., 2005a).  Research on polyphenols in disease 
prevention has only become prominent in the last 20 years due to their ambiguous nature in the 
diet together with diversity and complex chemical structures (Scalbert et al., 2005a).  Limitations 
on the insight from epidemiological studies with phytochemicals and specifically dietary 
polyphenols include incomplete knowledge on the phenolic content of the dietary sources, lack 
of information relating to changes in content and character with processing, seasonable 
variation and the physiological consequences of bioavailability and metabolism (Crozier et al., 
2009).   
In spite of many challenges in this research field, considerable evidence support a role of 
polyphenols from various dietary sources in the prevention of different diseases and has been 
extensively reviewed (Hollman & Katan, 1997; Hollman & Katan, 1999;  Middleton et al., 2000; 
Havsteen, 2002; Tapiero et al., 2002; Higdon & Frei, 2003; Karakaya, 2004; Manach et al., 
2004; Scalbert et al., 2005b; Khan & Mukhtar, 2007; Crozier et al., 2009; Prasain et al., 2010; 
Williamson & Carughi, 2010; Rodrigo et al., 2011, Wang et al., 2011, Quideau et al., 2011).  
There are numerous reports on their preventive or potential protection in cardiovascular 
diseases (Hertog et al., 1993; Hollman et al., 1999; Weinreb et al., 2004; Holt et al., 2009; 
Hodgson & Croft, 2010) and cancer (Mukhtar & Ahmad, 2000; Yang & Landau, 2000; Yang et 
al., 2001; Galati & O’Brien, 2004; Thomasset et al., 2006; Yang et al., 2007).  Polyphenols have 
also been investigated to play a role in prevention of osteoporosis (Hagiwara et al., 2011), 
neurodegenerative diseases (Mandel & Youdim, 2004; Singh et al. 2008; Chen et al., 2009), 
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diabetes mellitus (Scalbert et al., 2005b; Ong et al., 2011) and show potential as 
phytoestrogens (Duncan et al., 2003).   
In light thereof this review will not repeat a summary of the health benefits of polyhenols, but 
will rather focus on the current issues in research on the health properties of polyphenols and 
the impact and concerns of exposure to herbal products.  Shortfalls in this area includes 
controversy over the methods used to assess bioavailability, the experimental concentrations 
used in mechanistic studies, dose translation from animal to human studies and consideration of 
the effect of metabolism on bioavailability.  Different approaches have been developed, but 
many of the excisting measurements are flawed in not being a constant and accurate indication 
of what is aimed at being determined.  A brief overview of metabolism and bioavailability 
follows, as an understanding thereof is pivotal to researching health and potential adverse 
effects of dietary polyphenols.           
 
A brief overview of mechanisms involved in metabolism and bioavailability of dietary 
polyphenols 
Bioavailability of polyphenols is a concept that incorporates their bioaccessiblity, absorption, 
metabolism, tissue distribution and bioactivity (Stahl et al., 2002).  Bioaccessiblity refers to the 
amount of an ingested compound that becomes available for absorption in the gastrointestinal 
tract (Stahl et al., 2002; Scholz & Williamson, 2007) and is also referred to as ‘liberation’ (Holst 
& Williamson, 2008).  The term bioavailability is aimed at describing the concentration of a given 
compound or its metabolite at the target organ, but it has become a challenge to find a definition 
incorporating the intricate nature of the term.  Other variables integrated in this concept includes 
intestinal absorption, excretion of conjugates toward the intestinal lumen, metabolism by the 
microflora, intestinal and hepatic metabolism, plasma kinetics, the nature of circulating 
metabolites, binding to albumin, cellular uptake, intracellular metabolism, accumulation in 
tissues and biliary and urinary excretion (Manach et al., 2004).     
The pharmacological definition of bioavailability is often presented under the acronym 
LADME which refers to the following integrated processes: liberation, absorption, distribution, 
metabolism and excretion (Holst & Williamson, 2008).  These terms are defined below and 
indicated in the diagrammatic presentation of the potential routes of dietary polyphenols in the 
human body after consumption (Fig 1).  
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L  = Liberation: processes involved in the release of a compound from its matrix. 
A  = Absorption: the diffusion or transport of a compound from the site of administration into 
the systemic circulation. 
D  = Distribution:  the diffusion or transportation of a compound from the intravascular 
(systemic circulation) to the extra-vascular space (body tissues). 
M  = Metabolism, the biochemical conversion or biotransformation of a compound. 
E  = Excretion, the elimination of a compound, or its metabolite, from the body via renal-, 
biliary- or pulmonary processes. 
 
Exogenous factors affecting bioavailability of a compound are the complexity and composition of 
the food matrix, the dose and the chemical form of the compound as well as competition and 
interaction with co-ingested compounds (Scholz & Williamson, 2007).  Endogenous factors 
include the mucosal mass, intestinal transit time, rate of gastric emptying, metabolism and 
extent of conjugation, and protein-binding in blood and tissues (Holst & Williamson, 2008).  
These factors result in large inter- and intra-individual variations in bioavailability.   
The absorption of flavonoids from the diet was initially considered to be negligible, based on 
the fact that most flavonoids occurring in food as glycosides and the theory that only aglycones 
could be absorbed into the blood stream via the intestines (Ross & Kasum, 2002).  The 
metabolism and absorption of flavonoid glycosides has been a controversial issue (Walle, 
2004).  For instance, glycosides have been considered too hydrophilic for absorption by passive 
diffusion in the small intestine (Hollman, 2004) implicating that polyphenol O-glycosides needs 
to be deglycosylated in the small intestine (Walgren et al., 1998; Zhang et al., 2007) by β-
glucosidases, the broad-specificity cytosolic β-glucosidase (CBG) and lactase phlorizin 
hydrolase (LPH) (Day et al., 2000a), prior to absorption (Kroon et al., 2004).  LPH, present in 
the brush-border of the mammalian small intestine, is capable of hydrolyzing various flavonol 
and isoflavone glucosides (Day et al., 2000a).  Following deglycosylation, the flavonoid 
aglycone passively diffuses across the intestinal epithelium as a result of the increase in 
structural lipophilicity (Walgren et al., 1998).  Another important factor in flavonoid glycosyl 
movement across the apical side of the intestinal epithelium is interaction of the intact glucose 
moiety with active transporter proteins (Day et al., 1998).  This occurs through sodium 
dependent glucose transporter 1 (SGLT1) transporting from the lumen to the enterocyte cytosol 
followed by CBG deglycosylation and multi drug resistance protein 2 (MRP2) facilitating efflux 
from the enterocyte cytosol to the intestinal lumen (Day et al., 1998; Walgren et al., 2000).   
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Figure 1  Diagram presenting the potential fate of dietary polyphenols in the human body 
according to the LADME principle (adapated from Stahl et al., 2002; Holst & Williamson, 2008).     
In solution 
gastric/intestinal fluids 
solid liquid 
  
Release/Formation in 
the colon 
colonic microorganisms 
not 
absorbed 
ABSORPTION 
Epithelium 
Portal Circulation 
Liver Bile Intestine 
excretion 
in faeces 
 
Enterohepatic circulation 
excretion 
Metabolism 
Body tissues 
Systemic circulation 
Distribution 
Kidney 
excretion 
in urine 
Site of action 
gut lumen 
inside the body 
Renal clearance 
E 
E 
effect 
Gene regulation 
 
Signal transduction 
 
Cell  death/Apoptosis 
 
L     
A     
D     
M   
A     
Stellenbosch University  http://scholar.sun.ac.za
 16  
On the other hand, the absorption of intact flavonoid glycosides in the small intestine has also 
been proposed based on indirect evidence (Hollman et al., 1995).  However, a number of 
studies support the view that quercetin glycosides are not absorbed intact in humans and are 
not able to reach the systemic circulation (Erlund et al., 2000; Moon et al., 2000; Walle et al., 
2004).         
C-glycosides are more resistant toward acid, alkaline and enzymatic treatment than 
corresponding O-glycosides (Harborne, 1965), resulting in aromatic C-glycosides gaining 
increasing interest as drug candidates due to their stability and biological activities (Braune & 
Blaut, 2011).  Deglycosylation is not necessarily a prerequisite for C-glycosyl flavonoid 
absorption, since intact unhydrolysed metabolites and parent compounds have been reported in 
the urine with bioavailability studies in animals and humans (Kreuz et al., 2008; Courts & 
Williamson, 2009).  It was hypothesized that this is consequent to passive transcellular 
movement of the intact molecule across the intestinal epithelium (Huang et al., 2008).  This 
movement is attributed to SGLT1 on the apical side of the enterocyte and implies basolateral 
active transporter specificity toward intact glycosylflavonoids (Courts & Williamson, 2009).  
Paracellular diffusion has also been implicated as a potential mechanism of absorption.   
Following absorption in the small intestine polyphenols are metabolized by phase I or phase 
II enzymes (Williamson et al., 2000).  Cytochrome P450 (CYP450) enzymes are phase I 
monooxygenases fundamental in metabolism of drugs and other foreign compounds (Moon et 
al., 2006) and therefore thought to mediate flavonoid metabolism (Walle, 2004).  CYP450-
mediated metabolism of different flavonoids has been demonstrated with mouse, rat and human 
liver microsomes as well as membranes isolated from Escherichia coli (Silva et al., 1997; 
Nielsen et al., 1998; Breinholt et al., 2002; Otake & Walle, 2002a.  The phase I metabolism of 
flavonoids has, however, never been shown to be important in vivo or in intact cells, where 
conjugative metabolism may be expected to compete with CYP450-mediated metabolism 
(Walle et al., 2004).  This was demonstrated in a study with galangin as substrate and a S9 
fraction to include oxidation, glucuronidation and sulphation (Otake et al., 2002b).  The 
efficiency of glucuronidation was relatively high followed by sulphation, with a very minor 
contribution by CYP-mediated oxidation.   
Metabolism by the phase II drug-metabolising enzymes includes uridine-5’diphosphate 
glucuronosyl-transferases (UGT), sulfotransferases (SULT) and catechol-O-methyltransferase 
(COMT), leading to mono- or multiple glucuronidated, sulphated and methylated conjugates 
(Kroon et al., 2004; Zhang et al., 2007).  Following the metabolism in the small intestine, the 
predominant metabolites in the hepatic portal vein include glucuronides and possibly methylated 
glucuronides (Kroon et al., 2004).  These conjugates may enter hepatocytes and be further 
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glucuronidated, sulphated and methylated (O’Leary et al., 2003) with the type of conjugation 
varying according to the nature of the substrate and the dose ingested (Manach et al., 2004). 
Glucuronidation is considered as one of the most important metabolic pathways in the liver 
and intestine (Zhang et al., 2007).  Glucuronidation is mediated by different UGTs and their 
contribution to the first-pass glucuronidation has been demonstrated in a number of human 
studies (Zhang et al., 2007).  UGTs are membrane-bound enzymes located in the endoplasmic 
reticulum in many tissues and responsible for catalyzing transfer of a glucuronic acid from UDP-
glucuronic acid to polyphenols and numerous dietary consitutents, but also steroids, bile acids 
and xenobiotics (Manach et al., 2004).  Most UGT isoforms are present in the liver of which the 
isoforms regarded as most important in drug glucuronidation include UGT1A1, 1A3, 1A4,  1A6, 
1A9, 2B7 and 2B15 (Miners et al., 2004).  Isoforms that have also been found in the intestine 
include UGT 1A1, 1A3, 1A4, 1A6, 2B15 and 2B4, while UGTA7, 1A8 and 1A10 has been found 
only expressed in the intestine but not in the liver.   
Catechol-O-methyl transferase is present in the liver, kidney and small intestine and 
generally functions to eliminate the potentially active or toxic catechol structures of endogenous 
and exogenous compounds (Manach et al., 2004).  Sulfotransferases occur mainly in the liver 
and catalyse the transfer of a sulphate moiety from 3'-phosphoadenosine-5'-phosphosulphate to 
a hydroxyl group on various substrates, including steroids, bile acids and polyphenols. 
Sulphation is generally a higher affinity, lower-capacity pathway than glucuronidation, resulting 
in a shift from sulphation toward glucuronidation when the ingested dose increases (Koster et 
al., 1981).  Inhibition of methylation in HepG2 cells also leads to a shift in metabolim of 
quercetin glucuronides toward sulphation (O’Leary et al., 2003).  Irrespective of the contribution 
of the individual pathways, the capacity for conjugation is regarded as high and the 
concentration of free aglycones in the plasma is usually very low after intake (Manach et al., 
2004).  Circulating polyphenols are mostly conjugated derivatives extensively bound to albumin.   
Polyphenols that are not absorbed in the small intestine progress to the colon (large 
intestine) and are considerably modified in terms of chemical structure by the microflora (Rio et 
al., 2010).  Human gut bacteria have been shown to cleave C-glucoside derivatives of flavones 
(Hattori et al., 1988) and xanthones (Hattori et al., 1989; Sanugul et al., 2005a; Sanugul et al., 
2005b).  Colonic-derived catabolites are absorbed into the bloodstream and can be circulated 
through the body before excretion in the urine (Crozier et al., 2010).  There is a growing interest 
in these catabolites due to their importantance in the bioavailability and biological activities of 
polyphenols (Rechner et al., 2002; Crozier et al., 2010).   
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Assessment of bioavailability of dietary polyphenols 
The methods used to assess bioavailability of dietary polyphenols discussed include: total 
antioxidant capacity (TAC) in blood plasma, pharmacokinetic studies and concentration in the 
plasma and urine, biomarkers of exposure and effect as well as determination of tissue 
distribution.    
 
(i) Total antioxidant capacity (TAC) in blood plasma 
An increase in the antioxidant capacity of plasma following consumption of polyphenol-rich 
foods has been proposed to serve as indirect evidence of their absorption through the gut 
barrier (Scalbert & Williamson, 2000; Tapiero et al., 2002).  Increased antioxidant capacity has 
for instance been reported in human studies after consumption of green tea (Camellia sinensis) 
(Camargo et al., 2006; Khan & Mukhtar, 2007), the herbal tea rooibos (Aspalathus linearis) 
(Villaño et al., 2010), red wine (Fernández-Mar, 2012) and different types of fruit and vegetables 
(Wang et al., 2011).  However, when considering the extensive metabolism of dietary 
polyphenols, an observed increase of the total antioxidant capacity in plasma following the 
consumption of polyphenold-rich foods is often challenged as an effective means of 
measurement (Spencer et al., 2008).  
Determination of the total antioxidant capacity (TAC) is a non-compositional assay that does 
not examine the composition in terms of analytes and provides information in the form of 
integrated parameters (Sies, 2010).  This differs from customary practice in clinical research on 
medicine where measurements include individual chemical entities.  Foods contain many macro 
and micronutrients in addition to polyphenols that may directly or through their metabolism affect 
the TAC of plasma and it was recommended that direct assays of urate, ascorbate and 
tocophorol should be included in determination of the TAC in human plasma to gain more 
insight (Sies, 2007). Increased TAC in the plasma of humans following consumption of 
flavonoid-rich foods was attributed to increased uric acid levels (Lotito & Frei, 2006).  The latest 
guidance by the European Food Safety Authority (EFSA), stipulates that an overall antioxidant 
capacity of plasma is not established to exert a beneficial physiological effect in humans as 
required by the current European Regulations (EC) No 1924/2006 (EFSA, 2011).    
 
(ii) Pharmacokinetic studies and concentration in plasma and urine 
A more direct measurement and evidence of bioavailability is obtained by assessing the plasma 
and urine concentration of phenolic compounds following consumption or administration of 
individual phenolics or foodstuffs of which the phenolic content has been characterised 
(Scalbert & Williamson, 2000; Tapiero et al., 2002).  The metabolism of a number of 
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polyphenols and flavonoids has been established and the metabolites characterized (Kroon et 
al., 2004).   
Manach et al. (2005) reviewed 97 bioavailability studies that investigated the kinetics and 
extent of polyphenol absorption in adults for 18 major polyphenols after ingestion of a single 
dose of polyphenol as pure compounds, as part of a plant extract or whole food/beverage.  The 
findings indicate that bioavailability varies widely among polyphenols.  The total concentration of 
metabolites in the plasma ranged from 0 to 4 μmol/L following intake of 50 mg aglycone 
equivalents.  Isoflavones and gallic acid, followed by catechins, flavanones and quercetin 
glucosides are relatively well absorbed in humans, while proanthocyanidins and anthocyanins 
are poorly absorped.  Plasma kinetics differed among the polyphenol classes, with the 
maximum plasma concentration (Cmax) reached after 1.5 h and 5.5 h for others, with the site 
of intestinal absorption playing a pivotal role (Manach et al., 2005). 
Bioavailability studies in humans have demonstrated great variability in the quantities of 
polyphenols found intact in urine (Scalbert & Williamson, 2000).  A more recent review (Crozier 
et al., 2010) summarises the identification of metabolites, catabolites and parent compounds in 
plasma, urine and ileal fluid determined with mass spectrometry after consumption of dietary 
flavonoids.  Glucuronide, sulphate and methylated metabolites are the predominant form of 
compounds in circulation after absorption in the small intestine, and are quickly removed from 
the bloodstream. Therefore, plasma analysis is an effective measure of identity and 
pharmacokinetic profiles of circulating metabolites, but is not necessarily an accurate 
quantitative determination of uptake from the gastrointestinal tract.  Although analysis of the 
urine provides a more realistic indication, it does not incorporate the possibility of metabolites 
absorbed into tissue and therefore also poses an underestimate of absorption.   
Limited information is available on the accuracy of the measurements of polyphenols in 
plasma and urine.  Hydrolysis with -glucuronidase and sulphatase or a mixture containing both 
enzymes are often used as a step in sample-preparation for quantification of polyphenols in 
physiological fluids (bile, plasma, serum or urine) (Prasain et al., 2004).  This method of sample 
preparation may aid in identification of compounds, but may introduce a varying, unmeasured 
error factor due to variation in the efficacy of the enzymes used (Crozier et al., 2010).  Enzyme 
hydrolysis, for instance, results in the underestimation of isoflavone metabolites (Gu et al., 
2005).      
A study reviewing the urinary metabolites as biomarkers of polyphenol intake in humans, 
included 162 controlled intervention studies and the mean recovery yield and correlations with 
dose ingested for 40 polyphenols (Pérez-Jiménez et al., 2010).  Polyphenols with a high 
recovery yield (1237%) and a high correlation with the dose included daidzein, genistein, 
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glycitein, enterolactone and hydroxytyrosol, showing good sensitivity as biomarkers of intake 
throughout the different studies.  Hesperidin, naringenin, (-)-epicatechin, (-)-epigallocatechin, 
quercetin and three microbial metabolites of isoflavones (dihydrodiadzein, equol and O-
desmethylangolensin) displayed weaker correlations with dose and are therefore currently less 
suitable as biomarkers of intake.      
 
(iii) Tissue uptake and distribution 
Data on the bioavailability of polyphenol metabolites in tissues is very scarce, but is regarded to 
be more important than data on plasma concentrations (Manach et al., 2004).  The presence of 
polyphenols in a wide range of tissues of rats and mice including the brain (Datla et al., 2001; 
Abd El Mohsen et al., 2002), endothelial cells (Youdim et al., 2000), heart, kidney, spleen, 
pancreas, prostate, uterus, ovary, mammary gland, testes, bladder, bone and skin (Suganuma 
et al., 1998; Chang et al., 2000; Kim et al., 2000; Coldham & Sauer, 2000), have been 
confirmed.  Concentrations range from 30 to 3000 ng aglycone equivalents/g tissue depending 
on the dose and tissue.  It is estimated that the time of sampling will have a great influence on 
the concentration, due to the kinetics of penetration and elimination of polyphenols from the 
tissue (Manach et al., 2004).         
 
Biomarkers for investigating health and potential adverse effects of dietary polyphenols 
(i) Biomarkers of exposure and effect following dietary consumption of polyphenols 
Biomarkers have been defined as: “Observable properties of an organism that indicate variation 
in cellular or biochemical components, structure or function and that can be measured in 
biological systems or samples” (Bearer, 1998).  More recently, it has also been defined as: 
“Biometric measurements that provide information about the biological condition of the subject 
being tested” (Amacher et al., 2010).  Irrespective of the exact definition, a valid biomarker is 
expected to link the specific exposure of a dietary compound to a health outcome and is also an 
early signal of biological effects (Holst & Williamson, 2008).  The diagram in Fig. 2 presents a 
prospective overview of biomarkers and a description of the pathway from exposure to 
health/disease outcome.  Biomarkers for disease prevention and intervention may be measured 
anywhere along this pathway.  Earlier markers of disease are often regarded as more useful, 
since it can be used to prevent disease, but are associated with less certainty than later 
markers, which are more closely related to disease but offer fewer chances for dietary 
intervention.  A major challenge in applying biomarkers to nutrition research is a lack of 
understanding bioavailability and mode of action of bioactive food components (Holst & 
Williamson, 2008).  Polyphenols have been shown to improve the status of different oxidative 
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stress biomarkers (Williamson & Manach, 2005), but the relevance of the biomarkers used as 
predictors of disease risk and the suitability of the different methods applied are not always 
definite (Collins, 2005).  Epidemiologic studies have clearly indicated the protective effects of 
polyphenol consumption against cardiovascular risk (Arts & Hollman, 2005).   The evidence with 
regards to cancer and neurodegenerative diseases are less clear, but mostly based on animal 
and in vitro studies (Lambert et al., 2005).  When considering scientific substantiation of health 
claims and evidence-based nutrition, research in nutrition is entering a new stage where more 
diverse methodologies are required (Biesalski et al., 2011).   
 
(ii) Biomarkers of toxicity and oxidative stress 
Requirements with regards to safety and toxicity testing of nutraceuticals and products 
advertised to contain phytochemicals are currently not clear and therefore strict application of 
toxicology measures used for drug development may not be applicable.  However, the 
methodologies, guidelines and biomarkers used in drug development may offer good guidelines 
for toxicity assessment of value-added herbal products.     
When considering the preclinical biomarkers for liver toxicity, several approaches may be 
used and include measuring the depletion of antioxidant reserves, changes in activities of 
antioxidant enzymes, free radical production and the presence of free radical adducts to protein, 
lipids and DNA (Amacher et al., 2010).  End products of free radical attack are regarded as 
reliable determination of the occurrence of oxidative stress, while enzyme activities and cellular 
oxidants may display transient changes.  Evaluation of serum biochemical parameters to assess 
liver damage is conventionally used in basic toxicology research and in preclinical toxicity 
testing (Ramaiah, 2007).       
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a) Serum biochemical parameters (clinical pathology) used as indicators of toxicology 
Liver related biochemical parameters commonly employed in toxicity testing using animal 
models such as rats, dogs and non-human primates can be classified as indicated in Table 1, 
as (i) hepatocyte membrane leakage enzymes (ii) cholestatic-induction parameters and those 
related to (iii) liver function deficits (Ramaiah, 2007).   
The majority of the biochemical parameters classified as “leakage” enzymes are cytotosolic 
and leak out of the cytoplasm by reversible (membrane blebs) or irreversible (mitochondrial 
membrane damage) hepatic injury (Gores et al., 1990; Van Hoof et al., 1997).  Injury or 
metabolic disturbances results in a release of soluble cytosolic enzymes and causes elevation 
in the blood.  The activity of one of these enzymes, alanine aminotransferase (ALT), is often 
regarded as the clinical chemistry gold standard for detection of liver injury (Ozer et al., 2008).  
Cholestatic-induction enzymes are increased in the blood by impaired bile flow (cholestasis), 
drug treatment or endogenous corticosteroid excess (Sanecki et al., 1987), but the mechanisms 
are not clearly known (Ramaiah, 2007).  Cholestasis also results in increased serum bilirubin 
levels.             
 
 
 
a Classification is indicated with an “x” 
Table 1 Commonly employed hepatic biochemical parameters used to detect liver toxicity in 
animal models (rats, dogs and primates) and their classification (Ramaiah, 2007).  
Biochemical tests Hepatic ‘‘leakage’’ enzymes Cholestatic-
induction tests 
Hepatic function 
tests 
 Cytosol Mitochondria   
Alanine aminotransferase (ALT) X    
Aspartate aminotransferase (AST) X X   
Sorbital dehydrogenase (SDH)  X    
Glutamate dehydrogenase (GLDH)  X X   
Lactate dehydrogenase (LDH) X    
Alkaline phosphatase (ALP)   X  
Gamma glutamyltransferase (GGT)   X  
51-Nucleotidase (51-NT)   X  
Total Bilirubin   X X 
Total Bile acids   X X 
Amonia    X 
Albumin    X 
Coagulation times (APTT and PT 
times) 
   X 
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In spite of newer methods such as genomics and proteomics offering “novel” predictive markers 
to detect liver pathology before alterations in clinical and histopahylogy parameters occur, it is 
argued that serum biochemical parameters (clinical pathology) can provide very valuable 
information in assessing the extent, severity and type (membrane injury versus cholestasis and 
hepatic function) of liver damage (Ramaiah, 2007).   
 
b) Liver enzymes used as indication of oxidative stress 
Enzymes responsible for detoxifying free radicals are measured by in vitro activity assays and 
frequently used as an indication of the level of stress experienced in a cell or tissue (Amacher et 
al., 2010).  Measuring oxidative stress is complicated by endogenous systems correcting and 
repairing by reducing stress and consequently limits the ability of testing methods to detect a 
change (Blumberg, 2004).  These systems are induced by elevated oxidative stress and include 
antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione 
peroxidise (GPx).  Investigation of antioxidant depletion as a biomarker of oxidative stress could 
involve assessment of decreases in antioxidant enzyme concentrations.  It should therefore be 
noted that these changes may not be a true reflection of oxidative status or of clinical 
significance, since it may simply be an indication that the antioxidant defense system is 
functioning.         
Conventional hepatic safety biomarkers are regarded as confimation of organ toxicity after 
pathological damage has occurred (Amacher et al., 2010).  These biomarkers are regarded as 
suitable for in vivo preclinical regulatory studies, but not ideal for short-term predictive screening 
assays of new chemical entities, especially if limited quantities are available.  Development of 
reliable and early predictive toxicity biomarkers has therefore become an important and novel 
focus of regulatory agencies and pharmaceutical industries.  The potential of such biomarkers 
are currently being researched in recently advances technologies of toxicoproteomics and 
targeted, quantitative mass spectrometry.   
 
c) System biology tools for prediction of efficacy and safety of herbal product 
With regards to herbal medicine, system biology tools such as functional genomics, 
transcriptomics, proteomics, metabolomics, pharmacogenomics and toxicogenomics are 
predicted to become a new translational platform between western medicine and traditional 
Chinese herbal medicine (TCM) (Lo et al., 2011).  DNA microarray analysis has been applied in 
studies with Chinese herbal medicine since 1998, with the main focus on elucidating the 
mechanisms involved in biological effects of herbs.  A bioactivity database with large-scale gene 
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expression profiles of quality control herbs has been applied for prediction of therapeutic 
potential, safety and drug development (Lo et al., 2011).  Furthermore, comparison of gene 
expression signatures indicated alterations in the expression levels of cytochrome P450, 
glutathione S-transferase and UDPglycosyltransferase genes, implicating potential herb-drug 
interactions.  Gene expression profiling in chemoprevention and cancer risk assessment studies 
is in the developmental phase (Sikkema et al., 2012).  Genome and transcriptome studies have 
lead to the identification of abnormal proteins or expression profiles for numerous malignancies, 
but the effects of these changes in gene expression on the cellular signalling network has not 
been clarified. Regarding drug discovery, direct modeling of toxic endpoints has been deceiving 
and prevents wide acceptance of computer predictions (Merlot, 2010).  Therefore simpler 
predictions focused on the mechanism of action together with in vitro and in vivo assays are 
regarded as more appropriate.     
Experimental concentrations applied in mechanistic studies with dietary polyphenols  
Associations of in vitro results with effects in vivo are complicated by the effective 
concentrations when studying the biological activities of dietary polyphenols (Yang et al., 2008).  
In this regard concentrations reported in the plasma and tissue only reach low micromolar 
levels, while the effective concentrations reported in in vitro studies are generally much higher, 
in the range of 1001000 micromolar (Yang et al., 2008).  In vitro investigations are often 
conducted at concentrations that cannot realistically be attained in the body (Manach et al., 
2004; Rio et al., 2010).  It has been argued that prolonged exposure as a consequence of 
continual ingestion of e.g. tea catechins will lead to cells being consistently exposed to 
epigallocatechin gallate (EGCG) or other catechins, which may result in a significant effect even 
if the concentration is low (Yang et al., 2008).  There is, however, no quantitative model that 
provides an understanding for correlation of the effective concentration in vitro to the plasma 
and tissue concentrations observed in animals and humans.     
Another consideration is that the dose of polyphenols administered will affect the type of 
conjugates, since the dose could influence the primary site of metabolism (Karakaya et al., 
2004).  Although the metabolic pathways of drugs and food polyphenols are similar, drugs are 
generally administrated in a fairly large concentrated doses (mg) leading to saturation of the 
metabolic pathways, while polyphenols are consumed at much lower doses.  When polyphenols 
are administrated at pharmacological doses, they are present in the free form in the blood 
(Scalbert & Williamson, 2000).  Large doses are mainly metabolized in the liver, while smaller 
doses are metabolized in the intestinal mucosa.  An increase in the ingested dose may also 
result in a shift from sulphation toward the glucuronidation metabolic pathway (Koster et al., 
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1981).  These factors may lead to measurements following the administration of single 
compounds at high doses in animal and human studies, not being representative of the 
absorption and metabolism of compounds at the level they are present in herbal preparations.  
 
Dose translation from animal to human studies  
Development of functional foods or dietary supplements from herbal extracts should consider 
similar guidelines to that used in drug development with regards to safety.  The production of a 
commercially available drug includes, among others, the following steps: investigation of the 
mechanism of action, pharmacokinetics, determination of the mechanisms of disposition, 
metabolism and excretion (ADME), safety testing and assessment of efficacy in clinical trails 
(Anon, 2005).  The calculated dose will be influenced by all these factors and in addition by the 
drug formulation (Hawk & Leary, 1995).  Extrapolation and translation of the drug dose from 
animal species to humans have become essential for new drug development (Reagan-Shaw, 
2008).  Challenges, however, exist with regards to the appropriate method for allometric dose 
translations, especially when starting new animal or clinical studies.  It is recommended that the 
normalization of body surface area (BSA) method should be used for the calculations of starting 
doses in humans as extrapolated from animals.  This method was originally used to derive a 
safe starting dose for phase I studies of anticancer drugs from preclinical animal toxicology 
data.  Conversions by simply calculating according to body weight alone may result in 
inappropriate comparisons between studies.  An example of such a case would be the 
antioxidant resveratrol (Baur et al. 2006;  Lagouge et al., 2006) receiving bad press in the public 
media since the dose used in rats was equivalent to hundreds or thousands of litres of wine per 
day in human equivalent doses (Wade, 2006).   
           
Effect of metabolism and bioavailability of dietary polyphenols on bioactivity 
The most abundant phenolic compound in the diet is not necessarily responsible for observed 
activity within the body (Manach et al., 2004).  Poor absorption, a high level of metabolism 
and/or rapid elimination may result in significantly altered biological activity of polyphenols after 
ingestion.  Several studies have indicated that aglycones are not significant metabolites in 
blood, attributed to extensive intestinal and hepatic conjugation (Manach et al., 2005).     
Regardless, many in vitro studies aimed at elucidating mechanisms of action of polyphenols 
still incorrectly focus on aglycones or glycosides rather than the identified metabolites and 
should reconsider their focus, since the biological and antioxidant properties of metabolites of 
flavonoids mostly differ from the parent compound (Manach et al., 2004; Rio et al., 2010; Lotito 
et al., 2011).  The relevance of the vast amount of data generated on the activity of the 
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aglycones in vitro is therefore questionable (Kroon et al., 2004).   Although a profound effect on 
activity is expected after flavonoids have been metabolised, knowledge on the biological 
properties of the conjugated derivatives in plasma and tissue is limited due to lack of precise 
identification and availability of commercial standards (Rio et al., 2010).   Due to their 
intermediate hydrophobicity, phenolic compounds are expected to act at water-lipid interfaces 
and possibly to be involved in oxidation regeneration pathways with vitamins C and E.  
However, glucuronidation and sulphation increases hydrophilicity and modifies the possibility of 
electron delocalization and consequently affects the site of action, interaction with other 
antioxidants and therefore their bioactivity (Manach et al., 1998; Rio et al., 2010).  Investigations 
on metabolism and activity of metabolites of the major dietary polyphenols have focussed on 
quercetin, tea flavan-3-ols, the flavanones naringenin and hesperetin, the grape stilbene 
resveratrol and catechins (Manach et al., 1998; Harada et al., 1999; Day et al., 2000a; Lu et al., 
2003; Justino et al., 2004; Dueñas et al., 2010; Lotito et al., 2011).  Results of these studies are 
summarised in Table 2.    
 Conjugation of quercetin (Figure 3) resulted in decreased activity when comparing the 
protection against Cu2+-induced oxidation of human low density lipoprotein (LDL) (Manach et al., 
1998).  However, the conjugates, specifically 3-O-methylquercetin, still demonstrated 
significantly protective effects.  Glucuronidation of (+)-catechin and (-)-epicatechin did not affect 
their antioxidant activity (determined as superoxide anion radical scavenging activity), while 3-
O-methylation resulted in a nearly complete loss of antioxidant activity (Harada et al., 1999).    
Investigation on the bioavailability and effects of biotransformation on the in vivo activity of 
polyphenols should, in addition to identification of the nature and number of the conjugating 
groups, also assess the position(s) on the polyphenol structure (Manach et al., 2004).   
For instance, the conjugation position of quercetin influences whether activity is retained 
(Day et al., 2000b).  Quercetin and two of its glucuronides (3 - and 4 -) were found to be potent 
inhibitors of xanthine oxidase and have superoxide scavenging activity (Table 2).  The activity of 
lipoxygenase, involved in early stages of atherosclerosis, was moderately inhibited by 
glucuronides of quercetin, with the exception of quercetin-3-glucuronide.  Quercetin-3-sulphate 
and quercetin-3-glucuronide did not effectively retain activity when compared to quercetin.  
In another study with EGCG and ()-epigallocatehin (EGC) (Figure 3), glucuronidation with 
human, mouse and rat microsomes did not affect loss in activity when evaluated as potential to 
inhibit the release of arachidonic acid form HT-29 human colon cancer cells (Lu et al., 2003).  
EGCG-4-glucuronide was the major EGCG glucuronide obtained with all three different 
microsomal incubations, while glucuronidation of EGC appeared to be lower than that of EGCG.  
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Table 2  Summary of studies conducted to investigate the biological activity of phenolic compounds after metabolism to illustrate the 
effect of biotransformation on bioactivity.   
 
Compound Metabolite(s) Assessment of activity Results Reference 
quercetin 3-O-methylquercetin effect on Cu2+-induced 
oxidation of human LDL 
metabolites retain some activity, but half 
as effective as quercetin 
Manach et al., 1998 
(+)- catechin (+)-catechin 5-O-β-glucuronide 
3-O-methyl (+)-catechin  
superoxide anion radical 
scavenging activity (xanthin-
xanthinoxidase system) 
glucuronidated metabolites displayed 
similar antioxidant activity as the parent 
compounds 
Harada et al., 1999 
(-)- epicatechin (-)-epicatechin 5-O-β-glucuronide 
3-O-methyl (-)-epicatechin  
superoxide anion radical 
scavenging activity (xanthin-
xanthinoxidase system) 
3-O-methylation resulted in a near loss 
of antioxidant activity 
Harada et al., 1999 
quercetin  3-methylquercetin 
quercetin-3-sulfate 
quercetin-3-glucuronide 
quercetin-7-glucuronide 
quercetin-4-glucuronide 
quercetin-3-glucuronide 
inhibition of xanthine oxidase 
and lipoxygenase 
certain metabolites retain activity at 
expected plasma concentrations 
depending on conjugation position.  
Quercetin-4-glucuronide: very potent 
inhibitor of xanthine oxidase 
Day et al., 2000a 
(-)-epigallocatechin 
gallate (EGCG) 
(-)-EGCG-4-O-glucuronide 
(-)-EGCG-3-O-glucuronide 
(-)-EGCG-7-O-glucuronide 
inhibition of the release of 
arachidonic acid from HT-29 
human colon cancer cells   
a number of the EGCG glucuronides 
retain radical quenching and other 
biological activities of the aglycone 
Lu et al., 2003  
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Table 2 (Cont.) 
Compound Metabolite(s) Assessment of activity Results Reference 
(-)- epigallocatechin 
(EGC) 
(-)-EGC-3-O-glucuronide 
(-)-EGC-7-O-glucuronide 
inhibition of the release of 
arachidonic acid from HT-29 
human colon cancer cells   
certain EGC glucuronides 
retained the activities of their parent 
compounds in radical scavenging and in 
inhibiting the release of arachidonic acid 
from HT-29 human colon cancer cells 
Lu et al., 2003 
quercetin glucuronides, sulfoglucuronides 
and sulfates.  
conjugation occurs on the 5- and 7-
OH groups.  
 
determination of plasma 
antioxidant status   
increased antioxidant status was 
assumed to be evidence of metabolites 
retaining antioxidant activity   
Justino et al., 2004 
quercetin 
 
3-O-methylquercetin 
(isorhamnetin)  
4-O- methylquercetin (tamarixetin)  
Quercetin 3-O-sulphate  
Quercetin 4-O-sulphate 
Isorhamnetin 3-O-sulphate  
Quercetin 3-O-glucuronide 
FRAP a, ABTS b assay 
 
 
conjugation results in reduced 
antioxidant activity   
Dueñas et al., 2010 
quercetin 
 
(-)-  epigallocatehin-3-O-
gallate (EGCG) 
3- or 4-O-methyl-quercetin, 
quercetin-3-O-glucuronide, 
quercetin-3-O-sulfate,  
4-O-methyl EGCG,  
4,4-di-O-methyl-EGCG quercetin 
anti-inflammatory effects 
inhibition of effects on tumor 
necrosis factor  (TNF )-
induced protein expression 
of cellular adhesion 
molecules in human aortic 
endothelial cells   
two of the metabolites: 
 3- and 4-O-methyl-quercetin inhibited 
the expression of intercellular adhesion 
molecule-1 
Lotito et al., 2011 
a FRAP refers to ferric reducing antioxidant power assay, b ABTS refers to the ABTS+• scavenging assay.    
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Figure 3 Chemical structures of quercetin (Erlund, 2004) and the major catechins in green tea 
(Camellia sinensis) (Yang et al., 2000).    
Quercetin  
(-) Epicatechin (-) Epicatechin gallate 
(-) Epigallocatechin (-) Epigallocatechin gallate 
OH 
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The glucuronidation of EGCG and EGC in mouse microsomes were more similar to that 
occurring in human microsomes than to rats.  A number of the glucuronides retained the 
activities of their parent compounds in radical scavenging and inhibiting the release of 
arachidonic acid from HT-29 human colon cancer cells.  Justino et al. (2004) investigated the 
structure-antioxidant activity relationships of quercetin and its metabolites in vivo in plasma of 
rats following intragastrically administeration by stomach intubation (10 mg quercetin/200 g 
body weight) through a catheter.  Quercetin was reported to be primarily metabolized to 
glucuronides and sulfoglucuronides and to a lesser extend to sulphates.  Based on LC-MS/MS 
analysis, glucuronidation and sulphation is thought to occur on the hydroxyl groups located at 
position 5 and 7 and not at 3-OH and 4-OH groups.  It was argued that quercetin metabolites 
retain antioxidant activity, since the plasma antioxidant status of rats was increased following 
administration of quercetin.  
Dueñas et al. (2010) compared the antioxidant activity of several conjugates of quercetin 
with -tocopherol in the ferric reducing antioxidant power (FRAP) and ABTS radical cation 
assays.  Substitution of hydroxyl groups of quercetin significantly reduced activity in the 
antioxidant assays, but the conjugates were more active than -tocopherol in the ABTS assay, 
with the exception of isorhamnetin-3-O-sulphate.  This was attributed to the double substitution 
of quercitin, i.e. on the B- and C-rings (Table 2).     
A recent study on the biological and antioxidant activity of several major metabolites of 
quercetin and (-) epigallocatehin-3-O-gallate (EGCG), that have been identified in humans,  
confirmed that the activity of metabolites differ from the parent compounds (Lotito et al., 2011).  
The anti-inflammatory effects were assessed by determining the inhibitory effects on tumor 
necrosis factor  (TNFα)-induced protein expression of cellular adhesion molecules in human 
aortic endothelial cells.  The metabolites, 3′- or 4′-O-methyl-quercetin, quercetin-3-O-
glucuronide, quercetin-3′-O-sulphate, 4′′-O-methyl-EGCG and 4′,4′′-di-O-methyl-EGCG as well 
as quercetin were evaluated.  The expression of intercellular adhesion molecule-1 was 
effectively inhibited by 3′-O-methyl-quercetin, 4′-O-methyl-quercetin, and their parent aglycone 
compound, quercetin.  This study indicated that biotransformation of dietary flavonoids may 
result in a loss or gain of biological or antioxidant activity which cannot necessarily be predicted 
from the chemical nature of the flavonoid.  Bioactivity and beneficial effects in humans and 
animals have therefore been attributed to the circulating glucuronides, sulphates and O-
methylated forms of dietary polyphenols (Spencer et al., 2004).  
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POTENTIAL ADVERSE EFFECTS OF DIETARY POLYPHENOLS 
In spite of increased interest in using polyphenols as dietary supplements alone or in 
combination with other drugs as medicine, there are associated risks such as hepatoxicity and 
possible herb-drug interactions (Prasain et al., 2010).  Flavonoid concentrates and herbal 
remedies are aggressively marketed and the nontoxic therapeutic effects are exaggerated, 
despite the lack of substantiation by regulated clinical trails (Skibola & Smith, 2000).  The 
recommended doses of such products far exceed the level of polyphenols that could be attained 
with a normal diet, based on the hypothesis that “if a little of something is good, then more is 
better”, resulting in individuals ingesting extremely high levels.  An understanding of the role of 
reactive oxygen species (ROS) in the normal physiology and disease and the interaction of 
dietary polyphenols is fundamental to the role, protective or detrimental, of polyphenols.     
 
Reactive oxygen species (ROS) and dietary antioxidants 
(i) The role of ROS in normal physiology and disease 
Reactive oxygen species (ROS) refers to a variety of diverse chemical species, which include 
superoxide anions, hydroxyl radicals and hydrogen peroxide (Finkel & Holbrook, 2000).  The 
production of ROS in the cell has mostly been viewed as harmful due to association between 
abnormal production and incorrect regulation with the development of diseases and aging 
(Finkel & Holbrook, 2000; Holbrook & Ikeyama, 2002).  Diseases such as diabetes, Alzheimer’s 
and other neurodegenerative diseases, atherosclerosis contributing to cardiovascular disease 
and cancer have been attributed to the actions of ROS (Seifried et al., 2007).  On the other 
hand, ROS generation is a normal physiological process required for immunocompetence and 
in coordination and activation of several signal transduction pathways (Seifried et al., 2007).  
Consequently, ROS are referred to as a double-edged sword.   
Althought originally implied that the targets of ROS are random, indiscriminate and 
cumulative, it has been demonstrated that ROS can act as specific signaling molecules under 
both physiological and pathophysiological conditions (Finkel & Holbrook, 2000).  The 
involvement and importance of oxidants in biological processes is illustrated in Fig. 4.  The 
generation of ROS within limits is therefore required to maintain homoeostasis.  Intracellular 
oxidants have two potential outcomes which are determined by the level present: they may 
damage various cell components or trigger the activation of specific signaling pathways.  
Numerous cellular processes are influenced by both these effects and are associated with 
ageing and development related diseases.  
In addition to endogenous generation of ROS, environmental stimuli such as ultraviolet 
radiation or chemotherapeutic agents may increase oxidative stress disturbing the normal redox 
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balance (Finkel & Holbrook, 2000).  Survival of the cell will depend on the ability to cope with the 
stress and to repair or replace damaged molecules.  Cells may also respond by undergoing 
apoptosis, which is described as a process of eliminating the damaged cell as a mechanism of 
preservation.   
(ii) Interaction of dietary antioxidants with ROS 
After the link between ROS and certain diseases became apparent, a monumental effort went 
into antioxidant research (Seifried et al., 2007).  Antioxidants are used in normal cellular 
processes to mediate the immune response, cell proliferation, signal transduction and also 
quenching excess ROS.  Polyphenols are renowned for displaying antioxidant activity (Quideau 
et al., 2011), because of the ability to scavenge reactive oxygen species (ROS) which includes 
radicals such as O2-, OH, LOO and LO and non-radical oxygen species such as HOCL, H2O2, 
O2 and O3 (Halliwell et al., 1995). 
Polyphenols also act as anti-oxidants by chelating metal ions such as iron (II)/copper (I) and 
iron (III)/copper (II) involved in Haber-Weiss and Fenton type reactions that lead to formation of 
OH radicals from H2O2 (Collins, 1999; Quideau et al., 2011).    
   
Fe 2+  +  H2O2           Fe 3+ +  OH-  +  OH     (Fenton reaction) 
Fe 3+     +  O2-              Fe 2+ +   O2          
H2O2    +   O2-              OH  +    OH-  +  O2  (Haber-Weiss reaction)   
         
The degree of oxidative stress is determined by the balance between ROS production and 
antioxidant defenses (Finkel & Holbrook, 2000).  Dietary supplementation has been seen as an 
effective measure and practical approach to increase antioxidant defense and consequently 
reduce the level of oxidative stress.  This is supported by numerous studies conducted in vitro 
(Finkel & Holbrook, 2000), but a link between dietary antioxidant supplementation and the 
protection against diseases such as cancer has not been established (Hayden et al., 2007; Lin 
et al., 2009).  Limited success has been reported for antioxidant therapy in animal models 
(McCall & Frei, 1999; Yu, 1999).  A greater understanding of the pharmacological properties of 
many of the agents will be required for successful application of antioxidants to reduce oxidative 
stress, including knowledge on rates of absorption, tissue distribution, metabolism and the 
microenvironment where they act (Finkel & Holbrook, 2000).  Simply adding a pharmacological 
agent to achieve increased antioxidant defense will not be effective, since most free-radical 
scavengers act in oxidation-reduction reactions that are reversible and several can act as 
antioxidants as well as pro-oxidants, depending on the conditions.  Determining the the optimal  
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Figure 4 Sources and cellular responses to reactive oxygen species (ROS) (Finkel & Holbrook, 2000).   
concentration is used to prevent disturbing the delicate redox balance required for the maintenance  
of normal cell functions.      
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dose of supplements is, in addition, complicated by the role of ROS as mediators of normal signaling 
processes, as discussed above and shown in Fig 4.  It is important that the optimal 
                            
Dietary polyphenols and toxicity 
The use of dietary polyphenol supplements and polyphenol rich food products increased due to 
the numerous reports on positive effects of polyphenols on disease (Scalbert et al., 2005b).  
These products do not necessarily contain specified health claims, but different polyphenols 
have been implicated to reduce oxidative stress and aging, while isoflavones have been 
recommended to limit hot flushes and to improve bone health in post-menopausal women.  
Consumption of such products and foods leads to increased intake of polyphenolic compounds 
beyond the levels of exposure associated with a normal diet and may pose a number of adverse 
effects and risks.  Toxicity has been reported in animals for some herbal products.  A green tea 
(C. sinensis) derived preparation, Teavigo, containing more than 90% EGCG, showed toxicity 
when administered at high doses (2000 mg/kg) in rodents (Isbrucker et al., 2006).  
Administration of a single dose of 1500 mg/kg EGCG in mice caused hepatotoxicity (Lambert et 
al., 2010).  However, a critical review of the data on the safety of quercetin reported a lack of 
evidence of in vivo toxicity, and also a lack of genotoxic/cardinogenic properties (Harwood et al., 
2007).  When considering risks and safety of polyphenols, the following hazards are potentially 
related to polyphenol intake: carcinogenicity/genotoxicity, thyroid toxicity, oestrogenic activity of 
isoflavones, antinutritional effects, such inhibition of iron absorption and interactions with 
pharmaceuticals/drugs (Mennen et al., 2005).           
  
(i) Pro-oxidant effects of dietary polyphenols 
a) Pro-oxidant acitivity in vitro 
Plant-derived antioxidant polyphenols have both pro-oxidative and antioxidative properties that 
will be determined by their metal-reducing potential, chelating behaviour, pH and solubility 
characteristics (Babich et al., 2011).  Evaluating the pro-oxidant activity of quercetin, p-
courmaric acid and their derivatives in NADPH/peroxidase/H2O2 and DNA cleavage systems, 
indicated that the balance between antioxidant and pro-oxidant effects was not apparent (Yang 
et al., 2012).  When considering metal-reducing potential, phenolic compounds with a catechol 
moiety (aromatic rings with two hydroxyl groups in the ortho position) have pro-oxidant effects 
under certain conditions by reducing iron (III) or copper (II) ions, thus generating hydroxyl 
radicals through the Fenton reaction (Scalbert et al., 2005b; Quideau et al., 2011).  
Furthermore, consumption of high concentrations could potentially lead to pro-oxidant effects 
(Scalbert et al., 2005b).  When considering the role of the structure of polyphenols in pro-
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oxidant behaviour, critical factors are the number of hydroxyl groups, hydrophilicity, steric 
hindrance and the concentration (Rietjens et al., 2002).  
When considering protection against lipid peroxidation in cell cultures, flavonoids with a 
phenol-type substitution pattern on the B-ring may act as pro-oxidants at concentration, where 
other flavonoids are still active as antioxidants (Galati et al., 1999).  The pro-oxidant activity is 
postulated to result from oxidation of reduced glutathione (GSH) and potentially proceeds as 
outlined in figure 5 (a).  Dietary polyphenols with phenol rings are metabolized by peroxidase to 
form pro-oxidant phenoxyl radicals in hepatocytes (Galati et al., 2002).  The flavonoid 
semquinone radical is then generated by enzymatic and/or chemical (auto)oxidation (Galati et 
al., 1999) and is scavenged by GSH regenerating the flavonoid while generating the thiyl radical 
of glutathione.  This anion radical then rapidly reduces molecular oxygen to superoxide anion 
radicals.  Under specific conditions, the phenoxyl radicals are able to oxidize both GSH and 
NADH and lead to extensive oxygen uptake and reactive oxygen species formation (Galati et 
al., 2002).  Incubation of hepatocytes with dietary polyphenols containing phenol rings partially 
oxidizes hepatocyte GSH to GSSG.   
Flavonoids with a catechol type substituent pattern in their B-ring, especially a 3,4-catechol 
type moiety, are related to the formation of quinone type oxidation products (Rietjens et al., 
2002). Scavenging by GSH for these compounds seems to rather occur via conjugate 
formation, instead of chemical reduction and the formation of GSH flavonoid adducts have been 
demonstrated (Galati et al., 2001; Galati et al., 2006).  For gallic acid and gallic acid tea 
derivatives, GSH conjugates formation in primary hepatocytes was attributed to their low redox 
potentials (Galati et al., 2006).  Studies in hepatocytes have shown that the catechol B-ring-
containing flavonoids with low redox potentials, such as luteolin and quercetin, depleted 
hepatocyte GSH without causing GSSG formation (Galati et al., 2002).  Polyphenols containing 
a phenol ring were found to generally be more pro-oxidant than polyphenols containing a 
catechol ring (Galati et al., 2002).  
 
b) Pro-oxidant activity in vivo 
Inspite of numerous in vitro studies reporting on pro-oxidant and mutagenic potential of 
polyphenols, quinone reductase, catechol-O-methyltransferase and other conjugating enzymes 
are expected to limit the formation of quinones in endogenous tissues (Scalbert et al., 2005b).    
Very few studies have been conducted to investigate the pro-oxidant activity of phenolic 
compounds in vivo in laboratory animals or humans (Babich et al., 2011).  The low dose of 
polyphenols resulting from habitual diets together with food matrix effects are posed as reasons 
for lack of reports on toxicity of polyphenols in epidemiologic studies (Mennen et al., 2005).   
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Figure 5 (A) Pro-oxidant chemistry of phenol-type flavonoids and (B) catechol-type flavonoids 
(Rietjens et al., 2002). 
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However, carcinogenic and endocrine system-disrupting effects of certain polyphenols reported 
in animal studies question the ethics of human trials with high doses of these polyphenols.   
 
(iii) Pro-mutagenic/pro-carcinogenic activity of dietary polyphenols  
Despite in vitro genotoxicity, carcinogenicity studies of flavonoids in mammals are 
predominantly negative (Middleton & Kandaswami, 1993; Das et al., 1994).  Studies in cell 
cultures have indicate that some polyphenols, including quercetin, could be mutagenic (Scalbert 
et al., 2005b), yet numerous studies with quercetin showed anticarcinogenic effects in rodents 
(Scalbert et al., 2005b).  However, reports of pro-carcinogenic effects of quercetin in rat models 
of nitrosomethylurea-induced pancreatic cancer (Barotto et al., 1998) and azoxymethane-
induced colon cancer (Pereira et al., 1996), together with consistent findings of positive 
mutagenic effects in vitro have resulted in a intense debate around carcinogenicity of quercetin 
(Harwood et al., 2007).   
 
Potential interactions of dietary polyphenols with drugs/xenobiotics 
(i) Interference with metabolism 
Metabolism and elimination of phytochemicals follow the same biochemical pathways and 
employs the same metabolic enzymes, transporters and efflux pumps as the majority of drugs 
(Holst & Williamson, 2008).  On this basis, phytochemicals may compete with drugs for 
enzymes, co-factors and transporters and therefore have a significant potential to influence drug 
uptake, metabolism and clearance from the body (Holst & Williamson, 2008).  Although drug-
nutrient interactions during absorption and metabolism are very likely to occur and may have 
enormous health implications, these have rarely been considered (Holst & Williamson, 2008).    
Changes in metabolism and absorption caused by nutraceuticals might markedly alter the 
pharmacokinetics of medications given concurrently resulting in potential unwanted effects 
(Verschoyle et al., 2007).  The concentrations of a drug could be either increased or decreased 
leading to toxicity or decreased efficacy, respectively, or even treatment failure.    
 
(ii) Modulating effect of polyphenols on enzymes 
 
Potential adverse effects of polyphenols may also result from the modulating effects on 
enzymes.  In this regard, the ability of polyphenols to inhibit the activity of a number of enzymes 
has also been established (Fraga et al., 2010).  According to Middleton et al. (2000), important 
enzymes as targets of polyphenols are enzymes with purines, such as adenosine triphosphate 
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(ATP) as substrates and enzymes with NADPH as a cofactor.  Enzymes with purines as 
substrate include kinases, ATPases, cyclic nucleotide phosphodiesterase, adenylate cyclase, 
reverse transcriptase, xanthine oxidase, RNA and DNA polymerases, ribonuclease, human 
DNA ligase, while enzymes with NADPH as a cofactor would comprise aldose reductase, 
malate dehydrogenase, lactic dehydrogenase, nitric oxide synthase, glutathione reductase, 11-
-hydroxysteriod dehydrogenase.  The inhibiting effect of polyphenols on ATP-dependent 
enzymes is attributed to the competitive binding to the enzyme ATP-binding site (Middleton et 
al., 2000) of which structural requirements include two hydroxyl substitutions in the 5,7 position 
in the flavonoid A-ring and 2, 3 unsaturation together with a 4-keto group in the C-ring (Lotito & 
Frei, 2006).        
There is an increasing focus on the importance of considering herb-drug interactions 
(Chavez et al., 2006).  The effect of polyphenols on phase I enzymes, cytochrome P450 (CYP), 
are of critical importance in this regard as these enzymes are involved in the majority of drug 
metabolism.  The effects of polyphenols on phase I enzymes as reviewed in a systematic 
evaluation of 60 polyphenols and related compounds on human CYP 3A4 and CYP2C9 activity, 
revealed that some dietary polyphenols may have the potential to inhibit the metabolism of 
clinical drugs (Kimura et al., 2010).  These included three coumarins and 12 flavonoids 
displaying inhibitory activities against CYP3A4 or CYP2C9.       
Regarding the effects of polyphenols on Phase II enzymes several flavonoids induce UGTs 
(Zhang et al., 2007).  The flavonoid chrysin has been shown to induce UGT1A1 in human 
hepatic and intestinal cell lines, Hep G2 and Caco-2 (Walle & Walle, 2002).  Another study 
demonstrated that quercetin and kaempferol induced the expression of UGT1A1 and CYP1A2 
in HepG2 cells, but not in human primary hepatocytes (Li et al., 2009).    
 
GLOBAL MARKETING TRENDS AND REGULATION OF HEALTH AND SAFETY ASPECTS 
OF PRODUCTS CONTAINING DIETARY POLYPHENOLS 
 
Nutraceuticals, functional foods and supplements containing polyphenols 
Bioactive compounds are currently available in a variety of pharmaceutical forms including pills, 
capsules, solutions, gels, powders or granules or incorporated in food extracts or phychemical 
or polyphenol-enriched extracts (Palthur et al., 2010).  These products are directly or indirectly 
implicating beneficial physiological functions, but cannot be classified as food, nutrients or 
pharmaceuticals and are often refered to as nutraceuticals.  Nutraceuticals are defined as “a 
substance that may be considered a food or part of a food and provides medical or health 
benefits, including the prevention and treatment of disease” (Palthur et al., 2010).  Inspite of the 
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term being recognized internationally, there is no general consensus on its definition and 
meaning and it creates an open environment for new products that promise novel solutions to 
health‐related issues.  Phytochemicals available on the nutraceutical market include 
polyphenols such as anthocyanins, proanthocyanidins, flavonols, stilbenes, hydroxycinnamates, 
coumarins, ellagic acid (EA), isoflavones, lignans and many more.  This product type/food group 
is expected to contribute greatly to future therapeutic developments, but many challenges lie 
within public policy and regulatory aspects.  Although functional foods are regulated in the EU 
and nutraceuticals are not, the distinction between the two is not always clear (Palthur et al., 
2010).  Functional foods are defined as foods that exert a specific health-beneficial effect 
beyond their nutritional properties, of which the effect must be scientifically substantiated.      
The doses of freely available nutritional supplements rich in polyphenols, whether 
registered, regulated or not, are most alarming.  Recommendations for some products are 
within that attainable in a normal diet, eg. a dose of 50 mg of isoflavones per day could be 
obtained from soy products in Japan and 100300 mg grape seed extracts rich in 
proanthocyanidins per day may be equivalent to that obtained from wine consumption in 
European countries (Mennen et al., 2005).  Others are recommended at intakes far exceeding 
dietary levels.  Examples of capsules available on the internet include 300 mg quercetin, 1 g 
citrus flavonoids, or 20 mg resveratrol recommended to use 16 capsules per day, resulting in a 
dose of approximately 100 times that obtainable from a Western diet.  Furthermore methods of 
extraction used to produce the supplements may influence the nature of the compounds and 
consequently also their safety.              
 
Global regulation of safety and health claims for dietary polyphenols in food products 
and supplements 
  
Dietary supplements and functional foods are not classified as drugs and therefore do not 
require approval to be marketed in most countries. Subsequently, potential toxicities and drug 
interactions of these products are mostly unknown.  Though not regulated, potential safety 
issues regarding daily consumption of large doses of flavonoids and isoflavones have been 
stated (Galati & O’Brien, 2004).     
In the European Union (EU), the European Directive 2004/24/EC, released by the European 
Parliament and by the Council of Europe in 2004 (European Commission, 2004), provided the 
basis for the use of herbal medicines in Europe.  The Directive established that herbal 
medicines to be released on the market need authorization by the national regulatory authorities 
of each European country and that these products must have a recognized level of safety and 
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efficacy.  The safety of herbal medicinal products is evaluated on the basis of existing scientific 
literature, i.e. data from clinical studies, case reports, pre-clinical studies.  When data on safety 
is not sufficient, it is required to be communicated to consumers.  According to the criteria of 
safety and efficacy, herbal medicinal products are classed as: i) ‘well established use herbal 
medicinal products’ (medicinal herbs with a recognized level of safety and efficacy); and (ii) 
‘traditional use herbal medicinal products’.  A transitional period of 7 years to register traditional 
medicinal products that were already on the market was given, which expired on 30 April 2011.  
All herbal medicines therefore currently require full licensing throughout the EU.  There is, 
however, often controversy over foods being classified as a functional food, drug or a foodstuff, 
which complicates regulation thereof.  This has resulted in dietary supplements being included 
in regulations of health claims on foodstuffs by some regulatory authorities.  Regulation and 
requirements for health claims in the United States of America (USA), Japan and Codex 
Alimentarius are relatively different (Verhagen et al., 2010).  The categories of health claims in 
USA, i.e. nutrient content, structure/function claims and health claims, are similar to that used in 
the EU, but the regulatory status and procedures for use and approval are essentially different.  
Japanese and USA regulatory provisions for health claims are regarded as quite liberal when 
compared to the high level of scientific substantiation required in the EU.        
The first harmonised legislation governing the use of nutrition and health claims regarding 
food in the EU came into effect in 2007 (European Commission, 2006).  Claims on food labels in 
the EU were previously controlled on member state level, of which many did not have any 
legislation (Gilsenan, 2011).  The current regulations include the listing of all voluntary beneficial 
claims relating to food and beverages targeting consumers, and also food supplements and 
dietetic foods. This has major implications for supplements produced from herbal extracts and 
functional foods containing increased polyphenols which supposedly increase antioxidant 
activity and associated health properties.  Regulation of claims is not restricted to the 
packaging, but also includes adverstising material, promotional campaigns, websites, catering 
establishments, menus and also branded images and trademarks that may be interpreted as a 
nutritional or health claim (Gilsenan, 2011).     
Currently there are no regulations regarding the marketing, testing and sales of herbal 
products in South Africa.  The Medicines Control Council (MCC) has attempted to include 
complementary medicines in the medicine legislation, but this has been rather problematic.  
Nevertheless, complementary medicine account for a significant share of the medicine market in 
South Africa.  Herbal remedies and dietary supplements are not included in the strict regulation 
that governs pharmaceutical drugs (Starling, 2011) and are therefore not required to be tested 
or certified as safe.  Regarding health claims, the current labeling regulations in South Africa 
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(R.146) stipulate that the words “health” or “healthy” or other words or symbols implying that a 
food, or a substance contained therein, has health-giving properties is prohibited.  Futhermore, 
the word “cure” or any other medicinal claim, which includes prophylactic and therapeutic claims 
are also prohibited.  With regards to a claim for antioxidant activity, the Foodstuffs, Cosmetics 
and Disinfectants ACT (Act No. 54 of 1972) Regulations relating to the labeling and advertising 
of foodstuffs (R.146/2010), specify that the claim shall be subjected to pre-market approval and 
registration by the South African Health Products Regulatory Authority (SAHPRA) for efficacious 
daily and single serving levels.  However, initiation and set-up of SAHPRA is still in progress 
(personal communications with the South African Department of Health) and currently no health 
claims are allowed on food packaging in South Africa.   
 
SOUTH AFRICAN HERBAL TEAS: ROOIBOS AND HONEYBUSH AS DIETARY SOURCES 
OF PHENOLIC AND POLYPHENOLIC COMPOUNDS  
 
The South African herbal teas, rooibos and honeybush, were relatively unknown internationally 
less than a decade ago, but have become exceedingly popular worldwide (Heinrich & Prieto, 
2008).  The many traditionally and scientifically established health properties of rooibos and 
honeybush have been comprehensively discussed in recent reviews (Joubert et al., 2008a, 
Joubert et al., 2009, Joubert & De Beer, 2011).  The following section, therefore, incorporates a 
brief summary on the background, current research, marketing and the major chemical 
constituents of rooibos and honeybush.  A discussion of the metabolism and bioavailability of 
the major phenolic compounds present in rooibos and honeybush are included and possible 
adverse effects of rooibos and honeybush polyphenols are considered.    
 
Rooibos (Aspalathus linearis) 
(i) Background, current research and marketing trends  
Rooibos tea is produced from Aspalathus linearis (Burm.f.) Dahlg., belonging to the genus 
Fabaceae, Tribe Crotalarieae, and is endemic to the Cape Floristic Region (Joubert & De Beer, 
2011).  This herbal tea is currently consumed in more than 37 countries and a report by the 
Swiss Business Hub South Africa (Anon, 2007) predicted that rooibos may become the second 
most commonly consumed beverage tea ingredient in the world after ordinary tea (Camellia 
sinensis).   
Potential pharmaceutical product applications of rooibos include use as an anti-diabetic 
agent (Mose Larsen et al., 2008; Kawano et al., 2009; Joubert et al., 2010), treatment of 
neurological and psychiatric disorders of the central nervous system (Bruno & Dimpfel, 2009) 
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and in topical skin products (Marnewick et al., 2005).  Many South Africans cannot afford 
pharmaceuticals and rely on traditional remedies and herbal beverages such as rooibos for its 
medicinal properties.  Rooibos has been associated with numerous health claims over the 
years, some of which were often inflated and not based on scientific research.  However, since 
the establishment of the South African Rooibos Council (SARC, www.sarooibos.org.za) 
interpretation and communication of new findings relating to the potential health-benefits of 
rooibos is handled in a more responsible manner (Joubert et al., 2011).  The SARC consist of 
producers, processors, manufacturers and local marketers and exporters and was established 
in April 2005 to promote the interests of the South African rooibos industry locally and 
internationally.  Additional to its use as herbal tea, rooibos is also applied as intermediate value-
added products such as extracts for food, nutraceuticals and cosmetics (Joubert & De Beer, 
2011).  Current and on-going research projects involving the SARC and conducted in South 
Africa on health properties of rooibos include investigation of rooibos on satiety, anti-stress 
potential by inhibition of cortisol, the effect of rooibos on sport performance and ongoing 
research on anti-cancer properties of rooibos.  Other aspects of rooibos currently researched 
include objective quality and sensory parameters as well as chemical composition.     
 
(ii) Chemical composition of rooibos (Aspalathus linearis)  
A major selling point of rooibos as a herbal tea, when compared to tea (Camellia sinensis), is 
that it is naturally caffeine-free (Blommaert & Steenkamp, 1978).  Rooibos has also been 
marketed as a low tannin tea, but it is estimated that an aqueous extract contains approximately 
50 % tannin-like substances (Joubert et al., 2008a). 
  The chemical composition and structures of the major monomeric phenolic compounds 
present in rooibos are summarised in Table 3.  Rooibos has an unique flavonoid composition 
due to the presence of the dihydrochalcone C-glucoside, aspalathin (Koeppen & Roux, 1965) 
and a cyclic dihydrochalcone, aspalalinin (Shimamura et al., 2006).  Aspalathin is the principle 
monomeric flavonoid in unprocessed rooibos tea (Koepen & Roux, 1965).  Nothofagin, another 
rare dihydrochalcone C-glycoside present in rooibos, is structurally similar to aspalathin, except 
for the hydroxylation pattern of the B-ring (Table 3).  Other phenolic compounds present in 
rooibos regarded as major include flavones, and flavonols (Koeppen et al., 1962; Koeppen & 
Roux, 1965; Marais et al., 2000; Rabe et al., 1994; Shimamura et al., 2006).  These include the 
flavones isoorientin, orientin (Koeppen et al., 1962; Koeppen & Roux, 1965), vitexin, isovitexin, 
chrysoeriol (Rabe et al., 1994) and luteolin (Snyckers & Salemi, 1974) and the flavonols rutin, 
isoquercitrin (Koeppen et al., 1962) and quercetin (Snyckers & Salemi, 1974).  Phenolic acids  
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Table 3   The major phenolic compounds and contents in unfermented and fermented rooibos (Aspalathus linearis) plant material (Joubert & 
De Beer, 2011).    
Polyphenol  subgroup Compound Substitution 
Unfermented  
Polyphenol concentration a 
g/ 100 g extract 
Fermented  
Polyphenol concentration a 
g/ 100 g extract 
Dihydrochalcone 
   
OH
OH O
OH
R1
OH
R2
 
aspalathin 
nothofagin 
R1=OH, R2=C--D-glucopyranosyl 
R1=H, R2=C--D-glucosylpyranosyl 
2.56 b ± 0.70 
0.25 ± 0.23 
0.42 ± 0.02 
0.04 ± 0.022 
Flavone 
   OH
O
O
OH
R1
R3
R4
R2O
 
isoorientin 
orientin 
vitexin 
isovitexin 
luteolin 
luteolin-7-O-glucoside 
chrysoeriol 
R1, R2=H, R4=OH, R3=C-β-D-glucopyranosyl 
R1=C-β-D-glucopyranosyl, R2, R3=H, R4=OH 
R1=C-β-D-glucopyranosyl, R2, R3, R4=H 
R1, R2, R4=H, R3=C-β-D-glucopyranosyl 
R1, R2, R3=H, R4=OH 
R1, R3=H, R2=β-D-glucopyranosyl, R4=OH 
R1, R2, R3=H, R4=OCH3 
0.45 ± 0.16 
0.26 ± 0.09 
0.04 ± 0.02 
0.05 ± 0.03 
0.01  ±  0.01   
0.02  ±  0.01   
0.003  ±  0.001 
0.33 ± 0.05 
0.20 ± 0.03 
0.04 ± 0.01 
0.04 ± 0.01 
0.01 ±  0.01 
0.02  ±  0.01     
0.01  ±  0.002  
  
rutin  R=rutinosyl 0.25 ± 0.14 0.17 ± 0.02 
quercetin R=H 0.001 ± 0.001 0.01 ± 0.001 
Flavonol 
OH
OH
O
O
OH
OR
OH
 
hyperoside R=galactopyranosyl 
 
0.02 ± 0.01 0.02 ± 0.02 
a  The same plant material was used to produce unfermented and fermented rooibos,  b Values are the means  SD given as g/100 g dry plant material of three samples 
(n=3) as determined with HPLC analyses.   
Stellenbosch University  http://scholar.sun.ac.za
 45  
that have been isolated from rooibos tea include p-hydroxybenzoic, protocatehuic, vanillic, 
caffeic, p-coumaric and feurulic acids (Rabe et al., 1994).  A phenylpyruvic acid glycoside was 
identified by Marais et al. (1996).  Other compounds identified include: lignans, flavone 
diglycosides, (+)-catechin, the flavonol quercetin-3-O-robinobioside and the coumarins, 
esculetin and esculin (Beltrán-Debón et al., 2011; Breiter et al, 2011; Shimamura et al., 2006);  
patuletin 7-glucoside, esculin, safflomin A, carlinoside, isocarlinoside, neocarlinoside, 2-O--
arabinopyranosylorientin and vicenin-2, eriodictyol 5,3di-O-glucoside, quercetin-3-O-
arabinoglucoside and scoparin was reported for the first time by Iswaldi et al (2011).  The 
presence of a new luteolin-6-C-pentoside-8-C-hexoside and a novel C-8-hexosyl derivative of 
aspalathin in rooibos were reported recently (Beelders et al., 2012).    
Traditional preparation of rooibos includes fermentation to produce the oxidized form 
(Joubert & De Beer, 2011).  Recent investigation of the oxidative products of aspalathin, 
showed in addition to flavanones and flavones, the formation of dimers and dibenzofuran during 
fermentation (Heinrich et al., 2012).  Processed tea is often referred to as fermented, while 
unfermented tea refers to processed tea (crushed and dried) where processing did not involve 
chemical oxidation (fermentation).  The fermentation process results in significant quantitative 
changes with regards to the phenolic composition as shown in Table 3 and is discussed in detail 
by Joubert et al. (2008a), Joubert & De Beer (2011) and Beelders et al. (2012).  Limited 
information was available on the mineral content of rooibos (Joubert & De Beer, 2011) until 
recently when the presence and levels of 11 minerals including Na, Mg, K, Ca, P, S, Fe, Mn, Zn, 
Cu and Al was reported (Olivier et al., 2012).            
 
(iii) Metabolism and bioavailability of aspalathin and other major phenolic compounds in 
rooibos 
Several of the flavonoids in rooibos are glycosylated and therefore it would be expected that 
transformation to their corresponding aglycones by human intestinal bacteria is required for 
absorption (Joubert et al., 2008a).  A study conducted on the absorption of aspalathin as the 
pure compound and also from an aspalthin-enriched rooibos extract used human abdominal 
skin in Franz diffusion cells and Caco-2 cell monolayers (Huang et al., 2008) (Table 4).  A low 
level of permeation was evident through skin and distribution in skin layers.  The transport of 
aspalathin was fast and concentration-dependent when considering Caco-2 cells.  A significant 
finding was that transport of aspalathin from the extract preparation, containing aspalathin at a 
similar concentration than the preparation with the pure compound, showed significantly higher 
transport, potentially attributed to the presence of other phytoconstituents.  It was implied that 
higher blood levels of aspalathin would be achieved through oral intake of rooibos (aqueous 
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extract) rather than with a supplement formulation containing pure aspalathin (Huang et al., 
2008).  Biotranformation was however not considered.   
The in vitro methylation of aspalathin was evaluated by Courts & Williamson (2009), with 
human liver cytosolic and human intestinal cytosolic fractions.  Two isomeric products evident 
after incubation of both fractions with different concentrations of aspalathin were identified as 3-
O-methylaspalathin and 4-O-methylaspalathin.  The position of hydroxyl methylation was not 
confirmed, but assumed based on previous research on catechol and quercetin methylation.  
The relative O-methylation rate of the intestinal extract was slightly higher than the liver extract 
for both metabolites.  The potential for hepatic biotransformation, specifically sulphation and 
glucuronidation, of aspalathin and glucuronidation of nothofagin was demonstrated in vitro with 
rat liver fractions (van der Merwe et al., 2010).  Two aspalathin and two nothofagin 
monoglucuronidated metabolites were present and one sulphated aspalathin metabolite.  No 
sulphation was evident for nothofagin.  Glucuronidation resulted in a loss of antioxidant activity 
of aspalathin in HPLC-ABTS+• and HPLC-DPPH• assays, which may have important implications  
with regards to in vivo bioactivity of aspalathin.  It was proposed that the two likely sites of 
conjugation for aspalathin are 4-OH or 3-OH on the A-ring, while for nothofagin, the 4-OH (A-
ring) and 6-OH (B-ring) seemed to be involved. 
In vivo investigation of the metabolism and absorption of aspalathin was first conducted in 
pigs over an 11 day period (Kreuz et al., 2008) (Table 5).  No aspalathin or metabolites were 
detected in the plasma with LC-MS analyses, with the exception of traces of aspalathin with an 
increased dose.  Aspalathin and five metabolites were detected in the urine and included O-
methylated and/or glucuronidated aspalathin, a glucuronidated aglycone of aspalathin and an 
O-methylated and glucuronidated eriodictyol metabolite.   
Following a bioavailability study of aspalathin in humans (n=6) after consumption of a single 
oral dose of 300 mL of an aqueous extract of rooibos containing 91.2 mg of aspalathin, two 
methylated metabolites were present in the urine, 3-O-methylaspalathin and 3-O-
methylaspalathin glucuronide (Courts & Williamson, 2009).  However, 4-O-methylaspalathin 
obtained with in vitro methylation could not be detected in the urine of human volunteers.  The 
presence of unhydrolysed methylated metabolites of aspalathin in human urine served as 
indication that deglycosylation is not necessarily a prerequisite for C-glycosyl flavonoid 
absorption in humans.  After ingestion of 500 mL of either fermented or unfermented rooibos by 
10 volunteers no metabolites or none of the parent compounds could be detected in the plasma 
(Stalmach et al., 2009).  Eight metabolites were detected in the urine including O-linked 
methylated, sulphated and glucuronidated metabolites of aspalathin and an eriodictyol-O-
sulphate.  
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Table 4  In vitro studies on the metabolism and absorption of aspalathin.   
 
Compound/Extract Model Analytical Method Outcome Reference 
aspalathin measure transport across human abdominal skin in 
vertical Franz diffusion cells 
Caco-2 cell monolayers 
HPLC low level of permeation through 
skin and distribution in skin 
layers 
Huang et al. 2008 
unfermented 
aspalathin enriched 
rooibos extract 
measure transport across human abdominal skin in 
vertical Franz diffusion cells 
Caco-2 cell monolayers 
HPLC fast, concentration-dependent 
transport of aspalathin; higher 
transport from extract than pure 
aspalathin 
Huang et al. 2008 
     
aspalathin human liver cytosolic fraction with SAM a (co-factor) LC-MS/MS 3-O-methylaspalathin, 
4-O-methylaspalathin 
Courts & Williamson, 2009 
 human intestine cytosolic fraction with SAM (co-factor) LC-MS/MS 3-O-methylaspalathin,  
4-O-methylaspalathin 
Courts & Williamson, 2009 
     
aspalathin liver biotransformation of aspalathin and nothofagin 
and the effect glucuronidation on antioxidant activity of 
aspalathin 
   
 rat liver cytosolic fraction with PAPS b (co-factor) HPLC/ LC-MS and 
LC-MS/MS 
one sulfated asplathin 
metabolite;  
no sulfated nothofagin 
Van der Merwe et al., 2010 
 rat liver microsomal fraction for glucuronidation with 
UDPGA (co-factor)  
HPLC/ LC-MS and 
LC-MS/MS 
Online radical 
scavenging assays 
two glucuronidated metabolites 
for both aspalathin and 
nothofagin 
Van der Merwe et al., 2010 
a  S-adenosyl methionine (SAM), b 3-phosphoadenosine-5-phosphosulfate (PAPS).   
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Table 5 In vivo studies on the metabolism and bioavailability of aspalathin.   
 
Substance 
Consumed 
Administration/ 
Dose 
Subjects 
(no.) 
Method of 
Analysis 
Aspalathin and metabolites Reference 
aspalathin-enriched 
unfermented rooibos  
(Aspalathus linearis) 
oral dose 
157-167 mg 
aspalthin/kg bw a 
per day for 11 days 
pigs  
(n=3) 
LC-MS no metabolites detected in plasma 
aspalathin and 5 metabolites detected in the urine:  
O-methylated and/or glucuronidated  aspalathin,  
glucuronidated aglycone of aspalathin  
O-methylated and glucuronidated eriodictyol metabolites 
Kreuz et al., 2008 
unfermented 
Aspalathus linearis 
(aqueous extract) 
single oral dose 
91.2 mg 
humans  
(n=6) 
LC-MS/MS 3-O-methylaspalathin and 3-O-methylaspalathin 
glucuronide present in the urine    
Courts & Williamson, 
2009 
      
unfermented and 
fermented rooibos 
Aspalathus linearis 
(aqueous extract) 
single oral dose 
  
humans 
(n=10) 
HPLC-MS no metabolites detected in the plasma 
nine metabolites detected in the urine:  
O-linked methyl, sulfate and glucuronide metabolites of 
aspalathin and an eriodictyol-O-sulfate 
Stalmach et al., 2009 
2 rooibos drinks: 
(i) unfermented 
Aspalathus linearis 
(aqueous extract) 
 (ii) active fraction from 
unfermented 
Aspalathus linearis 
isolated by HSCCC 
(aqueous extract) 
 
single oral dose 
(water, 
unfermented dose 
or active fraction) 
287 mg 
humans 
(n=12) 
HPLC-MS/MS trace amounts of unchanged flavonoids in plasma 
aspalathin and nothofagin detected intact in urine 
seven metabolites detected in the urine: 
sulfated, glucuronidate and methylated aspalathin and 
methylated glucuronidated aspalathin.  
methylated aspalathin was the main metabolite. 
Beiter et al., 2011 
a bw=body weight.   
 
Stellenbosch University  http://scholar.sun.ac.za
 49  
The main compounds excreted differed for the unfermented and fermented tea and were O-
methyl-aspalathin-O-glucuronide and eriodictyol-O-sulphate, respectively.  Poor bioavailability of 
the dihydrochalcone aspalathin and the flavanone C-glucosides from unfermented and 
fermented rooibos tea were indicated by excretion of only trace amounts in urine up to 24 h after 
consumption.  It was assumed that most rooibos flavonoids pass from the small to the large 
intestine where they are subjected to the action of colonic microflora followed by cleavage of the 
sugar moiety and ring fission producing low molecular weight phenolic acids.  These catabolites 
would then be absorbed into the portal vein (Stalmach et al., 2009). 
More recently a human study with twelve volunteers was conducted with rooibos prepared from 
the unfermented tea and a drink prepared from an isolated active fraction from rooibos (Breiter 
et al., 2011).  Seven metabolites of aspalathin and nothofagin were identified in the urine 
samples.  Intact aspalathin and nothofagin were also detected in urine.  The metabolites 
included sulphated, glucuronidated and methylated aspalathin and also a methylated 
glucuronidated aspalathin.  Methylated aspalathin was the main metabolite excreted.  Other 
compounds present were the glucuronidated aglycone of aspalathin (2,3,4,4’,6-pentahydroxy- 
dihydrochalcone) and glucuronidated nothofagin and its glucuronidated aglycone 
(glucuronidated 2‘,4,4‘,6‘- tetrahydroxy-dihydrochalcone).     
 
Honeybush (Cyclopia spp.) 
(i) Background, current research and marketing trends  
Honeybush tea is made from Cyclopia spp., which belongs to the endemic fynbos biome genus 
Cyclopia Vent. (family Fabaceae; tribe Podalyrieae) and occurs on the coastal plains and 
mountainous regions of the Western and Eastern Cape provinces of South Africa (Joubert et al., 
2011).  It is a traditional South African herbal tea and is becoming increasingly popular as a 
result of a growing amount of scientific evidence implicating its potential health benefits, 
specifically with regards to its anticancer,  phytoestrogenic properties (Joubert et al., 2008a) and 
recently the potential to treat diabetes (Muller et al., 2011).  It was a very small, also referred to 
as “cottage” industry until the mid-1990’s, but during the last three years honeybush has been 
sold in 25 countries, which includes the Netherlands and Germany (Joubert et al., 2011).  A 
recent comprehensive review of South African herbal teas (Joubert et al., 2008a) included 
honeybush and focused on the phenolic composition and biological properties.  Research 
activities during the past 20 years including propagation, production, genetic improvement, 
processing, composition and the potential for value-adding are discussed in detail in the review 
by Joubert et al. (2011).    
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Current developments include patent protection with regards to the anti-diabetic potential for 
extracts produced from honeybush (Cyclopia) (Mose Larsen et al., 2008).  An aqueous extract 
of C. intermedia was recently shown to be effective in reducing plasma glucose concentration in 
a streptozotocin (STZ)-induced diabetic rat model (Muller et al., 2011).  With regards to value-
adding potential of Cyclopia the demand of the tea still exceeds the supply (Joubert et al., 
2011).  A small quantity of extracts is however produced for use in food products, cosmetics and 
toiletries.    
 
(ii) Chemical composition of honeybush (Cylopia spp.)  
Due to increased interest in honeybush (Cyclopia spp.) as a herbal tea and its potential as a 
nutraceutical, characterisation of the phenolic composition has become important (De Beer & 
Joubert, 2010).  The major phenolic compounds present and their content in three commercially 
important Cyclopia spp., C. genistoides, C. subternata and C. genistoides, are summarised in 
Table 6.  Similar to rooibos, honeybush is caffeine free (Greenish, 1881) with a low tannin 
content (Terblanche, 1982).  Processing of honeybush, as for rooibos, is important for 
development of its characteristic sweet aroma and flavour and the dark reddish brown colour  
(Joubert et al., 2011).  The process is also referred to as fermentation and results in a significant 
reduction of the total polyphenol content (Joubert et al., 2008b).  Unfermented or unprocessed 
(green) honeybush is produced by preventing oxidation and browning of the plant material 
(Joubert et al., 2011).       
De Nysschen et al. (1996) screened methanol extracts from the leaves of 22 unprocessed 
Cyclopia spp. for the presence of phenolic compounds and reported three major constituents, a 
xanthone C-glycoside, mangiferin, and the two flavanones hesperetin and isosakuranetin.  The 
polyphenol composition of only two of the Cyclopia spp., C. intermedia and C. subternata, has 
been studied in depth (Ferreira et al., 1998; Kamara et al., 2003; Kamara et al., 2004).  De Beer 
& Joubert (2010) recently developed a HPLC method for the phenolic analysis of C. subternata, 
which was applied to the three other species, C. intermedia, C. genistoides and C. sessiliflora.  
This study analysed the unfermented as well as the fermented plant material.  The major 
compounds present in all four species are the xanthones, mangiferin and isomangiferin and the 
flavanone, hesperidin (De Beer & Joubert, 2010).  Several other compounds have been 
identified and include flavanones, flavones, flavonols, coumestans and other compounds (De 
Nysschen et al., 1996; Ferreira et al., 1998; Kamara et al., 2003, Kamara et al., 2004; 
Kokotkiewicz et al., 2012).  Flavanones identified in Cyclopia spp. include eriocitrin, narirutin, 
naringenin, hesperetin, eriodictyol-5-O-β-D-glucopyranoside, eriodictyol, naringenin-5-O-β-D-
glucopyranoside, eriodictyol-7-O-β-D-glucopyranoside and an unidentified flavanone-glycoside.   
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Table 6  The major phenolic compounds and contents in green (unfermented) honeybush (Cyclopia spp.) plant material (De Beer & 
Joubert, 2010).    
Polyphenol  subgroup and 
structure  
Compound/Substitution 
C. genistoides 
Polyphenol concentration  
C. subternata 
Polyphenol concentration 
C. intermedia 
Polyphenol concentration 
 
mangiferin   
(R1 =  C--D-glucopyranosyl, R2 = H) 
 
9.55 a  ± 3.0 2.73 ± 1.65 4.35 ± 1.93 
Xanthone 
OH
O OH
OOH
OH
R2
R1
 
isomangiferin  
( R1 = H, R2 = C--D-glucopyranosyl) 
2.72 ±  0.67 0.86 ± 0.28 1.4 ± 0.49 
Flavanone 
hesperidin  
( R1= rutinosyl, R2=OH, R3=OCH3) 
0.71 ± 0.09 0.62 ± 0.17 0.62 ± 0.16 
eriocitrin  
( R1=rutinosyl, R2=R3=OH) 
traces 0.32 ± 0.07 0.13 ± 0.05 
Eriodictyol-glucoside 
(unidentified) nd 
 
0.35 ± 0.07 
 
0.07 ± 0.04 
    
 
OH
O
O
R2
R3
R1O
 
    
Flavone  
  
RO
OH
O
O
OH
OH
 
 
 
scolymoside  
( R=rutinosyl) 
 
traces 
 
 
0.68 ± 0.62 
 
0.04 ± 0.01 
a Values represent the mean ± SD given as g/100 g dry plant material of six samples (n=6) as determined with HPLC analysis.   
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Flavones shown to be present were luteolin, 5-deoxyluteolin, scolymoside and diosmetin, 
isoflavones were formononetin, a formononetin-diglucoside, aformosin, calycosin, wistin, orobol, 
pseudobaptigenin, fujikinetin and isosakuranetin and flavonols included several kaempferol 
glucosides.  Coumestans comprise medicagol, flemmichapparin and sophoracoumestan and 
other compounds present are EGCG, p-coumaric acid, tyrosol and several tyrosol derivatives.   
The method developed by De Beer & Joubert (2010) enabled quantification of several well-
known as well as unidentified phenolic compounds and is suitable for quantification of the major 
phenolic compounds present in the water extracts of unfermented and fermented C. subternata, 
C. intermedia, C. genistoides and C. sessiliflora.  Compounds previously identified and reported 
following analysis with this method included mangiferin, isomangiferin, eriocitrin, hesperidin and 
scolymoside, while narirutin and luteolin were detected in most samples, but could not be 
quantified due to low concentrations and/or co-elution with other compounds.  Unknown 
compounds were identified according to their retention time and UV-Vis spectra based on the 
evaluations with UV-Vis, LC-ESI-MS and LC-ESI-MS/MS data.  These included a flavone 
glycoside, eriodictyol-glucoside and an unidentifed compound; all quantified as hesperidin 
equivalents, exept an unidentified hydroxycinnamic acid derivative quantified as mangiferin 
equivalents.  Isolation of the unidentified compounds and investigation of bioactivities were 
recommended.     
Variations found in phenolic composition within the same Cyclopia species has been mostly 
attributed to differences in solubility of phenolic compounds, due to the solvents used for 
analysis, but it has also been postulated that growth and the leaf to stem ratio of the plant 
material used in production influences the phenolic composition of the final product (Joubert et 
al., 2003).  Variations in the polyphenolic content of two types of C. genistoides due to date of 
harvesting have been demonstrated.  Large variation in samples of the same species, attributed 
to the nature of the plant material, was also reported by De Beer & Joubert (2010).  Qualitative 
and quantitative differences are evident between Cyclopia species when considering the 
phenolic composition.  Fermentation is used as a high-temperature process that involves non-
enzymatic oxidation to develop the traditional sensory attributes.  It is, however, also  
responsible for a decrease in the content of most phenolic compounds (De Beer & Joubert, 
2010), and also antioxidant activity of all species, with the exception of the ability of C. 
genistoides to inhibit lipid peroxidation in vitro (Joubert et al., 2008b).  The unfermented plant 
material of different Cylopia spp. has a higher mangiferin content than their fermented 
counterpart after processing.     
It is apparent that the phenolic composition of Cyclopia spp. is influenced by wide-ranging 
factors, which necessitate proper characterization of the extracts when investigated for 
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biological properties.  Regarding supplementary chemical anaysis, the volatile fraction of 
unfermented and fermented C. genistoides has been studied by headspace gas 
chromatography with mass spectrometry (GC-MS) and olfactory (GC-O) detections (Le Roux et 
al., 2008; Le Roux et al., 2012) reporting major quantitative differences in fermented and 
unfermented preparations.         
 
(iii) Metabolism and bioavailability of mangiferin and other major phenolic compounds in 
honeybush 
The outcome of a number of studies on the absorption and metabolism of mangiferin is 
summarised in Table 7.  It appears that deglycosylation is not a requirement for absorption of 
mangiferin as demonstrated by the presence of the parent compound in plasma, urine, bile and 
tissue (Li & Bi, 2003; Lai et al., 2003; Wang et al., 2006; Wang et al., 2007; Li et al., 2008; Ma et 
al., 2008; Liu et al., 2011).  The oral bioavailability has, however, been shown to be relatively 
poor in the pig and rats (Bock et al., 2008; Han et al., 2010).  
The metabolites, 1,7-dihydroxyxanthone (euxanthone) and its glucuronidated derivative, 
were detected in rabbit urine after administration of an oral dose of mangiferin (Krishnaswamy 
et al., 1971).  An HPLC method was developed for determination of mangiferin in plasma and 
urine of rats after intravenous administration of 10 mg/kg (Geodakyan et al., 1992a).  This was 
followed by a pharmacokinetic study of mangiferin, the main component of the drug Alpizarin in 
rats with intravenous injection of the drug in a single dose of 0.3, 1, 3, 10 and 30 mg/kg and also 
after oral administration in a single doses of 50500 mg/kg (Geodakyan et al., 1992b).  HPLC 
analysis of plasma did not detect mangiferin.  Detection of mangiferin in rat plasma followed by 
determination of pharmacokinetic parameters after administration of Zhimu, a traditional 
Chinese medicine (TCM) containing mangiferin, indicated that mangiferin is absorbed slowly (Li 
& Bi, 2003).  Intravenous administration of three doses of mangiferin (10, 30 and 100 mg/kg) 
resulted in the presence of mangiferin in rat blood as determined using dialysis (Lai et al., 
2003).  With regards to pharmacokinetics, a linear relation was evident for the lower dose, 10 
and 30 mg/kg, while higher doses resulted in a nonlinear pharmacokinetics.  Metabolites 
identified in the bile dialysate with LC-MS/MS included methylated glucuronidated, sulphated 
and methylated mangiferin.  Phase II metabolites of mangiferin that have been detected include 
O-methylated-O-monoglucuronidated and O-methylated mangiferin in rat urine (Ma et al., 2008) 
and bile (Lai et al., 2003) and glucuronidated mangiferin (Lai et al., 2003; Ma et al., 2008).    
Sulphated mangiferin was found in rat bile (Lai et al., 2003), but sulphation could not be 
confirmed in pigs (Bock et al., 2008).   
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Table 7  A summary of studies conducted on bioavailability and in vivo detection of mangiferin.   
 
Substance 
Consumed 
Administration/ 
Dose 
Days Subjects  Method of Analysis Mangiferin and Metabolites Reference 
mangiferin   rabbit HPLC two metabolites in urine 
1,7-dihydroxyxanthone (euxanthone) and its 
glucuronide 
Krishnaswamy et al., 1971 
       
mangiferin oral  
50-500 mg/kg 
single dose rat HPLC no mangiferin detected in plasma Geodakyan et al., 1992 
       
Zhimu decoction 
TCM a (1g/mL)  
oral              
20 mL/kg 
single dose rat HPLC 
 
mangiferin detected in rat plasma  Li & Bi., 2003 
  single dose  pharmacokinetic application 
HPLC 
  Li & Bi., 2003 
mangiferin intravenous 
administration 
10, 30 and 100 
mg/kg 
single dose rat  dialysate collected every 10 
min and injected directly into 
microbore HPLC system. 
Pharmacokinetic Application 
HPLC 
mangiferin detected in rat blood 
 
10–30 mg/kg - linear relation, 
30–100 mg/kg - nonlinear pharmacokinetic 
relation 
 
Lai et al., 2003 
 intravenous 
administration 
100 mg/ kg 
 
  Phase I and II metabolites bile 
dialysate 
LC- MSMS 
 
m/z 611 (methylated glucuronidated 
mangiferin),  
m/z 501 (sulphated mangiferin), 
m/z 435 (methylated mangiferin) 
Lai et al., 2003 
a Traditional Chinese Medicine (TCM).   
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Table 7 (Cont.) 
Substance 
Consumed 
Administration/ 
Dose 
Days Subjects  Method of Analysis Mangiferin and Metabolites Reference 
mangiferin oral 
120 mg/kg 
single dose rat pharmacokinetic application 
HPLC 
mangiferin detected in plasma and urine Wang et al., 2006  
mangiferin oral 
120 mg/kg 
single dose rat  HPLC four metabolites detected in rat urine: 
1,3,7-trihydroxyxanthone,  
1,3,6,7-tetrahydroxyxanthone,  
1,3,6-trihydroxy-7-methoxyxanthone 1,7-
dihydroxyxanthone 
Wang et al., 2007 
Rhizoma 
Anemarrhenae 
extract 
15 g/kg single dose rat 
 
pharmacokinetic application 
HPLC 
mangiferin in plasma 
mangiferin was extensively distributed in most of the in 
tissue samples (brain, heart, liver, spleen, lung, kidney, 
stomach, intestine, smooth muscle, skeletal muscle and 
testis) of rats 
Li et al., 2008 
unfermented  
C. genistoides 
oral  
74 mg 
mangiferin/kg 
per day for 11 
days 
pig 
 
metabolites 
 
LC- MS 
LC-MSMS 
norathyriol in plasma 
methylated mangiferin, norathyriol and glucuronidated 
norathyriol in urine 
 
Bock et al., 2008 
unfermented  
C. genistoides 
oral  
74 mg 
mangiferin/kg 
per day for 11 
days 
pig metabolites 
 
LC- MS 
LC-MSMS 
phenolic acids detected in feces.  3,4-dihydroxybenzoic 
acid, 3,4 dihydroxyphenylacetic acid, 2,4,6-
trihydroxybenzoic acid and 3,4,5-trihydroxybenzoic acid 
Bock et al., 2010 
mangiferin intravenous 
administration 
10, 25 and 50 mg 
mangiferin /kg 
 rat HPLC 5.69  1.48 μg/ml mangiferin in the retina 0.5 h after 
administration (50 mg/kg) 
plasma concentration was dose-dependent.  
Hou et al., 2010 
mangiferin oral  
0.1, 0.3 and 0.9 g 
single dose  human 
(male)  
HPLC-MS 38.64  6.75 ng/mL mangiferin in plasma 1 h after 
administration of 0.9 g 
elimination half-life (t1/2) 7.85  1.72 
absorption increase with dose 
nonlinear pharmacokinetics 
Hou et al., 2012 
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A study with Rhizoma Anemarrhenae (Zhimu), one of the herbs used in TCM, reported that 
mangiferin was distributed extensively in different tissue samples (brain, heart, liver, spleen, 
lung, kidney, stomach, intestine, smooth muscle, skeletal muscle and testis) after oral 
administration in rats.  The highest level was present in the stomach with a concentration of 193 
μg/g at 0.5 h (Li et al., 2008).  Peak concentrations of mangiferin in the smooth and skeletal 
muscle, small intestine, heart and lung was evident after 4h and then declined.     
Oral administration of a green Cyclopia genistoides extract failed to show mangiferin or 
phase II metabolites in the plasma of pigs, while methylated mangiferin was detected in the 
urine (Kreuz et al., 2010).  The transformation of mangiferin into norathyriol by human fecal flora 
has been demonstrated in vitro (Hattori et al., 1988, Sanugal et al., 2005a; Sanugal et al., 
2005b) indicating an important role of bacteria metabolizing mangiferin in the disposition of 
norathyriol and its subsequent metabolites in vivo.  Phenolic acids detected in faeces of pigs 
after oral consumption of unfermented C. genistoides included 3,4-dihydroxybenzoic acid, 3,4 
dihydroxyphenylacetic acid, 2,4,6-trihydroxybenzoic acid and 3,4,5-trihydroxybenzoic acid (Bock 
et al., 2010).  The first pharmacokinetic study of mangiferin in humans reported a plasma 
concentration of 38.64  6.75 ng/mL plasma after oral administration of 0.9 g mangiferin and an 
apparent elimination half-life (t1/2) of 7.85  1.72 h (Hou et al. 2012).     
 
Potential adverse effects of the South African herbal teas, rooibos and honeybush 
The historical use of rooibos and honeybush as herbal teas in South Africa has led to a general 
assumption of its safety (Joubert et al., 2008a).  The safety of herbal medicines can, however, 
not always be guaranteed by long-standing use. For instance, modern phototherapy often 
incorporates the use of plants in a new manner resulting in unknown risks (Calapai, 2008).  This 
is specifically applicable to development of value added products from rooibos or honeybush.   
To date, no reports of toxicity for the normal use as a herbal tea has been documented for 
rooibos, with the exception of a case report by Sinisalo et al. (2010), indicating possible 
hepatotoxicity due to rooibos ingestion in a female with low-grade B-cell malignancy.  However, 
the adverse effects were attributed to possible contamination of the tea with hepatotoxic 
compounds, genetic predisposition and/or adverse drug interactions with the tea.  In vitro pro-
oxidant activity has been reported for rooibos (Joubert et al., 2005).  This would imply that a 
hydroxyl radical could be generated in the presence of iron, which could result in significant 
adverse effects in vivo under disease conditions when iron is mobilized.  It can, however, be 
predicted that the absorption and biotransformation will have significant effects on the activity of 
the parent compound and therefore the pro-oxidant activity displayed in vitro is not necessarily 
an indication of pro-oxdiant activity in vivo.  A mutagenic effect was evident with rooibos when 
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considering sex coupled recessive lethal mutations in Drosophila (Neethling et al., 1988).  The 
concentration used was, however, 220230 times that of the concentration of rooibos consumed 
in a normal cup of tea (Joubert et al., 2008a).      
Limited information is available on the in vivo effects of Cyclopia spp.  Most studies on the 
health associated properties of honeybush have been conducted in vitro.  Regarding, 
mangiferin, the major phenolic present in honeybush, no lethal effect was observed in rats when 
administrated up to the very high level of 1000 mg/kg body weight (Prabhu et al., 2006).  A 
study on the protection of mangiferin against isoproterenol (ISPH)-induced myocardial infarction 
(MI) and contribution toward the tissues defense system against cardiac damage (Prabhu et al., 
2006) included four different treatment groups, i.e. control, ISPH treated, mangiferin treated and 
pre-treated with mangiferin followed by ISPH treatment.  In the mangiferin treated group 
receiving 100 mg/kg bodyweight i.p. for 28 days, glutathione and antioxidant enzymes in the 
heart tissue of rats were not significantly altered when compared to the control group.  However 
these parameters were significantly improved in mangiferin pre-treated rats compared to the 
ISPH induced group (Prabhu et al., 2006).       
An important factor in the promotion of rooibos and honeybush teas in future would be 
knowledge on the potential herb-drug interaction and consequent adverse effects.  Following 
treatment of rats with rooibos for three days, the expression of CYP2C11, known to metabolise 
a variety of drugs, was inhibited (Jang et al., 2004).  Consequences of inhibition of this CYP 
would potentially include an increased half life and could lead to toxicity.  In another study 
administering rooibos in the drinking water of rats, the activity and expression of intestinal 
CYP3A were increased (Matsuda et al., 2007).  This resulted in the increased hydroxylation of 
the drug midazolam, which is a short acting benzodiazepine derivative.  CYP3A catalyzes the 
metabolism of numerous therapeutic drugs and it is therefore apparent that rooibos might 
interfere with xenobiotic metabolism presumably by interfering with the formation of the 
substrate enzyme complex.  It was recently shown that polyphenol-enriched rooibos and 
honeybush (C. subternata and C. genistoides) herbal extracts differentially alter the expression 
of genes associated with xenobiotic metabolism in rat liver and kidneys after administering in 
the feed for 28 days (Abrahams et al., 2009; Abrahams, 2012).  This study was the first 
investigation of the in vivo effects of polyphenolic-enriched extracts of the South African herbal 
teas on the expression of genes encoding xenobiotic metabolising enzymes in rat liver and 
kidneys.  The herbal teas significantly altered the gene expression of xenobiotic metabolising 
enzymes in the liver and kidneys of male Fischer rats, suggesting that rooibos and honeybush 
herbal teas can inhibit and/or enhance the metabolism of both foreign and endogenous 
compounds.  Greater effects were observed for C. subternata as compared to C. genistoides 
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inspite of significantly higher xanthone content (mangiferin and isomangiferin).  Further 
investigation into the effects on protein expression of the altered genes and enzyme binding 
was proposed to provide insight into the downstream effects.     
Other potential adverse effects of rooibos and honeybush and their products would be their 
effect on iron absorption.  The effect of tea on the absorption of iron has been a controversial 
issue for many years.  Marnewick et al. (2003) did not report any effect on the serum iron levels 
following consumption of unfermented and fermented rooibos and honeybush (C. intermedia) in 
rats for 10 weeks.  The effect of rooibos on iron absorption was investigated in 10 human 
volunteers receiving 200 ml fermented rooibos, black tea (fermented Camellia sinensis) or water 
with 20 mL milk and 20 g sugar added to each sample (Hesseling et al., 1979).  The serum 
parameters were monitored after 14 days and included hemoglobin, ferritin, transferring, serum 
iron and iron binding capacity.  No effect was indicated for rooibos, while black tea reduced iron 
uptake.  A study in school children consuming two 200 mL servings of fermented rooibos and 
black tea daily for a more extended period of 16 weeks, also did not report any adverse effects 
on the iron levels (Breet et al., 2005).  In addition, a recent study on the effect of rooibos on 
biochemical and oxidative stress parameters in adults at risk for cardiovascular disease did not 
report any effect on the serum iron levels after six weeks of consuming six cups of the  
fermented rooibos herbal tea per day (Marnewick et al., 2011).   
 
CONCLUSIONS 
 
Only rigorous scientific testing adhering to the principles of evidence-based medicine will assist 
in the use of herbal medicine to become more than a fashionable trend (Stickel & Schuppan, 
2007).  It is essential to confirm the effects observed with aglycones through studies using 
physiologic concentrations of the metabolites that have been identified in the body (Manach et 
al., 2004).  The major problems in research on the health effects of polyphenols include limited 
knowledge on biotransformation and absorption, biological activity of metabolites, absorption, 
cellular levels and excretion of these compounds.  Further complications arise from challenges 
with regards to application of the available knowledge in order to unravel the mechanisms 
involved in health effects observed for dietary polyphenols and their modulatory effects on 
enzymes.  Significant progress has nevertheless been made with respect to reseach on the 
health properties and contents of the South African herbal teas, rooibos and honeybush, 
however, many areas, such as safety and effective dose levels require further clarification.       
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IN VITRO HEPATIC BIOTRANSFORMATION OF ASPALATHIN AND NOTHOFAGIN, 
DIHYDROCHALCONES OF ROOIBOS (ASPALATHUS LINEARIS), AND 
ASSESSMENT OF METABOLITE ANTIOXIDANT ACTIVITY 
 
ABSTRACT 
 
Aspalathin (2,3,4,4,6-pentahydroxy-3-C--D-glucopyranosyldihydrochalcone) is the major 
flavonoid present in the South African herbal tea, rooibos.  In vitro metabolism of aspalathin and 
a structural analogue nothofagin, lacking the A-ring catechol group, was investigated by 
monitoring the formation of glucuronyl and sulphate conjugates using Aroclor 1254-induced and 
un-induced rat liver microsomal and cytosolic subcellular fractions.  Following glucuronidation of 
both aspalathin and nothofagin, HPLC-DAD, LC-MS and LC-MS/MS analyses indicated the 
presence of two metabolites, one major and one minor.  Only one aspalathin metabolite was 
obtained after sulphation, while no metabolites were observed for nothofagin.  Two likely sites of 
conjugation for aspalathin are 4-OH or 3-OH on the A-ring. For nothofagin, the 4-OH (A-ring) 
and 6-OH (B-ring) seem to be involved. The glucuronyl conjugates of aspalathin lack any 
radical scavenging properties in on-line post-column DPPH radical and ABTS radical cation 
assays.  Deconjugation assays utilizing glucuronidase and sulfatase resulted in the 
disappearance of the metabolites, with the concomitant formation of the unconjugated form in 
the case of the glucuronidated product.  The balance between conjugated and unconjugated 
forms of aspalathin could have important implications regarding its role in affecting oxidative 
status in intra- and extra-cellular environments in vivo. 
 
INTRODUCTION 
 
The biological properties of polyphenols have been the topic of many research investigations. 
Assessing biological activity in vitro does not give a true reflection of their activity in vivo, since 
polyphenols are known to be metabolized, especially by phase I and phase II enzymes in the 
liver, leading to high levels of conjugates in the plasma and urine (Walle, 2004).  Studies in 
animals and humans indicated that these conjugation reactions also occur in the kidneys 
(McGurk et al., 1998). This could explain why certain metabolites are not detected in blood, but 
high levels are present in urine. Metabolic alterations possibly reduce or abolish the biological 
properties associated with the parent compound in vitro (Day et al., 2000).  However, 
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conjugation/deconjugation reactions in the liver related to sulphate and glucuronide metabolites 
play an important role in the physiological regulation of xenobiotics (O’Leary et al., 2001).   
The health promoting properties of rooibos (Aspalathus linearis) have been reported in 
different in vitro and in vivo assays, stimulating studies on the bioactivity of its polyphenolic 
constituents, as they relate to their bioavailability and metabolism (Joubert et al., 2009).  
Aspalathin and nothofagin (Fig. 1), two C-linked dihydrochalcone glucosides, are the major 
flavonoid constituents in green rooibos (Joubert & Shulz, 2006) with nothofagin demonstrating 
slightly less potent antioxidant activity in an aqueous environment when using in vitro radical 
scavenging assays (Krafczyk et al., 2009; Snijman et al., 2009).  Furthermore, nothofagin 
exhibits a far less protecting effect against Fe(II)-induced lipid peroxidation in a lipid 
environment when using a hydrophobic biomembrane assay system (Snijman et al., 2009). 
Conformational differences and the absence of the catechol moiety in the nothofagin molecular 
structure were postulated to explain differences in their antioxidant effects in 
hydrophobic/hydrophilic environments.  
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Figure 1 Structures of the C-β-D-glucopyranosyl dihydrochalcone aspalathin (R1 = OH) and 
nothofagin (R1 = H).  
 
Recent studies on in vivo metabolism of aspalathin showed that its deglycosylation is not a 
prerequisite for its absorption. O-linked methyl, sulphate, glucuronide and O-methyl-O-
glucuronide aspalathin metabolites were found to occur in the urine of human subjects after 
ingesting rooibos tea (Courts & Williamson, 2009; Stalmach et al., 2009).  No nothofagin, nor 
any of its metabolites, could be detected in urine in spite of a very low detection limit (Stalmach 
et al., 2009).  Ingestion of an aspalathin-enriched green rooibos extract over a two week period 
showed no increase in the plasma antioxidant status of humans (Sauter, 2004), probably due to 
either poor bioavailability and/or loss of potency as a result of aspalathin metabolism.  A feeding 
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study with pigs conducted with a similar green rooibos extract showed that aspalathin could not 
be detected in the plasma, except in trace quantities, when a high dose (ca 480 mg/kg body 
weight) was ingested (Kreuz et al., 2008).  In contrast to Stalmach et al. (2009), Laue et al. 
(2009) found unmetabolized aspalathin in the plasma samples of humans.  
The aim of the present study was to investigate in vitro metabolism of aspalathin by 
subcellular rat liver fractions obtained from induced (Aroclor 1254) and un-induced (control) 
male Fischer rats.  The metabolism of nothofagin was also investigated to provide information 
on the possible site of conjugation since it lacks the catechol moiety. The effect of the in vitro 
biotransformation on the antioxidant activity of aspalathin was investigated with two on-line 
HPLC radical scavenging assays.  Both DPPH• and ABTS+• were used as they display different 
scavenging mechanisms.   
 
MATERIALS AND METHODS 
Chemicals and water purification                                                                                                   
Tris [hydroxymethyl] aminomethane (TRIZMA base) (99.9%), bovine serum albumin (BSA), 
Trolox (6-hydroxy-2,5,7,8-tetramethyl chroman-2-carboxylic acid, 97%), citric acid (anhydrous), 
2,2-diphenyl-1-picrylhydrazyl (DPPH), uridine 5-diphosphoglucuronic acid trisodium salt 
(UDPGA), 3-phosphoadenosine-5-phosphosulphate (PAPS), -glucuronidase type IX-A from 
E. coli (1 134 600 units/g solids), sulfatase from Helix pomatia (15 000 units/g solids), -
nicotinamide adenine dinucleotide phosphate (NADPH) and Sepharose 2B were obtained from 
Sigma Chemicals Co. (St. Louis, USA). Sodium dithionite (85%) (sodium hydrosulfite; Na2S2O4 
+ H2O; assay idiometric) and Triton-X-100 were supplied by BDH Chemicals Ltd. (Poole, United 
Kingdom).  Carbon monoxide (99.3%) was supplied by AFROX, BOC Special Products (Cape 
Town, South Africa).  Dimethyl sulfoxide (DMSO for UV-spectroscopy, 99.8%) and 2,2-
azinobis (3-ethylbenzthiazoline-6-sulfonic acid) diammonium salt (ABTS) were supplied by 
Fluka (Steinheim, Germany).  BCA protein assay reagent A containing sodium carbonate, 
sodium bicarbonate, BCA detection reagent, and sodium tartrate in 0.1 N sodium hydroxide and 
BCA protein assay reagent B were purchased from Separations (Cape Town, South Africa).  
Aroclor 1254 was obtained from Monsanto (St. Louis, USA).  Methylene chloride (99%) was 
supplied by Merck (Darmstadt, Germany).  Aspalathin and nothofagin (purity of both ≥95% as 
determined by HPLC and LC-MS) were isolated from green rooibos and supplied by the 
PROMEC (Programme on Mycotoxins and Experimental Carcinogenesis) Unit of the Medical 
Research Council (MRC) (Bellville, South Africa).  De-ionized water was prepared using a 
Modulab Water Purification System (Separations, Cape Town, South Africa).  For HPLC eluant 
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and sample preparation, de-ionized water was further purified by means of a Milli-Q 185 
Académic Plus water purification system (Millipore, Bedford, MA).  The solvents required for 
HPLC analysis were HPLC grade acetonitrile (Merck, Darmstadt, Germany) and formic acid 
(98%) supplied by BDH Chemicals Ltd. (Poole, England).  Solvents for LC-MS and LC-MS/MS 
analyses were HPLC grade acetonitrile from Romil (Cambridge, United Kingdom) and formic 
acid from Sigma Chemicals Co. (St. Louis, USA).   
 
Preparation of rat liver microsomes and cytosolic fractions 
Induced and un-induced livers were obtained from male Fischer rats.  The induction of drug 
metabolizing enzymes was conducted according to the method described by Czygan et al. 
(1973).  The induction procedure involved dilution of Aroclor 1254 in sunflower oil to a 
concentration of 200 mg/mL and administration of a single intraperitoneal injection of 500 mg/kg 
to each Fischer rat (ca 200 g) 5 days before sacrifice.  Freshly excised livers were weighed and 
washed several times in chilled KCl before being homogenised in 0.15 M KCl (3:1 w/v) for 1 
min, using a Thomas homogeniser (Maron & Ames, 1983).  The homogenate was filtered 
through double-layered cheesecloth and homogenised using 10 strokes in a glass tissue grinder 
with a tight plunger.  The homogenate was centrifuged at 9 000 x g for 10 min and aliquots of 
the supernatant (S9 fraction) were stored in glass vials at 80 ºC until use.   
Microsomal and cytosolic fractions were prepared by applying the S9 fraction to a 
Sepharose 2B column (2.8 x 30 cm, 1.7 mL/min flow rate) and eluting with a 50 mM Tris-HCl 
buffer (pH 7.4) containing 150 mM KCl.  The microsomal and cytosolic fractions were 
collected based on visual separation and stored at 80 C.  The fractions were thawed at 
room temperature on the day of the assay and diluted to the required protein concentration 
using ice-cold Tris-HCl buffer.  The protein concentration of the microsomes and cytosol was 
determined according to the method described by Kaushal and Barnes (1986), using BSA as 
standard.  The use of experimental animals was approved by the Ethics Committee for 
Research on Animals (ECRA) of the Medical Research Council (MRC) (Belleville, SA).  
 
Phase II conjugation 
The phase II conjugation of aspalathin and nothofagin was investigated using microsomal and 
cytosolic fractions as the respective sources of glucuronosyltransferase and sulfotransferase.  
Co-factors comprised UDPGA and PAPS.  The optimum protein concentration and incubation 
period for biotransformation were determined with aspalathin in preliminary experiments.  
Microsomal protein concentrations of 0.5, 1 and 2 mg/mL and cytosolic protein concentrations of 
1, 2 and 4 mg/mL were used, while incubation times investigated were 30, 60, 90, 120 and 180 
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min.  Different co-factor and aspalathin (50200 µM) concentrations were also employed to 
optimize glucuronidation.  Solvents for reconstitution of samples were evaluated for optimal 
recovery prior to HPLC analyses and included 50% acetonitrile-water, DMSO, methanol and de-
ionized water.  
 To estimate extraction recoveries of aspalathin, a spiked sample with a known concentration 
of aspalathin added prior to incubation and clean-up was included in every experiment.  
Controls were incubated in the absence of the co-factor, while sample blanks, which did not 
contain the polyphenol or co-factor, were used to screen for interfering substances in the matrix 
during HPLC and LC-MS analyses.   
The stabilities of aspalathin, nothofagin and their metabolites in the reconstituted samples 
were investigated at room temperature by repeated HPLC analysis every 4 h over a period of 24 
h.  The stabilities of aspalathin and its metabolites during storage at 20 °C were monitored by 
analyzing two samples at day 0 and again after 21 days.  
 
Glucuronidation 
A typical reaction mixture (490 μL) for glucuronidation, consisting of 100 μM nothofagin or 200 
μM aspalathin, 2 mg/mL  microsomal protein, 2 mM NADPH, 0.02% Triton-X-100 and 50 mM 
Tris-HCl buffer (pH 7.4) was equilibrated for 3 min at 37 °C.  The reaction was initiated by 
adding 10 L of a 100 mM UDPGA stock solution to obtain 2 mM in the final reaction volume 
(500 μL).  Incubations were carried out at 37 °C for 120 min in a shaking waterbath.  Each 
reaction was terminated by addition of an equal volume of ice-cold methanol to precipitate 
proteins, followed by centrifugation at 10 000 x g for 10 min at 4 °C.  The supernatant was 
extracted with 500 μL methylene chloride to remove lipids and Triton-X-100, followed by 
centrifugation at 10 000 x g for another 10 min at 4 °C.  The supernatant was evaporated to 
dryness under a stream of nitrogen gas and stored at 20 °C.  The dried samples were 
reconstituted in purified water (200 μL) and vortexed prior to HPLC analysis.   
 
Sulphation                       
The final reaction mixture (500 μL) for sulphation contained either 100 μM nothofagin or 200 
μM aspalathin, 25 mM MgCl2, 50 μM PAPS and cytosol (4 mg/mL in 50 mM Tris-HCl buffer, 
pH 7.4).  The reaction was initiated by adding 10 μL of a 2.5 mM PAPS stock solution to 
obtain 50 μM PAPS in the final reaction volume.  Samples were incubated for 60 min.  
Termination and subsequent sample preparation were conducted as described above.       
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Enzymatic hydrolysis 
Glucuronidation and sulphation of aspalathin were performed as described above.  Following 
the respective incubation periods, the conjugation reaction was terminated by centrifugation at 
16 000 x g at 4 °C for 30 min.  Aliquots (200 μL) of the respective supernatants were 
incubated for 120 min at 37 °C with 20 μL β-glucuronidase (5000 U/mL) or 20 μL sulfatase 
(125 U/mL).  This reaction was terminated by adding an equal volume of ice-cold methanol 
and further prepared for HPLC analysis as described above.  The control sample contained a 
buffer instead of β-glucuronidase or sulfatase.       
 
HPLC analysis of metabolites 
HPLC separations were conducted using an Agilent 1200 series HPLC (Agilent Technologies, 
Waldbronn, Germany) consisting of a quaternary pump, autosampler, in-line degasser, column 
thermostat, diode-array detector and Chemstation software for LC 3D systems (Rev. B.02.01).  
The column used was a 150 x 4.6 mm i.d., 3 μm, Phenomenex Luna Phenyl-Hexyl, with a 
RP/C18 5 μm Jour Guard column (Separations, Johannesburg, South Africa).  Column 
temperature was maintained at 30 C and the following solvent gradient with acetonitrile (eluent 
A) and 1% formic acid (eluent B) at a flow rate of 1 mL/min was applied: 12% A (06 min); 
1218% A (67 min); 18-25% (714 min); 25-40% A (1419 min); 40-90% A (1924 min); 90% 
A (2429 min); 9012% A (2935 min); 12% A (3540 min).  Samples were filtered through 
Millex-HV hydrophilic PVDF syringe filter units (0.45 μm, 4 mm, Millipore) directly into HPLC 
sample vials for duplicate injection (10 μL).  Tentative identification was made on the basis of 
the UV/Vis spectra and retention times of the aspalathin and nothofagin standards.  
Quantification of compounds at 288 nm for calculation of recoveries was based on peak area, 
obtained with valley-to-valley integration.  The concentration range of the respective calibration 
series used for quantification was based on the expected concentration of the compounds in the 
spiked samples.   
  
Liquid chromatography-mass spectrometry (LC-MS) analyses  
LC-MS analysis of glucuronidated and sulphated samples was performed using a Waters API 
Quattro Micro triple quadropole mass spectrometer connected to a Waters Alliance 2690 
quaternary HPLC pump with a 966 diode-array detector (Waters, Milford, MA.).  Sample 
preparation and separation conditions were the same as described for HPLC analysis.  
Electrospray ionization in the negative mode was carried out under the following conditions: 
Stellenbosch University  http://scholar.sun.ac.za
 85  
desolvation temperature, 370 °C; nitrogen flow rate, 350 L/h; source temperature, 100 °C; 
capillary voltage, 3.5 kV and cone voltage, 18 V.  
Liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) analysis 
For further confirmation of aspalathin conjugation LC-MS/MS analysis was performed using a 
Waters API QTOF Ultima apparatus with a Waters UPLC system.  Sample preparation and 
separation conditions were the same as described for HPLC analysis.  Electrospray ionization in 
the negative mode was carried out under the following conditions: desolvation temperature, 350 
°C; nitrogen flow rate, 350 L/h; source temperature, 100 °C; capillary voltage, 3.7 kV; cone 
voltage, 35 V and collision energy 20.   
 
Qualitative assessment of radical scavenging ability of aspalathin metabolites 
The sample mixture containing aspalathin and its glucuronidated metabolites was subjected to 
on-line HPLC-DPPH• and HPLC-ABTS+• analyses.  The on-line radical scavenging methods 
were set up as described by Dapkevicius et al. (2001) and Pellegrini et al. (2003), 
respectively, with some modifications to improve radical intensity and prevent precipitation.   
The on-line system consisted of an LKB Bromma 2150 HPLC pump (Bromma, Sweden), in-
line Phenomenex Degasser Model DG-4400 and LKB Bromma 2151 UV/Vis variable 
wavelength detector and is presented in a diagram in Addendum B.  Mixing of the HPLC 
effluent and the radical solution, at a flow rate of 0.5 mL/min, was achieved with a high 
pressure static mixing tee (Upchurch, Anatech, Cape Town, South Africa).  The reaction coil 
was made of 5.24 m PEEK tubing (0.25 mm i.d.) to give a reaction time of 0.5 min.  Data were 
captured using DataApex Clarity v2.4.1.91 software (DataApex, Prague, Czech Republic).  
Scavenging of the DPPH• and ABTS+• was detected as negative peaks at 515 and 430 nm, 
respectively.  An injection volume of 30 L was used.   
 The DPPH• stock solution (58 mg/L) was freshly prepared in acetonitrile on the day of 
analysis and kept in a flask protected from light.  The working solution, containing 250 mL of a 
0.068 mM citric acid phosphate buffer (6.8 mL of 0.01 M citric acid added to 93.2 mL of 0.02 
M Na2HPO4 and made up to 1000 mL with de-ionized water) and 750 mL DPPH• in acetonitrile 
was filtered (0.45 m PVDF-filter, Milipore) before use.   
The ABTS+• stock solution (7 mM) was prepared as described by Pelligrini et al. (2003). A 
working solution was prepared on the day of the analysis and contained 250 mL citric acid 
phosphate buffer (6.8 mL 0.01 M citric acid and 93.2 mL 0.02 M Na2HPO4 made up to 1000 
mL with de-ionized water), 25 mL ABTS+• stock solution and 750 mL acetonitrile.  The 
temperature of the ABTS+• solution was maintained at 4 C using a thermostatically-controlled 
cooling bath.   
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The antioxidant activity of the sulphated aspalathin and glucuronidated nothofagin was not 
investigated since only a low level of biotransformation was achieved.  It would not have been 
likely to observe activity of the metabolites at such a low concentration in the on-line system. 
 
RESULTS 
 
Optimization of phase II conjugation 
The solvent used for reconstitution of the samples had a significant effect on the compound 
separation and repeatability of the HPLC chromatograms.  De-ionised water proved to be the 
optimum solvent for reconstitution (data not shown).  Incubation for 120 min was sufficient to 
obtain a relatively high level of glucuronidated metabolites, while 60 min was adequate for 
sulphation.  Aspalathin was stable in the reconstituted samples at room temperature over 24 h 
and when stored at 20 ºC for 21 days, with its extraction recoveries varying from 90100%.  In 
contrast, nothofagin and its metabolites were rapidly degraded over time.  Samples were 
therefore reconstituted less than 10 min before injection.  No matrix peaks were observed in 
sample blanks in either microsomal or cytosolic fractions with HPLC and LC-MS analyses.  
 
Glucuronidation  
No metabolism was observed when incubating with the microsomal fraction (induced and un-
induced) in the absence of the co-factor UDPGA (control samples) (Fig. 2A and 2C). 
Glucuronidation of aspalathin with induced microsomes resulted in two conjugates, represented 
in the HPLC chromatogram (Fig. 2B) by one minor peak (AG1) and one major peak (AG2).  The 
retention times of AG1 and AG2 (10.65 and 11.54 min, respectively) corresponded to molecular 
species more polar than aspalathin (tr = 11.95).  Incubation with un-induced microsomes 
resulted in only one peak with the same retention time as AG2. In this case a substantially 
smaller metabolite peak was obtained (data not shown).  The LC-MS analysis confirmed the 
presence of a pseudomolecular ion ([M-H]-) with m/z 627 (Table 1) for both peaks, indicating 
two regio-isomers of monoglucuronidated aspalathin.  Treatment with β-glucuronidase resulted 
in the disappearance of both peaks (AG1 and AG2), with concomitant formation of aspalathin 
observed as an increase in the aspalathin peak (data not shown).  LC-MS/MS analysis resulted 
in the characteristic C-linked glycoside losses of 90 and 120 amu, giving the respective 
fragment ions m/z 361 and 331 for aspalathin, and m/z 537 and 507 for both aspalathin 
glucuronides, AG1 and AG2.  Although the same fragment ions were produced for these 
metabolites, their relative abundance differed (Table 2).  The neutral loss of 176 amu to give a 
fragment ion with m/z 451 is due to the cleavage of the glucuronide moiety.  
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Glucuronidation of nothofagin with induced microsomes also resulted in two metabolites, 
one major (NG1) and one minor peak (NG2) (Fig. 2D).  LC-MS analysis of the two metabolites 
gave [M-H]- ions at m/z 611 (Table 1), indicating that NG1 and NG2 correspond to two regio-
isomers of monoglucuronidated nothofagin.  Incubation with un-induced microsomes only 
resulted in the presence of the major metabolite (NG1) (Table 1) and the extent of 
biotransformation was less than with induced microsomes (data not shown).            
 
Sulphation  
No metabolism was observed when incubating the compounds with the cytosolic fraction 
(induced and un-induced) in the absence of the co-factor PAPS (control samples) (Fig. 2E).  
Sulphation of aspalathin with the Aroclor-induced cytosolic rat liver fraction resulted in one 
metabolite (AS) (Fig. 2F).  A metabolite eluting at the same retention time was present when 
incubating aspalathin with un-induced cytosol.  The retention time of AS (16.15 min) 
corresponds to a molecular species less polar than aspalathin (tr = 11.71).  LC-MS analysis of 
the sulphated samples of both induced and un-induced cytosolic fractions gave a 
pseudomolecular ion [M-H]- with m/z 531 (Table 1).  Treatment with sulfatase resulted in 
disappearance of AS, but also decreased the concentration of aspalathin. The sulphated 
metabolite (m/z 531) produced a fragment ion with m/z 451 (aspalathin) upon loss of 80 amu 
(sulphate moiety).  The other two fragment ions present were m/z 361 and 331, characteristic of 
aspalathin.  No sulphation of nothofagin was observed under the experimental conditions. HPLC 
analysis did not show any additional peaks to those present in the controls after incubation.      
 
Qualitative assessment of radical scavenging ability of metabolites 
The combined HPLC and DPPH• quenching chromatograms of aspalathin and its 
glucuronidated metabolites (AG1 and 2) are shown in Fig. 3A.  Aspalathin scavenged DPPH•, 
as manifested by the decrease in absorbance, while no activity was obtained for the conjugates, 
even though considering that AG2 was present in a slightly higher concentration than 
aspalathin.  This difference in peak height between AG2 and aspalathin was even more 
prominent in the sample used for testing the ABTS+• scavenging ability of the metabolites (Fig. 
3B).  In spite of this, and the greater sensitivity of the ABTS+• scavenging assay, as implicated 
by the positive/negative peak ratio’s for aspalathin in the respective assays, no activity could be 
demonstrated for the metabolites.      
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Figure 2 Representative HPLC chromatograms showing a control (absence of UDPGA) sample 
spiked with aspalathin (A), a sample containing aspalathin glucuronides (AG1 and AG2) (B), a 
control sample spiked with nothofagin (absence of UDPGA) (C), a sample containing nothofagin 
glucuronides (NG1 and NG2) (D), a control (absence of PAPS) sample spiked with aspalathin (E), 
and a sample containing sulphated aspalathin (F).   
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Table 1  LC-MS of aspalathin, nothofagin and glucuronidated and sulphated metabolites. 
Liver fraction Compound Mr LC-MS ions (m/z) 
 Aspalathin 452 451 
Induced microsomes Aspalathin monoglucuronide (AG1) 628 627 
Induced microsomes Aspalathin monoglucuronide (AG2) 628 627 
    
Un-induced microsomes Aspalathin monoglucuronide (AG2) 628 627 
    
Induced cytosol Aspalathin monosulphate (AS) 531 531 
    
Un-induced cytosol Aspalathin monosulphate (AS) 531 531 
    
 Nothofagin 436 435 
Induced microsomes Nothofagin monoglucuronide (NG1) 612 611 
Induced microsomes Nothofagin monoglucuronide (NG2) 612 611 
    
Un-induced microsomes Nothofagin monoglucuronide (NG1) 612 611 
    
Induced cytosol Nothofagin sulphate nd a nd a 
a nd not detected.   
 
Table 2  LC-MS/MS of aspalathin and glucuronidated and sulphated metabolites.      
 
 
Compound 
Precursor ion 
(m/z) 
LC-MS/MS product ions 
(m/z) (% relative abundance) 
Aspalathin 451 361 (13); 331 (100); 209 (52); 167 (35) 
Aspalathin monoglucuronide (AG1)  627 627 (7); 537 (100); 507 (84); 361 (48); 331 (43) 
Aspalathin monoglucuronide (AG2) 627 627 (13); 537 (74); 507 (100); 361 (26); 331 (33) 
Aspalathin monosulphate 531 531 (13.57); 451 (41.65); 361 (100); 331 (62.42) 
Stellenbosch University  http://scholar.sun.ac.za
 90  
 
 
                                  
   
 
    
 
 
 
 
 
Figure 3 Combined UV and radical quenching chromatograms of aspalathin and glucuronidated 
metabolites.  DPPH• (A); ABTS+• (B).  
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DISCUSSION 
 
Conjugation of catechols is one of the major metabolic reactions that occur in biological systems 
and allows for their rapid excretion into the bile and urine (Antonio et al., 2002).  Conjugation 
reactions are mainly catalyzed by UDP-glycuronosyltransferases (UGT), sulfotransferases 
(SULT), and the catechol O-methyl transferases (COMT) (Manach et al., 2004).  Competition 
between the different conjugation reactions for the same substrate depends on various factors.  
These include the dosage of the polyphenol and the hydrophobic/hydrophilic nature of the 
subcellular environment (Koster et al., 1981; Antonio et al., 2002).  An increased dose will result 
in a shift from sulphation toward glucuronidation, since sulphation is generally a higher-affinity, 
lower-capacity pathway than glucuronidation (Koster et al., 1981).  Methylation by COMT also 
results in a shift of conjugation of polyphenols from sulphation to glucuronidation (O’Leary et al., 
2003). 
Aspalathin, due to its prominence and radical scavenging activities, has been implicated in 
many of the antioxidant properties of rooibos (Joubert et al., 2009).  Nothofagin is also a good 
ABTS •+ scavenger (Snijman et al., 2009), and is of particular interest for the present study due 
to the absence of the catechol group, from which insight might be gained on the relative position 
of conjugation of dihydrochalcone C-glycosides.  Aroclor 1254 was selected as an enzyme 
inducer, since it has been shown to enhance the glucuronidation rate of catechols up to 15-fold 
in rat liver microsomes (Elovaara et al., 2004).  One major and one minor glucuronidated 
product of both aspalathin and nothofagin were observed after incubation with Aroclor 1254-
induced microsomes.  The presence of the aspalathin glucuronides was confirmed by LC-MS as 
indicated by a neutral loss of m/z 176, representing the glucuronide moiety.  The fragmentation 
pattern of aspalatin and aspalathin-O-glucuronide, which is characteristic of C-linked glycosides 
(Kazuno et al., 2005), was in accordance with that previously reported (Stalmach et al., 2009; 
Kreuz et al., 2008).     
Only one minor product was noticed for aspalathin and nothofagin when incubated with un-
induced microsomes.  PCB inducers such as Aroclor 1254 have been found to induce several 
UGT activities and, in particular, high-affinity enzyme isoforms (Elovaara et al., 2004), which 
explains the higher level of biotransformation and additional metabolite observed when using 
induced microsomes.  This study indicates that the major glucuronidated product of aspalathin 
and nothofagin results from conjugation at the 4-OH, since nothofagin lacks the 3-OH on the A-
ring.  Glucuronidation studies of quercetin with human liver microsomes indicated four products 
of which the catechol (4-OH) also represents the major conjugate, followed by the 3-OH (Day 
et al., 2000).  The minor glucuronidated product of aspalathin may result from conjugation of the 
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3-OH on the catechol group or one of the OH groups on the B-ring, presumably the 6-OH, due 
to the steric hindrance of the C-glycoside involving the 2- and 4-OH groups.  This became 
evident as it is known that conformational distribution of these dihydrochalcone exists due to 
hydrogen bonding between the C2 and C4-OH groups and the C2-OH and the ethereal 
oxygen of the glucopyranosyl moiety (Snijman et al., 2009).  The minor glucuronidated 
metabolite of nothofagin will therefore most likely result from conjugation on the 6-OH.     
Sulphation yielded one minor conjugated product for aspalathin with both induced and un-
induced rat liver cytosolic fractions.  The MS fragmentation pattern obtained after sulphation 
was analogous to that reported for an aspalathin-O-sulphate (Stalmach et al., 2009).  Sulphation 
seems to be one of the major pathways in the conjugation of aspalathin, since aspalathin-O-
sulphate, in addition to O-methyl glucuronide and O-methylsulphate conjugates has been 
identified in human urine (Stalmach et al., 2009).  Nothofagin was not sulphated, which implies 
that the catechol is required for sulphation, or that the sulphated product is unstable under in 
vitro and in vivo conditions.  
The relative contribution of the conjugation reactions in the metabolism of aspalathin will 
depend on the distribution of aspalathin between the aqueous and lipid phases within the cell.  
At physiological pH of 7.4 most polyphenols are associated with the polar head groups of the 
membrane phospholipids.  This makes the OH groups more accessible to glucuronidation 
(Verstraeten et al., 2003).  However, more polar metabolites will largely favor the aqueous 
compartment phase, making them more accessible to cytosolic conjugation such as methylation 
and sulphation.  As the major urinary metabolite of aspalathin in humans is O-methyl 
glucuronide (Stalmach et al., 2009) it would appear that methylation in the cytosol and the 
subsequent glucuronidation in the endoplasmic reticulum are the major conjugating pathways 
involved.  This agrees with the notion that methylation diverts the conjugation reaction away 
from sulphation (O’Leary et al., 2003).   
Although conjugation of polyphenols has been recognized for many years, most biological 
studies have been carried out with the unmetabolized, naturally occurring, plant polyphenols.  
Glucuronidated products are one of the predominant forms of flavonoids in blood circulation and 
their biological activities have been of interest (Zhang et al., 2007).  However, very little is 
known about the biological properties of conjugated polyphenolic derivatives due to the lack of 
commercial standards.  Conjugation renders them more hydrophilic than the parent compounds, 
which may affect their site of action and their interaction with antioxidants in the cell if they retain 
their antioxidant properties.  In the present study the on-line HPLC antioxidant assays, utilizing 
DPPH• and ABTS+•, showed that glucuronidation of aspalathin eradicated its antioxidant 
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properties under the assay conditions.  The assay conditions, however, do not allow detection of 
slow radical scavenger due to the reaction time (Dapkevicius et al., 2001). 
Although aspalathin metabolites apparently lost their radical scavenging properties the 
conjugated products are likely, as in the case of quercetin conjugates, to exhibit some other 
biological properties (Day et al., 2000; Zhang et al., 2007).  Quercetin conjugates retain 
differential inhibitory function of xanthine oxidase and lipooxygenase with the 4'-O-
glucuronidated product exhibiting an inhibitory effect relative to the parent compound with 
respect to inhibition of the xanthine oxidase (Day et al., 2000).  Glucuronides of quercetin and 
epicatechin also possess biological activity, including antioxidant activity and inhibition of the 
growth of human lung cancer cells (Zhang et al., 2007).  The antioxidant activity of the 
nothofagin metabolite was not tested in the present study, but based on its structure and relative 
antioxidant activity in the ABTS+• assay (Snijman et al., 2009), it may be assumed that these 
metabolites would also display no activity.  The antioxidant activity of the sulphated aspalathin 
was not investigated, since only a low level of biotransformation was achieved and it would not 
have been likely to observe activity of the metabolite at such a low concentration in the on-line 
system. 
Unconjugated polyphenols and some of their conjugates may accumulate in the body to 
produce pharmacological activities (Zhang et al., 2007).  Therefore, despite the poor 
bioavailability of aspalathin and nothofagin (Joubert et al., 2009; Stalmach et al., 2009) they are 
likely to accumulate in tissue and body fluids and still exert effects due to being available in both 
conjugated and unconjugated forms. In this regard, unmetabolized aspalathin has been 
detected in human plasma (Laue et al., 2009).  In addition to the liver, glucuronidation could 
also occur in the kidneys and contribute to the presence of the conjugated products of 
aspalathin found in the urine of humans after consumption of rooibos (Courts & Williamson, 
2009; Stalmach et al., 2009).  Some isoforms such as UGT1A8/9 that are highly expressed in 
the human kidney (McGurk et al., 1998) exhibit a broad spectrum of substrate specificity, and 
could be involved in the metabolism of aspalathin.  Low concentrations of nothofagin in rooibos 
and/or the poor stability of the parent compound and metabolites could be reasons why they 
were not detected in urine.  In this regard phase II metabolism and subsequent bile excretion 
coupled to microbial metabolism is likely to lead the enterohepatic recycling of conjugated and 
deconjugated forms.  As the deconjugating enzyme -glucuronidase is present in the blood, 
liver and kidneys, it will result in sustained hepatic and/or blood circulation of polyphenols and/or 
their metabolites (O’Leary et al., 2001).  Lysosomal -glucuronidase released from neutrophils 
can deconjugate flavonoid glucuronides to the aglycone when injury such as inflammation occur 
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(O’Leary et al., 2001).  The turnover rate of the conjugated and unconjugated forms of 
aspalathin will be important to evaluate its biological properties in vivo. 
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MANGIFERIN GLUCURONIDATION: IMPORTANT HEPATIC MODULATION OF 
ANTIOXIDANT ACTIVITY 
 
ABSTRACT 
 
Mangiferin displays an extensive spectrum of pharmacological properties, including antioxidant 
activity.  Its phase II metabolism in the presence of Aroclor 1254-induced and un-induced 
microsomal and cytosolic fractions from rat liver and the antioxidant potency of the 
glucuronidated conjugates were investigated.  Mangiferin was not a substrate for the cytosolic 
sulfotransferases. Glucuronidation led to the formation of two monoglucuronidated metabolites 
of mangiferin and a monoglucuronidated metabolite of homomangiferin (a minor constituent of 
the mangiferin standard).  Deconjugation utilising glucuronidase resulted in the disappearance 
of the metabolites, with the concomitant formation of the two parent compounds.  Considering 
steric hinderance caused by the C-2 glucosyl moiety and the relative acidity of the xanthone OH 
groups, the 6-OH of mangiferin and, to a lesser degree the 7-OH, are likely to be the primary 
glucuronidation targets.  The ferric iron reducing ability of the glucuronidated reaction mixture 
was reduced, while the free radical scavenging abilities of mangiferin, utilising on-line post-
column HPLC-DAD-DPPH• and HPLC-DAD-ABTS•+ assays, were eliminated, providing further 
evidence that the catechol arrangement at C-6 and C-7 was the preferred site of conjugation.  
This paper provides the first evidence that the glucuronidated metabolites of mangiferin resulted 
in a loss in free radical scavenging and ferric iron reducing ability.  
 
INTRODUCTION 
 
Mangiferin (1,3,6,7-tetrahydroxy-xanthone-C2-β-D-glucoside) (Fig. 1) is increasingly receiving 
attention as a major biologically active compound in plant extracts used in traditional medicines 
(Li, 2002; Pinto et al., 2005).  A wide spectrum of pharmacological properties has been 
attributed to mangiferin with the antioxidant properties forming the basis for some of the 
biological effects, including anti-inflammatory and immunomodulatory effects  (Pinto et al., 
2005).  An aqueous extract of mango bark with mangiferin as major constitutent has recently 
been commercialised as the antioxidant nutritional supplement, Vimang® (Núñez-Sellés et al., 
2002). 
Occurrence of mangiferin in the normal diet is limited, with exposure largely due to 
consumption of mango, and recently also the herbal tea, honeybush, prepared from Cyclopia 
species (family Fabaceae; tribe Podalyrieae) (Joubert et al., 2009).  Use of this South African 
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herbal tea has become very popular during the past 10 years and apart from the major markets 
(Germany, the Netherlands, United Kingdom and United States of America) also includes 
traditional tea-drinking countries such as India, Japan and China (Joubert et al., 2011).  The 
dietary burden of mangiferin contributed by honeybush will depend on the Cyclopia species and 
the state of processing of the plant material.  Traditionally, honeybush was consumed in 
‘fermented’ (oxidised) form, which contains much lower levels of mangiferin than the plant 
material as a result of its degradation during ‘fermentation’.  The subsequent decrease in in vitro 
antioxidant and antimutagenic activity of the herbal tea (Van der Merwe et al., 2006; Joubert et 
al., 2008a) resulted in the development of green honeybush tea for the preparation of 
mangiferin-enriched antioxidant extracts for the food and nutraceutical markets.  
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Figure 1 Structures of mangiferin (R = H) and homomangiferin (R = CH3). 
 
In vitro antioxidant activity observed for plant extracts does not necessarily lead to an in vivo 
biological effect due to poor bioavailability, rapid metabolism and excretion and the role of efflux 
transporters (Liu & Hu, 2007).  Polyphenols are treated by the body as xenobiotics, undergoing 
detoxification by phase II conjugating enzymes.  Although information on the changes in 
biological activity of the metabolites is limited, some studies showed that at least some of the 
antioxidant activity of the parent compound is retained. Investigations of dietary polyphenols 
have focussed on the ubiquitous flavonol, quercetin, tea flavan-3-ols, the citrus flavanones, 
naringenin and hesperetin, and the grape stilbene, resveratrol (Manach et al., 1998; Day et al., 
2000a; Lu et al., 2003; Justino et al., 2004; Pollard et al., 2006; Hoshino et al., 2010; Dueñas et 
al., 2011).  
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Studies using the pig and rat confirmed poor oral bioavailability for mangiferin (Bock et al., 
2008; Han et al., 2010).  Oral administration of a green Cyclopia genistoides extract failed to 
show mangiferin or phase II metabolites in the plasma of pigs, while methylated mangiferin was 
detected in the urine.  Studies on rats reported the presence of the parent compound in plasma, 
urine, bile and tissue of rats (Lai et al., 2003; Li & Bi, 2003; Wang et al., 2006; Wang et al., 
2007; Li et al., 2008; Ma et al., 2008).  Phase II metabolites, specifically O-methylated-O-
monoglucuronidated and O-methylated mangiferin, have been detected in rat urine (Ma et al., 
2008) and bile (Lai et al., 2003).  Sulphated mangiferin was found in rat bile (Lai et al., 2003), 
but sulphation could not be confirmed in pigs (Bock et al., 2008).  Sulfotransferases are either 
absent in pigs or some of the isoforms are present at low levels when compared to UDP-
glucuronyltransferases (Witkamp & Monshouwer, 1998). The interaction between 
sulfotransferase and glucuronidation pathways is of interest and it appears that the former is 
active at low concentrations, while the latter comes into play at higher concentrations of plant 
polyphenols (Williamson et al., 2000). 
Mangiferin is the major antioxidant of Cyclopia species and has been recently implicated in 
the chemopreventative properties of Cyclopia intermedia (Marnewick et al., 2005; Marnewick et 
al., 2009; Sissing et al., 2011), necessitating insight into the biological properties of its 
conjugated metabolites.  The aim of the present study was to investigate phase II conjugation, 
i.e. glucuronidation and sulphation, of mangiferin by subcellular rat liver fractions obtained from 
Aroclor 1254-induced and un-induced male Fischer rats.  Aroclor 1254 enzyme induction 
(Lilienblum et al., 1982) was aimed at achieving a higher concentration of conjugated 
metabolites that would facilitate the screening of their potential antioxidant activity.  The effect of 
the in vitro biotransformation on the antioxidant activity of the reaction mixture was investigated 
with the ferric reducing antioxidant power (FRAP) assay.  In lieu of isolating the metabolites for 
testing of activity, two on-line HPLC-DAD (diode array detector) radical scavenging assays, 
using the synthetic radicals, 2,2-diphenyl-1-picrylhydrazyl (DPPH•) and 2,2-azinobis(3-
ethylbenzthiazoline-6-sulfonic acid (ABTS•+), were applied to qualitatively assess the in vitro 
antioxidant activity of the individual metabolites relative to the parent compound.  
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MATERIALS AND METHODS 
 
Chemicals  
General analytical grade laboratory reagents were purchased from Sigma-Aldrich (St. Louis, 
USA) and Merck (Darmstadt, Germany).  Mangiferin from Mangifera indica leaves ( 98%), 
bovine serum albumin (BSA), 2,2-diphenyl-1-picrylhydrazyl (DPPH), uridine 5-diphos 
phoglucuronic acid trisodium salt (UDPGA), 3-phosphoadenosine-5-phosphosulphate (PAPS), 
-glucuronidase type IX-A from E. coli (1 134 600 Units/g solids), -nicotinamide adenine 
dinucleotide phosphate (NADPH), Sepharose 2B, 2,4,6-tri(2-pyridyl)-s-triazine (TPTZ) (Fluka), 
2,2-azinobis(3-ethylbenzthiazoline-6-sulfonic acid) diammonium salt (ABTS) (Fluka) and Trolox 
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) (Aldrich) were obtained from Sigma-
Aldrich.  The BCATM protein assay kit was obtained from Pierce (Pierce Perbio Science France, 
Brebières, France), while Aroclor 1254 was from Monsanto (St. Louis, USA).  General purpose 
laboratory grade de-ionised water was prepared using a Modulab Water Purification System 
(Continental Water Systems Corp., San Antonio, USA).  The solvents required for HPLC 
analysis were HPLC grade acetonitrile (Merck), formic acid (BDH Chemicals Ltd) and de-ionised 
water, further purified by means of a Milli-Q 185 Académic Plus water purification system 
(Millipore, Bedford, USA).  Solvents for liquid chromatographymass spectrometry (LC-MS) and 
liquid chromatography tandem mass spectrometry (LC-MS/MS) analyses were HPLC grade 
acetonitrile (Romil, Cambridge, United Kingdom) and formic acid (Sigma).  
 
Preparation of rat liver microsomes and cytosolic fractions 
The induction of drug metabolising enzymes in male Fisher 344 rats with Aroclor 1254 was 
conducted according to the method described by Czygan et al. (1973).  Preparation of the S9 
fraction of induced and un-induced rat livers and the microsomal and cytosolic fractions were 
carried out as described by Van der Merwe et al. (2010).  The protein concentration of the 
microsomal and cytosolic fractions was determined with the BCA protein assay kit according to 
the method described by Kaushal & Barnes (1986), using BSA as standard. The use of 
experimental animals was approved by the Ethics Committee for Research on Animals (ECRA) 
of the Medical Research Council (MRC) (Belleville, SA). 
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Phase II conjugation 
 
Preliminary studies 
Microsomal and cytosolic fractions were used as the respective sources of 
glucuronosyltransferase and sulfotransferase.  Optimum conditions for glucuronidation of 
mangiferin, including protein and co-factor concentrations and incubation period, were 
determined.  A spiked sample containing a known concentration of mangiferin (added before 
incubation and cleanup) was included to estimate extraction recoveries.  Control samples, 
incubated in the absence of the co-factor and sample blanks (without co-factor and mangiferin), 
were used to screen for interfering substances in the matrix during HPLC and LC-MS analysis.  
Two methods for sample clean-up before analysis were investigated, i.e. solid phase extraction 
and protein precipitation using methanol.  Samples were dried after clean-up and different 
reconstitution solvents, i.e.  50% acetonitrile-water, dimethyl sulfoxide (DMSO), methanol and 
de-ionised water were evaluated in terms of HPLC separation of peaks and repeatability.  
Differences in solubility of mangiferin and its metabolites between reconstitution solvents 
resulted in major variation of the HPLC results and poor separation in some cases.  De-ionised 
water proved to be the optimum solvent for reconstitution, resulting in consistent and repeatable 
HPLC results.  An incubation time of 60 min resulted in a high level of glucuronidated 
metabolites.  No interfering matrix peaks were observed in the sample blanks of either the 
microsomal or cytosolic fractions with HPLC and LC-MS analyses.  
Protein precipitation with methanol and liquid-liquid extraction with methylene chloride for 
sample clean-up before HPLC and LC-MS was achieved by addition of an equal volume of ice-
cold methanol, which also terminated the conjugation reaction, followed by centrifugation at 
10,000 × g for 10 min at 4 °C.  The supernatant was extracted with 500 μL of methylene 
chloride to remove lipids and Triton-X-100, followed by centrifugation at 10 000 × g for 10 min at 
4 °C. The supernatant was evaporated to dryness under a stream of nitrogen and stored at 20 
°C.  The dried samples were reconstituted in 200 μL purified water and vortexed prior to HPLC 
analysis. 
Solid phase extraction (SPE) was investigated as a further clean-up method, after protein 
precipitation and liquid-liquid extraction.  Samples were reconstituted to 1 mL with water, mixed 
thoroughly and 900 μL applied on a SPE column (PS-RP, 3 mL/500 mg, Chromabond; 
Macherey-Nagel, Düren, Germany), pre-conditioned with 2 mL methanol and 5 mL potassium 
phosphate buffer (50 mM, pH 3). After applying the sample, it was washed with 5 mL each of 
buffer and de-ionised water, eluted with 8 mL methanol and analysed directly with HPLC.  The 
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remaining 100 μL was subjected to HPLC analysis without SPE cleanup.  An extremely low 
amount of mangiferin was detected after elution with methanol (less than 50%). Subsequently, 
only the protein precipitation method using ice-cold methanol followed by methylene chloride for 
sample clean-up was used before HPLC and LC-MS analyses.  Extraction recoveries of 
mangiferin from the microsomal fraction varied between 75 and 83%.  All peaks in the reaction 
mixture after glucuronidation of the mangiferin standard were stable at room temperature over a 
24 hour period and all analyses were carried out within this period. 
 
Glucuronidation 
The reaction mixture for glucuronidation contained 200 μM mangiferin, 2 mg/mL microsomal 
protein, 2 mM NADPH, 0.02% Triton-X-100 and 50 mM Tris-HCl buffer (pH 7.4) in a final 
volume of 500 μL.  Samples were equilibrated for 3 min at 37 °C and the reaction was initiated 
by adding 2 mM UDPGA in 50 mM Tris-HCl buffer. Incubations were carried out at 37 °C for 
60 min by continuous shaking.  The reaction was terminated by the addition of an equal 
volume (500 μL) of ice-cold methanol, followed by methylene chloride extraction and sample 
preparation as described.  The stability of mangiferin and the glucuronides were monitored 
over 24 hrs at room temperature. 
 
Sulphation 
The sulphation of mangiferin (100 μM) was conducted in the presence of 25 mM MgCl2, 50 
μM PAPS and cytosol (4 mg/mL in 50 mM Tris-HCl buffer, pH 7.4) in a final volume of   500 
μL.  The reaction was initiated by addition of 10 μL of a 2.5 mM PAPS stock solution prepared 
in 50 mM Tris-HCl buffer.  The samples were incubated for 60 min in a shaking water bath at 
37 °C.  The reaction was terminated by the addition of ice cold methanol, followed by 
methylene chloride extraction and sample preparation as described. 
 
Enzymatic hydrolysis of glucuronidated metabolites 
Glucuronidation was performed as described. Following the incubation period, the conjugation 
reaction was terminated by centrifugation at 16 000 × g at 4 ºC for 30 min. Aliquots (200 μL) of 
the supernatant were incubated for 120 min at 37 ºC with 20 μL of β-glucuronidase (5000 
Units/mL).  The reaction was terminated by adding an equal volume of ice-cold methanol, 
followed by methylene chloride extraction and sample preparation as described for 
glucuronidation.  The control sample contained an equal amount of buffer instead of β-
glucuronidase. 
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HPLC analysis of glucuronidated metabolites 
HPLC separations were conducted using an Agilent 1200 series HPLC (Agilent Technologies, 
Waldbronn, Germany) consisting of a quaternary pump, autosampler, column thermostat, diode-
array detector and Chemstation software for LC 3D systems.  Separation was achieved at 30 C 
on a Phenomenex Synergy Fusion-RP column (150 × 4.6 mm i.d.; 4 m particle size, 80 Å pore 
size), protected with a RP/C18 5 μm particle size Jour Guard column (Vici AG International, 
Schenkon, Switzerland).  The following solvent gradient with acetonitrile (eluant A) and 0.1% 
formic acid (eluant B) at a flow rate of 1 mL/min was applied: 10% A (05 min); 1015% A (512 
min); 1590% A (1216 min); 9040% A (1617 min); 4010% A (1721 min).  Samples were 
filtered through Millex-HV hydrophilic PVDF syringe filters (0.45 μm pore size, 4 mm diameter, 
Millipore) directly into a HPLC sample vial for duplicate injection (10 μL).  Tentative identification 
was achieved on the basis of the UV/Vis spectrum and retention time of mangiferin.  
Quantification of compounds at 320 nm for calculation of recoveries was based on peak area.  
The glucuronidated conjugates and the impurity in the mangiferin standard were quantified in 
terms of mangiferin, assuming the same molar extinction coefficients.  The concentration range 
of mangiferin used for the calibration standards was based on the concentration used in the 
spiked samples. 
 
Liquid chromatography-mass spectrometry (LC-MS) and -mass spectrometry/mass 
spectrometry (LC-MS/MS) analysis   
LC-MS analysis of glucuronidated samples was performed using a Waters API Quattro Micro 
triple quadropole mass spectrometer, connected to a Waters Alliance 2690 quaternary HPLC 
pump with a 966 photodiode array detector (Waters, Milford, USA), applying the same 
separation conditions as for HPLC analysis.  Electrospray ionisation in the negative mode was 
carried out under the following conditions: desolvation temperature, 350 °C; nitrogen flow rate, 
350 L/h; source temperature, 100 °C; capillary voltage, 3.5 kV; and cone voltage, 18 V. 
For further confirmation of mangiferin conjugation, LC-MS/MS analysis of mangiferin 
glucuronides was performed using a Waters API QTOF Ultima apparatus equipped with a 
Waters UPLC system, consisting of a quarternary pump and autosampler.  The same 
separation conditions as for HPLC were applied. Electrospray ionisation in the negative mode 
was carried out under the following conditions: desolvation temperature, 350 °C; nitrogen flow 
rate, 350 L/h; source temperature, 100 °C; capillary voltage, 3.7 kV; cone voltage, 35 V; and 
collision energy, 30 arbitrary units. 
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Ferric reducing activity of the glucuronidated reaction mixture 
The FRAP activity of the mangiferin glucuronidation reaction mixture was determined following 
the procedure described by Benzie & Strain (1996), modified for 96-well format, using Greiner 
polystyrene 96-well microplates and a Bio-Tek Synergy HT microplate reader equipped with 
Gen5 Secure software (Winooski, USA).  The FRAP reagent was prepared by mixing 100 mL 
acetate buffer (300 mM, pH 3.6), 10 mL 10 mM TPTZ (in 40 mM HCl) and 10 mL 20 mM 
FeCl3.6H2O.  The assay was optimised using standard mangiferin solutions (10–400 μM). 
Samples of the glucuronidated mixture were reconstituted in de-ionised water to obtain an 
estimated concentration of 40 mM of mangiferin in the control samples.  A 40 μL sample 
aliquot was mixed with 160 μL FRAP reagent, incubated at 37 ºC and the absorbance 
measured after 4 min at 593 nm.  For preparation of the calibration curve, a stock solution of 5 
mM Trolox was prepared in ethanol and diluted with water to obtain a concentration range of 
50–600 μM.  The FRAP value of the reaction mixture was expressed as μmole Trolox/mL.  All 
analyses were performed in triplicate for two separate experiments. 
 
Radical scavenging ability of individual metabolites 
The on-line HPLC-DAD-DPPH• and HPLC-DAD-ABTS•+ assays, based on the respective 
methods described by Dapkevicius et al. (2001) and Pellegrini et al. (2003), with some 
modifications to improve intensity and decrease precipitation, were set up as described by 
Van der Merwe et al. (2010).  The on-line system consisted of an LKB Bromma 2150 HPLC 
pump (Bromma, Sweden), in-line Phenomenex Degasser Model DG-4400 (Santa Clara, CA, 
USA) and a LKB Bromma 2151 variable wavelength detector.  Mixing of the HPLC effluent (1 
mL/min) and the radical solution (0.5 mL/min) was achieved with a high pressure static mixing 
tee (Upchurch, Oak Harbor, USA).  The reaction coil consisted of 15.24 m polyether ether 
ketone (PEEK) tubing (0.25 mm i.d.) to give a reaction time of ca 45 s. Data were captured 
using DataApex Clarity version 2.4.1.91 software (DataApex, Prague, Czech Republic).  
Compounds in the reaction mixture after glucuronidation of the mangiferin standard were 
separated by HPLC and reacted post-column with the radical reagents. Scavenging of DPPH• 
and ABTS•+ was detected as negative peaks at 515 and 430 nm, respectively. 
 
DPPH• reagent 
The freshly prepared DPPH• stock solution (750 mL; 58 mg/L in acetonitrile) was added to 250 
mL of a 0.068 mM citric acid phosphate buffer to obtain the working solution and filtered (0.45 
µm Millipore PVDF-filter) before use.  The working solution was protected from light and 
maintained at 20 ºC using a temperature-controlled cooling bath during the analysis. 
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ABTS•+ reagent 
A 7 mM ABTS•+ stock solution was prepared in water before adding 440 μL of 140 mM K2S2O8 
to convert ABTS to ABTS•+during storage in the dark for ca 16 hours. The ABTS•+ buffered 
working solution was prepared on the day of the analysis and contained 250 mL 0.068 mM 
citric acid phosphate buffer, the ABTS•+stock solution (25 mL) and 750 mL acetonitrile.  The 
ABTS•+ working solution was maintained at 4 C using a temperature-controlled cooling bath 
during the analysis. 
 
Statistical Analysis 
Statistical analyses were conducted on the HPLC and FRAP data of the reaction mixtures.  
The normality of the parameters among the groups as well as the homogeneity of the group 
variance were investigated using the Kolmogorov Smirnof Test and Levene’s Test, 
respectively. Variables complying with normality and homogeneity were tested using a One-
way ANOVA and post-hoc Tukey Test.  Where sample sizes were unequal the Tukey-Cramer 
adjustments were made automatically. The non-parametric Wilcoxon Rank-Sums Test was 
used along with the Tukey-Type post-hoc test where necessary.  Statistical analyses were 
performed with SAS v9.2 and STATA v11 and statistical significance was considered at 5% 
(P<0.05). 
 
RESULTS 
 
Phase II conjugation 
 
Glucuronidation 
No metabolism occurred when incubating the mangiferin standard with the microsomal fractions 
(Aroclor 1254-induced and un-induced) in the absence of the co-factor UDPGA (control 
samples) (Fig. 2).  A minor peak (tr = 10.91 min), present as an impurity in the mangiferin 
standard obtained from Mangifera indica (estimated at <2% according to the supplier), and 
assumed to be homomangiferin (Wu et al., 2010), gave a pseudo-molecular ion with m/z 435 
and fragment ions with m/z 315, 287 and 272 (Tables 1 and 2).  Glucuronidation of the 
mangiferin standard with Aroclor 1254-induced microsomes resulted in three metabolites eluting 
before mangiferin (tr = 9.43 min) (Fig. 3A).   
Two minor peaks (MG1 and HMG; tr = 5.93 and 8.06 min, respectively) and one major peak 
(MG2; tr = 6.70 min) were observed.  A similar chromatogram was obtained when using the un-
induced microsomes, although the prevalence of the metabolites was ca 20 times less 
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(quantified as mangiferin equivalents) than when using Aroclor 1254-induced microsomes (data 
not shown).  The presence of the conjugates after incubation with un-induced conjugates was 
confirmed with LC-MS analysis (Table 1). 
 LC-MS analysis of the reaction mixtures demonstrated the presence of a pseudo-molecular 
ion ([MH]) with m/z 597 (421 + 176) for both MG1 and MG2, indicating two regio-isomers of 
monoglucuronidated mangiferin.  The third conjugate (HMG) with m/z 611 (435 + 176) is 
attributed to the glucuronidation of homomangiferin (Table 1).  LC-MS/MS analysis of mangiferin 
resulted in neutral losses of 90 and 120 amu from the pseudo-molecular ion (m/z 421) giving the 
fragment ions m/z 331 and 301, respectively (Table 2).  Cleavage of the glucuronide moiety of 
MG1 and MG2 resulted in fragment ions with m/z 421 (neutral loss of 176 amu), which 
fragmented further to give m/z 331 and 301. The fragment ions for MG1 and MG2 were the 
same, but their relative abundance differed (Table 2).  LC-MS/MS analysis of HMG also resulted 
in cleavage of the glucuronide moiety (neutral loss of 176 amu), although no other major 
fragments were observed (Table 3).  A proposed fragmentation scheme for mangiferin and its 
glucuronidated metabolites, adapted from Ma et al. (2008), is illustrated in Fig. 4. 
 
 
 
           
Figure 2 HPLC chromatogram of the control (absence of UDPGA) sample included in the 
investigation of mangiferin glucuronidation. The sample was spiked with mangiferin standard 
that contains homomangiferin as a minor impurity. 
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Figure 3 Combined HPLC-DAD and HPLC-on-line radical quenching chromatograms using 
DPPH• (A) and ABTS•+ (B) of a sample containing glucuronidated mangiferin (MG1, MG2) and 
homomangiferin (HMG).  Glucuronidation was mediated by liver microsomes from Aroclor 1254- 
induced rats and UGT with UDPGA.  
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Table 1 LC-MS characteristics of mangiferin, homomangiferin and glucuronidated metabolites. 
Compound  [M-H]- 
Mangiferin  421 
Homomangiferin  435 
Metabolites with induced microsomal fraction   
Mangiferin monoglucuronide (MG1)  597 
Mangiferin monoglucuronide (MG2)  597 
Homomangiferin monoglucuronide (HMG)  611 
Metabolites with un-induced microsomal fraction   
Mangiferin monoglucuronide (MG1)  597 
Mangiferin monoglucuronide (MG2)  597 
Homomangiferin monoglucuronide (HMG)  611 
 
 
 
Table 2 LC-MS/MS characteristics of mangiferin, homomangiferin and glucuronidated meta- 
bolites. 
Compound Precursor 
ion (m/z) 
Product ions  
(m/z (% Relative abundance)) 
Mangiferin 421 331 a (48); 313 (6); 301 (100); 272 (15); 
271 (22); 259 (31); 258 (7) 
Homomangiferin 435 435 (83); 315 (66); 287 (100); 272 (82) 
Mangiferin monoglucuronide (MG1) 597 422 (6); 421 (34); 403 (7); 332 (4); 331 
(77); 302 (7); 301 (100) 
Mangiferin monoglucuronide (MG2) 597 421 (40); 403 (12); 332 (6); 331 (100); 
302 (5); 301 (90) 
Homomangiferin monoglucuronide  (HMG) 611 435 (100) 
a Numbers in bold represent fragment ions characteristic of mangiferin. 
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Figure 4 Proposed fragmentation mechanism for mangiferin and glucuronidated metabolites 
showing the major daughter ions (adapted from Ma et al., 2008). 
 
Enzymatic hydrolysis of glucuronidated metabolites 
Treatment with -glucuronidase resulted in the disappearance of all three conjugates with 
concomitant increase in the peak area of mangiferin and homomangiferin.  The chromatogram 
obtained after deconjugation is similar to that depicted in Fig. 2. 
 
Sulphation 
Sulphation of mangiferin with the Aroclor 1254-induced cytosolic rat liver fraction did not result 
in any detectable metabolites in the absence or presence of the co-factor PAPS.  LC-MS 
analysis confirmed the absence of any sulphated metabolites.  The m/z values for all possible 
pseudo-molecular ions ([M-H]-) that could result from sulphation of mangiferin were calculated 
and a search conducted for each after a full scan acquisition in the mass range 300 to 1000 
amu. 
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Ferric reducing activity of the glucuronidated reaction mixture 
Samples used to assess the effect of metabolism on the antioxidant activity of the reaction 
mixture (sample) in the FRAP assay were also subjected to quantification with HPLC analysis.  
Mangiferin was quantified with an external standard, while homomangiferin and the metabolites 
HMG, MG1 and MG2, were quantified as mangiferin equivalents. Approximately 27% of 
mangiferin remained unconjugated, contributing 25% to the total mangiferin equivalents (Table 
3).  Glucuronidation of mangiferin was accompanied by ca 60% decrease in its ferric reducing 
ability in the FRAP assay compared to the control, despite the fact that both the reaction mixture 
and the control contained a similar amount of total mangiferin equivalents (Table 3).  MG2 was 
the most prominent metabolite after glucuronidation and accounted for approximately 60% of 
the total mangiferin equivalents present in the metabolite reaction mixture. 
The homomangiferin concentration, similarly to that of mangiferin, was also extensively 
reduced (ca 70%) after glucuronidation.  The concentration of homomangiferin appears to be 
overestimated, since mangiferin used was of 98% purity according to the supplier and 
homomangiferin was quantified as 11.7% mangiferin equivalents.  Irrespective of this 
overestimation, its ‘quantification’ enables comparison of the relative content of the parent 
compounds and metabolites in the samples and the change in the activity with glucuronidation. 
 
Radical scavenging ability of individual metabolites  
Typical HPLC biograms for DPPH• and ABTS•+ scavenging are depicted in Figs 3A and 3B, 
respectively.  No activity was observed for any of the metabolites, while both mangiferin and 
homomangiferin scavenged DPPH• and ABTS•+, resulting in a decrease in absorbance, 
observed as negative peaks. 
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Table 3  Concentration a of compounds and metabolites in the reaction mixtures (samples) and their resulting FRAP b activity.  
 Mangiferin 
μg /mL 
Homomangiferin 
μg mang eq c/mL 
MG1 
μg mang eq c/mL 
MG2 
μg mang eq c/mL 
HMG 
μg mang eq c/mL 
Total 
μg mang eq c/mL 
FRAP 
μmoles Trolox/mL 
Control 116.67  8.39 a d 11.74  0.82 a - - - 120.19  14.35 0.50  0.05 a 
Reaction mixture         
 I   31.77   3.00 b   3.48  1.51 b 10.42  1.35 a 76.12  4.87 a 8.59  1.61 a 127.98    9.47 0.19  0.04 b 
 II   33.69   7.94 b   3.74  1.88 b 10.01  1.59 a 73.28  6.11 a 8.44  1.66 a 126.47  15.72 0.21  0.05 b 
 III   30.11   3.74 b   3.35  1.50 b   9.80  1.50 a 72.98  6.33 a 8.28  1.88 a 122.19  12.02 0.18  0.02 b 
        
Average % of total mang 
eq in reaction mixture 
25.37 2.81 8.02 59.05 6.72  
 
a HPLC analysis was conducted in duplicate for two independent experiments, each containing three samples, b FRAP analysis was conducted in triplicate for two 
independent experiments, each containing three samples, c Mang eq refers to mangiferin equivalents quantified with HPLC using mangiferin as standard, d Values in a 
column followed by different letters differed significantly (P<0.05). 
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DISCUSSION 
 
The polyphenol, mangiferin, occurs widely in various plants (Li, 2002; Pinto et al., 2005) and is 
one of the major antioxidants of Cyclopia species (Fabaceae), a South African herbal tea 
belonging to the Cape fynbos biome (Joubert et al., 2008b).  It occurs in relatively high 
concentrations (up to 4% m/m) in unfermented honeybush (Joubert et al., 2009) and is therefore 
expected to contribute substantially to the antioxidant properties of this herbal tea (Joubert et 
al., 2008a).  Apart from its antioxidant properties, mangiferin exhibits anti-apoptotic, 
immunomodulating, anti-inflammatory, cardioprotective and anti-diabetic potential (Pinto et al., 
2005; Prabhu et al., 2009).  The exact mechanisms of these biological effects are still under 
investigation, but its ability to scavenge reactive oxygen species seems to play an integral role. 
However, the modulating role of metabolism on the antioxidant/antiradical functions of 
mangiferin has not been clarified as yet.  Human intervention studies provide evidence that 
polyphenol conjugates retain some biological activity (Williamson et al., 2005). Investigations on 
the biological activity of glucuronidated polyphenols are increasing, as they constitute some of 
the predominant forms in circulation (Zhang et al., 2007), while the unconjugated forms are 
virtually absent (Scalbert et al., 2002).  
The presence of mangiferin has been reported in rat plasma after administration of Rhizoma 
Anemarrhenae extract (Li et al., 2008).  Norathyriol, the aglycone of mangiferin, was found to be 
the major metabolite in the plasma of pigs, following ingestion of an unfermented honeybush (C. 
genistoides) extract (Bock et al., 2008).  Other metabolites were O-glucuronidated norathyriol 
and O-methylated mangiferin (Bock et al., 2008).  The C-C link between the glucose moiety and 
aglycone would confer stability to mangiferin against hydrolysis by enzymes in the brush border 
of the small intestine (Day et al., 2000b).  On the other hand, Sanugal et al. (2005) described an 
intestinal bacterium that produces an enzyme that transforms mangiferin to norathyriol.  Greater 
insight into the biotransformation of mangiferin in rats was obtained in a recent study by Liu et 
al. (2011) that detected monoglucuronidated mangiferin in the urine and intestinal content after 
oral administration.  Other phase II metabolites included different variants of methylated and 
glucuronidated mangiferin and norathyriol.  Sulphated and O-glycosylated products of 
norathyriol were also detected.  
Mangiferin was not a substrate for sulphation under the experimental conditions of the 
present study; conditions that were conducive to the sulphation of aspalathin, a C-glucosyl 
dihydrochalcone (Van der Merwe et al., 2010).  In spite of the extensive investigation by Liu et 
al. (2011), no sulphated mangiferin was detected in the plasma and urine of rats treated with 
this xanthone.  The only previous evidence for sulphated mangiferin has been detected by Lai et 
Stellenbosch University  http://scholar.sun.ac.za
 113  
al. (2003) in bile dialysate of rats after intravenous administration of mangiferin.  It would thus 
appear that mangiferin is not a major substrate of the sulfotransferase. Of interest is that several 
sulphated-glucuronidated conjugates of norathyriol were detected in the urine and/or plasma of 
rats treated with mangiferin (Liu et al., 2011).  Sulphation is a competitive pathway for 
glucuronidation (Witkamp & Monshouwer, 1998) and polyphenols may therefore not be 
sulphated in vivo due to glucuronidation being predominant.  Catechol-O- methyltranferase 
(COMT) also compete with UDP-glucuronosyltransferase (UGT) in the metabolism of 
polyphenols (Lambert & Yang, 2003) and therefore could also be an important metabolic 
pathway of mangiferin in vivo.  The presence of methylated and glucuronidated metabolites of 
mangiferin in the urine and the bile of rats (Lai et al., 2003; Ma et al., 2008) supports this.  An 
investigation of the metabolites of green tea catechins demonstrated that COMT seems to be 
the preferred reaction at low concentrations while the UGT metabolic pathway is favoured at 
higher doses (Lu et al., 2003).   
In the present study, a major (MG2) and two minor (MG1 and HMG) metabolites were 
identified after glucuronidation of the mangiferin standard using LC-MS and LC-MS/MS 
analyses. The neutral loss of 176 amu was indicative of the glucuronide moiety for MG1 (m/z 
597), MG2 (m/z 597) and HMG (m/z 611).  The aglycones of MG1 and MG2 further fragmented 
to give the typical fragmentation pattern of C-linked glycosides (Lai et al., 2003; Bock et al., 
2008; Zhang et al., 2011), i.e. loss of 90 and 120 amu, confirming that these metabolites are 
monoglucuronides of mangiferin.  Homomangiferin, a xanthone present in Mangiferia indica (Wu 
et al., 2010), from which mangiferin was isolated, was identified based on a similar 
fragmentation pattern compared to that reported by Qin et al. (2009) and Zhang et al. (2011).  
HMG was identified as a monoglucuronide of homomangiferin based on the mass of the 
aglycone fragment ion (m/z 435). 
UDP-glucuronosyltransferase (UGT) consists of many isoforms with broad and overlapping 
substrate specificities and different tissue distribution (Fisher et al., 2001).  The selectivity of 
each UGT is determined by the position of the OH group on the substrate molecule (Wong et 
al., 2009).  In the present study, Aroclor 1254, containing a mixture of polycyclic hydrocarbons, 
specifically increased the UGT1A6 isoform of the enzyme in rats (Bock et al., 1998), which 
particularly catalyses the glucuronidation of small catechols (Harding et al., 1988).  As the 
glucuronidation rate of catechols is enhanced 10 to 15-fold by a standard polychlorinated 
biphenyl (PCB) inducer, Aroclor 1254 (Elovaara et al., 2004; Antonio et al., 2001), it resulted in 
the higher levels of glucuronidated mangiferin metabolites observed and facilitated 
investigations into their antioxidant activity in the present study.  
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UGT mediated glucuronidation occurs via bimolecular nucleophilic substitution (SN2) with 
the OH carrying out a nucleophilic attack on the C-1 of the UDP-glucuronic acid (UDPGA) (Yin 
et al., 1994).  The reactivity of substrates such as flavonoids can be influenced by steric 
hindrance, intra-molecular hydrogen bonding, as well as electron-donating and electron-
withdrawing effects of substituents on the rings (Zhang et al., 2007). Lowering of the electron 
density on the oxygen of an OH-group, due to delocalisation, would reduce its nucleophilicity 
and overall glucuronidation activity (Zhang et al., 2006). In spite of this, the C4'-OH of flavonoids 
seems to be one of the most favoured sites for conjugation (Zhang et al., 2007).  According to 
Rose et al. (2009), studying indazoles, the site of glucuronidation is likely to be the most acidic 
proton.  The same factors would also be relevant for the reactivity of xanthones such as 
mangiferin.  The most acidic proton of mangiferin is the 6-OH (lowest pKa value), followed by 3-
OH, 7-OH and 1-OH (Gómez-Zaleta et al., 2006).  The high acidity of the protons of 6-OH and 
3-OH, due to their position being located para to the keto function, would lead to a greater 
proportion of ionised forms present at pH 7.4. The C-2 glucosyl moiety would, however, hinder 
the approach to the carbon of UDGPA, probably making glucuronidation at 3-OH less 
favourable than at 7-OH. The low acidity of 1-OH as a result of intra-molecular hydrogen 
bonding with the adjacent keto group at C-9 (Zhang et al., 2006) and steric hindrance caused by 
C-2 glucosyl moiety would make it the least likely position to carry out a nucleophillic attack on 
UDPGA.  Taking this into account, MG2 and MG1 correspond most probably with C-6 and C-7 
conjugates, respectively.  
The on-line antioxidant assays performed in the present study provided some further insight 
into the position of glucuronidation and confirmed glucuronidation at either 6-OH or 7-OH.  Loss 
of the catechol arrangement through conjugation at C-6 or C-7 would result in a loss of 
antioxidant activity of xanthones as demonstrated for DPPH• scavenging activity by Lee et al. 
(2005).  In the current study glucuronidation of mangiferin resulted in loss of antioxidant activity 
in the FRAP assay, as well as in the on-line HPLC antioxidant assays using DPPH• and ABTS•+, 
indicating that the structural requirements for antioxidant activity were compromised by 
biotransformation.  HMG, the glucuronidated metabolite of homomangiferin, also did not display 
any radical scavenging.  In this case glucuronidation at 3-OH is not possible due to the 
presence of a methyl group.  However, the low quantity of homomangiferin in the mangiferin 
standard used, may explain why a second metabolite was not observed.  Future studies on the 
phase II metabolism of homomangiferin will provide further insight into the specific hydroxyl 
groups involved.  
Conversely, certain glucuronidated metabolites of quercetin have been shown to retain 
some biological properties by inhibiting xanthine oxidase and lipoxygenase, enzymes 
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associated with oxidative stress to related human diseases (Day et al., 2000a).  Therefore 
diverse biological effects of mangiferin metabolites in the body need to be investigated, since 
the loss of antioxidant activity may not necessarily indicate a loss in other biologically relevant 
activities.  As the catechol moiety seems to be a structural requirement for the iron reducing 
property of mangiferin, its glucuronidation is likely to prevent recycling of iron under pro-
oxidative conditions in the cell. On the other hand, loss of the catechol moiety and thus the 
ability to complex iron, would affect the secondary antioxidant activity of mangiferin in the cell 
(Pardo Andreu et al., 2005).  Interaction of mangiferin with iron, through complexing involving 
the catechol moiety, has been shown to be important in the protection against mitochondrial 
lipid peroxidation and DNA damage by inhibiting iron-mediated oxyradical formation (Pardo 
Andreu et al., 2005, 2007).  The latter also constitutes a potential protective mechanism against 
the pro-oxidant action of mangiferin.  The present study indicated that glucuronidation is likely to 
modulate these anti- and pro-oxidant properties of mangiferin via the impairment of the catechol 
moiety. 
The presence of β-glucuronidase in different organs and the notion that it is increased 
during inflammatory disease could play an important role in the turnover of polyphenols in the 
body and may result in the parent molecule becoming available to exhibit its antioxidant 
potential (O’Leary et al., 2001; Wong et al., 2009).  Alternatively, conjugated polyphenols may 
pass through the vascular monolayers and be converted to aglycones by hydrolysing enzymes 
(Shimoi, 2004).  Glucuronide metabolites might also be directly accessible to endothelial cells, 
although it is bound to albumin to a lesser extent than the aglycone (O’Leary et al., 2001).  The 
complex nature of polyphenol metabolism involving the liver and extra-hepatic organs, such as 
the lungs, kidneys and gastrointestinal mucosa, will create a delicate balance of conjugated and 
deconjugated metabolites that will likely contribute to the beneficial biological properties of 
mangiferin.  
The current study presented the first evidence of the impairment of the antioxidant activity of 
mangiferin through conjugation catalysed by the glucuronyltransferases.  It provides new 
perspectives regarding the potential of phase II mangiferin metabolites to modulate the redox 
status of the cell and hence their role in protecting against oxidative stress.  
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EFFECT OF SHORT-TERM AND SUB-CHRONIC DIETARY EXPOSURE 
TO POLYPHENOL-ENRICHED ROOIBOS (ASPALATHUS LINEARIS) 
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EFFECT OF SHORT-TERM AND SUB-CHRONIC DIETARY EXPOSURE TO POLYPHENOL-
ENRICHED ROOIBOS (ASPALATHUS LINEARIS) AND HONEYBUSH (CYCLOPIA SPP.) 
EXTRACTS ON RAT LIVER FUNCTION AND ANTIOXIDANT STATUS 
ABSTRACT 
 
Polyphenol-enriched extracts (PEEs) of unfermented rooibos [Aspalathus linearis (PER)] and 
honeybush [Cyclopia. subternata (PECsub) and C. genistoides (PECgen)] were fed to male 
Fischer rats in two independent studies for 28 and 90 days.  PECgen was only included in the 
28 day study.  Dietary intake of the PEEs at the administrated dose (2.0 g PER/kg diet and 2.5 g 
PECsub and PECgen/kg diet) did not significantly (P0.05) affect body weight gain (bwg) or 
relative liver and kidney weight.  PECsub resulted in a significant (P<0.05) increase in the total 
serum bilirubin (Tbili) after 28 days while the serum ALP levels only significantly (P<0.05) 
increased after 90 days, suggesting that the biliary system was possibly affected.  No other 
clinical biochemical serum parameters were adversely affected, although AST was significantly 
(P<0.05) reduced by PECsub and markedly (P<0.1) by PECgen after 28 days, while Tbili was 
significantly (P<0.05) reduced by PECsub after 90 days.  Both PER and PECsub significantly 
(P<0.05) reduced serum iron, but only after 90 days, indicating that the duration and level of 
exposure to dietary polyphenols are of importance.  Endogenous antioxidant enzyme activity, 
i.e. catalase (CAT) and superoxide dismutase (SOD), was not significantly (P0.05) altered in 
the liver after 28 or 90 days.  Glutathione reductase (GR) was significantly (P<0.05) increased 
after 28 days of all three PEE treatments.  Reduced glutathione (GSH) was significantly 
(P<0.05) decreased after 90 days following treatment with the PER extract, resulting in a 
notable, but not significant (P0.05) decrease in the GSH/GSSG ratio.  Similar changes, 
although not significant, were evident for PECsub.  GSH conjugation with the catechol type 
polyphenols via o-quinone formation is likely to be involved implying altered GSH metabolism 
and consequent affects on cellular oxidative status and defense.  Differential effects of the 
herbal teas were attributed to the diversity in the polyphenolic composition, with the 
dihydrochalcones, aspalathin and nothofagin, being prominent in rooibos and the xanthones, 
mangiferin and isomangiferin being major constituents of honeybush.  The total polyphenol 
consumption in the current study was in excess compared to the customarily use of these 
herbal teas.  The observed adverse biological effects as a function of the duration and level of 
polyphenol exposure may be valuable in future clinical studies investigating the safety and 
efficacy of value-added products and nutraceuticals derived from PEEs of rooibos and 
honeybush.     
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INTRODUCTION 
 
Phytochemicals, such as plant polyphenols are associated with beneficial effects in humans, but 
considerable scientific evidence exists to suggest that their chronic consumption may lead to 
adverse biological effects (Lambert et al., 2007).  Polyphenols can display pro-oxidative activity 
and this has been demonstrated for a major green tea (Camellia sinensis) flavonoid ()-
epigallocatechin gallate (EGCG) in vitro and in vivo at high dose levels (Galati et al., 2006; 
Lambert et al., 2007; Lambert et al., 2010).  The induction of oxidative stress by EGCG results 
from auto-oxidation and quinone formation with the production of H2O2, which in spite of 
potential adverse effects, is also linked to its anticancer properties (Yang & Landau, 2000; Yang 
et al., 2001).  When considering cancer cells, a relative narrow therapeutic window exist 
between the effective dose required to kill a cancer cell and the dose that results in an adverse 
toxic effect to the adjacent normal cells (Tascilar et al., 2006).  In general, polyphenols can thus 
play a dual role of which the outcome is determined by the levels consumed in conjunction with 
the physiological conditions of the cell (Skibola & Smith, 2000).   
Reactive oxygen species are produced from several reactions within a cell and is closely 
regulated by a multiple biological network of protection (Valko et al., 2007).  This network 
includes antioxidants, such as vitamin E together with the antioxidant enzymes, catalase (CAT), 
superoxide dismutase (SOD), glutathione peroxidase (GPx) and co-factors such as glutathione 
(GSH), ascorbate, -nicotinamide adenine dinucleotide phosphate (NADP) and glutathione 
reductase (GR) to regenerate the reducing molecules (Fang et al., 2002).  However, excessive 
exposure to polyphenols may overwhelm these antioxidant defense mechanisms in the cell, 
resulting in the over production of reactive oxygen intermediates (Skibola & Smith, 2000).  This 
ultimately contributes to cell injury and DNA damage, with the potential induction of irreversible 
preneoplastic lesions and carcinogenesis.  Beneficial antioxidant properties can thus be 
outweighed by adverse effects and consequently the unregulated use of commercially available 
polyphenol-enriched foods or dietary supplements are of concern (Skibola & Smith, 2000; 
Halliwell, 2007).  Many uncertainties exist about the relative safe levels for such products.    
Due to the historical use of the South African herbal teas, rooibos (Aspalathus linearis) and 
honeybush (Cyclopia spp.), they are generally regarded as safe for human consumption with an 
increasing number of reports establishing their beneficial biological effects related to their 
antioxidant, anticancer and phytoestrogenic properties (Joubert et al., 2008a; Joubert & De Beer 
2011; Joubert et al. 2011).  No reports of toxicity resulting from rooibos and honeybush 
consumption have been documented, with the exception of a case report by Sinisalo et al. 
(2010).  Possible hepatotoxicity was observed following the ingestion of rooibos tea, flavoured 
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with small amounts of strawberry, chamomile and petals of daisy, in a female with low-grade B-
cell malignancy when consuming 1 L/day.  However, the adverse effects were attributed to 
possible contamination of the tea with hepatotoxic compounds, genetic predisposition and/or 
adverse drug interactions with the tea.  A study in rats indicated that exposure to aqueous 
extracts of unfermented and fermented rooibos and honeybush (C. intermedia) as sole source 
of drinking fluid for 10 weeks did not affect the liver and/or kidney function (Marnewick et al., 
2003).  
There have been a number of recent advances regarding the health promoting properties of 
rooibos and honeybush.  Cyclopia subternata has potential for use in a phytoestrogen product 
aimed at the nutraceutical market (Mfenyana et al., 2008).  Cyclopia genistoides showed 
potential for production of an antioxidant product due to high levels of the bioactive C-glucosyl 
xanthone, mangiferin, the major phenolic compound in Cyclopia spp. (Joubert et al., 2009; 
Joubert et al., 2011a).  Currently, rooibos extracts are used as intermediate value-added 
products by the food, nutraceutical and cosmetic industries (Joubert & De Beer, 2011) and 
patent protection with regards to the anti-diabetic potential has been obtained for extracts 
produced from rooibos and honeybush (Mose Larsen et al., 2008a; Mose Larsen et al., 2008b; 
Muller et al., 2008; Joubert et al., 2011b).   An aqueous extract of C. intermedia was recently 
demonstrated to be effective in reducing plasma glucose concentration in a streptozotocin 
(STZ)-induced diabetic rat model (Muller et al., 2011) and mangiferin was reported to have 
potent antipyretic activity (Singh et al., 2011).  The major phenolic compound in rooibos, 
aspalathin, has hypoglycemic effects in animal models (Mose Larsen et al., 2008a; Kawano et 
al., 2009).   
 Due to these advances and the resultant potential use of rooibos and honeybush as value-
added products, food supplements and/or pharmaceutical products, it is becoming essential to 
assess possible adverse biological effects.  The aim of the present study was to evaluate 
changes in the serum clinical biochemical parameters and oxidative parameters in rat liver 
following the short-term and sub-chronic ingestion of dietary polyphenol-enriched extracts 
(PEEs) of unfermented rooibos (PER) and two unfermented honeybush species, C. subternata 
(PECsub) and C. genistoides (PECgen).   
 
MATERIALS AND METHODS 
 
Chemicals and water purification  
Deionized water was prepared using a Modulab Water Purification System (Continental Water 
Systems Corp., San Antonio, USA).  For HPLC eluant and sample preparation, deionized water 
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was further purified by means of a Milli-Q 185 Académic Plus water purification system 
(Millipore, Bedford, MA, USA).  The solvents required for HPLC analysis, acetonitrile ‘Far UV’ 
for gradient analysis was from BDH Chemicals Ltd. (Poole, England) and glacial acetic acid 
(>99.8%) from Fluka (Buchs, Switzerland).  Dimethyl sulfoxide (DMSO), ferrous sulphate 
(Fe(II)SO4), ascorbic acid and trichloro-acetic acid (ACS reagent; TCA) (>99%) were supplied 
by Sigma Chemicals Co. (St. Louis, MO, USA) and methanol and Fe(III)Cl (anhydrous FeCl3) 
were from Riedel-de Haën (Seelze, Germany).  The standards for quantification of rooibos 
flavonoids, isoorientin, vitexin and luteolin-7-glucoside were from Roth (Karlsruhe, Germany), 
while orientin, isovitexin, hyperoside, quercetin, luteolin and chrysoeriol were obtained from 
Extrasynthese (Genay, France).  Aspalathin and nothofagin (purity of both 95% as determined 
by HPLC and LC-MS), isolated from green rooibos, were supplied by the PROMEC 
(Programme on Mycotoxins and Experimental Carcinogenesis) Unit of the Medical Research 
Council (MRC, Bellville, South Africa).  Standards for quantification of phenolic compounds of 
the honeybush extracts included mangiferin from Sigma-Aldrich (Steinheim, Germany) and 
narirutin, eriocitrin, hesperidin, eriodictyol, naringenin and hesperetin from Extrasynthese 
(Genay, France). 
Folin-Ciocalteu’s phenol reagent, potassium chloride (KCl) (99.9%; ACS reagent) 
ethylenediaminetetra-acetic acid dipotassium salt (EDTA) and anhydrous sodium carbonate 
were obtained from Merck (Darmstadt, Germany).  Butylated hydroxytoluene (BHT, 2,[6]-di-tert-
betyl-p-cresol) (99%),  2-thiobarbituric acid (TBA) (98%), 6-hydroxydopamine (6-OHD), 
diethylenetriaminepentaacetic acid (DETAPAC), L-glutathione oxidized (GSSG, 98%), β-
nicotinamide adenine dinucleotide phosphate reduced trisodium salt (94%), glutathione 
reductase (GR) from baker’s yeast (S. cerevisiae), ammonium sulphate suspension, 100 – 300 
units/mg protein), hydrogen peroxide (30% H2O2 w/w), sodium acetate-3-hydrate (AR, PAL 
Chemicals), bovine serum albumin (BSA) and gallic acid were from Sigma Chemicals Co. (St. 
Louis, MO, USA).  TRIS (N2C(CH2OH)3 was obtained from Amersham (Ohio, USA).  Triton-X-
100 was supplied by BDH Chemicals Ltd. (Poole, England).  Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), 2,2-diphenyl-1-picrylhydrazyl (DPPH), 5,5 dithiobis-(2-
nitrobenzoic acid) (DTNB), 2,2′-azobis(2-methylpropionamidine) dihydrochloride (AAPH) and 
ferrous sulphate heptahydrate (99% FeSO4) were obtained from Sigma-Aldrich (Steinheim, 
Germany).  Fluorescein disodium, 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-4′,4′′-disulfonic acid 
sodium (ferrozine), 1-methyl-2-vinyl-pyridinium trifluoromethane sulfonate (M2VP) (>98%) and 
2,4,6-tri(2-pyridyl)-s-triazine (TPTZ) were obtained from Fluka (Buchs, Switzerland).  BCA 
protein assay reagent A (containing sodium carbonate, sodium bicarbonate, BCA detection 
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reagent, and sodium tartrate in 0.1 N sodium hydroxide) and BCA protein assay reagent B were 
purchased from Separations Scientific (Cape Town, South Africa).  Analytical grade solvents 
and chemicals were used except if stated otherwise.    
 
Preparation of polyphenol-enriched rooibos and honeybush extracts (PEEs)  
Powdered green rooibos (A. linearis) and green honeybush (C. subternata and C. genistoides) 
extracts, enriched in aspalathin and mangiferin respectively, through organic solvent extraction 
(Grüner-Richter et al., 2008), were supplied by the Raps Foundation (Freising-Weihenstephan, 
Germany).  The polyphenol-enriched extracts (PEEs) from rooibos (PER) and C. subternata 
(PECsub) and C. genistoides (PECgen) were stored desiccated in the dark.     
 
Antioxidant activity analysis of PEEs 
Total polyphenol content 
The total polyphenol (TP) content was determined in triplicate according to the method 
described by Singleton & Rossi (1965), adapted to microplate scale (Arthur et al., 2011).  A 
stock solution of gallic acid (1 mg/mL) was prepared in deionised water to obtain a standard 
series of 0.110 μg/mL in the final reaction volume.  Stock solutions of the PEEs were prepared 
at concentrations of 0.2 mg/mL for PECsub and PECgen and 0.1 mg/mL for PER, by dissolving 
the extract in 1 mL DMSO and further dilution in deionised water to a final volume of 10 mL. 
Assays were performed in Greiner 96-well clear flat-bottomed polystyrene plates (LASEC, Cape 
Town, South Africa) by adding 100 μL Folin-Ciocalteau reagent (1:10 dilution in deionised 
water) to 20 μL of water (blank), gallic acid standard (0.05–0.5 mg/mL) or 20 μL diluted extract.  
This was followed by 80 μL of Na2CO3 (7.5% w/v) added to each well within less than 8 min.  
Following incubation at 30 °C, absorbance values at 765 nm were recorded after 2 h on a Bio-
Tek SynergyHT microplate reader (Winooski, Vermont, USA) equipped with Gen5 Secure 
software.  Total polyphenol content was determined in triplicate and expressed as g gallic acid 
equivalents (GAE)/100 g extract.   
 
2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay 
Free radical scavenging activity was determined using the method of Rangkadilok et al. (2007) 
with slight modification for microplate format (Arthur et al., 2011).  Stock solutions of PEEs were 
prepared as described for total polyphenol analysis.  A Trolox stock solution (1 mM) was 
prepared in 10% ethanol and diluted with deionised water to obtain a concentration range of 5– 
40 μM in the final reaction volume.  For the reaction 270 μL of the DPPH solution (100 μM 
prepared in methanol and kept in the dark) was added to 30 μL of the blank (distilled water), 
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Trolox standards or PEEs in Greiner 96-deepwell polypropylene plates (LASEC, Cape Town, 
South Africa). The plate was sealed with a silicon mat to prevent evaporation of methanol and 
incubated at room temperature for 2 h, protected from light.  Following the incubation, 200 μL of 
the reaction mixture was pipetted into the corresponding wells of Greiner 96-well flat bottomed 
polystyrene plates and the absorbance measured at 515 nm using a BioTek SynergyHT 
microplate reader. The assay was performed in triplicate and results were expressed as mol 
Trolox equivalents (TE)/g extract.   
 
Ferric reducing antioxidant power (FRAP) assay  
The ferric reducing antioxidant power (FRAP) of the PEEs was determined using the method of 
Benzie & Strain (1996) with slight modifications for microplate format (Arthur et al., 2011).  
Trolox was used as standard with a concentration range of 5–60 μM in the final reaction volume.  
The freshly prepared FRAP reagent contained 100 mL of acetate buffer (300 mM, pH 3.6), 10 
mL of TPTZ (10 mM) in HCl (40 mM), and 10 mL of FeCl3 (20 mM).  Stock solutions of the PEEs 
were prepared at concentrations of 0.3 mg/mL for honeybush (PECsub and PECgen) and 0.14 
mg/mL for PER, by dissolving the extract in DMSO (1 mL) and further dilution in deionised 
water.  The assay was performed by adding 20 μL of distilled water as control, standards and 
dissolved tea extracts to their allocated wells in Greiner 96-well flat-bottomed polystyrene plates 
followed by addition of 180 μL of the FRAP reagent to each well.  Absorbance, due to the 
formation of a coloured TPTZ-Fe2+ complex, was monitored spectrophotometrically at 593 nm 
after a reaction time of 4 min at 37 °C, using a BioTek SynergyHT microplate reader (Winooski, 
Vermont, USA).  Determinations were in triplicate and results expressed as μmol TE/g extract.   
 
Oxygen radical absorbance capacity (ORAC) 
The oxygen radical antioxidant capacity (ORAC) of the PEEs was evaluated according to the 
method of Huang et al. (2002).  Stock solutions (1 mg/mL) of the herbal extracts were prepared 
in DMSO (1 mL) and further diluted with potassium phosphate buffer (75 mM, pH 7.4).  For 
calibration, a stock solution of Trolox (500 μM) was prepared by dissolving 0.25 g in 50 mL 
phosphate buffer (75 mM, pH 7.4), and diluting with the phosphate buffer to give calibration 
standards (5, 10, 15, 20, 25 and 30 μM). 
A stock solution of fluorescein (8 x 10-2 mM) was prepared in phosphate buffer (75 mM, pH 
7.4) and kept at 4 °C protected from light.  A freshly prepared fluorescein working solution (8.16 
x 10-5 mM) was prepared daily by dilution of the stock in the phosphate buffer.  AAPH (0.414 g) 
was dissolved in 10 mL of phosphate buffer (153 mM) and was kept on ice.  The AAPH solution 
not used within 8 h was discarded.       
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For the assay, 25 μL of sample, water or Trolox was added to the allocated wells in a black 
flat-bottomed Corning® polystyrene 96-well plate (Scientific Group, Cape Town, South Africa) 
with clear bottom.  Pre-incubation and fluorescence readings were measured using a Biotek 
Synergy HT microplate reader. A thermal barrier was created by filling a single row of the 
outside wells with 300 μL water.  Pre-incubation occurred for 10 min at 37 ºC after addition of 
150 μL of fluorescein working solution.  Following pre-incubation, 25 μL APPH solution was 
added to each well using the BioTek automatic reagent injection system.  Fluorescence 
measurements (kexcitation = 485 nm, kemission = 530 nm) were recorded from the bottom every 
minute over 35 min.   
The quantification of the antioxidant activity was based on the calculation of the area under 
the curve (AUC) of the sample after subtraction of the AUC for the blank, termed the AUCnet. 
The antioxidant activity by ORAC was calculated as μmol TE/g extract from the calibration curve 
of AUCnet for Trolox against Trolox concentration in the reaction volume. All samples were 
analysed in triplicate at three dilutions, and the mean value was used to obtain the ORAC value. 
 
HPLC analysis of PEEs 
HPLC analysis was conducted using an Agilent 1200 series HPLC (Agilent Technologies, 
Waldbronn, Germany) consisting of a quaternary pump, autosampler, in-line degasser, column 
thermostat, diode-array detector and Chemstation software for LC 3D systems (Rev. B.02.01).   
A Phenomenex Gemini C18 110Å column (150 x 4.6 mm i.d.; 5 μm) protected by a Gemini  
C18 guard cartridge (Phenomenex, Santa Clara, LA, USA) was used for analysis of PER.  
Separation was achieved with the solvent program described by Joubert (1996), adapted as 
follows: 0–3 min (20% B), 15-18 min (30% B), 27-29 min (35% B), 35 min (40% B), 54 min (60% 
B), 62 min (80% B), 68 min (60% B), 81 min (20% B), 90 min (20% B)  where A and B were 2% 
aqueous acetic acid (v/v) and methanol, respectively.  A flow rate of 0.4 mL/min was used for 
elution and 1.2 mL/min for reconditioning.  A stock solution of 6 mg/mL of PER was prepared by 
dissolving in 20% DMSO-water and ultra-sonication.  The standard calibration mixtures of the 
polyphenols and sample solution were filtered using 4 and 33 mm diameter 0.45 mm pore-size 
Millex-HV syringe filter devices (Millipore), respectively, prior to HPLC analysis.   An injection 
volume of 5 μL was used and separations were carried out at 38 ˚C.   
Analysis of the phenolic compounds of PECgen and PECsub was carried out using a 
Zorbax Eclipse XDB -18 column (150 x 4.6 mm i.d., 5 μm) from Agilent Technologies at 30 ºC 
and a flow rate of 1 mL/min,  using the following solvent gradient program: 0–6 min (12% B), 7 
min (18% B), 14 min (25% B), 19 min (40% B), 24 min (50% B), 29 min (12% B), where A and B 
were 0.1% aqueous formic acid (v/v) and acetonitrile, respectively (De Beer & Joubert, 2010).   
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The extracts were diluted in purified water prior to analysis to a concentration of 
approximately 6 mg/mL.  The calibration mixtures containing the standards and sample 
solutions were filtered as described for rooibos, prior to HPLC analysis.  Injection volumes of 5 
μL and 10 μL were used for PECgen and PECsub, respectively.   
Linear regression using the least squares method (Microsoft Excel 2003, Microsoft 
Corporation, Redmond, WA, USA) was performed on calibration curve data for each compound.  
For determination of isomangiferin a response factor was determined relative to mangiferin as 
described by De Beer & Joubert (2010).  Phloretin-3,5-di-C-β-glucoside (dihydrochalcone), 
iriflophenone 3-C-β-glucoside (benzophenone), an eriodictyol-glucoside (flavanone) and a 
hydroxycinnamic acid derivative were identified according to their retention time and UV-Vis 
spectra based on the tentative identification by De Beer & Joubert (2010) and Kokotkiewicz et 
al. (2012) using UV-Vis, LC-ESI-MS and LC-ESI-MS/MS data.  The latter compounds, for which 
no authentic standards were available, were quantified as hesperidin equivalents.    
     
Short-term (28 day) and sub-chronic (90 day) feeding studies in rats 
 
Animals and diets  
Male Fischer 344 rats (weighing between 150–200g; 7–8 weeks old) were obtained from the 
Primate Unit of the Medical Research Council of South Africa.  Animals were individually 
housed in stainless steel wire-bottomed cages fitted with Perspex houses in a closed 
environment (24–25 ºC), with a 12 h light-dark cycle and 50% humidity.  The rats received a 
mash prepared from feed cubes (Epol Ltd, Cape Town, South Africa) by milling (Christie & 
Norris Laboratory Mill, Sheffield, UK).  As the antioxidant activity of rooibos exceeds that of 
honeybush (Joubert et al., 2008a), the rooibos (PER) and honeybush (PECsub and PECgen) 
extracts were incorporated in the diet at levels of 2.0 g/kg feed and 2.5 g/kg feed respectively.  
The PEEs were mixed into the mash using a food mixer and stored under nitrogen at 20 ºC.  
The use of experimental animals was approved by the Ethics Committee for Research on 
Animals (ECRA) of the Medical Research Council of South Africa (Addendum C). 
 
Experimental design and sample collection 
The PEE-mash mixtures were fed to the rats for 28 and 90 days in two separate experiments.  
Rats were randomly divided into the three treatment groups (10 rats/group) for the 90 day study 
(control, PER and PECsub) and four treatment groups (10 rats/group) for the 28 day study 
(control, PER, PECsub and PECgen).  The same PER and PECsub extracts were used in both 
the 28 and 90 day feeding studies.  The treatment groups received the PEE-mash mixture ad 
Stellenbosch University  http://scholar.sun.ac.za
 130  
libitum, while the control groups (28 and 90 days) received only the mash.  Feed intake was 
monitored every second day and the body weight (bw) recorded weekly.   
Animals in the 90 day study were fasted overnight prior to termination and sacrificed under 
pentobarbital anesthesia.  Blood was obtained from the abdominal aorta and the liver and 
kidneys harvested, weighed and quickly frozen in liquid nitrogen.  The samples were stored at   
–80 C until use. The rats of the 28 day study were fasted overnight and terminated by cervical 
dislocation, blood collected and livers and kidneys harvested, weighed and treated as described 
above.  Upon sacrifice, a separate sample from each liver was rapidly snap-frozen in liquid 
nitrogen and stored at –80 ºC for investigating changes in the gene expression profiles 
addressed in Chapter 6.  Blood was collected in BD Vacutainer SST II advance (BD, Plymouth, 
UK) tubes and serum prepared by centrifugation (Sorvall Superspeed RC2-B centrifuge, 
Separations Scientific, Cape Town, South Africa)  at 2 000 x g for 10 min at 4 ºC and stored at –
80 ºC until analysed.   
 
Clinical biochemical parameters 
Clinical biochemical parameters, including total cholesterol (Chol), alkaline phosphatase (ALP), 
total iron, alanine transaminase (ALT), gamma-glutamyl transferase activity (GGT) aspartate 
transaminase (AST), total bilirubin (Tbili), unconjugated bilirubin (DBili), creatinine (Creat) and 
total protein levels were determined using a Technicon RA 1000 automated analyzer at the 
Nutritional Intervention Research Unit (NIRU) of the Medical Research Council of South Africa 
(MRC, Bellville, South Africa).   
 
Oxidative parameters in the liver 
Five samples were randomly selected from each treatment and control group of the 28 and 90 
day feeding studies and liver homogenates prepared for assessment of the activity of 
antioxidant enzymes, glutathione analysis and the extent of Fe(II)-induced hepatic lipid 
peroxidation.   
   
Antioxidant enzyme assays 
Preparation of liver homogenates  
Liver homogenates were prepared on ice by homogenizing ± 200 mg of tissue in 2 mL of 
sodium phosphate buffer (50 mM, 0.5% (v/v) Triton X-100, pH 7.5) with a Teflon Potter-
Elvehjem homogenizer using five strokes.  The homogenates were sonicated for two 15 s 
bursts, followed by centrifugation (Heraeus HS-F16/3 Megafuge 1.OR fitted with a #2704 rotor, 
Kendro Laboratory Products, Germany) at 15 000 × g for 10 min at 4 °C and stored at 80 ºC 
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until used.  An aliquot was diluted (100x) in 2% SDS (2 mM EDTA and 20 mM NaHCO3) and 
incubated for 15 min at 37 ºC before the protein concentration was determined in duplicate 
according to the method of Kaushal & Barnes (1986) using bovine serum albumin (BSA) as 
standard.  
 
Catalase (CAT) assay  
Catalase activity was determined by monitoring the decomposition of hydrogen peroxide at 240 
nm according to the method described by Aebi (1984).  A reaction buffer was prepared by 
diluting 30% commercial H2O2 stock (~9.4 M) in sodium phosphate buffer (50 mM, pH 7.0) to 
obtain a final 10.3 mM H2O2 solution.  Reactions were carried out in 1 mL UV grade 
PLASTIBRAND micro disposable cuvettes (Sigma Chemical Co., Cape Town, South Africa) and 
initiated by adding 10 μL of the liver homogenate supernatant (0.1 μg /μL of protein) to 490 μL 
of the reaction buffer.  The absorbance was recorded every 12 s at 240 nm against a blank 
containing 10 μL supernatant and 490 μL reaction buffer without H2O2 using the time drive 
mode (UVIKON 923 Double Beam UV/VIS Spectrophotometer (Analytical & Diagnostic 
Products, South Africa) for 2 min.    
The activity was calculated from the change in absorbance per min (blank subtracted), 
utilising linear regression and the molar extinction coefficient (ε) for H2O2 (0.0394 mM-1 cm-1 at 
240 nm).  Results were expressed as nmol H2O2/min/μg protein and represent the mean of 
duplicate determinations.    
 
Superoxide dismutase (SOD) assay 
Superoxide dismutase activity was determined according to the method of Ellerby & Bredesen 
(2000) as adapted for microplate reader format by Marnewick et al. (2009).  The auto-oxidation 
of 6-OHD was measured using a Dynex Opsys MR Microplate Reader (IMRA1396) (Dynex 
Technologies, Medical Electronic Distributors (Pty) Ltd., Cape Town, South Africa).  Liver 
homogenate samples were diluted to a concentration of 0.1 μg protein/μL in sodium phosphate 
buffer (50 mM, pH 7.4).  A stock solution of 0.1 mM DETAPAC was prepared using the same 
phosphate buffer.  For the reaction four different volumes (5, 10, 15 and 20 μL) of each diluted 
sample were added to 160 μL DETAPAC stock solutions in a Greiner 96-well clear flat-bottom 
plates.  Phosphate buffer (50 mM, pH 7.4) was added (15, 10 and 15 μL) to the wells to obtain a 
volume of 180 μL followed by addition of 20 μL of 6-OHD to initiate the reaction (final volume 
200 μL).  A stock solution of 6-OHD (1.6 mM) was prepared in 0.35% HClO4 (purged with 
nitrogen for 15 min) on the day of the experiment.  The reaction was recorded in duplicate at 
490 nm for 5 min at room temperature, using the kinetic mode of the plate reader.  The 
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percentage inhibition of autoxidation was obtained (Revelation Quicklink, version 4.25) and 
used to construct an inhibition curve with the quantity of protein added to the reaction.  The 
SOD activity was expressed as the amount of protein (ng) required to produce a 50% inhibition 
of auto-oxidation of 6-OHD and represent the mean of duplicate determinations.   
 
Glutathione reductase (GR) assay 
Glutathione reductase activity was measured spectrophotometrically (UVIKON 923 Double 
Beam UV/VIS spectrophotometer, Analytical & Diagnostic Products, South Africa) as described 
by Ellerby & Bredesden (2000) by following the oxidation of NADPH.  Samples were diluted with 
buffer (50 mM potassium phosphate, pH 7) to achieve a concentration of approximately 10 mg 
protein/mL.  A stock solution of oxidized glutathione (GSSG, 8 mM) was prepared in distilled 
water.  A NADPH (15 mM) solution was prepared by dissolving in a NaHCO3 solution (1% w/v).  
For the reaction 20 μL of the diluted sample was added to 960 μL of assay buffer (50 mM 
Tris/HCL, 1 mM EDTA, pH 8) and incubated at 20 ºC for 10 min.  Following incubation, NADPH 
(20 μL) was added, thoroughly mixed and the linear A340 decrease recorded in duplicate for 5 
min using 1 mL semi-micro poly-methylmethacrylate (PMMA) disposable cuvettes (Sigma 
Chemical Co.) with the assay buffer as blank.  Enzyme activity was expressed as pmole 
NADPH used/min/μg protein, using the mmolar extinction coefficient of 6.22 mM-1cm-1, for 
duplicate determinations.   
 
Glutathione analysis 
Reduced (GSH) and oxidized forms (GSSG) of glutathione were determined according to the 
method of Tietze (1969) as adopted for microplate reader format by Abel et al. (2004) with some 
modifications.  Homogenates were prepared by grinding ± 250 mg liver tissue in liquid nitrogen 
using a mortar and pestle (Akerboom & Sies, 1981).  Approximately 20 mg was weighed for 
protein determination according to the Lowry method as described by Markwell et al. (1978) 
using BSA as standard.    
Approximately 100 mg of each ground sample was weighed for GSH determination and 
deproteinized with 1 mL 15% (w/v) TCA containing EDTA (1 mM).  For GSSG determination an 
equal amount of the ground tissue was weighed and 1 mL 6% (v/v) perchloric acid (HClO4), 
containing freshly prepared 3 mM M2VP (dissolved in 0.1N HCl and EDTA (1 mM), was added.  
Samples were homogenized on ice with a Polytron PT3100 (LASEC, Cape Town, South Africa) 
at 14 000 rpm for 25 s and stored at 80 ºC until analyzed.  
A stock solution of NADPH (1 mM) was prepared with the assay buffer (500 mM sodium 
phosphate buffer, 1 mM EDTA pH 7.5) and the glutathione reductase (GR) enzyme stock 
Stellenbosch University  http://scholar.sun.ac.za
 133  
solution was prepared by adding 167 μL of the enzyme to 833 μL of the assay buffer to obtain    
5 U in 50 μL.  DTNB (0.6 mM) was prepared in the assay buffer.  After thawing, homogenates 
were centrifuged (Heraeus HS-F16/3 Megafuge 1.OR) at 15 000 x g for 10 min at 4 ºC and the 
supernatant diluted with 0.5 M sodium phosphate buffer containing 1 mM EDTA (pH 7.5) at 
1:600 for GSH and 1:30 for GSSG.  For the assay, 50 μL of samples or standards and 50 μL  
DTNB and 50 μL GR stock solution were added to the respective wells of Greiner 96-well clear 
flat-bottom polystyrene plates. The final reaction mixture contained 0.25 U GR, 0.15 mM DTNB 
and 0.25 mM NADPH in sodium phosphate buffer.  Following mixing and incubation for 5 min at 
room temperature, 50 μL of NADPH was added to initiate the reaction and absorbance was 
monitored in the kinetic mode (Dynex Opsys MR Microplate Reader (IMRA1396)) at 405 nm for 
5 min.  Determinations were done in duplicate.  The concentration of GSH and GSSG in 
samples was determined by using a standard curve (0.5–3 μM) for each and the results 
expressed as nmol GSH or GSSG/mg protein.   
 
Determination of Inhibition of lipid peroxidation in rat liver homogenates 
Conjugated dienes (CD) in rat livers are an indicator of early stage lipid peroxidation and were 
determined according to the method by Hu et al. (1989) with slight modifications.  Livers were 
homogenized on ice in 19 volumes potassium phosphate buffer (10 mM, 1.15% KCl, pH 7.4) 
with a Teflon motorized dounce and stored at 80 ºC until used.  An aliquot (800 µL) of the 
homogenate (containing approximately 2 mg protein) was extracted with chloroform/methanol 
(CM 1:2, v/v), vortexed for 30 s before adding chloroform (1 mL) and vortexed again for 30 s.  
This was followed by addition of saline [1 ml 0.9% NaCl, saturated with CM (1:2)], vortexing for 
30 s and centrifugation (Heraeus HS-F16/3 Megafuge 1.OR) at 1000 x g for 10 min at 4 ºC.  
The organic layer was transferred to a new tube and extraction of the aqueous phase with 
chloroform repeated.  The combined organic phases were evaporated to dryness under a 
stream of nitrogen, the lipids dissolved in 1 mL hexane and the absorbance recorded at 233 nm 
in quartz cuvettes (1 mL) using a UVIKON 923 Double Beam UV/VIS spectrophotometer.  Lipid 
peroxidation was expressed as nmole CD/mg protein, using a molar extinction coefficient of 27 
000 M-1 cm-1.  Determinations were done in duplicate.     
For determination of the thiobarbituric acid reacting substances (TBARS), liver homogenates 
(1 mg protein) were prepared as described above and an aliquot (containing  1 mg protein) 
was pre-incubated with 0.2 mL 2.5 mM Fe(II)SO4 for 1 hr at 37 ºC in a shaking waterbath.  
Potassium phosphate buffer (1.15% KCl 10 mM, pH 7.4) was added to untreated control 
samples to serve as the negative control and the positive control contained 0.2 ml 2.5 mM 
Fe(II)SO4.  Samples were deproteinised using 2 mL 10% trichloroacetic acid containing 1 mM 
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EDTA and 0.01% BHT.  Lipid peroxidation in rat liver homogenates was determined by the 
formation of TBARS over a 4 h time period, measured as malondialdehyde (MDA), according to 
the method described by Beuge & Aust (1978) with the following modifications: Samples (2 mL) 
were mixed with 2 mL ice-cold TCA reagent (10%) containing BHT (12.5 μM) and EDTA (0.372 
g/L).  After centrifugation (Heraeus HS-F16/3 Megafuge 1.OR) at 2000 x g for 15 min at 4 ºC the 
supernatant (2 mL) was reacted with an equal volume of 0.67% (w/v) TBA solution, added to 
inhibit further oxidation. Samples were incubated at 90˚C for 20 min, and after cooling to room 
temperature the absorbance was measured at 532 nm (Esterbauer & Cheeseman, 1990).  Lipid 
peroxidation was calculated as μmole MDA equivalents/mg protein, using a molar extinction 
coefficient of 1.56 x 105 M-1 cm-1 for MDA (Beuge & Aust, 1978).  Determinations were done in 
duplicate.   
 
Statistical analyses  
Normality among the groups for all parameters was investigated using the Kolmogorov Smirnof 
Test.  The homogeneity of group variances for all parametric parameters were tested using 
Levene’s Test. Group differences for these parametric parameters were then tested using One-
way ANOVA’s and post-hoc Tukey tests, which is a post-hoc comparison of all pairs after a 
significant F-test.  Where sample sizes were unequal the Tukey-Cramer adjustments were 
made automatically.  
For non-parametric parameters, significant group differences were investigated using the 
Kruskal-Wallis test, as well as the post-hoc Tukey-type test to ascertain which groups differed.  
Comparisons with only two parametric groups were tested with T-tests.  For those parameters 
with a time component (repeated measures), an ANOVA was used to test the two main effects, 
i.e. time and group, as well as an interaction effect.  Data for one of the rats receiving PECgen 
in the 28 day study were omitted due to inconsistent body weight gain (bwg) and clinical 
biochemical results compared to the other rats.   Statistical analyses were performed using SAS 
v9.2 and statistical significance was set at 5% (P<0.05). 
 
RESULTS 
 
Antioxidant activity analysis of PEEs  
PER displayed significantly (P<0.05) higher antioxidant activity when compared to PECsub and 
PECgen in the TP, FRAP, DPPH, and ORAC assays (Table 1). Of the honeybush extracts, 
PECsub exhibited the higher (P<0.05) antioxidant activity in all the assays.     
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Feed and extract intake parameters 
The rats receiving PECsub consumed significantly (P<0.05) more feed on average than the 
control and the PER treated rats during the 28 day feeding period (Table 2).  Feed consumption 
did not differ significantly (P0.05) between the PECsub and PECgen treated rats for this time  
 
Table 1 Antioxidant activity analysis of polyphenol-enriched extracts (PEEs) used in the 28 and 
90 day feeding studies.    
 
A. linearis 
(PER) 
C. subternata 
(PECsub) 
C. genistoides 
(PECgen) 
TP a 39.22 ± 1.10 b a c 24.83 ± 0.82 b 21.88 ± 0.59 c 
FRAP d 2128.03 ± 27.01 a 1169.51 ± 15.85 b  992.65 ± 14.10 c 
DPPH d 2773.62 ± 118.95 a 1478.44 ± 60.51 b 1257.26 ± 44.97 c 
ORAC d 12989 ± 105 a 10219 ± 54 b 9679 ± 24 c 
a TP (Total Polyphenol) expressed as g gallic acid equivalents (GAE)/100 g extract, b Values represent the mean ± 
standard deviation of triplicate analysis, c Means in the same row followed by different letters, differ significantly 
(P<0.05), d Total antioxidant activity using the FRAP, DPPH radical scavenging and ORAC assays is given as μmole 
TE/g extract.   
 
Table 2 Intake parameters of male Fisher rats receiving polyphenol-enriched extracts (PEEs) a 
for a period of 28 and 90 days. 
 Control 
A. linearis 
(PER) 
C. subternata 
(PECsub) 
C. genistoides 
(PECgen) 
28 days     
Feed intake b 9.73 ± 0.42 c a d 9.65 ± 0.39 a 10.35 ± 0.45 b 9.97 ± 0.49 ab 
PEE intake e  0.19 ± 0.01 a 0.26 ± 0.01 b 0.25 ± 0.01 b 
TP intake f  75.66 ± 3.04 a 64.27 ± 2.77 b 54.55 ± 2.70 c 
90 days     
Feed intake b 7.27 ± 0.49 a 7.97 ± 0.57 b 7.74 ± 0.8 ab  
PEE intake e  0.16 ± 0.01 a 0.19 ± 0.01 b  
TP intake f  62.70 ± 8.87 a 48.05 ± 6.23 b  
a Concentration of PEEs (PER, PECsub and PECgen) in the feed mixture was 2.0 g PER/kg and 2.5 g PECsub and 
PECgen/kg diet, b Feed intake was calculated as g feed/100 g bw/day, c Values represent the mean ± SD of ten rats 
(n = 10) per group with the exception of PECgen (n = 9), d Means in the same row followed by different letters are 
significantly different (P<0.05), e Intake of PEE was calculated as g extract/100 g bw/day per, f Total polyphenol (TP) 
intake was calculated as mg GAE/100 g bw/day.  
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period.  In contrast, during the 90 day feeding study, rats receiving the PER diet had a 
significantly (P<0.05) higher average daily intake than the control group, while that of the 
PECsub treated rats were not significantly higher (P≥0.05).  Due to the higher concentration of 
PECsub and PECgen mixed into the feed, the average PEE intake was significantly (P<0.05) 
higher when compared to the PER treated rats for both the 28 day and 90 day studies.  
However, the average TP intake was significantly (P<0.05) higher in the rats receiving the PER 
diet in both studies attributable to the higher TP concentration.    
The average feed, PEE and TP intake over the 90 day period was notably lower than that for 28 
days (Table 2) attributed to a reduced feed intake in older rats.  For comparative purposes, the 
feed intake indices were also calculated for three consecutive months (taken as 30 days) (Table 
3).  The feed intake and thus intake of PEEs and TP decreased, presumably as a result of the 
bwg, with time.  The average feed intake was significantly (P<0.05) lower in all the treatment 
groups at 90 days than after 60 days.  The intake of PER and PECsub was significantly 
(P<0.05) higher during the first two months of the 90 day study period.   
 
Table 3 Intake parameters of Male Fisher rats receiving polyphenol-enriched extracts (PEEs) a 
for a period of 90 days, calculated on a monthly basis (1 month taken as 30 days). 
 Control A. linearis C. subternata 
   (PER) (PECsub) 
Feed intake a    
30 days 8.01 ± 0.49 a b *c 8.95 ± 0.63 b  * 8.63 ± 0.84 ab * 
60 days 7.51 ± 0.48 a # 8.23 ± 0.56 b *  7.93 ± 0.43 ab * 
90 days 6.30 ± 0.6 a $ 6.70 ± 0.60 a # 6.65 ± 0.58 a $ 
PEE intake c      
30 days  0.18 ± 0.01 a * 0.22 ± 0.02 b * 
60 days  0.17 ± 0.01 a * 0.20 ± 0.01 b * 
90 days  0.13 ± 0.01 a # 0.17 ± 0.01 b # 
TP intake d      
30 days  70.22 ± 5.39 a * 53.59 ± 5.19 b * 
60 days  64.95 ± 4.31 a * 49.25 ± 2.66 b * 
90 days  52.92 ± 4.57 a #  41.30 ± 3.62 b # 
a Concentration of PEEs (PER, PECsub and PECgen) in the feed mixture was 2.0 g PER/kg and 2.5 g PECsub and 
PECgen/kg diet, a Feed intake was calculated as g feed/day/100 g bw, b Values represent the mean ± SD of ten rats 
per group (n = 10), Means in the same row followed by different letters are significantly different (P<0.05), c Means in 
the same column marked with different symbols (*, #, $) indicate a significant difference (P<0.05) between for the 
groups, d Total polyphenol (TP) intake was calculated as mg GAE/100 g bw/day.    
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Concentration in PEE and intake of polyphenol compounds 
The phenolic composition of PER is characterized by dihydrochalcones, flavones and flavonols 
(Table 4).  Aspalathin (18.73%) was the major flavonoid present followed by nothofagin (1.45%), 
isoorientin (1.45%) and orientin (0.81%).  A flavonol O-diglycoside in fermented and 
unfermented rooibos, tentatively identified as quercetin-3-O-robinobioside, was recently 
reported to co-elute with rutin (Beelders et al., 2012).  Under the separating conditions used in  
the present study, quercetin-3-O-robinobioside co-eluted with rutin and isoquercitrin.  The 
combined content obtained for these three quercetin glycosides was 2.10%.  The average 
aspalathin intake was 35.13 and 29.94 mg/100 g bw/day for the 28 and 90 day studies, 
respectively, which was more than 10 fold when compared to the other phenolic compounds. 
Typical chromatograms of the PEEs are presented in Addendum D.  The average daily intake of 
the respective flavonoids was less during the 90 day study due to the significantly (P<0.05) 
lower aforementioned average feed intake.  
Qualitative and quantitative differences were evident between the two honeybush extracts.  
Mangiferin was the major compound in both extracts with PECgen containing approximately 2x 
the concentration present in PECsub (Table 5).  In addition to mangiferin PECgen contained 
isomangiferin and iriflophenone 3-C-glucoside at >1%.  Other major compounds (1%) present 
in PECsub were isomangiferin, eriocitrin, scolymoside, iriflophenone 3-C-glucoside and 
phloretin-3,5-di-C-glucoside. Eriocitrin and scolymoside were not detected in PECgen, while 
phloretin-3,5-di-C-glucoside was present at a very low concentration.  The hesperidin content 
of the extracts was between 0.8% and 1%.  Several minor compounds, including luteolin and 
naringenin, were present in very low to trace quantities in both extracts.  The average daily 
intake of total xanthones was ca 30 mg/100 g bw for rats consuming PECgen compared to less 
than 13 mg/100 g bw for rats consuming PECsub.  On the other hand, intake of phloretin-3,5-
di-C-glucoside averaged 6 mg/100 g bw for PECsub during the 28 day study compared to 0.3 
mg/100g bw for PECgen.  For both species the average intake of iriflophenone 3-C-glucoside 
was substantial (> 4 mg/100 g bw) (Table 5).         
 
Body weight gain, relative organ weights and clinical biochemical parameters 
No deaths or obvious clinical signs were observed when conducting the short-term (28 day) and 
sub-chronic (90 day) studies with rats.  The bwg and relative kidney and liver weights were not 
significantly (P0.05) affected by the administration of the PEE diets (Fig. 1 and Table 6). The 
herbal tea extracts did not significantly affect the liver function enzymes during the 28 day  
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Table 4  HPLC quantification of phenolic compounds present in the polyphenol-enriched rooibos (PER) extract and the average daily 
polyphenol intake during the 28 and 90 day studies with male Fisher rats.   
Polyphenol  subgroup Compound Substitution 
Polyphenol 
concentration a 
g/ 100 g extract 
Daily Intake b 
28 days 
mg/100 g bw 
Daily Intake b 
90 days 
mg/100 g bw 
Dihydrochalcone 
   
OH
OH O
OH
R1
OH
R2
 
aspalathin 
nothofagin 
R1=OH, R2=C--D-glucopyranosyl 
R1=H, R2=C--D-glucosylpyranosyl 
18.73 
1.45 
36.13 ± 1.45  
2.80 ± 0.11 
29.94 ± 2.03 
2.32 ± 0.16 
Flavone 
   OH
O
O
OH
R1
R3
R4
R2O
 
isoorientin 
orientin 
vitexin 
isovitexin 
luteolin 
luteolin-7-O-glucoside 
chrysoeriol 
R1, R2=H, R4=OH, R3=C-β-D-glucopyranosyl 
R1=C-β-D-glucopyranosyl, R2, R3=H, R4=OH 
R1=C-β-D-glucopyranosyl, R2, R3, R4=H 
R1, R2, R4=H, R3=C-β-D-glucopyranosyl 
R1, R2, R3=H, R4=OH 
R1, R3=H, R2=β-D-glucopyranosyl, R4=OH 
R1, R2, R3=H, R4=OCH3 
1.45 
0.81 
0.30 
0.39 
0.06  
0.04 
0.02 
2.80 ± 0.11 
1.56 ± 0.06 
0.58 ± 0.02 
0.75 ± 0.03 
0.12  ±  0.005   
0.08  ±  0.003   
0.04  ±  0.001 
2.32 ± 0.16 
1.29 ± 0.09 
0.48 ± 0.03 
0.62 ± 0.04 
0.10 ±  0.01 
0.06  ±  0.004     
0.03  ±  0.002  
quercetin-3-O-robionobioside 
isoquercitrin  
R=robinobiosyl 
R=β-D-glucopyranosyl  
rutin  R=rutinosyl 
 
co-elute 2.10 
 
4.05  ± 0.23 
 
3.36 ± 0.23 
 
quercetin 
 
R=H 
 
traces 
 
traces 
 
traces 
Flavonol 
OH
OH
O
O
OH
OR
OH
 
hyperoside R=galactopyranosyl 
 
0.29 0.56  ±  0.02    0.46 ± 0.03 
a Values represent the percentage (g/100 g extract) and are the mean of duplicate analyses, b Values represent the average daily polyphenol intake per treatment group (10 rats/group), bw = body 
weight.   
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Table 5 HPLC quantification of phenolic compounds present in polyphenol-enriched C. subternata (PECsub) and C. genistoides (PECgen) and average daily 
intake during the 28 and 90 day studies in male Fisher rats.   
Polyphenol Subgroup Compound Substitution 
Polyphenol concentration a  
g/100 g extract  
       Daily Intake  b    
      mg/100 g bw 
   PECsub PECgen 
PECsub  
28 days             
PECgen 
28 days                         
PECsub  
90 days 
 
mangiferin 
 
R1=C--D-glucopyranosyl, 
R2=H 
3.79 
 
 
9.29 a,b 
 
9.81 ± 0.42 
 
23.16  ± 1.15 
 
7.34 ± 0.45 
Xanthone 
OH
O OH
OOH
OH
R2
R1
 Isomangiferin 
 
total xanthones 
R1=H, R2=C--D-
glucopyranosyl 
1.16 2.94 3.01 ± 0.13 
 
12.82 
7.33  ± 0.36 
 
30.49 
2.25 ± 0.14 
 
9.59 
Flavanone eriocitrin R1=rutinosyl, R2=R3=OH 1.10 - 2.85 ± 0.12 - 2.13 ± 0.13 
narirutin R1=rutinosyl, R2=OH, R3=H nq 
c nq c  -  
hesperidin 
R1=rutinosyl, R2=OH, 
R3=OCH3 
0.99 
0.83 2.56 ± 0.11 2.07 ± 0.10 1.92 ± 0.12 
eriodictyol R1=H, R2=R3=OH nq nq c  -  
 
OH
O
O
R2
R3
R1O
 
naringenin 
hesperetin 
eriodictyolO-glucoside 
R1=R3=H, R2=OH,  
R1=H, R2=OH, R3=OCH3 
Unidentified  (tr = 10.72 min)  d   
0.01 
nq 
0.23 
0.01 
 
0.03 
0.03 ± 0.001 
nq 
0.60 ± 0.03 
0.02 ± 0.001 
 
0.07 ± 0.004 
0.02 ± 0.001 
nq 
0.45 ± 0.03 
Flavone 
RO
OH
O
O
OH
OH
 
 
luteolin 
scolymoside  
 
R=H 
R=rutinosyl 
 
0.06 
1.29 
 
0.09 
- 
 
0.16 ± 0.01 
3.34 ± 0.14 
 
0.22 ± 0.011 
- 
 
0.12 ± 0.015 
2.50 ± 0.15 
Benzophenone 
OH
R
OH
OOH
OH
 
 
iriflophenone-3-C--glucoside R=C--D-glucopyranosyl 1.66 2.53 4.30 ± 0.19 6.31 ± 0.31 3.21 ± 0.20 
Dihydrochalcone 
OH
OH O
OH
R
R
OH
 
phloretin-3,5-di-C-β-glucoside R=C--D-glucopyranosyl 2.35 0.11 6.08 ± 0.26 0.27 ± 0.01 4.55 ± 0.28 
 hydroxycinnamic acid derivative Unidentified  (tr = 11.01 min)  d 0.72 - 1.86 ± 0.08 - 1.39 ± 0.09 
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feeding period, with the exception of PECsub that significantly (P<0.05) decreased AST levels, 
while increasing Tbili (P<0.05). PECsub resulted in a significant (P<0.05) increase in ALP in the 
serum during the 90 day feeding period.  For the same period both the PER and PECsub 
extracts resulted in significantly (P<0.05) decreased serum Fe and TBili levels.      
 
Oxidative parameters in the liver  
 
Activity of antioxidant enzymes 
The PEEs of rooibos and honeybush did not significantly (P0.05) alter the activity of the 
antioxidant liver enzymes CAT and SOD compared to the respective controls at 28 and 90 days 
(Table 7).  The activity of GR was, however, significantly (P<0.05) elevated following the 
treatment with PEEs for 28 days.           
 
Glutathione status 
The GSH concentration in the livers was not significantly affected by the PEEs during the 28 
day feeding period, although the honeybush extracts markedly increased the GSH level and 
GSH/GSSG ratio (Table 7).  However, in the 90 day study the PER containing diet significantly 
(P<0.05) lowered the GSH concentration in the liver when compared to that of the control rats, 
while rats receiving the PECsub diet also displayed marginal (P<0.1) reduction.  No significant 
(P0.05) effect was noted in the GSSG levels, while the GSH/GSSG ratio was markedly 
decreased in the rats, specifically those receiving the PECsub diet.   
 
Inhibition of lipid peroxidation in rat livers 
Consumption of PEEs for 28 and 90 days showed no significant (P0.05) effect on the CD 
levels in the liver although the PER diet resulted in a slight elevated CD level after 90 days.    
(Table 7).  The MDA levels of the Fe(II)-induced lipid peroxidation in the liver of the rats that 
received PECsub for 28 and PER extracts for 90 days, were slightly, but not significantly 
(P0.05) elevated.  
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A 
 
  B 
 
 
Figure 1  Mean body weight (bw) (average  standard deviation) of the control (CTRL) and treatment 
groups that received polyphenol-enriched extracts (PEEs) (PER, PECgen, PECsub) for 28 days (A) 
and  90 days (B).  Values represent the mean ± SD of ten rats (n=10) per group, with the exception of 
C. genistoides (n = 9).   
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Table 6  Body weight gains (bwg), relative liver and kidney weights and serum clinical biochemical 
indicators of liver function after dietary consumption of polyphenol-enriched extracts (PEEs) a by male 
Fisher rats for 28 and 90 days during two respective studies.   
 Control A. linearis  
(PER) 
C. subternata 
(PECsub) 
C. genistoides 
(PECgen) 
28 days     
Body weight gain (bwg) (g) b 94.50 ± 10.20 c a d 89.50 ± 12.94 a 92.00 ± 9.70 a 93.50 ± 12.83 a 
Relative liver weight (%) e 3.57 ± 0.18 a 3.70 ± 0.18 a 3.81 ± 0.25 a 3.57 ± 0.19 a 
Relative kidney weight (%) e 0.65 ± 0.03 a 0.63 ± 0.03 a 0.67 ± 0.03 a 0.66 ± 0.03 a 
Chol (mmol/L)  1.17 ± 0.18 b a c 1.15 ± 0.09 a 1.19 ± 0.13 a 1.18 ± 0.07 a 
ALP (U/L) 126.8 ± 11.36 a 136.90 ± 6.43 a 128.0 ± 7.31 a 135.11 ± 10.92 a 
GGT 2.70 ± 2.75 a 1.80 ± 2.70 a 2.90 ± 1.60 a 2.30 ± 1.95 a 
ALT (U/L) 44.20 ± 9.90 a 42.40 ± 5.04 a 41.90 ± 4.41 a 43.67 ± 5.87 a 
AST (µmol/L) 104.90 ± 21.93 a 105.40 ± 12.96 a 88.30 ± 5.10 b 89.33 ± 6.73 ab 
Tbili (µmol/L) 8.26 ± 1.75 a 7.78 ± 1.21 a 10.51 ± 1.38 b 8.60 ± 2.55 ab 
Dbili (µmol/L) 0.99 ± 0.41 a 0.84 ± 0.21 a 1.24 ± 0.33 a 1.05 ± 0.57 a 
Creat (µmol/L) 46.19 ± 4.54 a 46.09 ± 2.72 a 45.66 ± 2.92 a 45.34 ± 1.22 a 
Iron (µmol/L) f 11.04 ± 1.06 a 11.34 ± 1.27 a 11.41 ± 1.30 a 11.74 ± 2.12 a 
90 days     
Body weight gain (bwg) (g) b 126.85 ± 19.21 a 139.86 ± 17.41 a 146.75 ± 25.56 a  
Relative liver weight (%) e 2.73 ± 0.27 a 2.68  ± 0.20 a 2.76 ± 0.19 a  
Relative kidney weight (%) e 0.80 ± 0.14 a 0.75 ± 0.07 a 0.77 ± 0.05 a  
Chol mmol/l 1.37 ± 0.25 a 1.15  ± 0.13 a 1.17 ± 0.26 a  
ALP U/l 131.38 ± 21.89 a 143.76 ± 19.31 ab 183.73 ± 21.29 b  
GGT 3.00 ± 1.89 a 3.67 ± 2.00 a 3.90 ± 0.57 a  
ALT U/l 76.33 ± 7.57 a 83.00 ± 14.02 a 80.30 ± 31.61 a  
AST µmol/l 107.80 ± 25.73 a 121.00 ±  16.17 a 114.30 ± 33.59 a  
Tbili µmol/l 2.46 ± 0.36  a 2.09 ± 0.22 b 1.86 ± 0.24 b  
Dbili µmol/l 1.24 ± 0.23 a 1.30 ± 0.33 a 1.08 ± 0.21 a  
Creat µmol/l 64.70 ± 8.41 a 60.33 ± 3.77 a 60.80  ± 5.35 a  
Iron µmol/l 15.10 ± 1.82  a 11.37  ± 1.55 b 10.94 ± 1.56 b  
a Concentration of PEEs (PER, PECsub and PECgen) in the feed mixture was 2.0 g PER /kg and 2.5 g PECsub and 
PECgen/kg diet, b Bwg was calculated by subtracting the bw on the first day from the bw on the day of termination, c Values 
represent the mean ± SD of ten rats (n=10) per group, with the exception of C. genistoides (n = 9), d Means in the same row 
followed by different letters are significantly different (P<0.05), e Relative liver and kidney weights were calculated as a 
percentage of the bw on the day of termination. f Iron refers to the total iron determined in the plasma.     
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Table 7 Effect on lipid peroxidation, oxidative enzyme parameters and reduced glutathione 
(GSH), oxidized glutathione (GSSG) and the ratio GSH:GSSG in rat liver after dietary 
consumption of polyphenol-enriched extracts (PEEs) a by male Fisher rats for 28 and 90 days 
during two respective studies.   
 Control 
A. linearis 
(PER) 
C. subternata 
(PECsub) 
C. genistoides 
(PECgen) 
28 days     
CAT b 320.69 ± 36.85 c a d 296.56 ± 28.56 a 340.47 ± 40.76 a 330.73 ± 27.04 a 
SOD e 0.64 ± 0.06 a 0.58 ± 0.06 a 0.62 ± 0.05 a 0.58 ± 0.08 a 
GR f 41.71 ± 2.49 a 48.92 ± 0.85 b 51.64 ± 4.97 b 49.28 ± 3.67 b 
GSH g 18.34 ± 4.88 a 19.70 ± 7.45 a 25.95 ± 4.56 a 24.12 ± 3.93 a 
GSSG h 1.40 ± 0.42 a 1.66 ± 0.57 a 1.56 ± 0.26 a 1.59 ± 0.24 a 
GSH/GSSG i 12.80 ± 4.44 a 11.95 ± 5.77 a 16.00 ± 4.17 a 16.12 ± 3.28 a 
CD j 10.43 ± 2.08 a 10.20 ± 2.13 a 10.63 ±  2.13 a 10.88 ± 0.86 a 
MDA k 1.58 ± 0.53 a 1.67 ± 0.66 a 1.92 ± 0.08 a 1.74 ± 0.33 a 
90 days     
CAT b 323.47 ± 33.29 a 320.85 ± 37.48 a 290.91 ± 19.83 a  
SOD e 0.55 ± 0.09 a 0.53 ± 0.06 a 0.60 ± 0.09 a  
GR f 45.54 ± 3.47 a 44.96 ± 5.14 a 46.12 ± 6.20 a  
GSH g 19.69 ± 3.07 a 12.39 ± 0.59 b 12.87 ± 1.04 ab  
GSSG h 1.68 ± 0.33 a 1.26 ± 0.37 a 2.04 ± 0.94 a  
GSH/GSSG i 11.35 ± 3.79 a 9.66 ± 3.01 a 6.79 ± 4.11 a  
CD j   10.57 ± 1.68 a 12.27 ± 1.44 a 10.68 ± 1.56 a  
MDA k 1.50 ± 0.59 a  1.78 ± 0.43 a 1.63 ± 0.18 a  
a Concentration of PEE (PER, PECsub and PECgen) in the feed mixture was 2.0 g PER/kg and 2.5 g 
PECsub and PECgen/kg diet, b Catalase (CAT) activity measured as nmole/min/μg protein, c Values 
represent the mean ± SD of duplicate analysis of five random samples selected from each treatment group 
of ten rats (n = 10), with the exception of C. genistoides (n = 9), d Means in the same row followed by 
different letters are significantly different (P<0.05), e Superoxide dismutase (SOD) activity given as the 
amount of protein (μg) required to produce a 50% inhibition of auto-oxidation of 6-hydoxydopamine, f 
Glutathione reductase (GR) activity measured as pmole NADPH used per min/μg protein, g Reduced 
glutathione (GSH) concentration given as nmole/μg protein, h Oxidized glutathione (GSSG) concentration 
given as nmole/μg protein,  i GSH/GSSG ratio, j Conjugated diene (CD) concentration is given as nmole/mg 
protein, k Malondialdehyde (MDA) concentration given as μmole/mg protein.   
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DISCUSSION 
 
Investigation on specific health effects and required concentrations of polyphenols should 
incorporate studies establishing a “safety level” to avoid toxic or adverse effects (Finley et al., 
2011).  Studies in cell cultures and experimental animals indicated that antioxidants may cause 
toxicity, particularly when administered or consumed at high dose levels.  In relation to tea and 
tea products, a green tea (unfermented C. sinensis) derived preparation, Teavigo, containing 
more than 90% of the potent antioxidant EGCG, exhibited toxicity when administered at a high 
single dose (2000 mg/kg) to rats (Isbrucker et al., 2006).  Oral administration of a single bolus 
dose 500 mg/kg to dogs resulted in proximal tubular necrosis in the kidneys and elevated serum 
bilirubin and AST levels in males, with the female dogs presented with liver necrosis.  
Administration of a single dose of 1500 mg/kg EGCG also resulted in hepatotoxicity in mice 
(Lambert et al., 2010).  In humans, consumption of high doses of tea-based (C. sinensis) dietary 
supplements showed elevated ALT and bilirubin levels which were resolved following cessation 
of the supplement consumption (Bonkovsky, 2006).  Upon the re-introduction, the serum 
markers related to liver toxicity re-appeared indicating a causative role of the supplement.  
Detailed characterization of the chemical and biological properties of herbal extracts used in 
animal and human studies is imperative to facilitate the benchmarking of the biological 
properties and avoidance of potential adverse effects.  This has become important as 
differences in the chemical composition and biological activity exist and was illustrated in 
variations in the antimutagenic and antioxidant properties of rooibos and honeybush extracts 
(van der Merwe et al., 2006; Manley et al., 2006; Joubert et al., 2008b).   A recent study on 
rooibos indicated that the polyphenol content and the antioxidant activity varies between 
individual batches of plant material used, depending on stem content and the particle size of the 
raw material used (Joubert & De Beer., 2011). Therefore, comparison of the biological 
properties of the PEEs in the current study to in vivo studies conducted with aqueous extracts of 
rooibos and honeybush, should also compare differences in chemical composition and the in 
vitro antioxidant activities of extracts.  These parameters could potentially be applied as quality 
parameters or used to obtain prediction of outcomes in vivo.   
 
Comparative TP content and antioxidant activities  
The TP content of PER in the present study (39.22 g GAE/100 g extract) was higher than the 
averages of 35.08 and 35.12 g GAE/100 g reported for aqueous extracts of unfermented 
rooibos by Joubert et al. (2008b) and De Beer et al. (2011), respectively.  Enrichment of the 
current rooibos preparation (PER) resulted in an aspalathin content of 18.73 g/100 g extract, 
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approximately 2–3 fold the concentration when compared to the  aqueous unfermented rooibos 
extracts, while the levels of nothofagin and the flavone-glucosides, isoorientin, vitexin and 
isovitexin, were also increased (van der Merwe, 2004; Joubert et al., 2005, Beelders, 2011).  
The PER extract displayed increased antioxidant activity in the FRAP, DPPH and ORAC assays 
when compared to aqueous unfermented rooibos extracts (De Beer et al., 2011).  Increased 
activity is mainly attributed to the 2–3 fold enrichment in aspalathin, known to be a potent 
rooibos antioxidant when compared to the radical scavenging activity of quercetin and the green 
tea (C. sinensis) catechin, EGCG (Snijman et al., 2009).    
In contrast the TP content of PECsub and PECgen extracts (24.83 and 21.88 g GAE/100 g, 
respectively) were lower than the reported levels for aqueous extracts of unfermented C. 
subternata (32.41 g GAE/100 g) and C. genistoides (28.74 GAE/100 g) (Joubert et al., 2008b).  
The PECsub extract contained a higher level of mangiferin (3.79 g/100 g) when compared to 
aqueous extracts of unfermented C.subternata containing 1.19 g/100 g (Joubert et al., 2008b) 
and 2.73 g/100 g extract (De Beer & Joubert, 2010).  The mangiferin content of PECgen (9.29 
g/100 g) was similar to 10.04 g/100 g for the aqueous extracts of unfermented C. genistoides 
reported by Joubert et al. (2008b) and 9.55 g/100 g by De Beer & Joubert (2010).  The 
isomangiferin (1.16 and 2.94 g/100 g) and hesperidin contents (0.99 and 0.83 g/100g) were 
higher for both PECsub and PECgen than in these aqueous extracts.  In contrast the eriocitrin 
(1.10 g/100 g) and scolymoside (1.29 g/100 g) contents were slightly increased in PECsub 
compared to the reported levels in aqueous extracts of C. subternata (De Beer & Joubert, 
2010).  
The PECsub and PECgen extracts used in the current study were less effective antioxidants 
than unfermented aqueous extracts of these herbal teas, when evaluated in the FRAP 
antioxidant assay (Joubert et al., 2008b), which is attributed to compositional differences in 
batches of plant material used for preparation of the aqueous extracts and PEEs.  Apart from 
the mangiferin content in PECsub, the enrichment of the polyphenol content of honeybush 
(PECsub and PECgen) was not very effective in increasing TP and antioxidant activity. 
However, when considering these parameters PER was successfully enriched.  This 
emphasises the importance of quality of the raw material used to produce polyphenol-enriched 
extracts.  Furthermore, when benchmarking the chemical and biological properties of herbal 
extracts, the selection of plant material should be carefully considered.        
 
Modulation of clinical biochemical parameters 
No effect on the bwg and relative liver and kidney weights of the rats was observed during the 
28 and 90 day treatment periods.  However, AST levels was significantly and markedly 
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decreased by PECsub and PECgen after 28 days, respectively while PECsub significantly 
(P<0.05) increased serum Tbili levels.  The reason for the significant decrease in AST is not 
known at present.  The age of rats should be considered when interpreting the clinical 
biochemical parameters.  The baseline Tbili as higher in the younger rats as is evident form the 
levels in the 28 and 90 day studies.  It is also unclear why Tbili was increased in the serum of 
rats receiving PECsub for 28 days, while it significantly (P<0.05) decreased after 90.  A similar 
decrease was also evident in the rats receiving the PER extract. In contrast a significant 
(P<0.05) increase in ALP levels was evident in the rats receiving the PECsub extract after 90 
days while a marked increase was noticed for PER.  Although increased ALP levels are 
associated with drug-induced cholestasis (Wright & Vadenberg, 2007), GGT activity is 
considered to be a more reliable marker for cholestasis than ALP in rats (Ozer et al., 2008).  
The levels of GGT tended to be markedly, but not significantly, elevated in the serum of rats 
consuming PER and PECsub for 90 days.  The serum ALT levels, Tbili, ALP and bile acids are 
used supplementary to conventional biomarkers of liver function, in particular with regard to the 
differential diagnosis of biliary function (Ozer et al., 2008).  Total bilirubin is, however, regarded 
as a better indicator of disease severity than ALT in humans (Dufour et al., 2001).  Tbili is a 
product of hemoglobin degradation used as a marker of hepatobiliary injury, specifically 
reflecting cholestasis and biliary effects (Ozer et al., 2008).  Bilirubin levels may also be 
increased due to non-hepatic causes such as hemolysis.  Although in vitro studies indicated that 
polyphenols affect hemolyses in human erythrocytes due to phenoxyl radical formation (Galati 
et al., 2002) it is uncertain whether the serum levels of honeybush polyphenols could have 
reached adequate levels to induce a similar effect in vivo in the current study.  Dietary 
consumption of PECsub appears to adversely affect the biliary system after exposure for 28 and 
90 days, although differences exist in the manifestation thereof depending on age of the rats 
and the level of polyphenol exposure and duration.  
The different effects in the biochemical serum parameters between the two honeybush 
extracts (PECsub and PECgen) should be considered in view of their qualitative and 
quantitative differences in phenolic composition.  Firstly, the TP intake of PECsub was 
significantly higher when compared to PECgen and secondly, PECsub contained phenolic 
compounds not present in PECgen, i.e. eriocitrin and scolymoside.  PECsub also contained 
relatively high levels of both iriflophenone 3-C-glucoside and phloretin-3,5-di-C-glucoside when 
compared to PECgen.  In contrast the xanthone (mangiferin and isomangiferin) intake was 
approximately 2.5 fold lower for the rats fed the PECsub extract, suggesting that these 
polyphenols do not play a determining role in changes in the Tbili and ALP serum levels.   The 
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specific role of the polyphenols and/or the combination thereof in the disruption of biliary 
function as affected by PECsub is not known at present. 
The level of exposure and type and/or specific polyphenol composition of extracts will 
determine the outcome of the biological effects.  The significant higher TP level consumed by 
the PECsub treated rats during the 28 (64.27 mg GAE/100 g) and 90 day (48.05 mg GAE/100 
g) studies is considered to result in the effect on Tbili observed, while no effect were evident at 
the TP level of 22.90 GAE mg/100 g in the study by Marnewick et al. (2003) with aqueous 
extract of unfermented C. intermedia as sole available drinking fluid (10 weeks).       
 
TP exposure and time dependent effects on iron intake 
As indicated above the phenolic composition of the PEEs, the level of TP administered, time of 
exposure and the age of the rats are of importance when considered biological effects. With 
respect to the duration of exposure, the serum iron levels were significantly decreased by PER 
and PECsub after the 90 day dietary treatments, while no effect was evident after 28 days.  The 
latter is in agreement with a 10 week study in rats where no changes were observed in serum 
iron levels when exposed to aqueous fermented and unfermented rooibos and honeybush (C. 
intermedia) in the drinking water (Marnewick et al., 2003).  Studies in humans also fail to 
provide evidence of a reduction in serum iron following consumption of fermented rooibos.  
These include a study with 59Fe isotope in 30 human volunteers consuming a single serving of 
200 ml fermented rooibos tea (with 40 ml milk and sugar), black tea or water for 14 days 
(Hesseling et al., 1979) and a study in school children (175) consuming two 200 mL servings of 
fermented rooibos and black tea (fermented C. sinensis) with milk and sugar daily for an 
extended period of 16 weeks (Breet et al., 2005).  A recent study on the effect of rooibos on 
biochemical and oxidative stress parameters in adults at risk for cardiovascular disease also did 
not record any effect on the serum iron levels after six weeks of consuming six cups of the 
traditional fermented rooibos herbal tea per day (Marnewick et al., 2011).  The TP intake of the 
latter study as well as the 10 week study in rats (Marnewick et al., 2003) was approximately 3 
fold below that used in the present study over 90 days.  It is therefore apparent that sub-chronic 
exposure over a period of 90 days to high levels of TP for rooibos (62.70 mg GAE/100 g 
bw/day) and honeybush (48.05 mg GAE/100 g bw/day) adversely affect serum iron presumable 
by disrupting iron absorption from the gut which could have important implications in human 
regarding physiological conditions associated with anemia.  Inspite of the TP intake for PECsub 
being much lower than for PER, both significantly reduced iron levels, indicating that a upper 
limit for TP applies in terms of adversely affecting iron absorption and/or compositional 
difference.     
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Tannins from various food sources, including tea (C. sinensis) have been implicated in the 
inhibition of iron absorption (Graham et al., 2001).  However, the effect of tea consumption on 
the absorption of iron has been controversial for some time.  A recent study with green 
(unfermented C. sinensis) and black teas (fermented C. sinensis) in humans reported that the 
iron status parameters were not affected by their consumption of 1 L/day when using a four 
week cross over design (Schlesier et al., 2012).  Blood samples were collected prior to the one 
week depletion period, at the start of the intervention phase and thereafter weekly during 
intervention.  The only iron status parameter significantly affected was plasma ferritin values 
significantly reduced after tea consumption, especially in women with low basal ferritin values.  
Hemoglobin, hematocrit, transferring, total iron and iron binding were not significantly affected in 
healthy men and women.  In rats it has been postulated that habitual tea (C. sinensis) 
consumption protects against the inhibitory effects of tea on iron absorption (Kim et al., 2004).  
The duration of this investigation in rats was however only 24 days, but the findings indicate that 
rats possess adaptive mechanisms to partially overcome the inhibitory effects of tannins on iron 
absorption.  When considering the observed significantly reduced total serum iron in the 90 day 
studies, rooibos has been “branded” as low in tannins, but the hot water soluble solids of the 
fermented tea contains as much as 50% complex tannin-like substances (Joubert et al., 2008a).  
However, the tannin content is still far less when compared to black tea (Blommaert & 
Steenkamp, 1978).  The tannin content of honeybush is much lower and estimated to be 
approximately 4.34% of the hot water soluble solids in fermented honeybush (Du Toit & Joubert, 
1998).  Reduced iron-absorption has also been attributed to formation of nontransportable 
polyphenol-iron complexes (Kim et al., 2008), which seems to be the likely contributing factor in 
reduced iron levels in the current study due to the high levels of TP consumed.   
 
Bioavailability and modulation of cellular redox status in rat liver  
The role of phenolic compounds on the oxidative status of the liver and observed effects on the 
serum biochemical parameters should take cognizance of the bioavailability of these 
compounds.  The presence of both aspalathin and mangiferin, the major polyphenols of rooibos 
and honeybush, respectively, has been reported in plasma of humans.  A concentration of up to 
1.97 nmol aspalathin was reported in the plasma, 3 h after consumption of 500 mL (containing 
287 mg aspalathin) of rooibos by humans (Breiter et al., 2011).  Other intact compounds 
reported in the plasma in this study were isoorientin, orientin, isovitexin, vitexin and rutin, but at 
much lower levels than aspalathin.  A pharmacokinetic study in humans with mangiferin 
reported a concentration of 38.64  6.75 ng/mL after oral administration of 0.9 g mangiferin 
(Hou et al., 2011).  Aspalathin and mangiferin are deglycosylated and excessively metabolized 
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by phase II conjugating enzymes following absorption (Bock et al., 2008; Courts & Williamson, 
2009; Stalmach et al., 2009; Breiter et al., 2011).  Other rooibos phenolic compounds consumed 
at more than 1 mg/100 g bw/day in the present study included isoorientin, orientin and 
nothofagin.  Orientin has been detected at a level of 45.0760.74 µg/g in lung, liver and kidney 
tissue after intravenous administration of the pure compound (20 mg/kg bw) in rats, but no 
orientin could be detected in the plasma (Li et al., 2008).  Poor gastrointestinal absorption of 
orientin, isoorientin, vitexin and isovitexin was reported following gavage of a bamboo extract in 
rats (Zhang et al., 2005).   
Regarding the honeybush polyphenols, the aglycone of mangiferin, norathyriol, was the 
main metabolite detected in the plasma of pigs following the consumption of an extract of 
unfermented C. genistoides (Bock et al., 2008).  Metabolites reported for eriocitrin in plasma of 
rats include glucuronidated and/or sulphated conjugates of eriodictyol, homoeriodictyol and 
hesperetin (Miyake et al., 2000).  Small quantities of the free and conjugated form of 
hydrocaffeic acid were also detected.  Urine metabolites included unconjugated and conjugated 
forms of the flavanones and hydrocaffeic acid. Hesperidin metabolites recovered from human 
plasma after ingestion of orange juice include glucuronides and sulfoglucuronides of hesperetin 
(Manach et al., 2003).  It would appear that, in general very few unmetabolised polyphenols do 
occur in the body, although deglycosylated products and metabolites of the phenolic 
compounds may still contain an intact catechol moiety.  
Another measure of indirect evidence of absorption through the gut barrier is an increase in 
the antioxidant capacity of plasma after consumption of polyphenol-rich foods (Scalbert & 
Williamson, 2000; Tapiero et al., 2002).  The antioxidant status in plasma following ingestion of 
an aspalathin-enriched green rooibos extract over a two week period in humans showed no 
increase (Sauter, 2004), while Wanjiku (2009) and Villaño et al. (2010) reported a significant 
increase following consumption of rooibos tea.  Breiter et al. (2011) could also not detect a 
significant increase in the plasma antioxidant capacity after consumption of different rooibos 
formulations.  An increased total antioxidant capacity in plasma after the consumption of 
polyphenol-rich foods is often challenged as the effective means of measurement due to the 
extensive metabolism of dietary polyphenols (Spencer et al., 2008).  In relation to the South 
African herbal teas, both the major phenolic compounds in rooibos and honeybush, aspalathin 
and mangiferin, loose their antioxidant potency after phase II glucuronidation (Van der Merwe et 
al., 2010, Van der Merwe et al., 2012).  However, since some of the major phenolic compounds 
in both rooibos and honeybush are bioavailable, albeit to a limited extent, these compounds and 
their parent compounds and/or metabolites, could affect the oxidative status, activity of 
antioxidant liver enzymes and subsequently the biochemical parameters.   
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In the current study none of the PEEs significantly (P>0.05) effected oxidative stress in the 
liver although there was a marked increase in lipid peroxidation, as monitored by the CD level in 
the livers of rats treated with PECsub after 28 days.  After 90 days both CD and Fe(II)-induced 
lipid peroxidation were also markedly increased in the liver of rats receiving PER.  An underlying 
oxidative stress therefore, appears to exist in the liver of the rats following consumption of PER 
and PECsub.  A recent study demonstrated that an aqueous extract of fermented rooibos 
protects against lipid peroxidation in the liver of hepatotoxic carcinogen, fumonisin B1 treated 
rats (Marnewick et al., 2009).  No protection was, however, evident for unfermented rooibos, 
which tended to synergistically increase the hepatotoxic effect of fumonisin B1.  This was 
attributed to pro-oxidant effects as demonstrated for rooibos (Joubert et al., 2005).  Fermented 
rooibos, in contrast, prevented lipid oxidation and oxidative stress and demonstrated protection 
against carbon tetrachloride-induced liver damage in rats (Uličná et al., 2003; Uličná et al., 
2008).  In humans, an aqueous extract of fermented rooibos decreased the level of lipid 
peroxidation and increased the GSH concentration in red blood cells and plasma of 
occupationally workers exposed to lead (Nikolova et al., 2007).  These studies were conducted 
with fermented rooibos extracts that are customarily used and protection against oxidative 
damage was demonstrated under conditions of increased oxidative stress.  It is therefore 
apparent that protective effects of rooibos against lipid peroxidation are evident under conditions 
that are conducive to oxidative stress. Under normal physiological conditions, as indicated in the 
present study the marked increase in lipid peroxidation in the liver is rather an indication of an 
underlying oxidative stress.   
The activities of the antioxidant enzymes, CAT and SOD in the liver were not altered under 
the present experimental conditions.  However, the level of GR was significantly increased by all 
three PEEs after 28 days, while PER and PECsub did not affect GR significantly after 
consumption for 90 days.  The significantly increased activity of GR may result from a 
disturbance in the glutathione metabolism, not yet manifested in the levels of GSH and GSSG at 
28 days. The activity of the phase II enzymes, GSH-S-transferase and UDP-glucuronosyl 
transferase in the liver was significantly enhanced after 10 weeks of exposure to aqueous 
extracts of rooibos and C. intermedia as sole source of drinking fluid (Marnewick et al., 2003).  
This could possibly be a result of effective polyphenol metabolism in the liver and subsequent 
excretion in order to maintain the homeostatic balance regarding oxidative status in the liver. 
However, during conditions of oxidative stress, polyphenols may still play an important role in 
the body via the increased release of β-glucuronidase and/or sulfatase by inflammatory cells 
such as macrophages.  This will facilitate de-conjugation reactions, liberating the free 
unconjugated polyphenol thereby re-establishing its antioxidant characteristics (Kawai, 2011).  
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The metabolism of the major rooibos and honeybush polyphenols and implications thereof were 
discussed in detail in Van der Merwe et al. (2010) and Van der Merwe et al. (2012).  Mangiferin 
was shown to protect against isoproterenol-induced myocardial infarction in rats by contributing 
toward the tissues defense system (Prabhu et al., 2006) suggested to be related to the 
antioxidant potential of the unconjugated form in vivo.  Assessing the effects of rooibos and 
honeybush polyphenols in humans, specific endpoints should include the monitoring of the ratio 
of conjugated and unconjugated forms of relevant polyphenolic constituents.  In addition, other 
parameters, apart from monitoring the activities of antioxidant enzymes, would provide a better 
assessment of the beneficial and/or adverse effects of polyphenol-enriched extracts in in vivo 
models.   
 
Polyphenol and glutathione interactions 
Apart from the increased levels of GR after 28 days, additional evidence that the PEEs interfere 
with the oxidative status in the liver, is obtained from the finding that the GSH level was 
significantly and markedly decreased after the 90 day exposure regimens by PER and PECsub, 
respectively.  In contrast,  the 10 week study with fermented and unfermented rooibos and 
honeybush (C. intermedia) as sole source of drinking fluid significantly reduced oxidized 
glutathione (GSSG) levels in the liver of rats while GSH was markedly increased (Marnewick et 
al., 2003).  These changes resulted in a significant (P<0.05) increase in the GSH/GSSG ratio by 
the unfermented and fermented rooibos and unfermented honeybush (C. intermedia).  In 
humans, consumption of rooibos for six weeks improved several biomarkers of blood lipid status 
by decreasing lipid peroxidation and improving the redox status in the blood of adults at risk for 
developing cardio-vascular disease (Marnewick et al., 2011).  The plasma antioxidant capacity 
was not altered, likely related to the phase II metabolism of the polyphenols and the resultant 
loss in antioxidant activity.  However, the level of CD and TBARS in the plasma significantly 
decreased while GSH and the GSH/GSSG ratio were both significantly increased (Marnewick et 
al., 2011).     
The duration and level of exposure to PEEs appears to be the major determinants when 
considering glutathione as a biological marker for cellular oxidative stress.  GSH is a powerful 
intracellular antioxidant, present in mammalian cells, and its level is regarded as a good 
indication of oxidative stress (Green et al., 2006).  Depletion of GSH by polyphenols has been 
reported and may be affected by different mechanisms in the cell (Galati et al., 2002).  In cancer 
cells, GSH depletion by polyphenols has been proposed as a potential strategy to sensitize the 
cell to oxidative-induced cell death via phenoxyl radical-induced oxidative stress and 
mitochondrial membrane potential collapse (Galati et al., 2002; Kachadourian & Day, 2006).  
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Therefore, the generation of H2O2 and reactive semi-quinone radicals by dietary polyphenols 
could be valuable in anticancer therapy.  It is however of major concern when utilising 
supplements containing high doses of polyphenols due to the potential pro-oxidant activity of 
these compounds (Galati et al., 2002; Heim et al., 2002; Rietjens et al., 2002; Halliwell, 2007; 
Halliwell, 2008).  Pro-oxidant activity of aqueous extracts and their crude polymeric fractions of 
rooibos have been reported to be linear with the dihydrochalcone (aspalathin and nothofagin) 
and flavonoid content (Joubert et al., 2005).  Pro-oxidant activity was also demonstrated for 
pure aspalathin in vitro in the same study.  Fermentation (i.e., oxidation) of rooibos decreased 
the pro-oxidant activity of aqueous extracts, which was associated with a decrease in the 
dihydrochalcone content.  Pro-oxidant activity of mangiferin at the levels present in unfermented 
Cyclopia spp. has also been suggested (Joubert et al., 2008b).  
The chemical structures of flavonoids are an important determining factor when considering 
their pro-oxidant activity and their interaction with glutathione metabolism (Rietjens et al., 2002).  
The pro-oxidant activity of phenol-type flavonoids is prone to result in GSH oxidation, while 
catechol-type flavonoids may lead to GSH-conjugation.  Flavonoids with a phenol-type 
substituent pattern in the B-ring are enzymatically and/or chemically oxidized to generate a 
flavonoid semiquinone radical (Galati et al., 1999; Rietjens et al., 2002).  This radical is 
scavenged by GSH leading to regeneration of the flavonoid resulting in the formation of the thiyl 
radical of glutathione (Galati et al., 1999).  This radical then reacts with GSH to generate a 
disulfide radical anion which rapidly reduces molecular oxygen to superoxide anion radicals. 
Flavonoids with a catechol type substituent pattern in their B-ring, especially a 3,4-catechol 
type moiety, is related to the formation of quinone type oxidation products (Rietjens et al., 2002).  
These compounds scavenge GSH rather via conjugate formation instead of chemical reduction 
and the formation of GSH flavonoid adducts have been demonstrated (Galati et al., 2001; Galati 
et al., 2006).  For gallic acid and gallic acid tea (C. sinensis) derivatives, GSH conjugates 
formation in primary hepatocytes was postulated to be attributed to their low redox potentials 
(Galati et al., 2006), which are much lower than that calculated for the couple GS• H+/GSH (Em7= 
930 mV) (Wardman, 1990).  Although the exact mechanism of GSH depletion in the liver 
following the 90 day feeding study is not known at present, GSH oxidation seems not to be 
involved since the GSSG level was not altered. The formation of GSH conjugates via flavonoid 
quinone formation is therefore more likely to occur.  In this regard, studies in hepatocytes have 
shown that the catechol B-ring-containing flavonoids with low redox potentials, such as luteolin 
and quercetin, depleted hepatocyte GSH without causing GSSG formation (Galati et al., 2002).  
The major B-ring catechol containing flavonoids in PER are aspalathin, isoorientin and orientin 
followed by the quercetin glycosides rutin, isoquercitrin and quercetin-3-robinobioside.  Apart 
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from the catechol containing xanthones, mangiferin and isomangiferin, other catechol flavonoids 
of importance in honeybush with regards to GSH interaction in the present study will be 
eriocitrin, scolymoside and iriflophenone 3-C-glucoside.      
 
Conclusions 
 
The use of PEEs and the subsequent increased intake of polyphenols from rooibos and 
honeybush should be carefully managed, specifically under conditions of iron deficiency.  When 
considering the serum biochemical parameters, PECsub could influence the biliary system in 
rats when consumed at the high total polyphenol dose of 64.27 mg GAE/100 g/day for more 
than 28 days.  Slightly elevated CD levels and Fe(II)-induced lipid peroxidation (MDA) evident in 
the liver homogenates following consumption of PER and PECsub are likely associated with 
depletion of GSH, although other polyphenol/GSH interactions also need to be considered.  It is 
apparent that there should be clear differentiation between effects of phenolic compounds when 
investigated under a disease state such as cancer or cardiovascular disease as opposed to 
their effects in healthy subjects.  Toxicological risks may arise above a certain threshold limit 
following ingestion of polyphenol-enriched supplements as a function of the dose (Rietjens et 
al., 2002). This raises the question about the dose-effect responses for beneficial versus toxic 
affects of functional food ingredients, which are often unknown.   
The current study indicated that dietary PEEs of rooibos and honeybush had limited adverse 
affects in rats when administrated for 28 and 90 days in two separate studies, although the dose 
and duration of exposure should be carefully monitored.  The observed effects on glutathione is, 
however, of major concern, since the disruption of GSH metabolism will have a major impact on 
the cellular redox status as well as xenobiotic metabolism in terms of the normal physiology and 
defense against xenobiotic metabolism (Dickinson & Forman, 2002).  The biochemical serum 
parameters and oxidative parameters, i.e. antioxidant enzyme activity and glutathione analysis 
in rat liver are frequently used as indicators of oxidative stress.  The lack of sensitivity and 
specificity of these biomarkers during the safety assessment of high levels of polyphenols 
(enriched extracts, functional foods or nutraceuticals) is however, questionable and additional 
approaches may be required to provide a more thorough evaluation.   
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CHANGES IN EXPRESSION OF OXIDATIVE STRESS AND ANTIOXIDANT 
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CHANGES IN EXPRESSION OF OXIDATIVE STRESS AND ANTIOXIDANT 
DEFENSE RELATED GENES IN RAT LIVER FOLLOWING INTAKE OF 
POLYPHENOL-ENRICHED ROOIBOS (ASPALATHUS LINEARIS) AND 
HONEYBUSH (CYCLOPIA SPP.) EXTRACTS FOR 28 DAYS 
 
ABSTRACT 
 
The safety of value-added products and nutraceuticals derived from polyphenol-enriched 
extracts (PEEs) from the South African herbal teas, rooibos (Aspalathus linearis) and 
honeybush (Cyclopia spp.) has not been sufficiently investigated to date.  To provide additional 
insight into results from conventional biomarkers (serum clinical biochemical parameters and 
oxidative parameters in the liver), the changes in expression of oxidative stress and antioxidant 
defense related genes following the dietary consumption of PEEs prepared from these teas was 
assessed for the first time.  PEEs of unfermented rooibos (PER) and honeybush [Cyclopia. 
subternata (PECsub) and C. genistoides (PECgen)] were fed to male Fischer rats for 28 days.  
A quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) array was 
used for evaluation of the effect on gene expression of 84 oxidative stress and antioxidant 
defense related genes in the livers of rats.  Dietary intake of the PEEs at the administrated dose 
(2.0 g PER/kg diet and 2.5 g PECsub and PECgen/kg diet) significantly (P<0.05) altered the 
expression of several of these genes, i.e. seven as a result of PER intake and eleven by 
PECsub and PECgen, respectively, of which seven were mutually affected.  Intake of PER 
resulted in the up-regulated expression of four genes and down-regulated expression of three 
genes, which included the glutathione peroxidases (Gpx), Gpx2 and Gpx3, the aminoadipate 
semialdehyde synthase (Aass), neutrophil cytoxoic factor 2 (Ncf2), EH-domain containing 2 
(Edh2), isocitrate dehydrogenase 1 (Idh1) and NAD(P)H dehydrogenase, quinone 1 (Nqo1).  
The expression of genes  mutually  affected by PECsub and PECgen included antioxidant 
related genes, prostaglandin-endoperoxide synthase 1 (Ptgs1), kinesin family member 9 (Kif9), 
serine (or cysteine) peptidase inhibitor clade B member 1b (Serpinb1b) and genes involved in 
reactive oxygen species (ROS) metabolism, xeroderma pigmentosum complementation group A 
(Xpa), thioredoxin interacting protein (Txnip), as well as oxygen transporter related genes 
fanconi anemia complementation group C (Fancc) and vimentin (Vim).  The largest fold 
changes were neutrophil cytosolic factor 2 (Ncf2) down-regulated 4.78 fold by PER, NADPH 
oxidase organizer 1 (Noxo1) expression increased 19.97 fold by PECsub and a 372 fold 
increased expression of thyroid peroxidase (Tpo) affected by PECgen.  Variations and 
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differential modulation of gene expression was attributed to the differences in phenolic 
composition between rooibos and honeybush, as well as between the two honeybush species, 
C.subternata and C.genistoides.  Changes in the expression of the oxidative stress and 
antioxidant defense related genes could be indicative of an underlying stress affected by the 
PEEs in the liver.      
 
INTRODUCTION 
 
Polyphenols are known to activate or inhibit primary enzyme systems responsible for 
metabolism of xenobiotics, such as carcinogens, pharmaceutical drugs and environmental 
pollutants (Middleton et al., 2000; Moon et al., 2006).  This interaction is of critical importance 
with respect to drug metabolism as subsequent increased or decreased levels of a specific drug 
could result in toxicity or failure in treatment efficacy.  Therefore the effect of polyphenols on the 
expression of cytochromes P450 (CYP450) and other drug metabolizing enzymes have been 
the topic of many investigations (Hodek et al., 2002; Moon et al., 2006; Kimura et al., 2010).  
Furthermore, inhibition of key cellular enzymes, gene transcription and induction of tumor 
suppressor genes have been proposed as important mechanisms involved in the 
chemopreventive effects of green tea (unfermented Camelia sinensis) and (-)-epigallocatechin 
gallate (EGCG) in animal models (Lambert et al., 2010).  However, limited information is 
available on the effect of polyphenols and herbal extracts on oxidative stress and antioxidant 
defense related genes and specifically the potential adverse effects of excessive doses 
(Leonarduzzi et al., 2010).     
The induction of hepatic antioxidant enzymes in rats was demonstrated following ingestion 
of the phenolic acids, gentisic acid, gallic acid, ferulic acid and p-coumaric acid at a dose of 100 
mg/kg bw for 14 days (Yeh & Yen, 2006).  The increased expression in hepatic superoxide 
dismutase (Sod), glutathione peroxidase (Gpx) and catalase (Cat) mRNA levels, induced by 
these phenolic acids, were associated with increased enzyme activity and suggested to be 
important in the protection against adverse effects related to oxidative stress and mutagenesis.   
The South African herbal teas, rooibos (Aspalathus linearis) and honeybush (Cyclopia 
intermedia) as sole source of drinking fluid, significantly increased the activity of phase II liver 
cytosolic enzymes glutathione S-transferase  and UDP-glucuronosyl transferase in a 10-week 
study with rats (Marnewick et al., 2003).  Continuous ingestion of commercial rooibos as sole 
source of drinking fluid for two weeks resulted in induction of intestinal CYP3A in rats, implying 
potential herb drug interactions (Matsuda et al., 2007).  Effects of rooibos and honeybush and 
some of their major phenolic constituents on drug metabolizing enzymes have been reviewed 
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(Joubert et al., 2009).  Cardioprotective effects of aqueous rooibos extracts through inhibition of 
apoptosis were related to its flavonol content (Pantsi et al., 2011).  A recent study with 
polyphenol-enriched extracts of rooibos and honeybush (C. subternata and C. genistoides) 
administered in the feed for 28 days, indicated differential alteration of expression of genes 
associated with xenobiotics metabolism in rat liver and kidneys (Abrahams, 2012).  These 
studies have indicated the influence of rooibos and honeybush extracts on CYP450 and a few 
phase II xenobiotic metabolising enzymes, but no information is currently available regarding 
the modulation of the expression of genes associated with the antioxidant status in vivo.  This is 
of particular interest as a clinical study showed that consumption of six cups of the traditional 
fermented rooibos herbal tea over a period of six weeks improved the serum redox status and 
lipid biomarkers associated with cardiovascular disease (CVD) (Marnewick et al., 2011).    
Metabolic processes determining cellular oxidative status are complex and involve 
numerous genes, proteins and metabolites, making assays based on a few genes and/or 
physiological endpoints in assessing the beneficial or adverse effects of dietary nutrients, 
unreliable (Liu-Straton et al., 2004).  Conventional liver function assays include amongst others, 
serum bilirubin, serum albumin and selected hepatic enzymes that are representative of cellular 
disruption or damage (Amacher, 2010).  Although useful and mostly applicable across species, 
many of the conventional and experimental hepatotoxicity indicators currently used as 
preclinical biomarkers for liver toxicity are not exclusively liver-specific, or their activity in serum 
or plasma may be influenced by factors other than liver injury.  Due to hepatotoxicity and 
nephrotoxicity being important and continuing problems in the pharmaceutical industry, there is 
a need to improve toxicity testing methods (Taboureau et al., 2012).  Microarray technologies 
offer the ability to generate a large amount of gene expression information as an initial step to 
assess the molecular mechanisms of toxicologic changes, known as toxicogenomics.  
Quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) array analysis 
offers more specific information and is also more sensitive than microarrays (Buluchamy et al., 
2010) and hence can be applied as a screening tool to assess the impact of dietary constituents 
in health and disease.  Potential application would therefore be in investigating toxicity as part of 
a toxicogenomics approach and elucidation of mechanisms involved in protective or adverse 
properties.    
The current study investigated the modulatory effects of PEEs prepared from unfermented 
rooibos (PER) and honeybush (PECsub and PECgen) on the expression of 84 oxidative stress 
and antioxidant defense related genes in the liver after dietary administration to male Fisher rats 
for 28 days by using a commercially available quantitative RT-PCR array.     
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MATERIALS AND METHODS 
 
Chemicals 
Chemicals used for HPLC analysis were described in Chapter 5.  The majorities of chemicals 
for experimental use in this research chapter was obtained as part of experimental kits and are 
therefore indicated in the text in the methodology section.  Solvents and chemicals used were 
analytical grade except if stated otherwise.  
 
Animals, diet and sample collection 
Preparation of the diets containing the polyphenol-enriched herbal extracts (PEE) of rooibos 
(PER) and honeybush, C. subternata (PECsub) and C. genistoides (PECgen) are described in 
Chapter 5.   
The feeding study in rats was approved by the Ethics Committee for Research on Animals 
(ECRA) of the Medical Research council (MRC) and conducted as described (Chapter 5) over a 
period of 28 days.  Rats were randomly divided into four treatment groups (n=10) consisting of 
the control, PER, PECsub and PECgen treated rats.  As the antioxidant activity of rooibos 
exceeds that of honeybush (Joubert et al., 2008), the rooibos (PER) and honeybush (PECsub 
and PECgen) extracts were incorporated in the diet at levels of 2.0 g/kg feed and 2.5 g/kg feed, 
respectively.  Control rats received the untreated dietary mash as described (Chapter 5).  Feed 
intake was monitored every second day and the body weight was recorded weekly.  After the 28 
days feeding period, rats were terminated by decapitation and the livers were harvested, 
immediately snap frozen in liquid nitrogen and stored at 80°C until use.  The daily intake of the 
total polyphenols and the individual polyphenols were calculated as described (Chapter 5).  The 
average feed intake was calculated for the three rats in each treatment group and the control 
used in the RT-PCR analyses.  Selection of the rats utilised was based on the RNA quality 
extracted as described below.     
 
Quantitative RT-PCR array analysis 
Extraction of ribonucleic acid (RNA)  
Total RNA was isolated from the livers of five randomly selected rats for each of the four 
treatment groups, consisting of ten rats (n = 10).  A QIAGEN RNeasy mini kit (Whitehead 
Scientific, Cape Town, SA) which combines the selective binding properties of a silica-gel-based 
membrane with the speed of micro-spin technology to extract RNA in the presence of a 
specialized high-salt buffer system was used for RNA isolation.  Liver was thawed on ice and 
20–25 mg of each sample was lysed in 600 µL of a highly denaturing guanidine isothiocyanate 
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(GITC)-containing lyses buffer* (RLT) followed by homogenizing in a QIAGEN Tissuelyser II 
(Separations, Cape Town, SA) for 40 sec.  Beta-mercaptoethanol (β-ME) (14.3 M) was added to 
the buffer RLT prior to use.  The lysate was centrifuged (Heraeus HS-F16/3 Megafuge 1.OR 
fitted with a #2704 rotor, Kendro Laboratory Products, Germany) at 10 000 x g for 3 min and the 
supernatant was transferred to a clean microcentrifuge tube.  Ethanol (75%) (600 µL) was 
added to the lysate and the mixture (1200 µl) was fractionated on an RNeasy spin column by 
centrifuging for two 15 sec intervals at 8 000 x g.  The RNeasy spin column membrane was 
washed with RW1 buffer* (700 µl) by centrifugation at 8 000 x g for 15 sec.  A final washing step 
using RPE buffer* (500 µl) was performed by centrifuging again for two 15 sec intervals at 8 000 
x g and then for 2 min.  For evaluation of RNA quality and integrity, RNase-free water (50 µl) 
was added directly to the spin column membrane and centrifuged at 8 000 x g for 1 min.  
 
* Buffers are included in the QIAGEN RNeasy mini kit and therefore no information is available 
regarding the reagents, concentrations or pH.   
 
RNA cleanup and quality assessment 
Genomic DNA in the RNA samples was digested using the Ambion® Turbo DNA-free™ kit 
(Applied Biosystems, Johannesburg, South Africa) according to the manufacturer’s 
recommendations.  Briefly, RNA (20 µg), DNase buffer*, DNAse I* (4 units) and nuclease-free 
water* were mixed and samples incubated for 90 min at 37°C in a final volume of 20 µL.  The 
DNAse enzyme was then deactivated by incubating the mixture with 10 µL DNAse inactivation 
reagent* for 2 min at room temperature.  The RNA-containing supernatant was collected after 
centrifugation at 8 000 x g.  
The RNA quantity and purity were determined with a NanoDropTM 1000 spectrophotometer 
(Thermo Fisher Scientific, Wilmington, USA) and RNA integrity was confirmed by determining 
the RNA 28S:18S ratio with a Bioanalyzer 2100 (Agilent Technologies, Johannesburg, South 
Africa).  
Analysis comprised transferring a gel-dye mixture* (9 µl) to one of the wells on a RNA 6000 
Nano LabChip (Agilent Technologies) followed by spreading through plunging 1 ml of air with a 
syringe into the well for 30 sec.  The gel-dye mix (9 µL) was also transferred to two additional 
wells for quality control purposes.  The Nano marker buffer* (5 µL) was added to each of the 12 
sample wells and the well containing the RNA ladder.  The RNA samples (400 ng/µL) and 
Ambion RNA 6000 ladder* were denatured at 70 °C for 2 min before pipetting 1 µL into the 
respective wells.  The chip was vortexed for 1 min at 240 rpm followed by analyses on the 
Bioanalyser using an Agilent 2100 Expert software program.  The small (18S) and large (28S) 
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ribosomal RNA (rRNA) subunits were recorded as bands and peaks on an electrogram and 
RNA integrity numbers (RINs), displayed as numbers from 1 to 10 were determined from the 
ratio between the size of the 28S band to the 18S band.  Following the RNA quality 
assessment, samples (isolated RNA) were stored at 80 ºC prior to gene analyses.  Of the five 
randomly selected samples of each treatment group (n=10), three RNA samples were selected 
for further evaluation with RT2-Profiler PCR Array analyses based on RNA integrity parameters.   
 
*Reagents were part of the Ambion® Turbo DNA-free™ kit, therefore no specific details are 
available.   
 
cDNA synthesis 
First strand complimentary deoxyribonucleic acid (cDNA) synthesis of the isolated RNA was 
carried out using the RT2 First Strand Kit (SABiosciences, Whitehead Scientific, Cape Town, 
SA) following the manufacturer’s protocol.  Contamination of genomic DNA was eliminated from 
total RNA (1 µg) with 2 µL of a five times concentrated genomic DNA elimination buffer* and 
nuclease-free water to a final volume of 10 µL and incubated at 42 °C for 5 min.  The sample 
was subsequently mixed with oligo-dT primers a five times concentrated reverse transcription 
buffer* and reverse transcriptase to a final volume of 20 µL and incubated at 42 °C for 15 min. 
The RT reaction was terminated by heating at 95 °C for 5 min and stored at -20 °C until use. 
 
*Reagents were part of the RT2 First Strand kit, therefore no specific details are available.   
 
Quantitative RT-PCR array analysis 
Samples were diluted in SABiosciences RT2 qPCR master mix (Whitehead Scientific, Cape 
Town South Africa) according to the supplier’s directions and pipetted into the wells of 
SABiosciences 96-well RT2 Profiler rat oxidative stress and antioxidant defense PCR array 
plates (Whitehead Scientific, Cape Town South Africa) to evaluate the expression of 84 
oxidative stress and antioxidant defense genes (See Addendum E, Table 1 for the array layout 
and Table 2 for a detailed list of all genes evaluated). The RT2 Profiler Array (SABiosciences) is 
a commercially available set of optimized quantitative RT-PCR primer assays on a 96-well plate 
that are available for investigating different biological pathyways (URL: 
http://www.sabiosciences.com /PCRArrayPlate.php).  Analysis included a total of four plates, 
including liver samples from three rats for each treatment group (PER, PECsub and PECgen 
and Control).  The array contains 84 primer pairs of oxidative stress and antioxidant defense 
pathway-focused genes and five primers of house keeping genes: ribosomal protein large P1 
Stellenbosch University  http://scholar.sun.ac.za
 169  
(Rplp1), hypoxanthine guanine phosphoribosyl transferase (Hprt), ribosomal protein L13A 
(Rpl13a), lactate dehydrogenase A (Ldha) and β-actin (Actb).  Seven wells were used to test 
nontranscribed genomic DNA contamination and PCR performance.          
Preparation involved dilution of 20 µL cDNA in nuclease-free water to a final volume of 111 
µl.  A sub-sample (102 µl) was mixed with a two times concentrated RT2 qPCR SYBR green I 
master mix* (550 µl), containing HotStart DNA polymerase*, and nuclease-free water* (448 µl) 
to a final volume of 1100 µl.  For analysis 10 µL of the cDNA mixture was transferred to a PCR 
profiler array containing 84 genes, coding oxidative stress and antioxidant defense genes, five 
reference genes and quality control parameters.  A summary of the genes included is presented 
in Table 1.  Data was generated in real time from the ABI 7900HT real time PCR machine 
(Applied Biosystems, Johannesburg, South Africa)  with a two-step cycling program (1 cycle at 
95 °C for 10 min; 40 cycles at 95 °C for 15 s and then at 60 °C for 1 min).  Data were analyzed 
using the Excel-based PCR array data analysis template from the SABiosciences website: URL: 
http://www.superarray.com/pcrarraydataanalysis.php.    
 
*Reagents were part of the RT2 qPCR master mix, therefore no specific details are available.   
 
Genomic DNA and reverse transcription controls 
The cycle threshold (Ct) reflects the cycle number at which the fluorescence generated within a 
reaction exceeds the background noise and this inversely correlates to the initial amount of 
target template.  The mean Ct for each sample’s genomic DNA control (GDC) parameter was 
determined and was greater than 35 for all the test samples, indicating that the genomic DNA 
contamination did not affect the gene expression profiling results.  The mean Ct value for the 
control sample was between 30 and 35.   If a sample has a mean Ct between 30 and 35, a 
gene-by-gene analysis for each gene of interest (GOI) is done using the equation ΔCt = Ct 
(GDC) – Ct (GOI).  If a value of six or greater is obtained with this calculation it indicates that  
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Table 1 A summary of the genes evaluated by the RT2 Profiler rat oxidative stress and 
antioxidant defense PCR array.  Genes a are grouped according to their function based on the 
listing by SABiosciences (Frederick, MD, USA).    
Grouping of genes Gene symbol a 
a) Antioxidant defense related genes                      
(i) Glutathione peroxidases (Gpx) Gpx1, Gpx2, Gpx3, Gpx4, Gpx5, Gpx6, Gpx7, Gpx8, Gstk1 
(ii) Peroxiredoxins  
 
Ehd2, Prdx1, Prdx2, Prdx3, Prdx4, Prdx5, Prdx6 
(iii) Other peroxidases Aass, Apc, Cat, Ctsb, Duox1, Epx, Kif9, Lpo, Mpo, Ptgs1, Ptgs2, 
Rag2, Serpinb1b, Slc41a3, Tmod1 
 
(iv) Other antioxidants Gsr, Nxn, Sod1, Sod3, Srxn1, Txnrd1, Txnrd2, Zmynd17 
 
b) Genes involved in reactive oxygen species (ROS) metabolism 
(i) Superoxide dismutases (Sod): Sod1, Sod2, Sod3 
 
(ii) Other genes involved in superoxide metabolism: 
 
Ccs, Ncf1, Ncf2, Nos2, Nox4, Noxa1, Noxo1, Scd1 
(iii) Oxidative stress responsive genes Aass, Als2, Apoe, Cat, Ctsb, Dhcr24, Duox1, Duox2, Epx, Ercc2, 
Ercc6, Gab1, Gpx1, Gpx2, Gpx3, Gpx4, Gpx5, Gpx6, Gpx7, 
Idh1, Mpo, Mpp4, Nqo1, Nudt1, Nudt15, Park7, Ppp1r15b, 
Prdx1, Prdx2, Prdx6, Prnp, Psmb5, Sod1, Tpo, Txnip, Txnrd2, 
Ucp3, Xpa. 
c) Oxygen transporter related genes 
 
Aqr, Cygb, Dnm2, Fancc, Hba-a2, Hbz (Hba-x), LOC367198 
(Atr), Mb, Ngb, Ift172, Slc38a1, Slc38a4, Slc38a5, Vim, Xirp1 
 
a A detailed list of gene names, arranged according to function (grouping by 
SABioSciences) of each enzyme is summarised in Table 2 Addendum E.   
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the results, fold changes calculated with the mean Ct value, may still be used without further 
validation.  All values calculated for the control samples using this equation were six or greater.    
The reverse transcription control (RTC) indicates whether impurities in the RNA samples were 
significant enough to inhibit the reverse transcription reaction.  RTC signifies the difference 
between the average Ct of the RTC and the positive PCR control (PPC) and a value below 5 is 
evidence of no RT inhibition.  All test samples had a value below 5.  The value of the control 
sample was slightly more than 5 at 5.13 indicating some impurities.    
 
Data normalization, analysis and statistics 
The mean Ct value was determined for each cDNA sample by calculating the difference in Ct 
between the target gene and reference gene.  The comparative Ct (ΔΔCt) method was used to 
calculate the relative amount of transcripts in the treated and untreated samples (control): ΔΔCt 
= ΔCt (treated) – ΔCt (control).  The fold change for each treated sample relative to the control 
sample (obtained from rats receiving no tea treatment) was calculated using the formula of 2-
ΔΔCt.  Statistical calculations were conducted based on the ΔCt values using a two-tailed t-test.  
A P-value equal to and/or less than 0.05 (P0.05) was designated as significant.  
 
Statistical analyses of the average feed and polyphenol intake  
Normality among the groups for all parameters was investigated using the Komogorov-Smirnof 
Test.  The homogeneity of group variances for all parametric parameters was tested using 
Levene’s Test.  Group differences for these parameters were tested using One-way ANOVA’s 
and post-hoc Tukey test, which is a post hoc comparison of all pairs after a significant F-test.  
Where samples sizes were unequal the Tukey-Cramer adjustments were made automatically.  
For comparisons where only two parametric groups were present, T-tests were used.  The 
Pooled method was used where variances were equal, and the Satterthwaite method was used 
for unequal group variances.  Statistical analyses were performed with SAS v9.2 and statistical 
significance was set at 5% (P<0.05).   
 
RESULTS 
 
Daily feed, PEE and total polyphenol intake 
The average daily feed and total polyphenol (TP) intake parameters presented in Chapter 5 
were recalculated to represent only the data for the three rats for RNA liver samples selected for 
quantitative RT-PCR array analysis.  No significant differences were evident in the feed intake  
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Figure 1 Feed and total polyphenol (TP) intake of male Fisher rats receiving PEEs (2.0 g PER 
extract/kg and 2.5 g PECsub and PECgen/kg diet).  Feed intake was calculated as g feed 
consumed/100 g bw/day, TP intake was calculated as the mg gallic acid equivalents (GAE)/100 
g bw/day.  Values represent the mean ± SD of 3 rats per group (n = 3).  Statistical significance 
(P<0.05) is indicated as “*” on the error bars.   
 
of the four different treatment groups (n=3 rats/group), but the PECsub treated group consumed 
markedly more feed on average than the control and PER treated rats (Figure 1).  The average 
daily TP intake was significantly (P<0.05) higher in the rats receiving PER extracts as compared 
to the honeybush extracts.  The TP intake of the rats receiving PECsub was significantly 
(P<0.05) higher when compared to the PECgen treated rats.     
 
Intake of polyphenol compounds  
The average daily intake of the individual polyphenols for the rats receiving the PER, PECgen, 
PECsub is summarised in Tables 2 and 3.  The rats receiving the PER extract consumed an 
average daily intake of aspalathin (36.85 mg/100 g bw) (Table 2).  This far exceeded the 
average daily intake of any of the other phenolic compounds quantified in the extract with 
nothofagin (2.85 mg/100 g bw) and iso-orientin (2.85 mg/100 g bw), orientin (1.59 mg/100 g bw) 
and the combined flavonols obtained for the three quesceten glycosideds (4.13 mg/100 g bw)     
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Table 2  HPLC quantification of phenolic compounds present in the polyphenol-enriched rooibos (PER) extract and the average daily 
polyphenol intake during the 28 study with male Fisher rats.   
Polyphenol  subgroup Compound Substitution 
Polyphenol 
concentration a 
g/ 100 g extract 
Daily Intake b 
28 days 
mg/100 g bw 
Dihydrochalcone 
 
  
OH
OH O
OH
R1
OH
R2
 
aspalathin 
nothofagin 
R1=OH, R2= C--D-glucopyranosyl 
R1=H, R2=C--D- glucosylpyranosyl 
18.73 
1.45 
36.85 ± 1.35  
  2.85 ± 0.10 
Flavone 
 
OH
O
O
OH
R1
R3
R4
R2O
 
isoorientin 
orientin 
vitexin 
isovitexin 
luteolin 
luteolin-7-gluc 
chrysoeriol 
R1=H, R2=R4=OH, R3= C-β-D-glucopyranosyl 
R1=C-β-D-glucopyranosyl, R2=R4=OH, R3= H 
R1=C-β-D-glucopyranosyl, R2=OH, R3=R4=H 
R1=R4=H, R2=OH, R3= C-β-D-glucopyranosyl 
R1=R3=H, R2=R4=OH 
R1=R3=H, R2=O-β-D-glucopyranosyl, R4=OH 
R1=R3=H, R2=OH, R4=OCH3 
1.45 
0.81 
0.30 
0.39 
0.06  
0.04 
0.02 
  2.85 ± 0.10 
  1.59 ± 0.06 
  0.59 ± 0.02 
  0.77 ± 0.03 
  0.12  ±  0.005   
  0.08  ±  0.003   
  0.04  ±  0.001 
quercetin-3-robionobioside 
isoquercitrin  
R=O-robinobioside 
R=O-β-D-glucosyl   
rutin  R=O-rutinosyl 
 
co-elute 2.10 
 
  4.13  ± 0.15 
 
quercetin 
 
R= OH 
 
traces 
 
  traces 
Flavonol 
 
 
OH
OH
O
O
OH
OR
OH
 hyperoside R=O-galactopyranosyl 
 
0.29   0.57  ±  0.02    
a Values represent the percentage (g/100 g extract) and are the mean of duplicate analyses, b Values represent the average daily polyphenol intake per 
treatment group (3 rats/group), bw = body weight.   
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Table 3 HPLC quantification of phenolic compounds present in polyphenol-enriched C. subternata (PECsub) and C. genistoides (PECgen) and 
average daily intake during the 28 study in male Fisher rats.   
Polyphenol Subgroup Compound Substitution Polyphenol concentration  
g/100 g extract  
             Daily Intake  b   
             mg/100 g bw 
   
PECsub PECgen PECsub  
28 days             
PECgen  
28 days                         
mangiferin 
 
R1 =C--D-glucopyranosyl, R2 = H 
 
3.79 
 
9.29 a,b 
 
10.28 ± 0.42 
 
24.19  ± 0.95 
Xanthone 
OH
O OH
OOH
OH
R2
R1
 
isomangiferin R1 =H, R3 =C--D-glucopyranosyl 1.16 2.94   3.15 ± 0.13   7.65  ± 0.30 
Flavanone       
eriocitrin R1=rutinosyl, R2=R3=OH 1.10 -   2.98 ± 0.12 - 
hesperidin R1= rutinosyl, R2=OH, R3=OCH3 0.99 0.83   2.68 ± 0.11   2.16 ± 0.10 
naringenin R1=R3=H, R2=OH 0.01 0.01   0.03 ± 0.001   0.02 ± 0.001 
OH
O
O
R2
R3
R1O
 eriodictyolglucoside Unidentified  (tr = 10.72 min) 0.23 0.03   0.60 ± 0.03   0.07 ± 0.004 
Flavone 
 
RO
OH
O
O
OH
OH
 
 
luteolin 
scolymoside  
 
R=H 
R=O-rutinosyl 
 
0.06 
1.29 
 
0.09 
- 
 
  0.16 ± 0.01 
  3.50 ± 0.14 
 
  0.23 ± 0.01 
Bensophenone 
   
OH
R
OH
OOH
OH
 
iriflophenone 3-C--glucoside R = glycosyl 1.66 2.53   4.30 ± 0.19   6.59 ± 0.20 
Dihydrochalcone 
  
OH
OH O
OH
R
R
OH
 
phloretin-3,5-di-C-β-glucoside R = glucosyl 2.35 0.11   6.35 ± 0.26   0.26 ± 0.01 
Unknown hydroxycinnamic acid derivative Unidentified  (tr = 11.01 min) 0.72 -   1.86 ± 0.08  
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The average daily intake of both xanthones was significantly (P<0.05) higher in the PECgen 
(24.19 mg/100 g bw mangiferin and 7.65 mg/100 g bw isomangiferin) when compared to 
PECsub (10.28 mg/100g bw mangiferin and 3.15 mg/100g bw isomangiferin) treated rats (Table 
3).  Other phenolic compounds consumed at relatively high levels daily for honeybush 
treatments were the flavanone hesperidin (2.68 mg/100 g bw for PECsub and 2.16 mg/100g bw 
for PECgen) and the bensophenone, iriflophenone-3-C-glucoside (4.30 mg/100 g bw for 
PECsub and 6.59 mg/100g bw for PECgen).  PECsub treated rats consumed to relatively high 
daily levels of the dihydrochalcone phloretin-3,5-di-C-glucoside (6.35 mg/100 g bw).  The 
hydroxycinnamic acid derivative present in PECsub, and absent in PECgen was consumed at 
1.86 mg/100 g bw/day.     
  
RNA quality and integrity 
The quality of RNA was satisfactory with a RNA integrity number (RIN) greater than 8 and the 
A260/280 greater than 2.  A number of the A230/260 values were less than 2, indicating possible salt 
contamination.  As the RIN number and A260/280 was satisfactory and the A230/260 values were 
close to 2, the RNA was deemed as fit for use.   
 
Differential expression of oxidative stress and antioxidant defense related genes  
Results obtained with quantitative RT-PCR array analysis of the relative expression of 84 
oxidative stress and antioxidant defense genes in rat liver are summarised in Table 4 
(Addendum E).  The complete spectrum of differential gene expression and quantitative 
changes for all the genes tested are shown as 3-D profiles in Figure 2a, b and c.  Treatment 
with PER for 28 days resulted in significant (P0.05) changes in the expression of seven genes, 
of which one gene was mutually affected by PECsub and one by PECgen.  The treatments with 
PECsub and PECgen altered the expression of 11 genes, each of which seven were mutual 
(Table 4).      
 
a)  Antioxidant defense related genes 
PER treatment significantly affected the expression of two genes encoding for antioxidants, 
including the up-regulation of glutathione peroxidase 2 (Gpx2) with 1.8 fold and down-regulation 
of Gpx3 with -1.2 fold change.  PECsub resulted in -1.32 fold change down-regulation of 
peroxidase EH-domain containing 2 (Edh2).  Expression of other peroxidases genes 
significantly affected by PECsub and PECgen included the down-regulation of kinesin family 
member 9 (Kif9) by -1.87 and -1.96 fold and serine (or cysteine) peptidase inhibitor clade B 
member 1b (Serpinb1b) by -2.00 and -2.29, respectively.  PECsub and PECgen both also 
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Table 4  Fold change and P-values of the genes significantly affected by dietary consumption of polyphenol-enriched extracts (PEEs) of 
rooibos (PER) and honeybush (C.subeternata (PECsub) and C. genistoides (PECgen)) during the 28 study with male Fischer rats.   
 
 
 
 
 
 
 
 
 
Function grouping and name of gene Symbol  PER PECsub PECgen 
   FC a P-value 
b 
FC P-value FC P-value 
Antioxidant defense related genes        
(i) Glutathione Peroxidases         
Glutathione peroxidase 2 Gpx2  +1.80 c 0.04     
Glutathione peroxidase 3 Gpx3  -1.20 d 0.04     
         
(ii) Peroxiredoxins         
EH-domain containing 2 Ehd2    -1.38 0.042   
         
(iii) Other Peroxidases         
Kinesin family member 9 Kif9    -1.87 0.009 -1.96 0.005 
Prostaglandin-endoperoxide synthase 1 Ptgs1    +2.41 0.001 +1.67 0.048 
Serine (or cysteine) peptidase inhibitor, clade B, member 1b Serpinb1b    -2.00 0.015 -2.29 0.001 
a FC indicates the fold change, b  P≤0.05 designated as significant, c values preceded by + indicates up-regulation, values preceded by - indicates down-regulation.    
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Table 4 (Cont.) 
 
 
 
 
Function grouping and name of gene Symbol  PER PECsub PECgen 
   FC P-value FC P-value FC P-value 
Genes involved in reactive oxygen species (ROS) metabolism       
(i) Superoxide dismutases (SOD)        
Superoxide dismutase 1 Sod1    +1.18 0.002   
Other genes involved in superoxide metabolism        
Neutrophil cytosolic factor 2 Ncf2  -4.78 0.03     
NADPH oxidase organizer 1 Noxo1    +19.97 0.019   
(ii) Oxidative Stress Responsive Genes       
Aminoadipate-semialdehyde synthase Aass  +1.32 0.01 +1.25 0.005   
Apolipoprotein E Apoe  -1.27 0.05     
Isocitrate dehydrogenase 1  Idh1  +1.30 0.04     
NAD(P)H dehydrogenase, quinone 1 Nqo1  +1.68 0.02   +1.73 0.013 
Nudix (nucleoside diphosphate linked moiety X)-type motif 1 Nudt1      +1.71 0.008 
Proteasome (prosome, macropain) subunit, beta type 5 Psmb5      +3.94 0.039 
Thyroid peroxidase Tpo      +372.43 0.049 
Thioredoxin interacting protein Txnip    -1.61 0.045 -1.93 0.038 
Xeroderma pigmentosum Xpa    +1.97 0.005 +2.00 0.005 
(iii) Oxygen Transporters         
Fanconi anemia, complementation group C Fancc    +3.41 0.021 +2.72 0.005 
Vimentin Vim    +1.80 0.026 +1.67 0.031 
a FC indicates the fold change, b  P≤0.05 designated as significant, c values preceded by + indicates up-regulation, values preceded by - indicates down-regulation.    
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resulted in the up-regulation of prostaglandin-endoperoxide synthase 1 (Ptgs 1) with respective 
changes of 2.41 and 1.67 fold.  
 
b) Genes involved in reactive oxygen species (ROS) metabolism 
(i) SOD and other genes involved in superoxide metabolism 
Significantly (P0.05) affected genes involved in superoxide metabolism were the down-
regulation of neutrophil cytosolic factor 2 (Ncf2) with -4.78 fold change by PER, while an almost 
20 (19.97) fold up-regulation of NADPH oxidase organizer 1 (Noxo1) was evident for PECsub.  
PECsub also affected up-regulation in the expression of superoxide dismutase 1 (Sod1) with a 
1.18 fold change.   
 
(ii) Oxidative stress responsive genes   
All three tea treatments significantly (P0.05) affected oxidative stress responsive genes, 
although only one was mutual for PER and PECsub, one for PER and PECgen, but four for 
PECsub and PECgen.  PER and PECsub resulted in mutual up-regulation of aminoadipate-
semialdehyde synthase (Aass) with 1.32 and 1.25 fold changes respectively.  PER consumption 
resulted in the up-regulation of isocitrate dehydrogenase 1 (Idh1) and NAD(P)H dehydrogenase, 
quinone 1 (Nqo1) with 1.30 and 1.68 fold, respectively, while apolipoprotein E (Apoe) 
expression was down-regulated, -1.27 fold.   
PECgen affected most of these genes and resulted in the up-regulation of Nqo1 by 1.73, 
nudix (nucleoside diphosphate linked moiety X)-type motif 15 (Nudt1) by 1.71 and proteasome 
(prosome, macropain) subunit beta type 5 (Psmb5) by 3.94.  The largest fold increase recorded 
was the up-regulation of Tpo by 372.43 by PECsub.  PECsub and PECgen both up-regulated 
Xpa with fold changes of 1.97 and 2.00, respectively and both down-regulated Txnip with -1.61 
and -1.93, respectively.    
     
(iii) Oxygen transporter related genes 
Treatment with PER did not significantly (P>0.05) affect any of the genes for oxygen 
transporters.  The genes fanconi anemia complementation group C (Fancc) and vimentin (Vim) 
were up-regulated by both PECsub (3.41 and 1.8 fold, respectively) and PECgen (2.72 and 1.67 
fold, respectively).   
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Figure 2 3-D profile graph of the differential expression of 84 oxidative stress and antioxidant 
defense related genes indicating the fold difference of each gene between the PEE treated and 
the control rats for the three different dietary treatments with (A) PER, (B) PCsub and (C) 
PECgen.     
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DISCUSSION 
 
Quantitative gene expression is regarded as a valuable tool in identifying the differential 
expression of genes related to signal transduction pathways, several biological processes and 
disease related pathological states (Buluchamy et al., 2010). A quantitative RT-PCR array 
approach is recommended instead of whole genome microarrays, since it is regarded as a more 
reliable and sensitive gene expression profiling technology for analysis of panels of genes.  In 
the current study detection of differential expression of oxidative stress and antioxidant defense 
related genes in rat liver following exposure to PEEs from rooibos (PER) and honeybush 
(PECsub and PECgen) was conducted with this approach.  The 84 gene transcripts evaluated 
included the glutathione peroxidases (Gpx) and peroxiredoxins (Tpx), genes involved in reactive 
oxygen species (ROS) metabolism and oxygen transporter related genes.  It provided a logical 
starting point in investigating the effect of PEEs from rooibos and honeybush on gene 
expression in order to assess any possible adverse effects related to oxidative stress in rat liver.  
The PEEs significantly (P0.05) differentially altered the gene expression of a number of genes 
indicating the potential of the herbal tea extracts in altering the redox status in the liver.   
 
Comparative TP and polyphenolic and intakes  
The TP intake, polyphenol composition and intake of PER, PECsub and PECgen were 
discussed in detail in Chapter 5, but is shortly summarised again since it as was recalculated to 
include the data of the 3 rats relevant to the gene analysis.  The TP intake for PER treated rats 
was much higher than for honeybush due to a higher concentration in the enriched extract. The 
average daily aspalathin intake for the treatment group in this study (n=3 rats per group) for 
quantitative RT-PCR analysis was 36.85 mg/100 g bw, which is more than 10 fold higher than 
the daily intake of the other phenolic compounds present in PER.  Other compounds consumed 
at a level of more than 1 mg/100 g bw/day were the dihydrochalcones nothofagin and the 
flavones, isoorientin and orientin.   
The major phenolic compounds present in honeybush (PECsub and PECgen) were the 
xanthones, mangiferin and isomangiferin, which were consumed at an approximately 2.5 fold 
lower daily level in the rats receiving PECsub compared to PECgen.  Other major differences 
between these two extracts with regards to their phenolic composition included consumption of 
high levels of scolymoside and phloretin-3,5-di-C-glucoside for PECsub treated rats, while not 
detected and very low levels were present for PECgen.  Both PECsub and PECgen treated rats 
consumed relatively high levels of iriflophenone-3-C-glucoside and hesperidin.  Differences in 
phenolic composition between rooibos (PER) and interspecies differences for honeybush 
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(PECsub and PECgen) are implicated in differential gene expression observed.  The role of 
phenolic composition is deducted from PER only affecting one mutual gene with each 
honeybush species, i.e. Nqo1 with PECgen and Aass for PECsub.  On the contrary, similarities 
in composition of PECsub and PECgen is likely responsible for mutual modulation of the 
expression of seven genes.  However, the role of other herbal tea constituents, specifically the 
polymeric anthocyanidins and/or different combinations of the known polyhenolic constituent 
also needs to be considered.  
 
Modulation of gene expression by PER 
 
Antioxidant defense related genes 
Antioxidant defense related genes significant (P0.05) affected by PER included the two 
glutathione peroxidases, Gpx2 and Gpx3, of which the expression was up- and down-regulated, 
respectively.  The Gpx family is multiple isozymes regarded as a major component in the 
antioxidant defense of the cell and is responsible for the detoxification of hydrogen peroxide and 
organic peroxides that use glutathione as an electron donor (Gornicka et al., 2011).  Glutathione 
peroxidase 2 (Gpx2) is mainly expressed in the gastrointestinal tract, including the esophagus 
epithelium, but it is also detectable in human liver (Brigelius-Flohé & Kipp, 2009).  The role of 
Gpx2 in cell proliferating processes has been implicated and this gene is up-regulated in most 
preneoplastic cells, depending on the developmental stage of malignant transformation 
(Brigelius-Flohé & Kipp, 2009).  It is also a target for NF-E2-related factor 2 (Nrf2), a transcriptor 
factor that regulates important antioxidant and phase II detoxifying genes (Banning et al., 2005).  
Implications of effects of PER on Nrf2 is discussed together with the up-regulation of Nqo1.  
Gpx2 suppresses cyclooxygenase activity by removal of hydroperoxides required for enzyme 
activation thereby facilitating an anti-inflammatory function (Brigelius-Flohé & Kipp, 2009).  In 
this regard the up-regulation by PER may indicate an anti-inflammatory response as a result of 
underlying oxidative stress due to the high levels of polyphenols consumed.   
Glutathione peroxidase 3 (Gpx3) is expressed in heart, lung, breast and kidney and 
implicated in providing antioxidant activity extra cellular and a potential oxidant scavenger role in 
the plasma (Chu et al., 1992).  Down-regulation of Gpx3 by PER could facilitate oxidative stress 
due to reduced ROS quenching.  This gene is down-regulated during neoplastic transformation 
as compared to healthy tissue where it presumably plays a role as a tumor suppressor 
(Brigelius-Flohé & Kipp, 2009) and therefore further down-regulation by PER may be seen as 
unfavorable during various stages of cancer.  Increased expression of Gpx3 was evident in the 
hearts of diabetic mice, indicating a protective role from hyperglycemia induced oxidative stress 
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(Iwata et al., 2006), attributed to transcriptional up-regulation as a result of oxidative stress 
(Brigelius-Flohé & Kipp, 2009).  With regards to vascular disease, reduced Gpx3 expression 
under disease conditions is presumed to be a protective effect (Westpal et al., 2009).  When 
considering the Gpx family and effects of PEE consumption in the current study, no effects were 
evident for the expression of any of the other glutathione peroxidases, i.e. Gpx1, 4, 5, 6, 7 or 
glutathione reductase (Gsr) and glutathione S-transferase (Gstk 1).   
 
Genes Involved in reactive oxygen species (ROS) metabolism 
The expression of genes involved in ROS metabolism affected by PER included Ncf2, Apoe, 
Idh1 and Nqo1.  The neutrophil cytoxolic factor 2 (Ncf2/p67phox) gene was down-regulated       
(-4.78 fold) by PER.  This gene encodes for the cytosolic factor 2, the cytoxolic subunit of the 
multi-protein complex known as NADPH oxidase in neutrophils (Selemidis et al., 2008; 
Drummond et al., 2012).  The role of this gene in the liver is currently not clear, but if the down-
regulation of Ncf2 does affect NADPH activity in the liver the following applies.  The NADPH 
oxidase enzyme complex produces superoxide anion and other reactive oxygen species (ROS) 
from molecular oxygen, using NADPH as electron donor and influences a multitude of biological 
functions including host defense and redox signaling (Chan et al., 2009; Selemidis et al., 2008). 
Considering risk states, such as hypertention and hypercholesterolemia, for CVD, NADPH 
oxidase expression and activity are markedly up-regulated in the blood vessel wall and 
therefore implicated to contribute to artery disease (Selemidis et al., 2008).  Therefore, these 
enzymes are proposed as important therapeutic targets in CVD.  The down-regulation of Ncf2 
could therefore possibly be associated with a recent clinical study, demonstrating that rooibos 
decreased plasma markers of lipid peroxidation in adults at risk for CVD (Marnewick et al., 
2011).  A study with green tea (unfermented C. sinensis) and black tea (fermented C. sinensis) 
in bovine carotid artery endothelial cells implicates a role in protection against CVD and 
specifically hypertention by down-regulating of the NADPH oxidase subunits p22phox and 
p67phox (Ying et al., 2003).  Of importance is that down-regulation of Ncf2 expression by PER 
in rat liver occurred under normal conditions and verification in disease states will be required as 
part of further investigation on the potential use of rooibos as therapeutic agents in restricting 
oxidative damage in this regard.  None of the other genes encoding for NADPH oxidases 
proteins, NADPH oxidase 4 (Nox4), NADPH oxidase activator 1 (Noxa1) or NADPH oxidase 
organizer 1 (Noxo1) were affected PER, and therefore the final effect on NADPH oxidase 
activity is not clear.  However, modulation of oxidative stress related genes, including genes 
encoding for NADPH oxidase are considered as important in the development of many diseases 
such as cancer due to ROS levels effecting the growth indices and survival of different cancer 
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cells (Chan et al., 2009).  Therefore the inhibition of development of skin, liver and oesophageal 
preneoplastic lesions by rooibos in rats is applicable and has been related to the disruption of 
the growth regulatory mechanisms related to apoptosis (Marnewick et al., 2003, Marnewick et 
al., 2009; Sissing et al., 2011).   
Up-regulation of the expression of the peroxidase, Aass, encodes an enzyme that plays an 
antioxidant protective role in cells whilst also involved in lysine degradation.  A defective Aass 
gene is implicated in familial hyperlysinemia and accumulation of lysine, which may cause of 
neurological symptoms (Seminotti et al., 2008).  The implications of PER up-regulating this gene 
is currently unclear.  
The down-regulation of the expression of apolipoprotein E (Apoe) gene by PER may impact 
on cholesterol homeostasis as apolipoprotein E plays a key role in metabolism of cholesterol 
and triglycerides by binding to receptors in liver contributing to the clearance of chylomicrons, 
very low density lipoprotein (VLDL) and high density lipoprotein (HDL) from plasma (Issa  et al., 
2012).  This may be related to findings in a recent study with rooibos in humans indicating 
modulation of the serum lipid profile by significantly (P<0.05) decreased triacylglycerol and LDL-
cholesterol levels and increased HDL-cholesterol (Marnewick et al., 2011).   
These finding are also applicable to the up-regulation of the expression of Idh1 by PER, 
which could indicate increased expression for the protein isocitrate dehydrogenase 1 (Idh1), an 
NADP+-dependent isocitrate dehydrogenase (Reitman et al., 2010).  In normal cellular 
metabolism Idh1 is involved in lipid metabolism and plays a crucial role in glucose sensing.   
Isocitrate dehydrogenase 1 activity is involved in maintaining cellular cholesterol and fatty acid 
homeostasis through synthesis and degradation and is therefore suggested as a target enzyme 
for lipid-lowering pharmacological strategies (Shechter et al., 2003).  In addition to the normal 
cellular role, the activity of Idh1 is required as a major source for cytosolic NADPH (Shechter et 
al., 2003) and an association with cellular response to insults is evident from increased activity 
with a variety of oxidative insults (Reitman et al., 2010).  Increased activity of Idh1 and NADPH 
has been associated with less oxidative stress and kidney injury in ischemia/reperfusion 
conditions in mice presumably due to an increased GSH/total glutathione ratio (Kim et al., 
2011).  Mutations of Idh1 in cancer supports the theory that altered metabolism contributes to 
tumorigenesis (Oermann et al., 2012) and its up-regulation in breast, prostate, neuroglia and 
brain cancer tissue has been implicated in cancer promotion (Furuta et al., 2010).  Therefore 
up-regulation of Idh1 expression by PER may have important implications for oxidative stress in 
the liver, and potentially be involved in some of the advancing effects of unfermented rooibos in 
fumonisin B1-induced hepatocarcinogenesis in rats (Marnewick et al., 2009).  Dysregulation of 
Idh1 is a common phenomen in cancer cells as it functions at a crossroad of cellular metabolism 
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in lipid synthesis and cellular defense against oxidative stress and  cancer cells may gain from 
the glucose sensing role of Idh1 (Reitman et al., 2010).  When considering other disease states 
such as diabetes, expression and enzymatic activity of cytosolic Idh1 is up-regulated in the renal 
cortex of diabetic rats and mice (Lee et al., 2010).  Decreased activity of Idh1 is an early marker 
for hypertrophy before the onset of ventricular dysfunction in transgenic hypertrophic 
cardiomyopathic mice (Lucas et al., 2003) and spontaneously hypertensive rats (Benderdour et 
al., 2004) and therefore could be applicable to artherosclerosis and CVD.  The outcome of the 
up-regulation of Idh1 expression by PER will therefore depend on the specific conditions in 
terms of oxidative stress and disease.      
The Nqo1 gene encoding for a flavin adenine dinucleotide (FAD)-binding the NAD(P)H: 
quinone oxidoreductase was up-regulated by PER.  It is a cytoplasmic 2-electron reductase 
known to catalyse the metabolic detoxification of quinones protecting cells from redox cycling, 
oxidative stress and neoplasia (Long & Jaiswal, 2000).  This FAD-binding protein forms 
homodimers and reduces quinones to hydroquinones, thereby preventing the unwanted one 
electron reduction of quinones which results in the production of reactive oxygen species via the 
redox cycling of semiquinones (Vasilliou et al., 2006).  The expression is up-regulated as part of 
an oxidative stress response and found to be overexpressed in certain types of malignant 
tissues in the colon, breast, lung and liver (Strassburg et al., 2002).  Therefore the increased 
expression in the liver following PER consumption is of concern and warrants further 
investigation.  NAD(P)H:quinone oxidoreductase 1 is highly regulated by Nrf2 (Lin et al., 2007) 
and plays an integral role in cellular responses to oxidative stress and its expression is up-
regulated in an Nrf2-dependent fashion in mice following challenges with electrophilic chemicals 
(Nioi et al., 2003).  The expression of Nrf2 was up-regulated and activated by isoorientin in 
HepG2 cells leading to increased levels of antioxidant enzyme proteins, particularly Nqo1 (Lim 
et al., 2007).  The modulating effect of the green tea (unfermented C. sinensis) polyphenol (-)-
epigallocatechin-3-gallate (EGCG) on Nrf2 has been implicated in its chemoprevention and 
cytoprotective activities (Na & Surh, 2008).  The reversal (increase) of hyperhomocysteinemia 
associated decrease of Nqo1 activity and expression by red wine polyphenol supplementation is 
regarded as a potential protective mechanism in CVD (Noll et al., 2011).  The so-called 
“protective” effect resulting from up-regulated expression of Nqo1 by PER under the current 
study conditions is, however, questionable.  It may rather be an indication of oxidative stress in 
the liver.     
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Modulation of gene expression by PEEs from honeybush 
 
Exposure of rats to PEEs from honeybush (PECsub and PECgen) resulted in significant 
(P0.05) changes in the expression of eleven genes respectively of which seven were mutually 
affected.  
 
Antioxidant defense related genes 
PECsub selectively affected the expression of the gene EH domain containing 2 (Edh2) by 
down-regulating the expression with -1.38 fold.  This gene encodes for a protein (Edh2), a 
member of four highly homologous proteins (EHD1-4) that form part of a distinct subfamily of 
the Eps15 homology (EH) domain-containing protein family (Confalonieri & Di Fiore, 2002).  
These EH containing and binding proteins form a network of protein:protein interactions that 
coordinates cellular functions connected to endocytosis, actin remodeling and intracellular 
signal transduction. Edh2 is expressed predominantly in thymus, heart, muscle and lung and 
weakly in the liver (Blume et al., 2007).  The enzyme (Edh2) interacts with the insulin-
responsive glucose transporter (GLUT4) in rat adipocytes, which is suggested to play a key role 
in GLUT4 recruitment to the plasma membrane (Park et al., 2004).  The up-regulation of Ehd2 
expression is therefore of interest in the anti-diabetic effects of honeybush, recently 
demonstrated for C. intermedia (Muller et al., 2011).  PECsub resulted in the up-regulation of 
Aass expression and as for PER the implications is currently unclear.  Of the antioxidant 
defense genes, expression of Ptgs1 was up-regulated, while that of RGb156 encoding for 
serpinb1b was down-regulated by both PEEs prepared from honeybush. The up-regulation of 
Ptgs1, or cycloogyenase 1 (Cox-1), is applicable to an inflammatory process via the immediate 
prostanoid response.  Up-regulation by PECsub and PECgen, therefore, may indicate an 
inflammatory response, although excessive or inadequate activation may both have deleterious 
effects. Conversely, polyphenols are known to exhibit anti-inflammatory properties through the 
inhibition of Cox-1 and it has been considered as a molecular target that directly affects 
inflammation (Yoon & Back, 2005).  
The expression of Serpinb1b was down-regulated more than 2 fold by both the honeybush 
PEEs and may result in reduced serpinb1b activity which, together with Aass and Nqo1, are 
antioxidant enzymes that protects cells from oxidative stress.  Serpinb1b inhibits the 
accumulation of ROS, possibly indirectly by inhibiting inflammation (Polytarchou et al., 2008) 
hence the down-regulation may result in an increase in ROS production and subsequent 
oxidative stress.  
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Kif 9 is part of the kinesin family member 9 regulating podosomes and of podosomal matrix 
degradation. Both honeybush PEEs down-regulated Kif 9, which as a regulators of podosomes, 
are actin based matrix contacts in a variety of cell types such as monocytic cells, and apart from 
matrix degradation, are involved in cell migration and invasion.  Impairment of the function of 
this protein significantly impairs matrix degradation (Corfine et al., 2011).  The implications of 
down-regulation of Kif9 expression by PECsub and PECgen in the liver is currently not clear.     
 
Genes involved in reactive oxygen species (ROS) metabolism 
The oxidative stress responsive genes affected by both PEEs from honeybush included the 
expression of Txnip and Xpa, which were down- and up-regulated, respectively.  Txnip encodes 
for thioredoxin interacting protein, a glucose-regulated pro-apoptotic factor in beta-cells, which 
binds and inhibits thioredoxin thereby modulating cellular redox status by promoting oxidative 
stress (Chen et al., 2008).  Increased oxidative stress is known to play a role in vascular 
disease and diabetes mellitus due to reduced thioredoxin activity as a result of interaction with 
Txnip during hyperglycemia (Schulze et al., 2004).  Therefore, the further down-regulation of 
Txnip expression by PECsub and PECgen is likely to play a key role in the antidiabetic effects of 
honeybush when considering the affects on oxidative stress.  Mangiferin, which is the major 
phenolic compound in mangiferin, which is the major phenolic compound in Cyclopia spp. and 
were consumed at high levels in the current study decreases insulin resistance in mice (Ichiki et 
al., 1998; Miura et al., 2001) and is implicated in the antidiabetic properties of unfermented C. 
intermedia (Muller et al., 2011).  It should, however, be noted that modulation of the expression 
of the protein is affected by diverse nutrient factors such as glucose, glutamine and fatty acids 
(Schulze et al., 2004).  Txnip also exhibits anti-proliferative effects, inhibits tumor cell growth 
and is down-regulated in many cancer cell lines and tissues (Han et al., 2003; Pang et al., 
2009).  Txnip deficient mice have been shown to be predisposed in developing liver cancer 
(Sheth et al., 2006).   
Further to the anti-tumor properties of honeybush is the up-regulation of Xpa expression, 
encoded for xeroderma pigmentosum complementation group A protein that facilitates the 
assembly of a pre-incision complex during the processing of DNA damage by the nucleotide 
excision repair pathway via the interaction with replication protein A (Patrick & Turchi, 2002).  
The role of this mechanism in the chemopreventive properties of honeybush extracts in liver, 
skin and oesophagus carcinoma in rats (Marnewick et al., 2003, Marnewick et al., 2009; Sissing 
et al., 2011) would therefore be of interest.   
Modulation of the oxygen transporter related genes is of interest with respect to 
cacinogenesis.  The Fancc gene encodes the protein for fanconi anemia group C which delays 
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the onset of apoptosis and promotes homologous recombination repair of damaged DNA 
(Niedzwiedz et al., 2004).  This protein is frequently up-regulated in cancer cells and functions 
by preventing protein oxidation and apoptosis by inhibiting the formation of inactivating disulfide 
bonds within GSTP1 during apoptosis (Cumming et al., 2001).  Further up-regulation of the 
expression by PECsub and PECgen may therefore be of concern.     
The Vim gene encodes vimentin, a member of the intermediate filament family and is 
responsible for maintaining cell shape, integrity of the cytoplasm and stabilizing cytosdeletal 
interactions.  It also functions as an organizer of a number of critical proteins involved in 
attachment, migration and cell signaling.  Degradation of vimentin resulted in the morphological 
manifestation of apoptosis suggesting pro-apoptotic effects induced upon cleavage which could 
serve as a novel anti-cancer therapeutic target (Lahat et al., 2010).  Up-regulation of expression 
of these enzymes by honeybush could be in response to an underlying oxidative response in 
the liver due to high levels of polyphenols consumed and as postulated for Fancc could 
selectively promote the growth of cancer cells.      
Genes selectively affected by PECsub included Sod1, Noxo 1 and Edh2.  The protein 
encoded by Sod1 gene binds copper and zinc ions and is one of two isozymes responsible for 
destroying free superoxide radicals in the body (Zelko et al., 2002; Milani et al., 2011).  The 
encoded isozyme is a soluble cytoplasmic protein, acting as a homodimer to convert naturally-
occuring but harmful superoxide radicals to molecular oxygen and hydrogen peroxide.  The 
other two genes encoding for the superoxide dismutase proteins, mitochondrial superoxide 
dismutase 2 (Sod2) and extracellular superoxide dismutase 3 (Sod3) were, however, not 
affected.  The increased expression of Sod1 may be postulated to be an early indication of 
oxidative stress resulting from the high levels of polyphenols consumed leading to the up-
regulation of this antioxidant enzyme.        
A large fold change following PEE treatment was evident for PECsub resulting in up-
regulation of Noxo1 (19.97) expression, which encodes for the protein NADPH oxidase 
organizer (Noxo1) (Bedard & Krause, 2007). The function of Noxo1 is important in the 
organization of active Nox1, Nox2 and Nox3 complexes.  The Nox family NADPH oxidases are 
proteins that transfer electrons across biological membranes resulting in the generation of 
reactive oxygen species.  In general, the electron acceptor is oxygen resulting in the formation 
of superoxide.  The other two genes related to NADPH oxidases, Nox4 and Noxa1 were, 
however, not affected by PECsub and the implication of the large fold up-regulation of Noxo1 in 
the current study is therefore not clear.   
When compared to PECsub, treatment with PECgen selective up-regulated the expression 
of Nqo1, Tpo, Nudt1 and Psmb5 genes.  Both PER and PECgen up-regulates Nqo1 expression, 
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the outcome of which was discussed above. Specifically applicable to honeybush, mangiferin 
has been implicated in the hepatoprotective activity due to induction of antioxidant defense via 
the Nrf2 pathway (Das et al., 2012), which as discussed would involve Nqo1.  Up-regulation of 
Nqo1 in the current study may thus result from the high levels of mangiferin consumed.  This 
also further indicates the potential affects of PER and PECgen on the Nrf2 pathway although 
possibly triggered by different compounds, due to the significant differences in phenolic 
composition.      
The largest change following the treatment with PEEs was evident for PECgen resulting in 
up-regulation of the expression of thyroid peroxidase (Tpo) of 372 fold.  The Tpo gene encodes 
for the thyroperoxidase (Tpo) enzyme which is mainly expressed in the thyroid and liberates 
iodine for addition onto tyrosine residues on thyroglobulin for the production of thyroxine (T4) or 
triiodothyronine (T3), thyroid hormones (Ruf & Carayon, 2006).  The ability of Tpo to generate 
reactive oxygen species via Fenton type reactions is one of the mechanisms implicated in 
thyroid pathogenesis.  Alterations in the thyroid, such as hyperthyroidism is known to effect lipid 
peroxidation in the liver and heart (Venditti et al., 1997), however the reason for the up-
regulation in the liver by PECgen under the present experimental conditions is not clear and 
warrants further investigation.  Several flavonoids have been reported to inhibit thyroid 
peroxidase and interfere with thyroid hormone biosynthesis and ultimately thyroid function 
(Martin & Appel, 2010).   
The protein encoded by Nudt1 gene, nucleoside diphosphate linked moiety X-type motif 1 
(Nudt1), is an enzyme that hydrolyzes oxidized purine nucleoside triphosphates, such as 8-oxo-
dGTP, 8-oxo-dATP, 2-hydroxy-dATP and 2-hydroxy-rATP resulting from oxidative stress, to 
monophosphates.  Increased expression of Nudt1 and 8-oxodGTPase activity have been 
reported under conditions of oxidative stress in cell cultures (Meyer et al., 2000; Haghdoost et 
al., 2006).  Therefore up-regulation of the expression of this gene by PECgen may indicate 
oxidative stress in the liver.  PECgen treatment also resulted in up-regulation of Psmb5 
expression, encoding the protein proteasome (prosome, macropain) subunit, beta type 5.  This 
proteasome form part of the proteolytic machinery for the degradation of normal and damaged 
proteins (Chondrogianni et al., 2005) and plays a particular role during oxidative stress and 
aging as it is responsible for the degradation and removal of oxidative-induced damaged 
proteins, specifically in the nucleus (Breusing & Grune, 2008).  The latter could provide 
additional protection against the accumulation of these proteins during situations of oxidative 
stress and may be postulated to protect against aging.  However, up-regulation of this gene by 
honeybush could in the present study is indicative of an increased oxidative stress in the liver 
due to exposure to PECgen.  
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Conclusions 
 
The PCR array used in the current study indicated that expression of several genes related to 
the oxidative stress and antioxidant defense are significantly (P0.05) affected in rat liver by 
PEEs prepared from rooibos and honeybush consumed over a period of 28 days.  Investigating 
the effect of rooibos and honeybush on Nrf2 is an important consideration for future studies, 
since genes of antioxidant enzymes regulated by Nrf2 that were affected by rooibos and 
honeybush, included Gpx2, Gpx3, Sod1 and Nqo1.  Approaches focusing on Nrf2 have been 
suggested to provide protection against diabetes (Negi et al., 2011), which in the light of the 
anti-diabetic properties of rooibos and honeybush and their phenolic compounds (Mose Larsen 
et al., 2008a; Mose Larsen et al., 2008b; Muller et al., 2008; Kawano et al., 2009; Muller et al., 
2011; Singh et al., 2011) together with the findings in the current study, may be highly 
applicable.    
Investigations on the translational and post translational modification of the relevant proteins 
may assist in developing screening tools to assess the impact of the PEE extracts of rooibos 
and honeybush and their polyphenols in health and disease.  Further to conventional 
biomarkers for oxidative stress, the application of quantitative PCR-arrays may provide 
additional and more specific information and assist in elucidation of beneficial and adverse 
effects of consuming high concentrations of rooibos and honeybush polyphenols.  The 
differential modulation of expression of the oxidative stress and antioxidant defense related 
genes in rat liver by the PEEs of rooibos and honeybush in the current study indicate an 
underlying oxidative stress.  This could have very important implications for the development of 
certain diseases.       
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GENERAL DISCUSSION & CONCLUSIONS 
 
Polyphenol-enriched nutritional supplements are available without prescription for self-
medication and mostly lack any scientific substantiation and clear clinical evidence to support 
their beneficial health effects (Liu & Hu, 2007).   Due to their widely advertised anecdotal 
“superpowers”, polyphenols are very popular in scientific research and in the public media.  Key 
questions regarding complementary and alternative medicine (CAM) therapies concern their 
safety, effective dose and efficacy in disease prevention (Rapaka & Coates, 2006).   
Mechanisms of rooibos and honeybush polyphenols in disease prevention has not been 
clarified, due to uncertainties and limited investigations on their bioavailability, metabolism and 
alterations in activity of different enzyme systems and understanding their role in maintaining 
the cellular redox status.  Furthermore, potential herb-drug interactions and altering effects of 
rooibos and honeybush on signal transduction pathways with respect to different cell growth 
regulatory pathways are required.  This poses many challenges in extrapolating the effects of 
the polyphenolic constituents, their conjugated metabolites and the sensitivity and specificity of 
the measured biological endpoints used to evaluate possible beneficial and/or adverse 
biological effects in vivo.  Some of these aspects were addressed and critically evaluated in the 
current study.     
Rooibos (Aspalathus linearis family; Fabaceae, tribe Podalyrieae) and honeybush (Cyclopia 
spp.; family Fabaceae; tribe Podalyrieae) are indigenous herbal teas unique to South Africa 
(Joubert et al., 2008a).  Apart from their caffeine free market leverage, increased research on 
their health properties have led to international recognition in the herbal tea market (Joubert & 
De Beer, 2011; Joubert et al., 2011a).  It has been predicted that rooibos will become the 
second most consumed beverage tea in the world after green and black teas produced from 
Camellia sinensis and it is already consumed in more than 37 countries.  Honeybush is less 
well-known, but is also sold in 25 countries globally with main markets in the Netherland and 
Germany.  Both herbal teas have been implicated for use as value-added products and use as 
nutraceuticals (Joubert et al., 2008a).  Clinical studies with the South African herbal teas are 
limited to that by Sauter (2004) and Marnewick et al. (2011) for rooibos, while no studies for 
honeybush have been conducted.  In vivo studies for honeybush are few and recent 
investigations include effects of C. intermedia in a diabetic rat model (Muller et al., 2011), 
chemopreventive carcinogenesis models utilising rats (Marnewick et al., 2003; Marnewick et al., 
2009; Sissing et al., 2011) and bioavailability studies with C. genistoides in pigs (Bock et al., 
2008; Bock et al., 2010).   
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Effects of metabolism on antioxidant activity of major rooibos and honeybush 
polyphenols and implications for cellular oxidative status in the liver 
 
The effect of liver metabolism, specifically glucuronidation, on the antioxidant activity of the 
major rooibos polyphenols, aspalathin and nothofagin and honeybush polyphenol, mangiferin, 
was conducted utilising an on-line high performance liquid chromatography (HPLC) testing 
system.  The use of on-line biochemical detection assays coupled to HPLC has been applied to 
whole plant extracts and is regarded as an effective screening technique that overcomes 
challenges associated with pre-isolation (Malherbe et al., 2012).  This is achieved by measuring 
the effects of compounds post-column directly after separation.  In the current study, this system 
was applied to overcome losses of aspalathin and mangiferin glucuronides that would have 
been associated with pre-isolation due to instability of metabolites.  The online methodology 
provides a very effective and realistic model for future in vitro evaluation of polyphenol 
metabolites regarding antioxidant activity.  The loss in antioxidant activity reported following 
glucuronidation of both aspalathin and mangiferin was expected when considering structure 
related antioxidant activity of aspalathin (Snijman et al., 2009) and a loss of the catechol 
arrangement shown to eliminate the antioxidant activity of xanthones (Lee et al., 2005).  Apart 
from the loss in antioxidant activity, the modulating effect of conjugates on other cellular 
processes such as cell signaling and modulation of metabolic and antioxidant enzyme systems 
should be considered.  Phase II conjugates of certain flavonoids display higher activity than the 
parent compound and therefore it cannot be generally assumed that conjugation results in 
decreased biological activity (Beekman et al., 2012).       
Furthermore deconjugation by β-glucuronidase may assist in the parent molecule becoming 
available when increased antioxidant activity is required under conditions such as inflammation 
(Wong et al., 2009).  These conjugation-deconjugation reactions enables delivery of the parent 
compound as effector.  This is evident from the absence of quercetin in plasma, but 
demonstrable systemic effects in spite of weak in vitro bioactivity of plasma conjugates (Perez-
Vizcaino et al., 2012).   
 
Chemical composition, dose levels, duration of exposure and the oxidative stress 
parameters and iron   
For comparison of available data from in vivo studies with rooibos and honeybush, major 
shortcomings are the lack of compositional information and dose comparisons.  Sufficient 
chemical characterization of plants is vital for the potential use as herbal remedies, traditional 
medicines or foods and nutritional supplements and in studies on the biological effects such as 
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the prevention of DNA damage, antioxidant, anti-inflammatory effects and improvement of 
immune function (Verhagen et al., 2003; Knasmueller et al., 2012).     
Comparing polyphenol contents and antioxidant activities of the PEEs to previous reports for 
aqueous extracts of rooibos (Joubert et al., 2008b) and honeybush (Joubert et al., 2008b; De 
Beer & Joubert, 2010, De Beer et al., 2011) indicated that the rooibos extract (PER) was 
efficiently enriched, whereas enrichment was less effective for the honeybush extracts (PECsub 
and PECgen).  Therefore PER may be regarded as a potential “functional food”, whereas the 
honeybush extracts (PECsub and PECgen) is more closely related to unfermented honeybush 
extracts, currently available on the market.  Comparisons of the dose administrated and 
calculated human equivalent dose (HED) in terms of total polyphenol (TP), aspalathin (rooibos) 
and mangiferin (honeybush) intakes in the current study is presented together with estimates for 
in vivo studies conducted with rooibos (Marnewick et al., 2003; Marnewick et al., 2011) and 
honeybush (Marnewick et al., 2003) in Table 1.  The HED was calculated according to the body 
surface area (BSA) normalization method (Reagan-Shaw et al., 2008).   
A decrease in the TP content of rooibos and honeybush and specifically aspalathin and 
mangiferin content with the non-enzymatic processing step, fermentation, has been confirmed 
and reviewed (Joubert et al., 2008a; Joubert et al., 2009) and explains large differences in the 
TP, aspalathin and mangiferin contents between fermented and unfermented extracts (Table 1).  
The TP consumption resulting from an aqueous extract of unfermented rooibos for 10 weeks as 
sole source of drinking water in rats (Marnewick et al., 2003), was much higher than the HED 
calculated for a recent six week clinical study on the protection of rooibos (fermented) against 
risk indicators of cardiovascular disease (CVD) (Marnewick et al., 2011).  Volunteers in the six 
week study received a total dose of TP equivalent to 382.2 mg GAE/day and based on an 
average bodyweight (bw) of 60 kg an exposure of 6.37 mg GAE/kg/day could be calculated.  
This apparent dose is more than eight times below the current administrated HED for PER.       
The comparative TP exposure in rats when considering PECsub and PECgen were much 
lower than for PER for both the 28 and 90 day studies and are implicated in differences 
observed in biological effects between rooibos and honeybush.  To date no clinical studies have 
been conducted with any of the Cyclopia spp. and animal studies reporting on clinical 
biochemical parameters are limited to that of Marnewick et al. (2003) with aqueous extracts of 
fermented and unfermented C. intermedia in rats with a HED dose for TP more than 2 fold 
below that used in the current study (Table 1).  Interspecies differences for honeybush resulted 
in the HEDs of the major polyphenolic compound, mangiferin, being two fold higher for PECgen 
than for PECsub in the 28 day study.  It was not possible to calculate an estimated intake of 
mangiferin for the study by Marnewick et al. (2003) in rats, since the mangiferin contents of 
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species vary significantly (Joubert et al., 2008b) and a large scale study defining the intakes 
from a “cup-of-tea” has not been conducted for the respective Cyclopia species.  Doses of TP 
and the specific polyphenols in the current study were far higher than doses applicable and 
relevant for human consumption of the herbal teas from rooibos and honeybush.   
The TP doses and that of the major phenolic compounds in rooibos and honeybush, 
aspalathin and mangiferin, respectively, are implicated in differences observed on the biological 
effects in the liver including the significant (P<0.05) alteration of activity of glutathione reductase 
(GR) and the levels of reduced glutathione (GSH), total serum bilirubin (Tbili), and serum iron 
levels.  Considering the potential adverse effects observed for PECsub regarding serum Tbili 
and alkaline phosphatase (ALP) it was apparent that the age of rats, the polyphenol type and 
dose as well as the duration of exposure will determine how it is manifested.  Irrespective of the 
specific effects, the current study indicated that PECsub affects the biliary system and therefore 
warrants further investigation.  The marked increase in serum GGT following 28 and 90 days of 
PECsub consumption is a further indication of a disruptive effect on the biliary system.  In this 
regard, hepatoxicity of green tea (unfermented Camellia sinensis) dietary supplements in 
humans for a dose range of 7002100 mg/day included elevated transaminases and bilirubin 
levels amongst other (Mazzanti et al., 2009).  Bilirubin is regarded as a better marker than 
transaminases when evaluating toxicity in humans (Dufour et al., 2001).         
Considering the different doses, differential polyphenolic composition and consequent 
effects of rooibos and honeybush on serum iron, decreased levels has not been reported for 
rooibos and honeybush previously.  The significantly (P<0.05) reduced serum iron levels after 
90 days of PER and PECsub consumption is therefore of concern.  No significant effects were 
evident after 28 days in the current study and previous reports with different time-frames on 
rooibos and honeybush in rats (Marnewick et al., 2003) or rooibos in humans (Hesseling et al., 
1979; Breet et al., 2005; Marnewick et al., 2011). Regarding the effects of rooibos and 
honeybush on iron absorption, emphasis would thus be on the high levels of rooibos and 
honeybush polyphenols consumed for an extended period such as 90 days.  The much higher 
xanthone (mangiferin and isomangiferin) content of C. genistoides compared to PECsub and 
other honeybush species (Joubert et al., 2008b) and its effect on serum iron levels is an 
important consideration for future investigation. 
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Table 1 Summary of the average administrated dose, calculated human equivalent dose (HED), 
effects on serum clinical biochemical parameters and oxidative stress parameters in studies 
with rooibos and honeybush in rats and a human clinical study with rooibos (Aspalathus 
linearis).  
a Human equivalent dose (HED) refers to the human equivalent dose as calculated according to the body surface 
area (BSA) normalization method (Reagen-Shaw et al., 2007) and is presented as mg/GAE/kg body weight (bw)/day 
in parenthesis in italics, b  indicates increased;  indicates decreased significantly (P<0.05); oxidized glutathione 
(GSSG), reduced glutathione (GSH), glutathione reductase (GR), total bilirubin (Tbili), aspartate transaminase (AST),  
alkaline phosphatase (ALP), total iron (Iron), low density lipoprotein cholesterol;(LDL-C), high density lipoprotein 
cholesterol (HDL) c fermented aqueous extract (ferm),  unfermented aqueous extract (unferm) d The total polyphenol 
(TP) dose is given as the average galic acid equivalents (GAE) mg GAE/100 g bw/day, e The average aspalathin 
intake was calculated according to the estimation of Beelders (2011) analyzing a large number of rooibos infusions 
(n=114) showed that a “cup-of–rooibos tea” contains 5.84 mg aspalathin/L.   
Study 
Subject  
Administered Group/ 
Compound 
Dose 
mg/kg bw/day      
(HED) a 
Observed effects b Days  
Effects of fermented and unfermented rooibos and honeybush C. intermedia in rat liver  
(Marnewick et al. 2003)  
Rats unf c rooibos TP d 161.20 (26.14)  GSH/GSSG;  GSSG 70  
 unf honeybush TP 229.00 (37.14)  GSH/GSSG;  GSSG  
 ferm rooibos TP 64.00   (10.38)  GSH/GSSG;  GSSG  
 ferm honeybush TP 72.90   (11.82)  GSH/GSSG;  GSSG  
Effects of polyphenol-enriched extracts (PEEs) from unfermented rooibos (PER) and unfermented honeybush 
[C. subternata (PECsub) and C. genistoides (PECgen)] in rat liver (current study) 
Rats  PER TP  756.60 (122.71) 
627.00 (101.68) 
 GR;  
Tbili;  Iron, GSH 
28  
90  
 PECsub TP 642.70 (104.22) 
480.50 (77.92) 
 Tbili,  AST;  GR 
 Tbili,  ALP;  Iron,  GSH 
28  
90  
 PECgen TP 545.50 (88.46)  GR 28  
 PER aspalathin 361.30 (58.59) 
299.40 (48.55) 
 28  
90  
 PECsub mangiferin 98.10   (15.91) 
73.40   (11.90) 
 
 
28  
90  
 PECgen mangiferin 231.60 (37.56)  28  
Effects of fermented rooibos cardiovascular disease (CVD) parameters in human plasma  
(Marnewick et al., 2011) 
Human ferm rooibos TP 6.37  TP in plasma  
 CD TBARS  
42  
  aspalathin e  7.0  GSH/GSSG ; GSH; LDL-C; 
HDL-C 
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Differences in the administered dose and polyphenolic composition impacted on the glutathione 
metabolism.  Aqueous extracts of unfermented and fermented rooibos and unfermented 
honeybush (C. intermedia) significantly (P<0.05) increased the GSH/GSSG ratio and 
significantly (P<0.05) decreased the level of GSSG in rat liver (Marnewick et al., 2003) and 
fermented rooibos in human plasma (Marnewick et al., 2011), respectively (Table 1).  PER had 
a very different effect in the current study and the activity of glutathione reductase (GR) was 
significantly (P<0.05) increased after 28 days, while GSH levels were significantly (P<0.05) 
reduced after 90 days.  PECgen and PECsub also resulted in significantly (P<0.05) increased 
GR after 28 days and a marked decrease in GSH.  It is proposed that the high levels of TP led 
to an underlying oxidative stress and affects the glutathione metabolism.  Although not 
significantly, the level of Fe(II)-induced lipid peroxidation was markedly increased in the liver 
after 28 and 90 days by PECsub and PER, respectively.  The latter could be related to the 
reduced GSH level in the liver implying a specific interaction with rooibos and honeybush 
polyphenols.  GSSG levels were not increased and therefore GSH conjugation with the catechol 
type polyphenols via o-quinone formation is likely for both rooibos and honeybush.  GSH 
conjugation has been demonstrated for cathechol type B-ring-containing flavonoids in 
hepatocytes (Galati et al., 2002).  In this regard, catechol containing polyphenols present and 
consumed in high levels for rooibos comprise aspalathin, isoorientin and orientin and for 
honeybush are the xanthones mangiferin, isomangiferin, eriocitrin, scolymoside and 
iriflophenone 3-C-glucoside.  This observation is of concern as it indicates that rooibos and 
honeybush with increased polyphenol content as functional foods could lead to oxidative stress 
when consumed for extended periods and therefore warrants further investigation.   
 
Modulatory effects of rooibos and honeybush PEEs on oxidative stress and antioxidant 
defense related genes: association with oxidative stress parameters and serum clinical 
biochemical parameters  
Methods such as genomics and proteomics offer “novel” predictive markers to detect liver 
pathology before alterations in clinical and histopathology parameters occur, although serum 
biochemical parameters (clinical pathology) still provides valuable information in assessing the 
extent, severity and type (membrane injury versus cholestasis and hepatic function) of liver 
damage (Ramaiah, 2007).  Microarray technology has been applied in the pharmaceutical 
industry and drug development for early prediction and classification of hepatoxins (McMillian et 
al., 2004) and RT-PCR has become the preferred method for confirming results obtained from  
techniques involving gene expression (Gaj et al., 2008).  Application of RT-qPCR arrays in 
investigating toxicity of herbal extracts and mechanisms in disease prevention is, nevertheless, 
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relatively novel.  This approach was applied to rooibos and honeybush for the first time in the 
current study.   
The effects of PEEs on the serum clinical biochemical parameters, oxidative stress 
parameters together with the effects on expression of oxidative stress and antioxidant defense 
related gene are summarised in Table 2.  When considering PEE treatment for 28 days, the 
only serum biochemical parameters significantly (P<0.05) affected was an increase in Tbili and 
decrease in aspartate transaminase (AST) by PECsub.  The only oxidative stress parameters 
significantly (P<0.05) affected was increased GR by all three PEEs.  Conversely the significant 
(P0.05) effects on gene expression in rat liver following 28 days of PEE treatment included a 
whole range of different genes with a variety of functions.   
The majority of carcinogens is metabolically activated by cytochrome P450 (CYP450), 
whereas detoxification is catalyzed by a series of phase II enzymes facilitating conjugation of 
reactive carcinogenic species with endogenous moieties such as GSH, glucuronic acid, and 
sulfate for excretion (Na & Surh, 2008).  The antioxidant defense system at cellular level 
incorporates superoxide dismutase (SOD), catalase (CAT), GSH, glutathione peroxidase (GPx), 
polyphenols, and phase II detoxifying enzymes including glutathione S-transferase, UDP 
glucuronyltransferase, NADPH quinone oxidoreductase (Nqo1) and microsomal epoxide 
hydrolase (Negi et al., 2011).  Induction of phase II detoxifying enzymes is regarded as one of 
the most important components of cellular defense mechanisms and assists in eliminating 
electrophilic and prooxidative toxicants before DNA damage occurs.  In this regard the reduction 
of GSH levels in the liver by PER and PECsub could lower the defense mechanisms in the 
protection against oxidative stress and drug metabolism.  The redox-sensitive transcription 
factor, nuclear factor erythroid 2 p45 (NR-E2)-related factor (Nrf2) plays a key role in regulating 
induction of phase II detoxifying and antioxidant enzymes in response to stressful conditions 
(Wang & Jaiswal, 2006).  The activation of Nrf2 by polyphenols has been demonstrated for 
green tea (unfermented C. sinensis) polyphenols (Na & Surh, 2008) and one of the rooibos 
polyphenols, isoorientin (Lim et al., 2007).  Up-regulation of Nrf2 expression by polyphenols 
could thus be favourable under conditions of oxidative stress, but in healthy subjects it may 
pose an indication of oxidative stress, specifically applicable to the current study as a result of 
high dose levels of TP.   
Although no significant effects were evident for SOD and CAT activities in the current study, 
GSH was significantly (P<0.05) lowered by PER after 90 days and relevant genes affected after 
28 days include Gpx2, Gpx3 and Nqo1.  The Nrf2 system may serve as a potential target for the 
changing cellular antioxidant capacity by modulating gene expression, also referred to as 
indirect antioxidant activity (Jung & Kwak, 2010).  Antioxidant genes regulated by Nrf2 include 
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amongst others, Gpx1, Gpx2, Sod1 and Nqo1 (Jung & Kwak, 2010), which are applicable in the 
current study.  PER affected expression of Gpx2, Gpx3 and Nqo1, while PECsub and PECgen 
affected Sod1 and Nqo1, respectively.  Therefore investigating the effect of rooibos and 
honeybush and/or its polyphenols on Nrf2 is an important recommendation for future 
investigation.  Alterations of the cellular redox status due to elevated levels of ROS and 
electrophilic species and/or reduced antioxidant capacity (eg. lowered levels of GSH) are 
important factors in the signals triggering the transcriptional response of Nrf2 (Nguyen et al., 
2009).  The significant (P<0.05) decrease in GSH by PER after 90 days and increased activity 
of GR after 28 days together with the up-regulation of Nqo1 by PER and PECgen (28 days) in 
the current study points towards an effect of PER and PECgen polyphenols on the Nrf2 pathway 
as a result of oxidative stress caused by the high levels of TP consumed.     
The up-regulation of Nqo1 after 28 days could further explain the increased quinone 
formation by PER manifested as significantly (P<0.05) reduced GSH after 90 days, with no 
increase in GSSG.  Although activity of glutathione reductase (GR) was significantly increased 
after 28 days by PER and both honeybush extracts no modulatory effects were observed on the 
expression of glutathione reductase (Gsr) in these livers.  This discrepancy requires 
investigation together with the effects of rooibos and honeybush polyphenols on glutathione 
metabolism.   
Other contradicting results regarding gene analysis and oxidative stress parameters were 
evident for the effect of rooibos on SOD activity and modulation of Sod expression.  PER 
significantly (P0.05) up-regulated the expression of Sod1, while no significant effect was 
evident in activity of SOD in the liver.  Regarding gene regulation, only the gene for soluble SOD 
(Sod1) was up-regulated, while expression of mitochondrial (Sod2) and extracellular (Sod3) was 
not affected.  Although the up-regulation of Sod1 did not result in a measurable increased 
enzyme (SOD) activity, it may be an early indication of oxidative stress as a result of the high 
levels of polyphenols consumed in the current study.  The need to further investigate alterations 
in the expression of the different genes on a protein level is therefore evident.     
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Table 2  A summary of the significant (P<0.05) effects of 28 and 90 day studies with PEEs a (PER, PECsub and 
PECgen) in male Fisher rats on serum clinical biochemical and liver oxidative stress parameters and significant 
(P0.05) effects on expression of oxidative stress and antioxidant defense related genes in the liver after 28 days.   
Treatment Dose TP (HED) In vivo effects  b Genes c affected Applicable to in vivo findings 
PER 756.60 (122.71) 
 
 GR (28) 
 Tbili (90) 
  Iron (90) 
 GSH (90) 
 Gpx2 
 Gpx3 
 Aass d 
 Ncf2 
 Idh1 
 Nqo1 
 Apoe 
 
PECsub 642.70 (104.22) 
 
 AST (28) 
 Tbili (28) 
 ALP (90);  Tbili (90) 
 Iron (90) 
 Edh2 
 Aass 
 Sod1 
 Noxo 
 
PECgen 545.50 (88.46)  GR  Nqo1 
 Nudt1 
 Psmb5 
 Tpo 
 
Mutual 
genes 
affected by 
PECsub & 
PECgen 
   Kif9 
  Ptgs 
 Serpinb1b 
 Xpa 
 Txnip 
 Fancc 
 Vim 
 
a Concentration of PEEs (PER, PECsub and PECgen) in the feed mixture was 2.0 g PER /kg and 2.5 g PECsub and PECgen/kg 
diet.  b   indicates increased;  indicates decreased significantly (P<0.05);  c  indicates up-regulation;  down-regulation of 
significantly affected (P0.05) gene expression. Descriptions and gene names of the symbols presented are included in the 
detailed listing of the genes related to oxidative stress included in the rat oxidative stress and antioxidant defense RT2 Profiler 
PCR array in Table 2 Addendum E,  d genes mutually affected by PEEs indicated in bold.       
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Further indications of oxidative stress on a gene level is provided by the PEEs significantly 
(P0.05) modulating the expression of thioredoxin interacting protein (Txnip), neutrophil 
cytosolic factor 2 (Ncf2), xeroderma pigmentosum complementation group A (Xpa) and 
isocitrate dehydrogenase 1 (Idh1).  Down-regulation of the expression of Txnip by honeybush 
PEEs (PECsub and PECgen) in the current study correlates with the findings of mangiferin 
decreasing insulin resistance in mice (Ichiki et al., 1998; Miura et al., 2001) and anti-diabetic 
properties of C. intermedia (Muller et al., 2011).  Considering the chemopreventive properties of 
honeybush extracts (C. intermedia) in liver, skin and oesophagus carcinoma in rats (Marnewick 
et al., 2003; Marnewick et al., 2009; Sissing et al., 2011), upregulation of the expression of Xpa 
by PECsub and PECgen is of importance.  Evaluation of anti-tumor effects considering the 
differences in phenolic composition of Cyclopia spp. and effect on gene expression, specifically 
Txnip and Xpa, is recommended for elucidating anti-tumor properties of C. subternata and C. 
genistoides. 
Although PER did not significantly affect serum cholesterol in the current study, genes that 
may impact on cholesterol affected by PER include Ncf2, Apoe and Idh1.  It can be argued that 
no effect was observed in the current study on serum parameters due to observations being 
conducted in healthy subjects.  The effects observed on a gene level may be applicable to 
rooibos modulating the serum lipid profile by significantly (P<0.05) decreased triacylglycerol and 
LDL-cholesterol levels and increased HDL-cholesterol in the human study with subjects at risk 
for CVD (Marnewick et al., 2011).  Up-regulation of the expression of Idh1 on the other hand, 
could promote cancer growth as a result of glucose sensing and the associated reduction in 
oxidative stress.  However, potential lowered oxidative stress postulated with increased 
expression of Idh1 by PER together with its glucose sensing properties could be involved in 
anti-diabetic properties of rooibos.   
   
Effects of rooibos and honeybush on antioxidant defense and oxidative stress related 
genes in rat liver and relevance to protective or adverse effects under disease conditions    
The potential of rooibos and honeybush to modulate pharmaceutical drug metabolizing 
enzymes is evident (Joubert et al., 2008a, Joubert et al., 2009; Abrahams, 2012).  On the 
contrary, limited information is currently available on their impact on the oxidative stress and 
antioxidant defense related genes in vivo.  Applying the effects of rooibos and honeybush on 
oxidative stress and antioxidant defense related genes to gene regulation in cancer, CVD and 
diabetes illustrates the potential influence on modulating disease progression (Table 3).  The 
postulated effects are speculative and refer to the stages and disease to illustrate the 
implications of gene modulation by PER, PECsub and PECgen and should be considered in 
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context of affecting an increase or decrease in oxidative stress.  Examples are included for the 
antioxidant defense related genes, glutathione peroxidases (Gpx), Gpx2 and Gpx3 and the 
oxidative stress responsive genes, Idh1, Txnip and Nqo1 (Table 3).   
Up-regulation of the expression of Gpx2 may lead to protection against oxidative stress that 
will promote the growth of preneoplastic and cancer cells.  In this regard the down-regulation of 
Gpx3 expression will prevent the development of preneoplastic cells prone to be sensitized to 
oxidative stress (Schulte-Herman et al., 1997).  Up-regulation of the expression of Idh1 by PER 
could assist in the survival of cancer cells, but may at the same time have a protective effect in 
CVD.  When considering the down-regulation of Txnip expression by both honeybush extracts 
(PECsub and PECgen) increased oxidative stress is postulated, leading to protection against 
cancer by possible inhibiting the growth of preneoplastic cells via apoptosis (Shulte-Herman et 
al., 1997).  This may, on the contrary, potentially promote the development of atherosclerosis 
and diabetes. When considering the anti-proliferating effects of this gene (Han et al., 2003), 
down-regulation may also lead to cancer promotion and not protection as postulated with 
regards to the effect of oxidative stress.    
Modulation of oxidative stress and antioxidant defense related genes should therefore be 
interpreted with care as it is clear that the disease and stage of development will determine 
whether it could have a protective and/or promoting (enhancing disease) effect.  Specifically 
related to cancer, protection against oxidative stress during cancer initiation protects against the 
development of early lesions, while this protection may on the other hand inhibit apoptosis and 
stimulate the growth of cancer cells (Salganik et al., 2001).  In contrast an increase in oxidative 
stress is likely to have the opposite effect as it is known that cancer cells are sensitized and 
undergo oxidative stress-induced apoptosis (Schulte-Hermann et al., 1997).  In view of the 
postulated role of rooibos and honeybush in protection against or advancing diseases such as 
cancer, CVD and diabetes, verification of effects on gene expression under disease conditions 
will be required.  However, the effects of PEEs of rooibos and honeybush in the current study 
indicates that caution should be exercised in developing pharmaceutical products with 
specialised effects focused on one disease as it may promote the development of another. 
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Table 3  A summary of the modulating effects of rooibos and honeybush PEEs a on selected oxidative stress and antioxidant defense related genes 
in rat liver after 28 days and possible implications in carcinogenesis, diabetes and CVD/arteriosclerosis.   
Gene b Modulation c PEE  Disease condition Expression or activity 
in diseased condition 
Reference Postulated effect of PEEs 
[Protect/Inhibit (-) or Promote (+)] 
Antioxidant defense related genes 
Gpx2  PER carcinogenesis (preneoplastic)  up-regulated Brigelius-Flohé & Kipp, 2009 + 
Gpx3  PER carcinogenesis (neoplastic)  down-regulated Brigelius-Flohé & Kipp, 2009 - 
Genes involved in reactive oxygen species (ROS) metabolism   
  Oxidative stress responsive genes 
 
Idh1  PER carcinogenesis  up-regulated Furuta et al., 2010 + 
   diabetes  up-regulated Lee et al., 2010 - 
   atherosclerosis/CVD 
 cardiomyopathic mice 
 spontaneously hypertensive rats  
 
 down-regulated 
 down-regulated 
 
Lucas et al., 2003 
Benderdour et al., 2004   
 
- 
- 
Txnip  PECsub, PECgen cancer cell lines and tissue  down-regulated Han et al., 2003; Pang et al., 2009 +/- 
   diabetes  
  regulates oxidative stress 
 
 down-regulated 
 
Schulze et al., 2004 
 
+ 
   atherosclerosis  
   regulates oxidative stress 
 
 down-regulated 
 
Schulze et al., 2004 
 
+ 
Nqo1  PER, PECgen cancer - certain types of malignant    
tissue and tumours 
 up-regulated Strassburg et al., 2002; Vasiliou et al., 
2006 
+ 
   CVD 
   hyperhomocysteinemia 
 down-regulated Noll et al., 2011 - 
a Concentration of PEEs (PER, PECsub and PECgen) in the feed mixture was 2.0 g PER /kg and 2.5 g PECsub and PECgen/kg diet,  c  indicates up-regulation;  down-regulation of 
significantly affected (P0.05) genes in the current study,  Descriptions and gene names of the symbols presented are included in the detailed listing of the genes related to oxidative 
stress included in the rat oxidative stress and antioxidant defense RT2 Profiler PCR array in Table 2 Addendum E, d cardiovascular disease (CVD).   
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Conclusions  
 
Potential adverse effects of polyphenols and herbal extracts have mostly been down-played, but 
it is crucial when researching efficacy and health promoting potential of herbal products for 
application in nutraceuticals and/or functional foods.  Hepatic metabolism, specifically 
glucuronidation of the major rooibos and honeybush polyphenols affects antioxidant activity and 
could have implications for the oxidative status in the liver.  The in vivo studies provide essential 
information about safety aspects of increased intake of polyphenols from rooibos and 
honeybush and new perspectives on the dose levels and compositional differences.  The 
importance of chemical characterisation of herbal extracts in the evaluation of toxicity and 
disease prevention studies is confirmed again.    Effects of rooibos and honeybush polyphenols 
on oxidative stress and antioxidant defense related genes are considered for the first time and a 
screening with quantitative RT-PCR array provides a new method of investigating and 
understanding the effects of rooibos and honeybush administered as functional foods in the 
form of PEEs.  Associations and contradictions were observed and some genes may offer 
potential therapeutic opportunities for rooibos and honeybush.  Development of functional foods 
from rooibos and honeybush should critically consider potential adverse effects on iron 
absorption and probable indications of oxidative stress observed at the current doses.  The 
potential of rooibos and honeybush to advance adverse effects under disease conditions was 
postulated as a result of modulatory effects on gene expression and warrants clarification before 
applications of rooibos and honeybush at high dose levels.         
There is an obvious need for regulatory authorities and academic institutions to develop 
consensus on the requirements for toxicity and efficacy testing of herbal products, be it as 
herbal tea, functional food or other therapeutic applications.  Irrespective, the current study 
clearly indicate that considering the modulatory effects on the expression of oxidative stress and 
antioxidant defense related genes together with conventional biomarkers provides additional 
insight on safety and potential health attributes of rooibos and honeybush.    
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PRESENTATION INDICATED IN CHAPTER 3, 4 AND 5 
 
* Presentations are listed in the order indicated in the research chapters 3, 4 and 5   
 
CHAPTER 3:  
 
Van der Merwe J.D., Gelderblom W.C.A., Joubert E. & Manley, M. Bioavailability of the major phenolic 
compounds in the unique South African herbal tea, rooibos.  AstraZeneca 9th Annual Research Day, 
Groote Schuur Cape Town, South Africa, 14 February 2008 (Poster presentation). 
 
Van der Merwe J.D., Joubert E., Gelderblom W.C.A. & Manley, M. Liver metabolism of the major phenolic 
compound in rooibos (Aspalathus linearis): glucuronidation. South African Society of Biochemistry and 
Molecular Biology (SASBMB) meeting as part of Bio-08 conference, Grahamstown, South Africa, 2324 
January 2008 (Poster presentation).   
 
Van der Merwe J.D., Joubert E.,Gelderblom W.C.A., De Beer, D. & Manley, M.  Liver metabolism of 
2’,3,4,4’,6’-pentahydroxy-3-C--D-glucopyranosyldihydrochalcone: glucuronidation and sulphation.  
International Conference on Polyphenols ICP2008, Salamanca, Spain, 811 July 2008 (Poster 
presentation).   
 
CHAPTER 4:  
 
Van der Merwe J.D., Gelderblom W.C.A, Joubert E. & Manley, M. Biotransformation of mangiferin, a 
major phenolic compound in honeybush tea: implications for its bioactivity? 19th biennial SAAFoST 
Congress & Exhibition Durban, South Africa 25 September 2007 (Poster presentation).      
 
Van der Merwe, J.D., Joubert, E., Manley, M., De Beer, D., Malherbe, C.J. & Gelderblom, W.C.A. Liver 
metabolism of the major phenolic compound present in honeybush. Indigenous Plant Use Forum (IPUF), 
Stellenbosch, South Africa, 69 July 2009 (Oral presentation).    
 
Van der Merwe, J.D., Joubert, E., Manley, M., De Beer, D., Malherbe, C.J. & Gelderblom, W.C.A. Liver 
metabolism of the major phenolic compound present in honeybush: implications for bioactivity. MRC 
Research Day, Tygerberg, 1415 September 2009 (Oral presentation). 
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CHAPTER 5:  
 
Van der Merwe, J.D., Gelderblom, W.C.A., Joubert, E & Manley, M. Safety evaluation of an aspalathin-
enriched rooibos (Aspalathus linearis) extract as a cancer chemopreventive agent. 15th World Congress 
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(PROMEC) Unit of the Medical Research council (MRC), Cape Town, South African, 11 April 2008 (Oral 
presentation).    
 
Van der Merwe J.D., Gelderblom W.C.A., Joubert E. & Manley, M. What happens to rooibos in the body? 
1st Rooibos Science Café, MTN Science Centre, Century City, Cape Town, South Africa, 9 November 
2007 (Oral presentation). 
 
Van der Merwe J.D., Gelderblom, W.C.A, Joubert, E. & Manley, M. Flavonoid metabolism: Implication for 
the health properties of South African herbal teas Aspalathus linearis (rooibos) and Cyclopia 
(honeybush). External Review  of the Programme on Mycotoxins and Experimental Carcinogenesis 
(PROMEC) Unit of the Medical Research council (MRC), Cape Town, South Africa, 14 August 2007 (Oral 
presentation). 
 
Van der Merwe, J.D., Gelderblom, W.C.A., Joubert, E. & Manley, M. Bioavailability of the major phenolic 
compound in rooibos tea. Rooibos Council Annual Meeting, Clanwilliam, South Africa, 25 April 2007 (Oral 
presentation). 
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HPLC-DPPH ON-LINE DETECTION 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Instrumental set-up for the HPLC-DPPH on-line detection of radical scavenging 
compounds (Koleva et al., 2000). 
 
Reference 
 
Koleva, I.I., Niederlander, A.G. & van Beek, T.A. (2000).  An on-line HPLC method for detection 
of radical scavenging compounds in complex mixtures.  Analytical Chemistry, 72, 
23232328.   
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Figure 1 Typical HPLC chromatogram of the unfermented polyphenol-enriched rooibos (PER) 
extract used in the 28 and 90 day feeding studies with rats.  Polyphenolic compounds quantified 
and indicated on the chromatograms were: 1=aspalathin, 2=nothofagin, 3=orientin, 
4=isoorientin, 5=vitexin, 6=isovitexin, 7=luteolin-7-gluc, 8=hyperoside, 9=co-elution of quercetin-
3-robionobioside/isoquercitrin/rutin, 10=luteolin, 11=chrysoeriol.   
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Figure 2 Typical HPLC chromatogram of the unfermented polyphenol-enriched C. subternata 
(PECsub) extract used in the 28 and 90 day feeding studies with rats.  Polyphenolic compounds 
quantified and indicated on the chromatograms were: 1=iriflophenone-3-C-glucoside, 
2=unknown eriodictyol-glucoside, 3=phloretin-3',5'-di-C-glucoside, 4=hesperidin, 5=naringenin, 
6=mangiferin, 7=isomangifeirn, 8=luteolin, 9=unknown hydroxycinnamic acid derivative, 
10=scolymoside.      
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Figure 3 Typical HPLC chromatogram of the unfermented polyphenol-enriched C. genistoides 
(PECgen) extract used in the 28 day feeding studies with rats.  Polyphenolic compounds 
quantified and indicated on the chromatograms were:  1=iriflophenone-3-C-glucoside, 
2=unknown eriodictyol-glucoside, 3=phloretin-3',5'-di-C-glucoside, 4=hesperidin, 5=naringenin, 
6=mangiferin, 7=isomangiferin, 8=luteolin.    
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Figure 1. RNA integrity numbers (RINs) of RNA extracted from rat liver tissue as assessed with 
an Agilent 2100 Bioanalyzer.   Sample 1 – 3 (Control), Sample 4 – 6, (PER), Sample 7 – 9 
(PECgen) and Sample 10 – 12 (PECsub).   
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Figure 2 Quality parameters for isolated RNA as determined with a Bioanalyser RNA nanolabchip. Sample 1–3 (CTRL), Sample 4–6, 
(PER), Sample 7–9 (PECgen) and Sample 10–12 (PECsub).   
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Table 1  The array layout of the  RT² Profiler™ PCR array used to investigate 84 genes related to oxidative stress antioxidant defense 
after consumption of PEE for 28 days by Male Fisher rats.  Table presented as obtained from the www.sabiosciences.com on 
1/08/2012.   
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Table 2   Detailed listing of the genes related to oxidative stress included in the rat oxidative stress and 
antioxidant defense RT² Profiler™ PCR array as presented in the array layout (Table 1).  Presented as 
obtained from the www.sabiosciences.com on 1/06/2012.   
Position Symbol Description Gene Name 
    
A01  Aass Aminoadipate-semialdehyde synthase - 
A02  Als2 Amyotrophic lateral sclerosis 2 (juvenile) homolog (human) - 
A03  Apc Adenomatous polyposis coli RATAPC 
A04  Apoe Apolipoprotein E APOEA 
A05  Aqr Aquarius homolog (mouse) - 
A06  Cat Catalase CS1, Cas1, Cs-1, 
RATCAT01, 
RATCATL 
A07  Ccs Copper chaperone for superoxide dismutase - 
A08  Xirp1 Xin actin-binding repeat containing 1 Cmya1 
A09  Ctsb Cathepsin B - 
A10  Duox2 Dual oxidase 2 Thox2 
A11  Cygb Cytoglobin MGC95105, 
Staap, Stap 
A12  Dhcr24 24-dehydrocholesterol reductase - 
B01  Dnm2 Dynamin 2 DYIIAAB 
B02  Duox1 Dual oxidase 1 - 
B03  Ehd2 EH-domain containing 2 MGEPS 
B04  Epx Eosinophil peroxidase - 
B05  Ercc2 Excision repair cross-complementing rodent repair deficiency, complementation group 2 - 
B06  Ercc6 Excision repair cross-complementing rodent repair deficiency, complementation group 6 - 
B07  Fancc Fanconi anemia, complementation group C Facc 
B08  Fmo2 Flavin containing monooxygenase 2 - 
B09  Gab1 GRB2-associated binding protein 1 - 
B10  Gpx1 Glutathione peroxidase 1 GSHPx, GSHPx-
1 
B11  Gpx2 Glutathione peroxidase 2 GPX-GI, GSHPx-
2, GSHPx-GI 
B12  Gpx3 Glutathione peroxidase 3 GSHPx-3, 
GSHPx-P, Gpxp 
C01  Gpx4 Glutathione peroxidase 4 Phgpx, gpx-4, 
snGpx 
C02  Gpx5 Glutathione peroxidase 5 - 
C03  Gpx6 Glutathione peroxidase 6 OBPII, Ry2d1 
C04  Gpx7 Glutathione peroxidase 7 - 
C05  Gsr Glutathione reductase - 
C06  Gstk1 Glutathione S-transferase kappa 1 GST13-13, 
GSTkappa 
C07  Hba-a2 Hemoglobin alpha, adult chain 2 HBAM, Hba-a1, 
Hba1 
C08  Hbz Hemoglobin, zeta RGD1307486 
C09  Idh1 Isocitrate dehydrogenase 1 (NADP+), soluble - 
C10  LOC367198 Similar to Serine/threonine-protein kinase ATR (Ataxia telangiectasia and Rad3-related 
protein) 
- 
C11  Lpo Lactoperoxidase - 
C12  Mb Myoglobin - 
D01  Mpo Myeloperoxidase - 
D02  Mpp4 Membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) Dlg6 
D03  Ncf1 Neutrophil cytosolic factor 1 Ncf-1, p47phox 
D04  Ncf2 Neutrophil cytosolic factor 2 - 
D05  Ngb Neuroglobin - 
D06  Nos2 Nitric oxide synthase 2, inducible Nos2a, iNos 
D07  Nox4 NADPH oxidase 4 - 
D08  Noxa1 NADPH oxidase activator 1 - 
D09  Noxo1 NADPH oxidase organizer 1 - 
D10  Nqo1 NAD(P)H dehydrogenase, quinone 1 Dia4, MGC93075 
D11  Nudt1 Nudix (nucleoside diphosphate linked moiety X)-type motif 1 Mth1 
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Position Symbol Description Gene Name 
D12  Nudt15 Nudix (nucleoside diphosphate linked moiety X)-type motif 15 - 
E01  Nxn Nucleoredoxin - 
E02  Park7 Parkinson disease (autosomal recessive, early onset) 7 CAP1, DJ-1, Dj1, 
SP22 
E03  Ppp1r15b Protein phosphatase 1, regulatory (inhibitor) subunit 15b - 
E04  Prdx1 Peroxiredoxin 1 Hbp23, 
MGC108617 
E05  Prdx2 Peroxiredoxin 2 Tdpx1 
E06  Prdx3 Peroxiredoxin 3 Prx3 
E07  Prdx4 Peroxiredoxin 4 MGC72744 
E08  Prdx5 Peroxiredoxin 5 Aoeb166 
E09  Prdx6 Peroxiredoxin 6 - 
E10  Prnp Prion protein PrP, Prn 
E11  Psmb5 Proteasome (prosome, macropain) subunit, beta type 5 - 
E12  Ptgs1 Prostaglandin-endoperoxide synthase 1 Cox-3, Cox1, 
Cox3 
F01  Ptgs2 Prostaglandin-endoperoxide synthase 2 COX-2, Cox2 
F02  Rag2 Recombination activating gene 2 - 
F03  Gpx8 Glutathione peroxidase 8 RGD1307506 
F04  Serpinb1b Serine (or cysteine) peptidase inhibitor, clade B, member 1b RGD1560658 
F05  Kif9 Kinesin family member 9 RGD1565187 
F06  Scd1 Stearoyl-Coenzyme A desaturase 1 - 
F07  Ift172 Intraflagellar transport 172 homolog (Chlamydomonas) Slb 
F08  Slc38a1 Solute carrier family 38, member 1 Ata1, GlnT, Sat1 
F09  Slc38a4 Solute carrier family 38, member 4 Ata3 
F10  Slc38a5 Solute carrier family 38, member 5 SN2 
F11  Slc41a3 Solute carrier family 41, member 3 - 
F12  Sod1 Superoxide dismutase 1, soluble CuZnSOD 
G01  Sod2 Superoxide dismutase 2, mitochondrial - 
G02  Sod3 Superoxide dismutase 3, extracellular ECSODPT 
G03  Srxn1 Sulfiredoxin 1 homolog (S. cerevisiae) Ab2-390, Npn3 
G04  Tmod1 Tropomodulin 1 E-Tmod, Tmod 
G05  Tpo Thyroid peroxidase - 
G06  Txnip Thioredoxin interacting protein MGC94673, 
Vdup1 
G07  Txnrd1 Thioredoxin reductase 1 MGC93353, Tr 
G08  Txnrd2 Thioredoxin reductase 2 MGC93435, Tr3, 
Trxr2, Trxrd2 
G09  Ucp3 Uncoupling protein 3 (mitochondrial, proton carrier) - 
G10  Vim Vimentin - 
G11  Xpa Xeroderma pigmentosum, complementation group A - 
G12  Zmynd17 Zinc finger, MYND-type containing 17 - 
H01  Rplp1 Ribosomal protein, large, P1 MGC72935 
H02  Hprt1 Hypoxanthine phosphoribosyltransferase 1 Hgprtase, Hprt, 
MGC112554 
H03  Rpl13a Ribosomal protein L13A - 
H04  Ldha Lactate dehydrogenase A Ldh1 
H05  Actb Actin, beta Actx 
H06  RGDC Rat Genomic DNA Contamination RGDC 
H07  RTC Reverse Transcription Control RTC 
H08  RTC Reverse Transcription Control RTC 
H09  RTC Reverse Transcription Control RTC 
H10  PPC Positive PCR Control PPC 
H11  PPC Positive PCR Control PPC 
H12  PPC Positive PCR Control PPC 
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Table 3 Integrity parameters of the RNA isolated from liver tissue after exposure  
to PEEs for 28 days as determined with a NanoDropTM 1000 spectrophotometer.   
Sample ng/ul 260/280a 260/230b 
Control a 399.50 2.06 2.07 
Control b 743.96 2.10 1.93 
Control c 378.48 2.07 2.08 
PER a 445.50 2.05 2.03 
PER b 366.82 2.07 2.02 
PER c 345.24 2.08 1.91 
PECsub a 388.78 2.06 1.60 
PECsub b 448.69 2.05 1.97 
PECsub c 436.74 2.05 1.87 
PECgen a 434.74 2.05 2.06 
 
PECgen b 479.11 2.07 1.91 
 
PECgen c 405.97 2.06 2.06 
a Indicates protein and/or DNA contamination (Where ≥2 indicates pure RNA); b Indicates salt 
contamination (Where ≥2 indicates pure RNA).  
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Table 4 Complete list of fold change and P-values of oxidative stress and antioxidant defense related genes evaluated with quantitative RT-PCR array 
in rat liver following intake of polyphenol-enriched rooibos (PER) and honeybush (PECsub and PECgen) extracts for 28 days.   
      PER PECsub PECgen 
Position Unigene GeneBank Symbol Description Gene Name FC a P b FC P FC P 
A01 Rn.198671 XM_231524 Aass Aminoadipate-semialdehyde synthase N/A 1.320 0.014 1.254 0.005 1.080 0.435 
A02 Rn.6408 XM_343574 Als2 Amyotrophic lateral sclerosis 2 (juvenile) homolog 
(human) 
N/A -1.012 0.843 -1.066 0.591 -1.056 0.643 
A03 Rn.88057 NM_012499 Apc Adenomatous polyposis coli RATAPC 1.012 0.941 -1.046 0.785 1.060 0.681 
A04 Rn.32351 NM_138828 Apoe Apolipoprotein E APOEA -1.274 0.048 -1.040 0.881 -1.159 0.569 
A05 Rn.37299 XM_345418 Aqr Aquarius homolog (mouse) N/A -1.134 0.100 -1.217 0.113 -1.102 0.190 
A06 Rn.3001 NM_012520 Cat Catalase CS1/Cas1 -1.215 0.334 -1.036 0.786 -1.122 0.618 
A07 Rn.12311 NM_053425 Ccs Copper chaperone for superoxide dismutase Ccs -1.196 0.531 -1.240 0.510 -1.409 0.454 
A08 Rn.27588 XM_236702 Xirp1 Xin actin-binding repeat containing 1 Cmya1 -3.706 0.220 -2.448 0.316 -3.423 0.228 
A09 Rn.100909 NM_022597 Ctsb Cathepsin B Ctsb 1.004 0.997 -1.081 0.605 -1.282 0.235 
A10 Rn.55542 NM_024141 Duox2 Dual oxidase 2 Thox2 -1.398 0.125 1.659 0.110 -1.299 0.596 
A11 Rn.105938 NM_130744 Cygb Cytoglobin Staap/Stap 1.275 0.116 1.044 0.772 1.111 0.565 
A12 Rn.9470 XM_216452 Dhcr24 24-dehydrocholesterol reductase N/A 1.027 0.778 1.087 0.527 -1.075 0.748 
B01 Rn.11231 NM_013199 Dnm2 Dynamin 2 DYIIAAB -1.528 0.063 -1.385 0.090 -1.317 0.112 
B02 Rn.162682 NM_153739 Duox1 Dual oxidase 1 Duox1 -2.537 0.680 -1.571 0.250 -1.683 0.126 
B03 Rn.16016 NM_001024897 Ehd2 EH-domain containing 2 MGEPS -1.441 0.123 -1.385 0.042 -1.177 0.525 
B04 Rn.17695 XM_220834 Epx Eosinophil peroxidase Epx 1.178 0.874 1.200 0.922 1.254 0.987 
B05 Rn.74906 XM_218424 Ercc2 Excision repair cross-complementing rodent repair 
deficiency, complementation group 2 
LOC308415 -1.081 0.676 -1.012 0.901 -1.014 0.931 
B06 Rn.19370 XM_224627 Ercc6 Excision repair cross-complementing rodent repair 
deficiency, complementation group 6 
LOC306274 -1.212 0.340 -1.701 0.134 -1.539 0.153 
B07 Rn.10798 NM_012557 Fancc Fanconi anemia, complementation group C Facc -1.204 0.376 3.410 0.021 2.719 0.005 
B08 Rn.3928 NM_144737 Fmo2 Flavin containing monooxygenase 2 Fmo2 -1.030 0.705 1.559 0.579 1.245 0.981 
B09 Rn.1725 XM_341667 Gab1 GRB2-associated binding protein 1 Gab1 -1.027 0.923 -1.088 0.629 -1.004 0.995 
B10 Rn.11323 NM_030826 Gpx1 Glutathione eroxidise 1 GSHPx/GSHPx-
1 
2.623 0.161 2.213 0.306 2.780 0.246 
B11 Rn.3503 NM_183403 Gpx2 Glutathione eroxidise 2 GPX-GI/GSHPx-
2 
1.801 0.037 1.284 0.332 1.424 0.135 
B12 Rn.108074 NM_022525 Gpx3 Glutathione eroxidise 3 GSHPx-
3/GSHPx-P 
-1.202 0.037 -1.080 0.715 -1.268 0.414 
C01 Rn.3647 NM_017165 Gpx4 Glutathione eroxidise 4 Phgpx/gpx-4 -1.118 0.161 -1.105 0.479 -1.093 0.319 
a FC indicates the fold change, the comparative Ct (ΔΔCt) method was used to calculate the relative amount of transcripts in the treated and untreated samples (control): ΔΔCt = ΔCt (treated) – ΔCt (control). The fold-
change for each treated sample relative to the control sample was calculated using the formula of 2-ΔΔCt. b P indicates the P-value, Statistical calculations was done based on the ΔCt values using a two-tailed t-test. A 
P-value equal to and/or less than 0.05 was designated as significant. 
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Table 4 (Cont.)           
      PER  PECsub  PECgen  
Position Unigene GeneBank Symbol Description Gene Name FC P FC P FC P 
C02 Rn.218434 XM_001059839 Gpx5 Glutathione peroxidase 5 Gpx5 -1.167 0.604 -2.268 0.310 -1.445 0.511 
C03 Rn.9852 NM_147165 Gpx6 Glutathione peroxidase 6 OBPII/Ry2d1 -1.429 0.353 1.232 0.938 1.594 0.466 
C04 Rn.4130 XM_216473 Gpx7 Glutathione peroxidase 7 N/A -1.014 0.992 1.041 0.557 -1.092 0.412 
C05 Rn.19721 NM_053906 Gsr Glutathione reductase Gsr 1.193 0.152 1.163 0.066 1.055 0.503 
C06 Rn.109452 NM_181371 Gstk1 Glutathione S-transferase kappa 1 GST13-
13/GSTkappa 
1.101 0.656 1.151 0.507 1.033 0.940 
C07 Rn.107334 NM_013096 Hba-a2 Hemoglobin alpha, adult chain 2 HBAM/Hba-
a1 
-1.880 0.073 -1.774 0.090 -1.350 0.246 
C08 Rn.2703 XM_213268 Hbz Hemoglobin, zeta RGD1307486 -1.565 0.471 -2.268 0.310 -1.445 0.511 
C09 Rn.3561 NM_031510 Idh1 Isocitrate dehydrogenase 1 (NADP+), soluble Idh1 1.299 0.037 1.400 0.114 1.071 0.624 
C10 Rn.112309 XM_346005 LOC36719
8 
Similar to Serine/threonine-protein kinase ATR (Ataxia 
telangiectasia and Rad3-related protein) 
LOC367198 -17.684 0.372 -17.094 0.372 -16.332 0.372 
C11 Rn.60583 XM_220831 Lpo Lactoperoxidase N/A 1.990 0.621 2.214 0.451 1.483 0.957 
C12 Rn.40511 NM_021588 Mb Myoglobin Mb -2.447 0.173 -3.174 0.112 -1.720 0.655 
D01 Rn.47782 XM_220830 Mpo Myeloperoxidase Mpo 4.087 0.380 1.273 0.526 -1.417 0.533 
D02 Rn.163075 NM_021265 Mpp4 Membrane protein, palmitoylated 4 (MAGUK p55 
subfamily member 4) 
Dlg6 1.570 0.525 -2.268 0.310 1.626 0.453 
D03 Rn.38575 NM_053734 Ncf1 Neutrophil cytosolic factor 1 Ncf-
1/p47phox 
1.003 0.993 1.072 0.688 -1.225 0.612 
D04 Rn.162331 XM_344156 Ncf2 Neutrophil cytosolic factor 2 N/A -4.781 0.034 -1.311 0.682 -1.472 0.592 
D05 Rn.64645 NM_033359 Ngb Neuroglobin Ngb -2.197 0.430 1.239 0.965 -1.308 0.556 
D06 Rn.10400 NM_012611 Nos2 Nitric oxide synthase 2, inducible Nos2a/iNos 4.388 0.356 1.748 0.402 2.794 0.386 
D07 Rn.14744 NM_053524 Nox4 NADPH oxidase 4 Nox4 -1.220 0.483 -1.435 0.225 -1.220 0.342 
a FC indicates the fold change, the comparative Ct (ΔΔCt) method was used to calculate the relative amount of transcripts in the treated and untreated samples (control): ΔΔCt = ΔCt 
(treated) – ΔCt (control). The fold-change for each treated sample relative to the control sample was calculated using the formula of 2-ΔΔCt. b P indicates the P-value, Statistical calculations 
was done based on the ΔCt values using a two-tailed t-test. A P-value equal to and/or less than 0.05 was designated as significant. 
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Table 4 (Cont.)            
      PER  PECsub  PECgen  
Position Unigene GeneBank Symbol Description Gene Name FC P FC P FC P 
D08 Rn.162651 XM_231042 Noxa1 NADPH oxidase activator 1 noxa1 1.237 0.603 1.963 0.183 2.225 0.084 
D09 Rn.137764 XM_220221 Noxo1 NADPH oxidase organizer 1 N/A 3.413 0.339 19.967 0.019 16.466 0.072 
D10 Rn.11234 NM_017000 Nqo1 NAD(P)H dehydrogenase, quinone 1 Dia4 1.681 0.017 1.447 0.188 1.730 0.013 
D11 Rn.10669 NM_057120 Nudt1 Nudix (nucleoside diphosphate linked moiety X)-type 
motif 1 
Mth1 1.157 0.395 1.429 0.151 1.706 0.008 
D12 Rn.144747 XM_214236 Nudt15 Nudix (nucleoside diphosphate linked moiety X)-type 
motif 15 
N/A -1.271 0.280 -1.089 0.607 -1.133 0.536 
E01 Rn.105982 XM_340857 Nxn Nucleoredoxin N/A -1.272 0.093 -1.363 0.141 -1.199 0.099 
E02 Rn.30105 NM_057143 Park7 Parkinson disease (autosomal recessive, early onset) 7 CAP1/DJ-1 1.114 0.486 -1.083 0.622 1.014 0.863 
E03 Rn.78049 XM_222633 Ppp1r15b Protein phosphatase 1, regulatory (inhibitor) subunit 15b N/A 1.246 0.191 1.223 0.322 1.441 0.063 
E04 Rn.2845 NM_057114 Prdx1 Peroxiredoxin 1 Hbp23 1.138 0.349 1.026 0.900 -1.035 0.777 
E05 Rn.2511 NM_017169 Prdx2 Peroxiredoxin 2 Tdpx1 1.000 0.975 -1.009 0.910 1.014 0.932 
E06 Rn.2011 NM_022540 Prdx3 Peroxiredoxin 3 Prx3 1.222 0.092 1.069 0.594 1.002 0.916 
E07 Rn.17958 NM_053512 Prdx4 Peroxiredoxin 4 MGC72744 -1.208 0.286 -1.152 0.357 -1.143 0.410 
E08 Rn.2944 NM_053610 Prdx5 Peroxiredoxin 5 Aoeb166 2.152 0.308 1.118 0.652 1.368 0.168 
E09 Rn.42 NM_053576 Prdx6 Peroxiredoxin 6 Prdx6 1.220 0.228 1.050 0.695 1.209 0.137 
E10 Rn.3936 NM_012631 Prnp Prion protein PrP/Prn -1.224 0.410 -1.509 0.314 -1.250 0.359 
E11 Rn.2 XM_341314 Psmb5 Proteasome (prosome, macropain) subunit, beta type 5 Psmb5 3.307 0.114 3.279 0.098 3.944 0.039 
E12 Rn.44404 NM_017043 Ptgs1 Prostaglandin-endoperoxide synthase 1 Cox-3/Cox1 1.222 0.294 2.408 0.001 1.669 0.048 
F01 Rn.44369 NM_017232 Ptgs2 Prostaglandin-endoperoxide synthase 2 COX-2/Cox2 -3.425 0.288 -1.083 0.348 -12.092 0.352 
F02 N/A XM_001079235 Rag2 Recombination activating gene 2 Rag2 -21.013 0.165 -2.544 0.308 -1.643 0.298 
F03 Rn.106264 XM_215486 Gpx8 Glutathione peroxidase 8 RGD1307506 -1.259 0.212 -1.078 0.680 -1.131 0.573 
F04 Rn.137930 XM_225268 RGD1560
658 
Similar to serine (or cysteine) proteinase inhibitor, clade 
B, member 1b 
Serpinb1b -1.900 0.056 -1.995 0.015 -2.294 0.001 
F05 Rn.140344 XM_001077207 Kif9 Kinesin family member 9 RGD1565187 -1.157 0.241 -1.875 0.009 -1.958 0.005 
F06 Rn.1023 NM_139192 Scd1 Stearoyl-Coenzyme A desaturase 1 Scd1 -1.547 0.327 -1.697 0.155 -1.550 0.134 
a FC indicates the fold change, the comparative Ct (ΔΔCt) method was used to calculate the relative amount of transcripts in the treated and untreated samples (control): ΔΔCt = ΔCt 
(treated) – ΔCt (control). The fold-change for each treated sample relative to the control sample was calculated using the formula of 2-ΔΔCt. b P indicates the P-value, Statistical calculations 
was done based on the ΔCt values using a two-tailed t-test. A P-value equal to and/or less than 0.05 was designated as significant. 
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      PER  PECsub  PECgen  
Position Unigene GeneBank Symbol Description Gene Name FC P FC P FC P 
F07 Rn.171849 NM_053792 Ift172 Intraflagellar transport 172 homolog (Chlamydomonas) Slb -1.419 0.136 -1.693 0.059 -1.627 0.073 
F08 Rn.162022 NM_138832 Slc38a1 Solute carrier family 38, member 1 Ata1/GlnT -2.754 0.058 -2.549 0.064 -1.708 0.083 
F09 Rn.17990 NM_130748 Slc38a4 Solute carrier family 38, member 4 Ata3 -1.080 0.672 -1.179 0.445 -1.094 0.864 
F10 Rn.81033 NM_138854 Slc38a5 Solute carrier family 38, member 5 SN2 -2.479 0.197 1.248 0.599 -1.407 0.432 
F11 Rn.190829 NM_001037492 Slc41a3 Solute carrier family 41, member 3 Slc41a3 2.115 0.102 1.060 0.969 -1.686 0.612 
F12 Rn.6059 NM_017050 Sod1 Superoxide dismutase 1, soluble CuZnSOD -1.394 0.784 1.183 0.002 1.212 0.122 
G01 Rn.10488 NM_017051 Sod2 Superoxide dismutase 2, mitochondrial Sod2 1.102 0.445 1.097 0.494 1.209 0.093 
G02 Rn.10358 NM_012880 Sod3 Superoxide dismutase 3, extracellular ECSODPT -1.275 0.162 1.028 0.906 -1.338 0.295 
G03 Rn.2835 XM_215887 Srxn1 Sulfiredoxin 1 homolog (S. cerevisiae) Ab2-390/Npn3 -1.565 0.471 -1.641 0.425 -1.445 0.511 
G04 Rn.1646 NM_013044 Tmod1 Tropomodulin 1 E-Tmod/Tmod -1.604 0.490 4.000 0.255 4.310 0.209 
G05 Rn.91199 NM_019353 Tpo Thyroid peroxidase Tpo -1.565 0.471 47.697 0.145 372.430 0.049 
G06 Rn.2758 NM_001008767 Txnip Thioredoxin interacting protein Vdup1 -1.434 0.067 -1.606 0.045 -1.930 0.038 
G07 Rn.67581 NM_031614 Txnrd1 Thioredoxin reductase 1 MGC93353 -1.200 0.441 -1.216 0.501 -1.059 0.695 
G08 Rn.6300 NM_022584 Txnrd2 Thioredoxin reductase 2 Tr3/Trxr2 -1.159 0.099 -1.060 0.606 1.007 0.886 
G09 Rn.9902 NM_013167 Ucp3 Uncoupling protein 3 (mitochondrial, proton carrier) Ucp3 6.537 0.172 2.340 0.402 18.383 0.212 
G10 Rn.2710 NM_031140 Vim Vimentin Vim -1.446 0.386 1.802 0.026 1.672 0.031 
G11 Rn.12469 XM_216403 Xpa Xeroderma pigmentosum, complementation group A LOC298074 -1.010 0.939 1.967 0.005 1.998 0.005 
G12 Rn.25565 XM_214130 Zmynd17 Zinc finger, MYND-type containing 17 N/A -4.496 0.075 1.400 0.530 -1.375 0.759 
H01 Rn.973 NM_001007604 Rplp1 Ribosomal protein, large, P1 MGC72935 -1.250 0.233 -1.072 0.456 1.067 0.622 
H02 Rn.47 NM_012583 Hprt1 Hypoxanthine phosphoribosyltransferase 1 Hgprtase/Hprt 1.090 0.507 1.070 0.478 -1.070 0.429 
H03 Rn.92211 NM_173340 Rpl13a Ribosomal protein L13A Rpl13a 1.223 0.441 1.277 0.320 1.317 0.303 
H04 Rn.107896 NM_017025 Ldha Lactate dehydrogenase A Ldh1 -1.111 0.522 -1.181 0.384 -1.100 0.567 
H05 Rn.94978 NM_031144 Actb Actin, beta Actx 1.042 0.594 -1.079 0.421 -1.195 0.029 
H06 N/A U26919 RGDC Rat Genomic DNA Contamination RGDC       
H07 N/A SA_00104 RTC Reverse Transcription Control RTC       
H08 N/A SA_00104 RTC Reverse Transcription Control RTC       
H09 N/A SA_00104 RTC Reverse Transcription Control RTC       
H10 N/A SA_00103 PPC Positive PCR Control PPC       
H11 N/A SA_00103 PPC Positive PCR Control PPC       
H12 N/A SA_00103 PPC Positive PCR Control PPC       
a FC indicates the fold change, the comparative Ct (ΔΔCt) method was used to calculate the relative amount of transcripts in the treated and untreated samples (control): ΔΔCt = ΔCt 
(treated) – ΔCt (control). The fold-change for each treated sample relative to the control sample was calculated using the formula of 2-ΔΔCt. b P indicates the P-value, Statistical calculations 
was done based on the ΔCt values using a two-tailed t-test. A P-value equal to and/or less than 0.05 was designated as significant. 
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